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ABSTRACT OF THE DISSERTATION 
PROTEIN-LIGAND INTERACTIONS AND ALLOSTERIC REGULATION OF 
ACTIVITY IN DREAM PROTEIN 
by 
Walter Gabriel Gonzalez 
Florida International University, 2016 
Miami, Florida 
Professor Jaroslava Miksovska, Major Professor 
Downstream regulatory antagonist modulator (DREAM) is a calcium sensing protein 
that co-assembles with KV4 potassium channels to regulate ion currents as well as with 
DNA in the nucleus, where it regulates gene expression. The interaction of DREAM with 
A-type KV4 channels and DNA has been shown to regulate neuronal signaling, pain 
sensing, and memory retention. The role of DREAM in modulation of pain, onset of 
Alzheimer’s disease, and cardiac pacemaking has set this protein as a novel therapeutic 
target. Moreover, previous results have shown a Ca2+ dependent interaction between 
DREAM and KV4/DNA involving surface contacts at the N-terminus of DREAM. 
However, the mechanisms by which Ca2+ binding at the C-terminus of DREAM induces 
structural changes at the C- and N-terminus remain unknown. Here, we present the use of 
biophysics and biochemistry techniques in order to map the interactions of DREAM and 
numerous small synthetic ligands as well as KV channels. We further demonstrate that a 
highly conserved network of aromatic residues spanning the C- and N-terminus domains 
control protein dynamics and the pathways of signal transduction on DREAM. Using 
molecular dynamics simulations, site directed mutagenesis, and fluorescence spectroscopy 
 vii 
we provide strong evidence in support of a highly dynamic mechanism of signal 
transduction and regulation. A set of aromatic amino acids including Trp169, Phe171, 
Tyr174, Phe218, Phe235, Phe219, and Phe252 are identified to form a dynamic network 
involved in propagation of Ca2+ induced structural changes. These amino acids form a 
hydrophobic network connecting the N- and C-terminus domains of DREAM and are well 
conserved in other neuronal calcium sensors. In addition, we show evidence in support of 
a mechanism in which Ca2+ signals are propagated towards the N-terminus and ultimately 
lead to the rearrangement of the inactive EF-hand 1. The observed structural motions 
provide a novel mechanism involved in control of the calcium dependent KV4 and DNA 
binding. Altogether, we provide the first mechanism of intramolecular and intermolecular 
signal transduction in a Ca2+ binding protein of the neuronal calcium sensor family.  
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anisotropy of the fluorophore in the absence of rotational diffusion 
and r0 represents the limiting anisotropy determined from the 
modulated anisotropy extrapolated a high frequencies. (Bottom 
right) Steady state anisotropy determined and limiting anisotropy 
determined for the ANS-W169 FRET pair used to calculate the 
lower and upper limits for the kappa squared parameter.  ..............................91 
 
Figure 3.15: Decrease in the emission intensity of 1,8-ANS bound to 
Ca2+DREAM upon addition of  arachidonic acid (a). The change    
in 1,8-ANS fluorescence intensity as a function of arachidonic    
acid concentration. The solid line corresponds to the fit of the 
experimental data using a single binding site model (solid line)    
(b). The position of the docking site for arachidonic acid in the C-
terminal domain of DREAM (c).  ...................................................................92 
 
Figure 3.16. A cartoon model depicting DREAM interactions with Mg2+ and 
Ca2+ ions and arachidonic acid. Association of the Mg2+ ions to 
apoDREAM tetramer does not lead to substantial changes in 
DREAM structure (step 1). Subsequent binding of Ca2+ to EF-3   
and EF-4 promotes tetramer dissociation and concomitant   
exposure of the hydrophobic cavity located in the C-terminal 
domain by repositioning of the C-terminal α-helix (step 2)   
allowing binding of the arachidonic acid to the C-terminus 
hydrophobic cavity (step 3). ...........................................................................95 
 
Figure 4.1. (a) Fluorescence emission of 15 μM apoDREAM(Δ65) and 15 μM Ca2+ 
DREAM(Δ65) in the absence and presence of 30 μM   NS5806, λexc = 
295 nm. (b) Titration of DREAM(Δ65) with NS5806 by monitoring the 
change in tryptophan fluorescence in the apo and calcium bound form. 
The recovered dissociation constants were determined using Eqn. 2.8.1 
(solid lines)  and are listed in Table 4.1. (c) Average tryptophan 
fluorescence lifetime of 15 μM DREAM(Δ65) and 15 μM 
DREAM(Δ160) in the Ca2+ bound state as a function of NS5806.       
Solid lines represent the best non-linear fit using a single site Hill 
equation. .  ......................................................................................................100 
 
Figure 4.2. (a) Quenching of the tryptophan fluorescence of DREAM(Δ65) and 
DREAM(Δ160)) in the apo-state as a function of NS5806, analyzed using 
a modified Stern-Volmer equation (inset). The linear fit recovered a slope 
of 45 ± 2 μM and intercept of 1.0 ± 0.2 for DREAM(Δ65) and slope of 80 
± 4 μM and intercept of 1.8 ± 0.2 for DREAM(Δ160). The inverse of the 
intercept for DREAM(Δ160) indicates that only 56 % of the tryptophan 
residues are quenched at saturating amounts of NS5806. After     
correction for the fraction quenched, both constructs result in identical 
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dissociation constant values of ~40 μM in the apoform. (b) The 
tryptophan fluorescence of 5 μM Zn2+Kv4.3(1-152)-GST decrease due   
to binding of NS5806, inset shows the structural formula of NS5806.     
(c) Fluorescence intensity change as a function of NS5806    
concentration, solid line represents best fit using eq. 1 with recovered 
Kd=11 ± 2 μM. .  .............................................................................................101 
 
Figure 4.3. (a) Fluorescence emission of 1,8-ANS:DREAM(Δ65) complexes   
as a function of increasing concentrations of NS5806, inset shows 
the shift in emission spectra maximum as a function of NS5806.   
(b) Replacement curves for the 1,8-ANS- DREAM(Δ65) complex  
in the apo and calcium bound states as a function of NS5806 
concentration. The dissociation constants recovered using Eq.   
2.8.2 are Kd =  23 ± 7 μM and Kd =  2.5 ± 0.3 μM for apo and 
calcium bound forms, respectively. Conditions: 95 μM 1,8-ANS,  
10 μM Ca2+ DREAM(Δ65) in 20mM MOPS, pH 7.4, and      
100mM NaCl. (c) Change in fluorescence lifetime     pre-
exponential parameters α1 and α2 as a function of NS5806 
concentration. Pre-exponential parameters were recovered using      
a triple discrete exponential decay model from analysis of    
emission decay data of  10 μM 1,8-ANS bound to 10 μM 
DREAM(Δ65) in the apoform and Ca2+ bound state. The lifetime   
of unbound ANS was set as a fixed value at 0.28 ns (measured 
separately), while the second and third decay lifetimes were set as 
linked variables with lifetimes of 5.7 ± 0.4 ns and 15.4 ± 0.9 ns in 
the apoform (χ2=2.7)and 6.3 ± 0.5 ns and 16.7 ± 0.5 ns in the 
calcium bound state (χ2=1.7). .......................................................................105 
 
Figure 4.4.  ITC binding isotherms for NS5806 association to 
Mg2+Ca2+DREAM(Δ65) (left) and to Mg2+Ca2+DREAM(Δ160) 
(right). The upper panels of each profile reflects the thermal    
power expressed in units of µcal·s-1. The lower panel shows 
integrated reaction heats (ΔH) normalized for bound NS5806 and 
expressed in units of kcal·mol-1. The solid lines represent fitting 
curves using the two-set of sites model. Conditions: 10 µM 
Mg2+Ca2+DREAM in  20 mM MOPS, pH 7.4, and  100 mM     
NaCl, 1mM CaCl2 and 5 mM MgCl2.   ........................................................107 
 
Figure 4.5. Titration curve for (a) Site 1 (Kv4.3(2-21)) binding to 
apoDREAM(Δ65) (open symbols) and apoDREAM(Δ160) (solid 
symbols) in the absence (circles) and presence of 200 μM NS5806 
(up triangle). Conditions: 0.5 μM Kv4.3(2-22) and 200 μM   
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NS5806 in 20 mM MOPS, pH 7.4, and  100 mM NaCl. (b)  
Titration curves of Ca2+ (open symbols) or NS5806 (solid    
symbols) binding to the DREAM-site 1 complex in the presence    
of NS5806 or Ca2+. Solid lines represent fits to a Hill equation,  
with dissociation constants for NS5806 binding to Ca2+DREAM-
site 1 of Kd = 51 ± 2 μM and to apoDREAM-site 1 Kd = 21 ± 1   
μM. The recovered Ca2+ dissociation constants do not reflect the 
actual apparent calcium affinities since EDTA was present in the 
samples. Conditions: 1 μM Kv4.3(2-22) and 20 μM    
DREAM(Δ65) in 20mM MOPS, pH 7.4, 100mM NaCl with     
1mM Ca2+ or 100 μM EDTA. (c) Time profile of the change in 
fluorescence intensity of 100 nM Kv4.3(2-22) peptide upon   
binding to 5 μM Ca2+ DREAM(Δ65) in the absence and presence   
of 200 μM NS5806. Solid line represents the NLLS fit using a 
double exponential decay model, recovered parameters listed on 
Table 4. .........................................................................................................108 
 
Figure 4.6. (a) Docking site for NS5806 on DREAM(Δ65) and (b) 
DREAM(Δ160). Solid line indicates the distance between 
tryptophan 169 and the dibromophenyl ring of NS5806. The    
initial NMR structures of DREAM(Δ65) (pdb: 2JUL) and 
DREAM(Δ160) (pdb:2E6W) were used as docking 
macromolecules, EF-1 shown in green, EF-2 in orange, EF-3 in 
blue, EF-4 in red and NS5806 shown as licorice model. (c) 
Mutation of Tyr174 or Phe218 to alanine completely abolishes     
the affinity enhancement observed in the absence of calcium     
upon binding of NS5806. Conditions as described in figure        
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Figure 4.7. Titration curve for calcium binding to 1μM DREAM(Δ65)      
labeled with the biarsenical fluorophore FlAsH-EDT2 in the  
absence (squares) and in the presence (circles) of NS5806. The  
solid line represents the NLLS fitting using equation 4.    
Conditions: 1μM DREAM(Δ65), 200 μM NS5806 in 20 mM 
MOPS, pH 7.4, and  100 mM NaCl.  ............................................................116 
 
Figure 4.8.  Reorganization of the hydrophobic pocket in the DREAM C-
terminus upon binding of NS5806 and/or site 1. Top left: Position of 
helix-10 (shown in yellow) in the C terminus hydrophobic pocket of 
DREAM(Δ65) is stabilized by stacking interactions among F218, 
F252 and Y174. Top right:  Binding of NS5806 to the 
DREAM(Δ65) leads to the displacement of F252 and NS5806 is 
stabilized by hydrophobic interactions with F218 and Y174. Bottom 
left: Orientation of site 1 in the C-terminus hydrophobic pocket      
of DREAM(Δ65) with focus on the interaction of W19 from site     
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1 with hydrophobic residues from DREAM(Δ65). Bottom right:  
The reorientation of the hydrophobic domain at the DREAM C-
terminus upon concomitant binding of site 1 and NS5806. .........................124 
 
Figure 5.1. (a) Bioinformatics analysis of the first 100 residues at the N-
terminus of mouse DREAM indicating regions of helical     
structure and charge distribution. Proposed sites for 
posttranslational modification and ligand interactions are shown.  
(b) Helical plot analysis of residues 29 to 44 of DREAM. (c) 
DREAM amino acid sequence disorder prediction using the 
PONDR-FIT and VL3 prediction servers. (c) Potential energy 
surface of apoDREAM (lacking the first 77 residues) calculated 
using the published NMR structure and the APBS plugin of the 
VMD software with CHARMM parameters at 150 mM mobile     
ion concentration.  ........................................................................................130 
 
Figure 5.2. Titration curves for calmodulin binding to (a) 100 nM of a FITC 
labeled peptide analogous to residues 29-44 of mouse DREAM 
“DRE29” in the absence (circles) or present (squares) of 1mM 
calcium (Kd = 136 ± 10 nM) and in the presence of calcium and    
30 μM Trifluoperazine (up triangles).  (b) Fluorescence emission 
spectra of 5 μM DRE29 peptide in the presence or absence of 10 
μM Ca2+CaM, sample was excited at 300 ± 4 nm which resulted    
in negligible contribution from tyrosine on CaM. Buffer  
background emission was subtracted to decrease Rayleigh,     
Raman and 2nd harmonic peaks contributing to the signal. (c) 
Observed shift and increase in tryptophan fluorescence upon 
calmodulin binding. (d) Normalized tryptophan fluorescence  
change at 370 nm  of DREAM(1-256) upon addition of    
calmodulin in the absence (circles) and presence (squares) or    
1mM calcium (Kd = 3.3 ± 0.9 μM).  ............................................................131 
 
Figure 5.3. (a) Fluorescence intensity quenching of 1 μM DRE29 upon 
association to Ca2+CaMRR2. (b) Plot of the FRET efficiency 
between DRE29 and Ca2+CaMRR2 complex, a dissociation  
constant of 134 ± 16 nM was recovered using a Hill equation.       
(c) Fluorescence anisotropy of 100 nM DRE29 versus calculated 
TFP free calmodulin. The drug free calmodulin concentration     
was determined assuming that a single TFP molecule is bound to 
calmodulin with an affinity of 1 μM, 30 μM TFP was held    
constant while the concentration of CaM was increased.  ............................132 
 
Figure 5.4. Anisotropy change upon addition of DREAM and DREAM(Δ65)   
to 1 μM DRE29 peptide in the presence of CaCl2 (solid symbols)   
or EDTA (open symbols). Line represent the best fit using Eqn.      
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1, with dissociation constant for DREAM of 57 μM while 
DREAM(Δ65) resulted in a Kd ~ 30 μM in the absence of salt      
and Kd ~ 0.3 mM in the presence of 100 mM NaCl.  ...................................134 
 
Figure 5.5. (a) Modified Stern-Volmer analysis of tryptophan fluorescence 
quenching upon binding of NS5806 to apo and Ca2+DREAM,    
solid lines illustrate the expected traces for complete quenching   
and dashed lines show the intercept a 2.83 ± 0.12. (b) Association  
of Kv4.3(1-22)-FITC with apo and Ca2+DREAM monitored using 
fluorescence anisotropy; solid lines represent the best fit to the    
data using a Hill binding model with the recovered parameters 
shown in the inset. (c) Fluorescence spectra of 1,8-ANS bound       
to apoDREAM with λmax = 478 nm and Ca2+DREAM with λmax       
= 475 nm. These results support the idea that the accessibility of   
the hydrophobic cavity at the C-terminus of DREAM is not 
compromised by the presence of the N-terminus residues 1-65.  .................135 
 
Figure 5.6.  Eight 10 ns MD simulation at 313 K of DREAM N-terminus 
(residues 1-66) showing the overall stability of the predicted α0 
helix. Bulky hydrophobic residues which form part of the CaM 
binding region (shown in red) are drawn as licorice model.  .......................137 
 
Figure 5.7.  (a) Far-UV CD spectra of DREAM(Δ65) and DREAM in the 
presence of 100 μM calcium in 5mM phosphate buffer pH 7.4.     
(b) Near-UV CD spectra of DREAM(Δ65) and (c) DREAM in     
the absence and presence of calcium.   .........................................................138 
 
Figure 5.8. Dissociation kinetics of (a) 10 μM CaM and 1 μM DRE29 and (b)   
1 μM CaMRR2 and 10 μM DREAM upon addition of 1mM    
EDTA monitored using T-format fluorescence anisotropy as a 
function of temperature. (c) Eyring plot analysis of the    
dissociation constant as a function of temperature, solid lines 
represent best linear fit to the data.  ..............................................................140 
 
Figure 5.9. Frequency-domain fluorescence decay of apo and Ca2+CaM-
IAEDANS (b) Frequency-domain anisotropy decay of  
Ca2+      bound CaM-IAEDANS in the absence and presence of       
DREAM. Phase delay and modulation ratio are shown as open    
and solid symbols, respectively. Solid lines represent the best fit 
using multi-exponential decay models, recovered parameters are 
listed in Table 5.3 and 5.4.  ...........................................................................142 
 
Figure 5.10. (a) Fluorescence emission spectra transition of 5 μM CaM-
IAEDANS upon association with 20 μM DREAM. (b) Global 
fluorescence decay lifetime χ2 surface for the two component 
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exponential decay of CaM-IAEDANS in the presence (red) or 
absence (black) of Ca2+ and Ca2+CaM-IAEDANS:DREAM (blue) 
and Ca2+ free complex (green). Rotational correlation time χ2 
surface from the global analysis of the anisotropy decay data    
using a two component exponential decay for CaM-IAEDANS    
and triple exponential decay model for the CaM-
IAEDANS:DREAM complex, color scheme as in panel b.  ........................146 
 
Figure 5.11. Initial structure of DREAM built using the protocol described in 
the Material and Methods section, where the structure derived   
from the published NMR is shown in green and the predicted 
structure of residues 1 to 75 is shown in orange with the CaM 
binding site highlighted in red licorice model. Calcium atoms are 
shown as yellow spheres.  .............................................................................147 
 
Figure 5.12. Molecular dynamics simulation of DREAM using an initial    
model constructed by combining a peptide model for residues 1     
to 76 with the published NMR structure of DREAM (residues 76   
to 256) shown in green. The alpha-helical section of the   N-
terminus domain was predicted using secondary prediction tools  
and shown in orange, the CaM binding region corresponding to 
residues 29-44 is shown in red licorice. All structures are       
aligned using residues 76 to 256; calcium is shown as yellow 
spheres. (a) Two final structures of DREAM after 80 ns       
classical MD simulations. (b) Three final structures of DREAM 
after 30 ns accelerated MD simulations. (c) Three independent 
structures of DREAM after 1000ns of coarse grained molecular 
dynamics simulation in the absence of Ca2+, showing a collapsed  
N-terminus. The hydrophobic surface known to mediate ligand 
binding on DREAM is highlighted by a blue ellipse, the 
electronegative surface identified on Figure 5.1 is highlighted in 
black.  ............................................................................................................148 
 
Figure 5.13. Fluorescence anisotropy increase due to 0.5 μM FITC labeled 
dsDNA homologous to the DRE sequence of human     
prodynorphin gene binding to 5 μM DREAM in the presence or 
absence of Ca2+. Addition of CaM in increasing concentrations      
(0 μM, 20 μM, 40 μM and 60 μM) results in a concomitant  
decrease in fluorescence anisotropy. Chelation of Ca2+ by 2 mM 
EDTA results in an increase in anisotropy due to dsDNA 
association with DREAM, even in the presence of 60 μM CaM.  ...............150 
 
Figure 5.14. Carton representation of the proposed model for a   
heterotetrameric DREAM:CaM complex. The DREAM dimer is 
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shown  in cyan and calmodulin is shown in orange, calcium is 
shown as yellow spheres.  ............................................................................155 
 
Figure 6.1. (a) NMR structure of DREAM monomer with highlighted 
hydrophobic residues (gray mesh) and charged residues (red    
mesh) (pdb entry 2JUL)7. The four EF-hand of DREAM are    
shown in green (EF-hand 1), orange (EF-hand 2), blue   (EF-hand 
3), and red (EF-hand 4). Calcium are shown as an orange sphere.  
(b) Coordination geometry of calcium bound to EF-hand 3 (left)  
and EF-hand 4 (right). Residues involved in coordination of 
Ca2+  are shown in licorice model. EF-hand 3 shows a clear 
pentagonal bipyramidal coordination whereas EF-hand 4 is 
distorted. (c) Geometry and consensus sequence of EF-hand binding 
loops as well as sequence homology between neuronal calcium 
sensors     and calmodulin at the metal binding loops.  ................................162 
 
Figure 6.2: Intrinsic fluorescence changes of  40 μM (a) CaM and (b) 
DREAM(Δ65) upon binding of 1 mM calcium or 160 μM Tb3+     
on CaM or 80 μM Tb3+ for DREAM(Δ65), excited at 280 ± 4      
nm. The observed tyrosine fluorescence change upon 
Tb3+       binding to CaM shows a small deviation from that observed 
for Ca2+, likely due to quenching of the fluorescence by energy   
transfer to Tb3+. The Tb3+ induced transition for DREAM(Δ65)       
is identical to that observed in the presence of Ca2+.  Sensitized 
emission of (c) 160 μM Tb3+ bound to CaM and (d) 80 μM 
Tb3+ bound to DREAM(Δ65), excited at 280 nm with and without    
2mM EDTA. The background emission of the Tb3+:EDTA   
complex is shown as reference. The observed sensitized emission  
of Tb3+ shows the characteristic sharp bands at 489, 544 (major), 
586 and 622 nm due to 
the 5D4–7F6, 5D4–7F5, 5D4–7F4, 5D4–7F3 transitions of Tb3+, 
respectively. The major peak at 545 nm     for DREAM(Δ65) is 40 
% smaller than that observed for CaM. Addition of 2 mM EDTA to 
either CaM or DREAM(Δ65)     resulted in an emission identical to 
that of Tb3+ in solution. .................................................................................164 
 
Figure 6.3: (a) Excitation spectra of DREAM constructs bound to Tb3+, 20     
μM protein 40 μM  Tb3+. The spectra was normalized so that the 
intensity corresponding to backbone to Tb3+ energy transfer at 
240nm is the same for DREAM(Δ65), DREAM(Δ160), and 
DREAM(Y174A) while the magnitude is half for DREAM(E186Q) 
and DREAM(E234Q). (b) Calcium/terbium binding sites of EF-
hand 3 and 4, only EF-hand 3 is shown (in blue) for clarity. (c) 
Titrations of Tb3+ into DREAM(Δ65) and DREAM(Δ160) in 20 
mM TRIS pH 7.4 and 100 μM Ca2+ with and without 5 mM Mg2+. 
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(d) Titration of Tb3+ into DREAM(E186Q) and DREAM(E234Q) 
under identical conditions as panel (c). Solid lines represent the  
best fit using the quadratic equation for N-binding sites. .............................166 
 
Figure 6.4. (a) Tryptophan fluorescence lifetime distribution of     
DREAM(Δ64) in the presence of Ca2+ or Tb3+, decay data was 
modeled as a Gaussian distribution and a discrete decay,  
parameters listed in Table 1. (b) Circular dichroism spectra of 40 
μM DREAM(Δ64) in the presence of 1 mM Ca2+, 2 mM EDTA     
or 160 μM Tb3+ in 5mM TRIS pH 7.4. (b) Binding of Tb3+ or     
Ca2+ to 10 μM DREAM(Δ64) in the presence of 40 μM 1,8-ANS.  ............171 
 
Figure 6.5: ITC isotherms for Tb3+ displacement of Ca2+ from CaM, 
DREAM(Δ64) and DREAM(Δ160). The upper panels of each 
profile reflects the thermal power expressed in units of µcal·s-1.  
The lower panel shows integrated reaction heats (ΔH) expressed    
in units of kcal·mol-1. The solid lines present the best fitting curve 
with parameters shown in Table 6.2.  ...........................................................174 
 
Figure 6.6: (a) Luminescence decay of Tb3+ bound to CaM and constructs of 
DREAM, with stoichiometric ratios of 4:1 Tb3+:CaM and 2:1 
Tb3+:DREAM. Solid lines represent the best fit using Globals 
software analysis, recovered parameters listed in Table 3. (b) 
Luminescence intensity decay profiles as a function of Tb3+   
binding to 10 μM DREAM(Δ64). The luminescence decays in (b) 
were analyzed using a triple discrete model and the fractional 
intensity contribution of the two slowest lifetimes is shown in (c). 
The fastest decay component had a lifetime of ~80 μs with less   
than 10 % contribution and is not shown. (d) Luminescence     
decay Tb3+ bound to DREAM and DREAM(Δ64) as a function      
of the hydrophobic molecules TFP (top) bound to DREAM and 
NS5806 (bottom) bound to DREAM.  ..........................................................180 
 
Figure 6.7: (a) Typical nanoESI mass spectra of DREAM(Δ64) in the    
presence of Ca2+ and of DREAM(Δ64) in the presence of Ca2+     
and Tb3+.  The isotopic distribution of the DREAM(Δ64):2Ca2+   
and DREAM(Δ64):2Tb3+ are shown for clarity. (b) NanoESI   
TIMS mobility spectra of DREAM(Δ64) bound to Ca2+ and/or  
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Figure 6.8: Plot of T∆S versus ∆H for Tb3+ displacement of Ca2+ from 
DREAM(Δ64), DREAM(Δ161), DREAM(E186Q), 
DREAM(E234Q) and CaM. Solid line represents the best linear    
fit to the data.  ...............................................................................................189 
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Figure 7.5. (a) PBD signal amplitude of Na2(CrO4)2 in 20 mM MOPS pH       
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Figure 7.6. (a) PBD signal of Na2(CrO4)2 in 20 mM MOPS pH 7.4 upon 
excitation with 1100 μJ power at 355 nm. (b) PBD signal as a 
function of pump laser repetition rate at 20 °C. Inset shows the 
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Figure 7.7. A representative trace highlighting the kinetics of a photo triggered 
processes and the amplitude of the slow and fast phases used to 
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Figure 8.4. (a) Root mean square deviation (RMSD) of the alpha carbon (Cα) 
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Notice that the classical simulation must undergo over 400 ns to 
reach a deviation similar to that observed using aMD. Heat map  
plot showing the RMSD of the Cα of each residue as a function      
of simulation time for the cMD simulation (b) and for the aMD 
simulation (c). Note the similar patter or reorganization between 
residue 76 to 96 on both simulations (marked as 1). The region 2 
corresponds to residues connecting the exiting helix of EF-hand      
3 and entering helix of EF-hand 4.  ..............................................................226 
 
Figure 8.5. Global structural changes following 100 ns of aMD simulation.     
(a) Initial structure of DREAM following minimization and 
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Ca2+ before (shown in solid colors) and after 100 ns of aMD 
simulation (shown in diffuse color with solid lines representing    
the backbone atoms). All alignments were conducted using the   
first 12 amino acids of the entering helix (shown horizontal). The 
EF-hand 1 residues 89 to 122 (a), EF-hand 2 residues 128 to 160 
(b), EF-hand 3 residue 163 to 198 (c), EF-hand 4 residue 210 to  
242 (d), and the H10 helix residues 243 to 256.  ..........................................228 
 
Figure 8.7. Structure of the N-terminus domain of DREAM (EF-hand 1 in 
orange and EF-hand 2 in green) (a) before simulation and (b)     
after 100 ns of aMD simulation in the absence of Ca2+. Root     
mean square deviation per residue of the last 10 ns compared to    
the initial structure of Ca2+ bound DREAM (red) and Ca2+ free 
DREAM (black). The approximate positions of the EF-hand   
 xxix 
helices shown as colored squares, EF-hand 1 in orange, EF-hand     
2 in green, EF-hand 3 in blue, and EF-hand 4 in red. Heat map 
representation of the RMSD per residue as a function of time for 
Ca2+ bound DREAM during 100 ns of aMD simulation.  ............................229 
 
Figure 8.8. (a) Root mean square deviation (RMSD) and root mean square 
fluctuation (RMSF) of the EF-hand 2 (residues 163 to 198. RMSF 
calculated with a moving window of 1 ns with a step of 0.2 ns.    
The RMSD (c) and RMSF(d) of EF-hand 4. White square  
highlights the N-terminus of the metal binding loop.  ..................................230 
 
Figure 8.9. (a) Cartoon representation of the proposed DREAM dimer in    
which Leu155, Leu158, Leu159, and Leu251 are shown in    
licorice model with a diffuse surface. The N-terminus EF-hand        
1 and 2 shown in blue and the C-terminus EF-hand 3 and 4     
shown in red. (b) RMSD of the Cα in EF-hand 1 (residues 89 to  
102) as a function of aMD simulation time for the Ca2+ free and 
bound DREAM as well as the dimer of DREAM. (c) Heat map      
of the RMSD per residue as a function of simulation time for     
each DREAM subunit in  the dimer protein.  ...............................................232 
 
Figure 8.10. Residue cross correlation analysis of the cMD simulations for     
the (a) Ca2+ bound DREAM monomer, (b) Ca2+ bound DREAM 
dimer (only one subunit shown), and (c) Ca2+ free DREAM 
monomer. All the structure are based on the last 90 ns of a cMD 
simulation in which the RMSD changed by less than 1 Å. The 
structure of the Ca2+ free DREAM was obtained after 100 ns of 
aMD simulation. Regions of interest are marked and described in 
the text.  ........................................................................................................234 
 
Figure 8.11. Cartoon representation Ca2+ bound DREAM monomer with the 
colored communities shown as ball and stick colored cartoons. The 
structure was obtained following 100 ns of cMD simulation. (b) 
Cartoon representation of DREAM with EF-hands colored and 
helices labeled for reference to panel (a). (c) Structure of DREAM 
with overlaid dynamic networks highlighting the critical amino 
acids connecting the N- and C-terminus of DREAM (amino acids 
shown in purple licorice, H10 and gray network not shown for 
clarity). (d) Networks at the C-terminus showing the connection 
between the H10 helix (gray network) and the entering helix of   
EF-hand 4 (yellow network), critical amino acids shown in green 
licorice model. ..............................................................................................236 
 
Figure 8.12. (a) Cartoon representation Ca2+ free DREAM monomer with the 
colored communities shown as ball and stick colored cartoons.    
 xxx 
The structure was obtained following 100 ns of cMD simulation.  
(b) Cartoon representation of DREAM with EF-hands colored     
and helices labeled for reference to panel (a). ..............................................238 
 
Figure 8.13. (a) Cartoon representation of the proposed DREAM dimer on 
which the communities have been overlaid using a ball and stock 
representation. Subunit A and B are highlighted for reference.     
The figure shows one angle the other rotated 180 degrees. (b)  
carton representation of DREAM with EF-hands colored and     
Ca2+ metal shown, LxxLL motif shown in purple licorice model.  
(c) Intersubunit salt bridges formed between DREAM subunits.  ................239 
 
Figure 8.14. Dynamic networks at the C-terminus, highlighting the strong 
dynamic coupling between the exiting helix of EF-hand 4 (cyan) 
and the entering helix of EF-hand 3 (purple), (a) in the presence     
of Ca2+ and (b) in the absence of Ca2+. Reorganization of the C-
terminus aromatic amino acids upon removal of Ca2+ from the     
EF-hands 3 and 4 of DREAM.  ....................................................................242 
 
Figure 8.15. (a) Sequence alignment of mouse NCS-1, recoverin, VILIP-1, 
GCAP-1, and DREAM. Turn loops of EF-hand 1, 2, 3, and 4 are 
shown in bold and underlined. the negatively charged amino     
acids involved in metal coordination shown in red. The      
conserved aromatic amino acids are shown in bold underlined  
green letters. Asterisks indicate identical residues, semicolon 
indicates very similar residues, and the period is for somewhat 
similar residues. Amino acids involved in Kv4 binding are      
shown in green.  ............................................................................................243 
 
Figure 8.16. (a) Sequence alignment of mouse NCS-1, recoverin, VILIP-1, 
GCAP-1, and DREAM. Turn loops of EF-hand 1, 2, 3, and 4        
are shown in bold and underlined. the negatively charged amino 
acids involved in metal coordination shown in red. The loop 
connecting the EF-hands 3 and 4 are shown in blue bold and 
underlined, the respective negatively residue with whom these 
amino acids interacts is shown in bold underlined orange color.   
The LxxLL motif is shown in blue and the the amino acid with 
whom they interact is shown in orange.  ......................................................245 
 
Figure 8.17. Far-UV circular dichroism spectra of DREAM mutants. (a) 
DREAM(Δ65), (b) DREAM(Δ160), (c) DREAM(Y174A), (d) 
DREAM(F218A), (e) DREAM(F235A), and (f) DREAM-NCS.  
The spectra are shown in the presence of 1 mM EDTA (apo), 5   
mM MgCl2 and 1 mM EGTA (Mg2+), 1 mM CaCL2 (Ca2+), and     
1 mM CaCl2 and 5mM MgCl2 (Mg2+Ca2+). The coloring scheme    
 xxxi 
is the same for all spectra. The protein centration was kept near     
10 μM for all protein constructs in 5 mM TRIS pH 7.4.  .............................248 
 
Figure 8.18. Tryptophan fluorescence spectra of DREAM mutants. (a) 
DREAM(Δ65), (b) DREAM(Δ160), (c) DREAM(Y174A), (d) 
DREAM(F218A), (e) DREAM(F219A), (f) DREAM(F235A),      
(g) DREAM(F252A), and (h) DREAM-NCS. The spectra are  
shown in the presence of 1 mM EDTA (apo), 5 mM MgCl2 and       
1 mM EGTA (Mg2+), 1 mM CaCL2 (Ca2+), and 1 mM CaCl2 and 
5mM MgCl2 (Mg2+Ca2+). The coloring scheme is the same for all 
spectra. The protein concentration was kept near 10 μM for all 
protein constructs in 5 mM TRIS pH 7.4.  ...................................................250 
 
Figure 8.19. Fluorescence emission spectra of 1,8-ANS bound to DREAM-
NCS1 in the presence of Ca2+, Mg2+, or both.  .............................................251 
 
Figure 8.20. Calcium binding experiments monitoring the tryptophan 
fluorescence change upon Ca2+ binding to each DREAM mutants. 
(a) All the titration curves for DREAM constructs showing a 
decrease in tryptophan fluorescence similar to that of  
DREAM(Δ65) and (b) DREAM mutants whose change in 
fluorescence is reverse to that observed in the DREAM(Δ65) 
protein. Protein samples contained 5 μM DREAM in 20mM   
MOPS pH 7.4 1 mM EGTA and 1 mM NTA. The concentration    
of calcium free was determined using the known fluorescence 
transition and dissociation constants of Quin-2.  ..........................................253 
 
Figure 8.21. Unfolding experiment of DREAM constructs, in which the 
tryptophan fluorescence maxima was monitored as a function of 
guanidium hydrochloride (GuHCl) concentration. The protein     
was kept at 5 μM for all protein construct and at all GuHCl 
concentrations.  .............................................................................................256 
 
Figure 8.22. Tryptophan fluorescence emission spectra as a function of    
GuHCl for (a) Ca2+ free and (b) Ca2+ bound DREAM(Δ65). The 
emission spectra of the native DREAM, intermediate, and  
unfolding protein in the absence of Ca2+ (c) and presence of Ca2+    
is shown (d)  ..................................................................................................258 
 
Figure 8.23. Representative unfolding trace of (a) DREAM (Δ65) and (b) 
DREAM-NCS in the apo, Mg2+, Ca2+, and Mg2+Ca2+ bound     
forms. Solid lines represent the best fit using equation 8.4.  ........................259 
 
 
Figure 8.24. Unfolding plot of (a) DREAM (F218A) and (b)     
 xxxii 
DREAM(F219A) in the apo, Mg2+, Ca2+, and Mg2+Ca2+ bound 
forms. Solid lines represent the best fit using equation 8.4.  ........................264 
 
Figure 8.25. Rotameric states of tryptophan in proteins. (a) Newman    
projection of the t rotamer and (b) g+ rotamer with view along      
the Cα-Cβ carbon bond. The corresponding indole conformations  
as observed in the aMD simulation of apoDREAM(Δ161). The 
measured Cα-Cβ and Cβ-Cγ angles are highlighted with black 
arrows.  .........................................................................................................267 
 
Figure 8.26. Plots of the Cβ-Cγ as a function of Cα-Cβ dihedral angle of 
tryptophan 169 in the Ca2+ bound (a) DREAM(Δ160), (c) 
DREAM(Δ65), and (e) DREAM(Y174A), as well as the Ca2+      
free of the (a) DREAM(Δ160), (c) DREAM(Δ65), and (e) 
DREAM(Y174A). A total of 4000 points representing 20 ps each 
are plotted, obtained from the aMD simulations.  ........................................269 
 
Figure 8.27. Plots of the Cβ-Cγ as a function of Cα-Cβ dihedral angle of 
tryptophan 169 in the Ca2+ bound (a) DREAM(F218A), (c) 
DREAM(F219A), and (e) DREAM(F252A), as well as the Ca2+  
free of the (b) DREAM(F218A), (d) DREAM(F219A), and (e) 
DREAM(F252A). A total of 4000 points representing 20 ps each 
are plotted, obtained from the aMD simulations.   .......................................270 
 
Figure 8.28. Plots of the Cβ-Cγ as a function of Cα-Cβ dihedral angle of 
tryptophan 169 in the Ca2+ bound (a) and Ca2+ free (b) of the 
DREAM(F235A). Solvent exposure of Trp169 in the (c) t     
rotamer with G- indole orientation and in the (d) g+ rotamer       
with G+ indole orientation. Inset shows the change in SASA as a 
function of time.  ..........................................................................................272 
 
Figure 8.29 (a) Helices of DREAM included in the analysis of fluctuations. The 
EF-hands 1 and 2 are shown in orange and green, respectively, and 
form part of the N-terminus. The EF-hands 3 and 4 are shown in 
blue and red, respectively, and form the C-terminus. The H1 helix, 
the connecting loop between EF-hand 3 and 4, and the H10 helix 
are not used in the calculations and are shown in diffuse cyan. (b) A 
representative RMSF plot of apoDREAM(Δ65) N- and C-terminus 
as a function of simulation time, the last 80 ns of simulation time 
was used for all constructs.  ..........................................................................274 
 
Figure 8.30. Plots of the root mean square fluctuations (RMSF) distribution    
for the last 80 ns of aMD simulation for N- and C-terminus of the 
(a) DREAM(Δ65), (b) DREAM(Y174A), (c) DREAM(F218A),   
(d) DREAM(F219A), (e) DREAM(F235A) and (f) 
 xxxiii 
DREAM(F252A) construct in the Ca2+ bound and free 
conformations.  .............................................................................................275 
 
Figure 8.31. Plots of the difference in unfolding energy (ΔΔG = ΔGI – ΔGU)    
as a function of the difference in RMSF (ΔRMSF =     RMSFN-
terminus – RMSFC-terminus). The results for DREAM(Δ65), 
DREAM(Y174A), DREAM(F218A), DREAM(F219A), 
DREAM(F235A), and DREAM(F252A) are shown in the apo 
(symbols with green outline) and Ca2+ bound form. ....................................277 
 
Figure 8.32. Binding site of the KV4.3 site 2 peptide at the N-terminus of 
DREAM.  ......................................................................................................278 
 
Figure 8.33. Emission spectra of dansylated KV4.3 site 2 peptide in the    
absence and in the presence of Ca2+ bound (a) DREAM(Δ65),      
(b) DREAM(Y174A), (c) DREAM(F218A), (d)    
DREAM(F235A), and € DREAM-NCS1.  ...................................................279 
 
Figure 8.34. (a) Structural alignment of the EF-hand 1 exiting helix of the Ca2+     
bound DREAM structure (PDB: 2jul) and the Ca2+ bound structure of 
KChIP1 bound to the T1-domain of Kv4.3, shown in yellow (PDB: 
2nz0). The exiting helix of EF-hand 1 was used for aliment. (b)  
Alignment of the exiting helix of EF-hand 1 of Ca2+ free DREAM 
(structure obtained after 432 ns of cMD simulation) and the exiting     
helix of KChIP1 in complex with the Kv4.3 channel.  .......................................280 
 
Figure 8.35. Structural reorganization of EF-hand 1 in the Ca2+ free form of     
DREAM obtained from: (a) 435 ns cMD simulation of apoDREAM    
and (b) 1 μs coarse-grained simulation. The inset shows the rotation  
Tyr97 into the hydrophobic cavity lining the N-terminus domain. The  
EF-hand 1 was aligned using the backbone atoms of residues 89 to      
160. (c) Structure of DREAM after 1 μs coarse-grained simulation 
showing the rotation of Arg98 and Lys101 in the absence of Ca2+. .....................281 
 
Figure 8.36. Summary of the mechanism by which binding of Kv4.3 site 1 at the 
hydrophobic surface of DREAM is regulated by Ca2+ binding and 
changes in structural dynamics. (a) Structure of KChIP1:Kv4.3 complex 
(PDB: 2nz0) highlighting the role of the N- and C-terminus hydrophobic 
cavity in ligand binding. (b) Dynamic network analysis which shows     
the collapse of the hydrophobic cavities on DREAM and the enhanced 
dynamic coupling of the H10 helix (black network).  .........................................287 
  
 xxxiv 
LIST OF ABREVIATIONS AND ACRONYMS 
 
ABBREVIATION    FULL NAME 
aMD    Accelerated molecular dynamics 
ΔH*    Activation enthalpy change 
Ka     Association constant 
BZF     Bezafibrate 
Ca2+    Calcium 
cMD    Classical molecular dynamics 
CD     Circular dichroism 
Edihed    Dihedral energy 
DMSO    Dimethyl sulfoxide 
Kd     Dissociation constant 
DTT     Dithiothreitol 
DREAM   Downstream regulatory element antagonist modulator 
EFX    EF-hand X 
ΔH     Enthalpy change 
λmax    Emission maxima 
EGTA Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-
tetraacetic  
GuHCl    Guanidine hydrochloride 
Ki     Inhibition constant 
IPTG    Isopropyl β-D-1-thiogalactopyranoside 
 xxxv 
ITC    Isothermal Calorimetry 
Mg2+    Magnesium 
MS    Mass spectrometry 
MEM    Maximum entropy method 
NLLS    Non-linear least squares 
NS5806 N-[3,5-Bis(trifluoromethyl)phenyl]-N'-[2,4-dibromo-6-
(2H-tetrazol-5-yl)phenyl]urea 
 
PAC     Photoacoustic calorimetry 
PBD     Photothermal beam deflection 
KChIP    Potassium channel interaction protein 
Φ     Quantum yield 
CaM    Rat calmodulin 
RMSD    Root mean square deviation 
SDS     Sodium dodecyl sulfate 
SASA    Solvent accessible surface area 
Tb3+    Terbium 
TIMS    Trapped-ion mobility spectrometer 
Etotal    Total energy 
ΔV     Volume change 
1,8-ANS    1-anilinonaphthalene-8-sulfonic acid 
PIPES    1,4-Piperazinediethanesulfonic acid 
DM-nitrophen   ((1-(2-nitro-4, 5-dimethoxyphenyl)-N, N, N’, N’-tetrakis 
[ (oxy-carbonyl) methyl]-1, 2-ethanediamine) 
 
2,6-ANS   2-anilinonaphthalene-6-sulfonic acid 
 xxxvi 
EDTA 2-({2-[Bis(carboxymethyl)amino]ethyl} 
(carboxymethyl)amino)acetic acid 
 
L35 2-[4-(3,5-dichlorophenyllureido)phenoxyl]-2-
methylpropionic acid 
TRIS    2-Amino-2-hydroxymethyl-propane-1,3-diol 
TnC    Troponin C 
MOPS    3-Morpholinopropane-1-sulfonic acid 
HEPES    4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
1,5-IAEDANS  (5-((((2-Iodoacetyl)amino)ethyl)amino)Naphthalene-1-
Sulfonic Acid) 
 
 1 
PREFACE 
This dissertation is a compilation of research studies carried out from January 2011 
to April 2016 by Walter G. Gonzalez. During this time, some of these results have been 
published in peer-reviewed journals. In particular, Chapter 3 (Gonzalez, Miksovska 2014), 
Chapter 4 (Gonzalez, Pham & Miksovska 2014), Chapter 5 (Gonzalez, Arango & 
Miksovska 2015), and Chapter 7 (Gonzalez, Miksovska 2014). The data presented in 
Chapter 6 has been accepted for publication in the Biochemistry journal of the America 
Chemical Society (Gonzalez, et al. 2016). Chapter 8 is presented in a format common in 
the field of biophysics and biochemistry, and will likely be submitted as two separate 
research articles. 
 
 
 
 
 
  
 2 
1. INTRODUCTION 
1.1 Brain, neurons, and calcium 
The vertebrate central nervous system (CNS) is the most complex biological system 
known and its morphological complexity is only overshadowed by the exceptional array of 
behaviors that it creates and controls. Among the numerous cells that actively regulate the 
CNS function, neurons are the essential building block controlling activity (y Cajal 1995, 
Hodgkin, Huxley 1952). It is estimated that there are on average about 130 billion neurons 
in the brain, each interconnected with thousands of other neurons in a maze of about 150 
trillion synapses (Saver 2006). Despite the enormous complexity of the CNS at the system 
level; at the molecular level, a certain level of organization and hierarchy begins to emerge. 
Indeed, decades of research have allowed a detailed (albeit, not yet complete) 
understanding of the signaling mechanisms controlling communication among distinct 
classes of neurons and other excitable cells, such as cardiac cells in the heart. The signaling 
mechanism is known as the action potential, and it involves the coordinated firing of 
numerous membrane bound ion channels and transporters (Barnett, Larkman 2007). Action 
potentials control cell excitability by effectively changing the normal negative polarity of 
the transmembrane voltage of the cell by allowing the influx of positive ions such as 
sodium and calcium, thus causing a membrane depolarization. The influx of positive ions 
is counteracted by the efflux of potassium or chloride ions, causing the hyperpolarization 
of the cell. Even though these are gross simplifications of the ion transport underlying the 
creation of the action potential, they provide a brief insight into the relevance of ion 
homeostasis in the cell. Indeed, it is the ion concentration inside the cell which controls the 
transmembrane voltage which in turns controls the gating of numerous voltage-gated ion 
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channels. If well, the prevalence of Na+, K+, Cl-, Ca2+, or other voltage-gated channels 
depends on the cell type, there is a widespread prevalence of K+ ions in the cytosol of 
excitable cells (Olaf 2009). On the other hand, the concentration of ions such as Ca2+ and 
Na+ is highly regulated (Carafoli 2002, Clapham 2007). More interestingly, excitable cells 
such neurons and myocardiocytes are partially devoid of Ca2+ in the resting state. The lack 
of Ca2+ ion in the cytosol of cells may have initially arisen in cellular organisms to prevent 
the precipitation of phosphate, a widely used molecular building block for all life forms 
(Clapham 2007). Alternatively, it seems that whatever necessary role a divalent cationic 
ion could have served in the cell, this role has been achieved by use of Mg2+  (Laires, 
Monteiro & Bicho 2004, Agus, Morad 1991). Unlike Ca2+, magnesium concentration in 
the cell is largely unregulated, with concentrations well in the 2-5 mM range in different 
compartments of the cell. This is in stark contrast to the 100 nM concentration of Ca2+ in 
resting neurons and cardiomyocytes (Clapham 2007).  
The energetic costs of maintaining low cytosolic concentration of Ca2+ is not 
without its benefits. In fact, vertebrates have evolved mechanisms that not only exploit the 
high extracellular concentration of Ca2+ for production of bone and teeth, but have also 
taken advantage of the chemical gradient of this ion that is present across the membrane. 
Calcium is maintained at about 2 mM in the extracellular environment, providing a strong 
chemiosmosis force that facilitates the fast influx of this ion. Additionally, the resting 
transmembrane voltage of -70 mM to -90 mV present in neurons and cardiomyocytes 
further enhances the force driving influx of Ca2+ into the cell (YELLEN 1998). Whenever 
a route of passage across the plasma membrane is activated, calcium ions can diffuse into 
the cell at rates exceeding 106 ion/sec (Naraghi, Neher 1997). These calcium influx routes 
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can be formed by voltage-gate calcium channels (CaV), which are part of over a dozen 
other voltage-gated ion channels controlling action potentials in neurons (Bean 2007). In 
neurons, about 4 to 5 voltage-gated calcium channels are expressed, which include, the 
low-voltage activated T-type channels (CaV3) and the high-voltage activated L-type 
(CaV1), among other channels (Bean 2007). However, the slower dynamics of these 
channels preclude Ca2+ from inducing depolarization of of the action potential, a role which 
is fulfilled by the much faster sodium channels. Thus, calcium entry is maximal during the 
falling phase of the action potential. More importantly, the rich repertoire of Ca2+ channels 
result in a wide range of temporally and spatially controlled influx of this ion. Furthermore, 
cytosolic increases of calcium concentrations can also be triggered by release of Ca2+ from 
intracellular stores, such as the endoplasmic reticulum (Berridge, Lipp & Bootman 2000, 
Gifford, Walsh & Vogel 2007b). The precise pattern and frequency of calcium spikes (also 
referred as “blips”, “puffs”, or “waves”) is used by neurons to regulate numerous cellular 
processes. Indeed, the spatiotemporal regulation of Ca2+ spikes has made this metal an 
essential player in the regulation of neuronal signaling in the brain.  
 
1.2 Calcium binding proteins and neuronal calcium sensors 
Despite calcium playing a pivotal role during the evolution of the action potential in 
both neurons and cardiomyocytes, these cells have evolved mechanisms to make further 
use of this ion. The influx of Ca2+ in the cell is further utilized to monitor and control 
numerous physiological processes. For instance, under hypoxic conditions, depletion of 
ATP induces reduction of ATP-dependent Ca2+ pumps activity and reduction in Ca2+ 
removal. Accumulation of Ca2+ in the cell has salso been shown to trigger apoptosis among 
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other processes (Jordán et al. 2000). Additionally, Ca2+ plays an essential role in regulating 
neurotransmitter release via interaction of this metal ion with synaptotagmins and SNARE 
proteins (Jahn, Scheller 2006, Hu et al. 2002). Gene regulation, morphological remodeling 
of cells (Babich, Burkhardt 2013), tumor progression (Chen et al. 2013), and cancer 
(Braunewell 2005), have also been known to be regulated by Ca2+.(Bito, Deisseroth & 
Tsien 1997). 
Figure 1.1: Three dimensional structures the most common families of Ca2+ binding 
proteins shown as a carton representation, with calcium metal shown as tallow spheres.  (a) 
Synaptotagmin 1 with Ca2+ bound to the C2-domain, (b) Annexin III with Ca2+ bound at 
the Annexin domain, and (c) calmodulin with Ca2+ bound at the the EF-hand. 
 
However, calcium itself would be devoid of any biological activity were it not for the 
numerous proteins that associate with this metal. Indeed, despite the drastic thousand-fold 
increase in Ca2+ concentration during repolarization of the action potential, most of the 
cytosolic Ca2+ is readily bound to proteins. The extent to which cells exploit Ca2+ signals 
is highlighted by the large number of calcium-binding proteins (CaBPs) which use this 
metal to trigger and/or regulate about every aspect of biological function (Clapham 2007, 
Berridge, Bootman & Roderick 2003, Berridge, Bootman & Lipp 1998).  
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The ever-growing list of CaBPs known to directly interact with Ca2+ is only 
overshadowed by the numerous biological processes they regulate. During evolution, these 
CaBPs evolved at least three common Ca2+ binding motifs: the C2 domain (Nalefski, Falke 
1996), the annexin domain (Raynal, Pollard 1994), and the EF-hand domain (Kuster et al. 
1991). The structure, amino acid composition, and affinity for Ca2+ of these three domains 
are markedly different (Figure 1.1).  
Figure 1.2: Three dimensional structure of a representative EF-hand motif (PDB: 2pvb). 
(a) Cartoon representation of the helix-loop-helix motif of the EF-hand with Ca2+ bound 
and shown as a yellow sphere. (b) The same structure as in (a) but shown as a licorice 
model, without hydrogens. 
 
The EF-hand is the most widespread Ca2+ binding motif (Figure 1.2), with over 250 
proteins belonging to this superfamily (Braunewell, Gundelfinger 1999). Proteins in this 
superfamily have been organized by those that function as calcium buffers and those which 
function as Ca2+ sensors (Yap et al. 1999, Ikura 1996). The Ca2+ buffer subfamily of EF-
hand proteins is exemplified by their ability to bind Ca2+ with the sole purpose of regulation 
of the Ca2+ levels inside the cell. Member of this subfamily include, parvalbumin, which 
was the first EF-hand protein whose Ca2+ binding loop was investigated in detail (Moews, 
Kretsinger 1975, Kretsinger, Nockolds 1973). In fact, the name of the EF-hand arose from 
the observation that the E and F helices of parvalbumin are orientated around the Ca2+ 
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coordinating loop in a manner which resembles the thumb and index finger of a hand. Other 
members of this subfamily include Calbindin D9k, Calbindin D28k, and Calretin (Ikura 
1996). The Ca2+ sensor subfamily is further divided into Ca2+ sensing proteins and neuronal 
calcium sensors (NCS) (Figure 1.3). 
Figure 1.3. Dendrogram showing the relationship between members of the intracellular 
calcium binding proteins. 
 
Member of the Ca2+ sensor group include Calmodulin, Troponin C, Calcineurin B, and 
the myosin light chains (McCue, Haynes & Burgoyne 2010). The second group, the 
neuronal calcium sensors, are characterized by five subgroups, including recoverin (group 
I), NCS-1 (group II), visinin-like proteins (group III), guanylyl cyclase-activating proteins 
(group IV), and the potassium channel interacting proteins (group V) (Braunewell, 
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Gundelfinger 1999, Yap et al. 1999). Of the NCS proteins, recoverin has been the most 
extensively studied (Ames et al. 1996, Ames, Hamasaki & Molchanova 2002, Ames et al. 
2006).  
Figure 1.4. (left) NMR structure of Ca2+ free recoverin (PDB: 1iku, conformation 1) with 
EF-hand 1 shown in orange, EF-hand 2 in green, EF-hand 3 in blue, and EF-hand 4 in red. 
The myristoyl group is shown as spheres. (Right) NMR structure of Ca2+ bound to EF-hand 
2 and 3 of recoverin (PDB: 1jsa, conformation 1). Calcium is shown as yellow spheres. 
 
Most member of the NCS group are exclusively expressed in the brain and retina, with 
the exception of the newly discovered KChIP subgroup (Braunewell, Gundelfinger 1999, 
Paterlini et al. 2000, Polans, Baehr & Palczewski 1996). The NCS proteins are 
characterized by the presence of four EF-hand domains of which the most N-terminal one 
(EF-hand 1) is always inactive and does not bind Ca2+, EF-hand 2 and 3 always bind 
calcium, and EF-hand 4 is functional in some members (Ames et al. 2006). Despite lack of 
Ca2+ binding to EF-hand 1 at the N-terminus, some NCS members are known to incorporate 
a myristoyl or palmitoyl group near this hand (Burgoyne et al. 2004). The hydrophobic 
prosthetic group has been shown to be effectively exposed upon Ca2+ binding to the C-
terminus (Figure 1.4) (Ames et al. 1996, Takimoto, Yang & Conforti 2002, Zozulya, Stryer 
1992, Hughes et al. 1995). Numerous studies have also highlighted the submicromolar 
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affinity for Ca2+ of EF-hands in NCS proteins, some of which can show a sequential, non-
cooperative, or cooperative behaviors (Cox et al. 1994, Ladant 1995, Osawa et al. 2005). 
 
1.3 The EF-hand Ca2+ binding motif 
Figure 1.5. (a) Crystal structure of Parvalbumin (PBD: 2pvb). Helices are shown in 
different colors and turn-loop involved in Ca2+ chelation is shown in licorice model. The E 
and F hand helices forming the EF-hand are shown in blue and red, respectively. (b) EF-
hand formed by the helix E and F of the Ca2+ bound parvalbumin (PBD: 1b8r). The entering 
helix is colored in blue and exiting helix in red, with calcium shown as a yellow sphere. 
 
 Following the initial identification of the EF-hand motif in parvalbumin 
(Kretsinger, Nockolds 1973), this motif was fund to be present in troponin C (Collins et al. 
1973), myosin light chains (Collins 1974), calmodulin (Stevens et al. 1976), and recoverin 
(Flaherty et al. 1993), to name a few. In fact, bioinformatics analysis indicate that this motif 
may be present in over 3000 other proteins (Grabarek 2006). The canonical EF-hand motif 
consist of a helix-loop-helix structure of roughly 30 amino acids, of which 12 comprise the 
Ca2+ binding loop (Figure 1.5) (Kretsinger, Nockolds 1973, Grabarek 2006). Analysis of 
numerous EF-hand containing proteins structures has revealed that: i) EF-hands are often 
present in pairs (Yap et al. 1999), ii) Ca2+ is always coordinated by the oxygen atoms of 
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aspartic, glutamic, and backbone carbonyls, (Cates et al. 1999), and that iii) association of 
Ca2+ induces stabilization and/or structural changes on these proteins (Gifford, Walsh & 
Vogel 2007b, Gifford, Walsh & Vogel 2007a). 
Figure 1.6. Coordination of Ca2+ at the x, y, z, -y, and -z by: (a) Asp73, Gln75, Asp75, 
Thr79, and Glu84 of EF-hand 2 in recoverin (PDB: 1jsa); (b) Asp109, Asp111, Asp113, 
Thr115, and Glu120 of EF-hand 3 in recoverin (PDB: 1jsa); (c) Asp131, Asp133, Asp135, 
His140, and Glu129 of EF-hand 3 in calmodulin (PDB: 1exr); (d) Asp93, Asp95, Gln97, 
Leu99, and Glu104 in EF-hand 4 of calmodulin (PDB: 1exr). 
1.3.1 EF-hand metal coordination 
 The coordination of Ca2+ and small chelating compounds, such as EDTA, is 
octahedral (Barnett 1979). However, the coordination of Ca2+ with oxygen atoms in EF-
hands varies among CaBPs, with a hepta-coordination being the most common (Grebarek 
2006) (Figure 1.6). The coordination bonds in most EF-hands also follow a pentagonal 
bipyramidal organization. The heptahedral coordination of Ca2+ allows the assignment of 
a coordinated system, with Ca2+ as the origin, in which the first three ligands are assigned 
the X, Y, and Z axes, respectively.  
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Figure 1.7. Crystal structure of calmodulin with Mg2+ bound at EF-1 (PDB: 3ucw). 
Coordinating amino acid involved in metal binding are shown in licorice model. Water 
molecules shown as red spheres. 
 
Sequence analysis of numerous EF-hand loops has revealed that glutamic acid at 
the –Z coordination is common among Ca2+ selective EF-hands. At the 12th position of the 
metal binging loop (-Z coordination), glutamic acid provides two coordination bonds to 
Ca2+. Nonetheless, in the absence of Ca2+ and millimolar concentrations of Mg2+, EF-hands 
can bind Mg2+ as shown in Figure 1.7 (Senguen, Grabarek 2012). The EF-hand loops 
containing aspartic acid at the –Z position often show higher selectivity for Mg2+ ions thank 
Ca2+ (da Silva, Kendrick-Jones & Reinach 1995). The preference of Mg2+ over Ca2+ arises 
from the shorter length of the sidechain of asparagine, which is ideally suited for the hexa-
coordination necessary to chelate Mg2+. On the other hand, the hepta-coordination of Ca2+ 
by EF-hand loops with aspartic acid at position 12 is satisfied by addition of a water 
molecule bridging the second oxygen (Senguen, Grabarek 2012). At the center of the EF-
hand loop, the –Y coordination is provided by a backbone carbonyl, for example, threonine 
in Figure 1.7. Next to the –Y coordination, a bulky hydrophobic amino acid stabilizes inter-
motifs interactions with the neighboring EF-hand (Grabarek 2006, Gifford, Walsh & Vogel 
 12 
2007a). The interaction between adjacent EF-hands has been shown to play a role in 
regulation of Ca2+ binding cooperativity (Strynadka, James 1989). The EF-hand loop has 
been observed to form a short β-sheet with the adjacent EF-hand named the EF-hand-β-
scaffold (Figure 1.8) (Grabarek 2006).  
Figure 1.8. EF-hand pair showing the formation of a β-sheet connecting the adjacent Ca2+ 
binding loops (PDB: 2jul). 
 
1.3.2 EF-hand structural changes 
Structural analysis of CaM (Grabarek 2005) and TnC (Gagne 1997) mutants have 
revealed that Ca2+ binding follows a multi-step mechanism in which the N-terminus of the 
EF-hand binding loop initially interacts with Ca2+. The initial interaction allows the 
subsequent coordination between Ca2+ and the bidentate Glu-12 at the –Z coordination. 
The coordination of the –Z amino acid positioned at ~ 2 Å triggers the structural 
rearrangement of the exiting helix and exposure of a hydrophobic cavity. The magnitude 
of the structural rearrangements induced by the –Z coordination is largely dependent on 
the EF-hand loop sequence as well as the inter-helical contacts between the entering and 
exiting helices of adjacent EF-hands (Yap et al. 1999, Nelson, Chazin 1998). In the model 
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presented above, the EF-hand-β-scaffold functions as a hinge connecting the N- and C-
terminus of the EF-hand loop.  
Figure 1.9. Reorientation of the EF-hands of calmodulin in the Ca2+ bound (PDB: 1cll) 
shown in solid color and Ca2+ free forms shown in diffuse color with backbone in thick 
cyan lines (PDB: 1cfc, conformation 1). (a) EF-hand 1, (b) EF-hand 2, (c) EF-hand 3, and 
(d) EF-hand 4. 
 
The structural changes associated with Ca2+ binding to the turn-loop of EF-hands 
was first simplified by observations of the Ca2+ free and Ca2+ bound calmodulin and 
troponin C (Sun, Brandmeier & Irving 2006, Yamniuk, Vogel 2004). These proteins 
revealed that Ca2+ induces conformational changes in the packing of the helices forming 
each EF-hand. The structural reorganization observed in TnC and CaM is often not 
observed in CaBPs that function as buffers, such as parvalbumin. The reorientation of the 
entering and exiting helices of the CaBPs that function as calcium sensors has been shown 
to follow a transition from an open to closed conformation (Figure 1.9). In the absence of 
Ca2+, the entering and exiting helices are oriented in antiparallel conformation with 
extensive hydrophobic contacts between helices. Coordination of Ca2+ by the EF-hand loop 
results in the repositioning of the helices to the open position in which the entering and 
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exiting helices are in an almost perpendicular orientation. Even though this closed to open 
transition is observed in many calcium sensor proteins, the magnitude of the reorientation 
varies among proteins and between EF-hands in the same protein (Nelson, Chazin 1998).  
Figure 1.10. Reorientation of the EF-hands of myristoylated recoverin in the Ca2+ bound 
(PDB: 1iku) shown in solid color and Ca2+ free forms shown in diffuse color with backbone 
in thick cyan lines (PDB: 1jsa). (a) EF-hand 2 and (b) EF-hand 3. 
 
Moreover, analysis of the Ca2+ bound and Ca2+ free structures of myristoylated 
recoverin reveals the lack of significant structural rearrangement of the helices in this 
protein (Figure 1.10). The lack of structural information on the Ca2+ free form of additional 
members of the NCS subfamily of EF-hand proteins precludes the interpretation of whether 
the static nature of EF-hand is specific to recoverin, or common among all NCS members. 
However, unpublished NMR data by Ames, et al. on the Ca2+ free myristoylated structure 
for neuronal calcium sensor-1 from fission yeast (PDB: 2l2e) shows a minimal 
reorganization of the EF-hand helices upon binding of calcium (Figure 1.11) (Ames et al. 
2000)). Structural and molecular dynamics simulations have also highlighted the flexibility 
of the EF-hand conformation. Solution studies of a CaM mutant in which Glu-12 was 
mutated to glutamine in the loop of EF-hand 4 showed that this mutant can undergo a global 
conformational exchange between an open and closed conformation (Evenäs, Malmendal 
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& Akke 2001). Similar transitions were observed in the wild-type bovine CaM (Vigil et al. 
2001, Chattopadhyaya et al. 1992).  
Figure 1.11. Reorientation of the EF-hands of myristoylated NCS-1 in the Ca2+ bound 
(PDB: 1fpw) shown in solid color and Ca2+ free non-myristoylated NCS-1 shown in diffuse 
color with backbone in in thick cyan lines (PDB: 2l2e). (a) EF-hand 2, (b) EF-hand 3, and 
(c) EF-hand 4. 
 
1.3.3 Ca2+ affinity of EF-hands 
The regulation of Ca2+ affinity in EF-hands can be understood by considering the 
energetic costs of structural changes and the biochemical  energy provided by Ca2+ binding 
(Gifford, Walsh & Vogel 2007a).  In this aspect, as described below, Ca2+ binding and the 
induced structural changes can be analyzed in terms of increase of disorder of the system 
(increase in entropy) or due to the formation of new favorable interactions (decrease in 
enthalpy). Thus, thermodynamic analysis of the processes occurring during Ca2+ binding 
can provide some insight into the molecular mechanism controlling the metal affinity of 
EF-hands.  
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Initially, both the protein and Ca2+ are solvated by a shell of water molecules. In 
particular, Ca2+ will have about 6 to 8 water molecules coordinating it while the negatively 
charged loop of the EF-hand will be solvated as well. In order for Ca2+ to associate with 
the chelating loop, both of them must release the water molecules. In the event that the 
water lost by Ca2+ is larger than that loss by dehydration of the loop, then the entropic gain 
will be substantial (Linse, Forsen 1995).  
The correlation between water loss and affinity can be used to explain the lower 
affinity of EF-hand loops in which position 12 is replaced by aspartic acid instead of 
glutamic acid. In these loops, aspartic acid is only able to provide a single direct 
coordination bond to Ca2+, while the additional bond is bridged by a water molecule. The 
decrease in entropic gain has been used to explain the lower affinity of the EF-hands 
containing aspartic acid at position 12 in oncomodulin and parvalbumin (Henzl, Hapak & 
Likos 1998, Henzl, Hapak & Likos 1998, Lee et al. 2004). However, the flexibility of the 
EF-hand loop in the absence of Ca2+ can also negatively impact the entropic gain upon 
calcium binding. In addition, the exposure of hydrophobic amino acids upon Ca2+ binding 
will also result in rearrangement of water molecules around the protein, and decrease in 
entropy. However, as mentioned above, not all CaBPs undergo significant structural 
changes. Therefore, it is possible that the interplay of these entropic factors plays a direct 
role in Ca2+ affinity (Gifford, Walsh & Vogel 2007a).  
The contribution of enthalpy to Ca2+ affinity is less clear; however, a model termed 
the ‘charge-ligand-balanced model’ has been proposed to explain the energetic 
contribution of metal coordination in metal affinity (Ye et al. 2005). In the charge-ligand-
balanced thermodynamic model, both the number of residues coordinating Ca2+ as well as 
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the repulsion of adjacent residues and stabilization of the chelation geometry can modulate 
metal affinity. In addition, the extensive presence of hydrogen bonds stabilizing the EF-
hand loops can have significant contribution to the enthalpy. These electrostatic 
interactions can be extensively modified by the presence of hydrophobic amino acids in 
the flanking helices of EF-hands. Hydrophobic amino acids can induce changes in the 
dielectric environment, which in turn will modify the electrostatic forces between residues. 
The electrostatic shielding has been implicated in increasing the Ca2+ affinity of the C-
terminus EF-hands of TnC, compared to that of calmodulin (Wang et al. 1998). 
Figure 1.12. Domain organization of CaBPs, EF-hand pairs near the N-terminus shown in 
blue and near the C-terminus shown in red. Calcium is shown as a yellow sphere. (a) 
Calbindin D9k (PDB: 3icb), (b) parvalbumin (PDB: 1b8r), (c) calmodulin (PDB: 1cll), (d) 
recoverin (PDB: 1jsa). 
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1.4 EF-hand domain organization 
The local organization of the EF-hands (open vs closed) are not the only factors 
that control the activity and classification of CaBPs. Another aspect which separates 
CaBPs, is the interdomain organization of the EF-hand pairs. At least five types of domain 
organization of the EF-hand pairs have been observed (Figure 1.12). The simples domain 
consist of a single active EF-hand pair as observed in calbindin D9k (Szebenyi, Moffat 
1986) and parvalbumin (Declercq et al. 1999). Second, in proteins such as TnC and CaM, 
two EF-hand pairs are connected via a flexible linker. The flexibility of the linker region 
plays a significant role in ligand recognition of these proteins (Sun, Brandmeier & Irving 
2006, Yamniuk, Vogel 2004). Third, proteins of the NCS subfamily contain short linkers, 
which position the EF-hand pairs at the N- and C-terminus is close contact. The orientation 
of the EF-hand domains in these proteins leads the formation of a large hydrophobic 
surface which mediates ligand recognition (McCue, Haynes & Burgoyne 2010, Ames, Lim 
2012). Fourth, the EF-hand domain organization in the sarcoplasmic calcium-binging 
proteins positions the Ca2+ binding loops at opposite sides of a tightly held hydrophobic 
cavity (Cook et al. 1993). In the globular domain organization, a hydrophobic cluster of 
hydrophobic amino acids lining the entering and exiting helices of each EF-hand form a 
large core. The overall globular fold of these proteins is quite distinct than that observed in 
the extended conformation of calmodulin. Lastly, proteins such as calbindin D28K and 
celretinin contain odd number of EF-hands (Kojetin et al. 2006). The presence of these 
unpaired EF-hand drives the homodimerization of these proteins in the presence of Ca2+, 
resulting in three pairs of EF-hands.  
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Furthermore, small angle x-ray scattering and NMR have shown that the linker 
connecting the EF-hand domains of calmodulin is flexible (Barbato et al. 1992, Heidorn, 
Trewhella 1988). These observation have been supported by molecular dynamics 
simulations of Ca2+ bound calmodulin which revealed that the extended structure of the 
protein can collapse to form a compact structure similar to that observed in the presence of 
binding peptides (Shepherd, Vogel 2004). Similarly, the NMR structure of Ca2+ bound 
recoverin shows multiple conformations in which the N-terminus myristoyl group is 
largely free to move (Figure 1.13) (Ames et al. 1997).   
Figure 1.13. Interdomain structural dynamics of (a) Ca2+ free CaM (PDB: 1cfc), where the 
C-terminus EF-hand 3 (blue) and EF-hand 4 (red) are aligned for clarity and the flexible 
N-terminus is shown as diffuse orange and green ribbons. (b) The NMR structure of Ca2+ 
bound myristoylated recoverin (PDB: 1jsa). EF-hand 1,2,3, and 4 are colored in orange, 
green, blue, and red, respectively. The EF-hands 3 and 4 were aligned to show the 
flexibility of the N-terminus. 
 
Molecular dynamics simulations of NCS-1 also support the idea that in solution, NCS-1 is 
more flexible than observed in crystal structures (Bellucci et al. 2013). In addition, 
unfolding experiments have shown that interdomain communications in the neuronal 
calcium sensor subfamily can regulate the stability of these proteins (Heidarsson et al. 
2013). However, the role of interdomain dynamics in calcium binding proteins, especially 
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the neuronal calcium sensors, have not been investigated in detail. Future work 
investigating the molecular mechanism by which domain organization affects protein 
activity will provide invaluable insight into their function.  
 
1.5 KChIPs and DREAM 
1.5.1 Potassium channel interacting proteins 
The K+ channel interacting proteins (KChIPs) subgroup are the newest member of 
the NCS family. This group was  discovered by pull down search of proteins which could 
interact with the N-terminus of Kv4 channels (An et al. 2000). Association of these proteins 
with the α-subunit of KV4 channels was found to reconstitute several biophysical features 
of A-type currents measured in vivo. Northern blot analysis also revealed that KChIP1 is 
highly expressed in the brain, KChIP2 is expressed in the brain, heart, and lung; while 
KChIP3 is expressed mainly in the brain (An et al. 2000). The last member of this group, 
KChIP4, was discovered by database search of proteins with similar sequence homology 
to KChIP1/2/3 (Holmqvist et al. 2002).  All four members of this group, KChIP1, KChIP2, 
KChIP3, and KChIP4, are known to interact with the N-terminus domain of K+ voltage-
gated channels and regulate the fast ISA and ITO currents in the brain and heart, respectively 
(An et al. 2000). Interaction of KChIP1, KChIP2, and KChIP3 with KV4 channels expressed in 
xenopus oocytes results in an increase in current density, acceleration of recovery from inactivation, 
and slower inactivation kinetics (An et al. 2000). Similar effects on the biophysical properties of 
neural fast inactivating K+ currents have been observed for KChIP1 (Bourdeau et al. 2011) and 
KChIP3 (Witzel, Fischer & Bähring 2012).
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Figure 1.14. Sequence alignment of KChIP 1 (panel A) and KChIP2 (panel B) for different 
isoforms. Identical amino acid positions shown in bold blue color. The turn-loop amino acids 
of each EF-hand are underlined. The position of the EF-hands are shown in colored cartoons 
for reference. Isoform 4 and 8 of KChIP2 not included for clarity. 
Panel A: KChIP1 isoforms 
 
MGAVMGTFSSLQTKQ-RRPSKDIAWWYYQYQRDKIEDELEMTMVCHRPEGLEQLEAQTNFTKRELQVLYRGFKNECPSGVVNEDTFKQIYAQFFPHGD---------------------- 97 
MGAVMGTFSSLQTKQR------------RPSKDKIEDELEMTMVCHRPEGLEQLEAQTNFTKRELQVLYRGFKNECPSGVVNEDTFKQIYAQF--------------------------- 81 
----------------------------------------MTMVCHRPEGLEQLEAQTNFTKRELQVLYRGFKNECPSGVVNEDTFKQIYAQFFPHGD---------------------- 58 
---MSGCSKRCKLGFVKFAQTIFKLITGTLSKDKIEDELEMTMVCHRPEGLEQLEAQTNFTKRELQVLYRGFKNECPSGVVNEDTFKQIYAQFFPHGD---------------------- 95 
MGAVMGTFSSLQTKQR------------RPSKDKIEDELEMTMVCHRPEGLEQLEAQTNFTKRELQVLYRGFKNECPSGVVNEDTFKQIYAQFFPHGALPCLEGSPCVEFLPPSPALLFC 108 
                                                                         EF-hand 1 
                          
---ASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESCQEDD 214 
------------------------------------RGTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESCQEDD 165 
---ASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESCQEDD 175 
---ASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESCQEDD 212 
LVDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESCQEDD 228 
               EF-hand 2                           EF-hand 3                                        EF-hand 4                                    
 
NIMRSLQLFQNVM 227 KChIP1.1 
NIMRSLQLFQNVM 178 KChIP1.2 
NIMRSLQLFQNVM 188 KChIP1.3       
NIMRSLQLFQNVM 225 KChIP1.4 
NIMRSLQLFQNVM 241 KChIP1.5 
 
Panel B: KChIP2 isoforms 
 
MRGQGRKESLSDSRDLDGSYDQLTGHPPGPTKKALKQRFLKLLPCCGPQALPSVSE---------------TLAAPASLRPHRPRLLDPDSVDDEFELSTVCHRPEGLEQLQEQTKFTRK 105 
MRGQGRKESLSDSRDLDGSYDQLTGHPPGPTKKALKQRFLKLLPCCGPQALPSVSE---------------------------------NSVDDEFELSTVCHRPEGLEQLQEQTKFTRK 87 
MRGQGRKESLSDSRDLDGSYDQLT-----------------------------------------------------------------DSVDDEFELSTVCHRPEGLEQLQEQTKFTRK 55 
MRGQGRKESLSDSRDLDGSYDQLT-----------------------------------------------------------------DSVDDEFELSTVCHRPEGLEQLQEQTKFTRK 55 
MRGQGRKESLSDSRDLDGSYDQLTGHPPGPTKKALKQRFLKLLPCCGPQALPSVSEIGRVFRFLGDSSLPSALAAPASLRPHRPRLLDPDSVDDEFELSTVCHRPEGLEQLQEQTKFTRK 120 
MRGQGRKESLSDSRDLDGSYDQLT-----------------------------------------------------------------DSVDDEFELSTVCHRPEGLEQLQEQTKFTRK 55 
MRGQGRKESLSDSRDLDGSYDQLT-----------------------------------------------------------------DSVDDEFELSTVCHRPEGLEQLQEQTKFTRK 55 
   
ELQVLYRGFKN-------ECPSGIVNEENFKQIYSQFFPQGDSSTYATFLFNAFDTNHDGSVSFEDFVAGLSVILRGTVDDRLNWAFNLYDLNKDGCITKEEMLDIMKSIYDMMGKYTYP 218 
ELQVLYRGFKN-------ECPSGIVNEENFKQIYSQFFPQGDSSTYATFLFNAFDTNHDGSVSFEDFVAGLSVILRGTVDDRLNWAFNLYDLNKDGCITKEEMLDIMKSIYDMMGKYTYP 200 
ELQVLYRGFKN-------ECPSGIVNEENFKQIYSQFFPQGDSSTYATFLFNAFDTNHDGSVSFEDFVAGLSVILRGTVDDRLNWAFNLYDLNKDGCITKEEMLDIMKSIYDMMGKYTYP 168 
ELQVLYRGFKN-------ECPSGIVNEENFKQIYSQFFPQGDSSTYATFLFNAFDTNHDGS----DFVAGLSVILRGTVDDRLNWAFNLYDLNKDGCITKEEMLDIMKSIYDMMGKYTYP 164 
ELQVLYRGFKN-------ECPSGIVNEENFKQIYSQFFPQGDSSTYATFLFNAFDTNHDGSVSFEDFVAGLSVILRGTVDDRLNWAFNLYDLNKDGCITKEEMLDIMKSIYDMMGKYTYP 233 
ELQVLYRGFKNPGALSFQECPSGIVNEENFKQIYSQFFPQGDSSTYATFLFNAFDTNHDGSVSFEDFVAGLSVILRGTVDDRLNWAFNLYDLNKDGCITKEEMLDIMKSIYDMMGKYTYP 175 
ELQVLYRGFKN-------ECPSGIVNEENFKQIYSQFFPQGDSSTYATFLFNAFDTNHDGSVSFE------------------------------------EMLDIMKSIYDMMGKYTYP 132 
               EF-hand 1                               EF-hand 2                           EF-hand 3                                             
 
ALREEAPREHVESFFQKMDRNKDGVVTIEEFIESCQKDENIMRSMQLFDNVI 270 KChIP2.1 
ALREEAPREHVESFFQKMDRNKDGVVTIEEFIESCQKDENIMRSMQLFDNVI 252 KChIP2.2 
ALREEAPREHVESFFQKMDRNKDGVVTIEEFIESCQKDENIMRSMQLFDNVI 220 KChIP2.3 
ALREEAPREHVESFFQKMDRNKDGVVTIEEFIESCQKDENIMRSMQLFDNVI 216 KChIP2.5 
ALREEAPREHVESFFQKMDRNKDGVVTIEEFIESCQKDENIMRSMQLFDNVI 285 KChIP2.6 
ALREEAPREHVESFFQKMDRNKDGVVTIEEFIESCQKDENIMRSMQLFDNVI 227 KChIP2.7 
ALREEAPREHVESFFQKMDRNKDGVVTIEEFIESCQKVQLPALYITLTWTQA 184 KChIP2.9 
                    EF-hand 4    
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Figure 1.15. Sequence alignment of KChIP3 (panel C) and KChIP4 (panel D) for different isoforms. Identical amino acid 
positions shown in bold blue color. The turn-loop amino acids of each EF-hand are underlined. For EF-hand that are active, 
the amino acids providing the coordination to the metal ion are shown in red. The position of the EF-hands are shown in 
colored cartoons for reference.  
Panel C: KChIP3 isoforms 
MQPAKEVTKASDGSLLGDLGHTPLSKKEGIKWQRPRLSRQALMRCCLVKW----------ILSSTAPQGSDSSDSELELSTVRHQPEGLDQLQAQTKFTKKELQSLYRGFKNECPTGLVD 110 
MQPAKEVTKASDGSLLGDLGHTPLSKKEGIKWQRPRLSRQALMRCCLVKW----------ILSSTAPQGSDSSDSELELSTVRHQPEGLDQLQAQTKFTKKELQSLYRGFKN-------- 102 
------------------------------------MGIQGMELCAMAVVVLLFIAVLKQFGILEPISMEDSSDSELELSTVRHQPEGLDQLQAQTKFTKKELQSLYRGFKNECPTGLVD 84 
                                                                                                                EF-hand 1                                 
      
EDTFKLIYAQFFPQGDATTYAHFLFNAFDADGNGAIHFEDFVVGLSILLRGTVHEKLKWAFNLYDINKDGYITKEEMLAIMKSIYDMMGRHTYPILREDAPAEHVERFFEKMDRNQDGVV 230 
--------------GDATTYAHFLFNAFDADGNGAIHFEDFVVGLSILLRGTVHEKLKWAFNLYDINKDGYITKEEMLAIMKSIYDMMGRHTYPILREDAPAEHVERFFEKMDRNQDGVV 208 
EDTFKLIYAQFFPQGDATTYAHFLFNAFDADGNGAIHFEDFVVGLSILLRGTVHEKLKWAFNLYDINKDGYITKEEMLAIMKSIYDMMGRHTYPILREDAPAEHVERFFEKMDRNQDGVV 204 
                              EF-hand 2                                EF-hand 3                                             EF-hand 4          
 
TIEEFLEACQKDENIMSSMQLFENVI 256 KChIP3.1 
TIEEFLEACQKDENIMSSMQLFENVI 234 KChIP3.2 
TIEEFLEACQKDENIMSSMQLFENVI 230 KChIP3.3 
 
 
 
Panel D: KChIP4 isoforms 
 
MNVRRVESISAQLEEASSTGGFLYAQNSTKRSIKERLMKLLPCSAAKTSSPAIQNSVEDELEMATVRHRPEALELLEAQSKFTKKELQILYRGFKNECPSGVVNEETFKEIYSQFFPQGD 120 
MNVRRVESISAQLEEASSTG----------------------------------DSVEDELEMATVRHRPEALELLEAQSKFTKKELQILYRGFKNECPSGVVNEETFKEIYSQFFPQGD 86 
--------------------------------------------------------------MATVRHRPEALELLEAQSKFTKKELQILYRGFKNECPSGVVNEETFKEIYSQFFPQGD 58 
MNLEGLEMIAVLIV-------------------IVLFVKL--LEQFGLIEAGLEDSVEDELEMATVRHRPEALELLEAQSKFTKKELQILYRGFKNECPSGVVNEETFKEIYSQFFPQGD 99 
-------------------------MSGCRKRCKREILKFAQYLLRLLTGSLHTDSVEDELEMATVRHRPEALELLEAQSKFTKKELQILYRGFKNECPSGVVNEETFKEIYSQFFPQGD 95 
                                                                                               EF-hand 1                                              
                                                                                
STTYAHFLFNAFDTDHNGAVSFEDFIKGLSILLRGTVQEKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKEDAPRQHVETFFQKMDKNKDGVVTIDEFIESCQKDENIM 240 
STTYAHFLFNAFDTDHNGAVSFEDFIKGLSILLRGTVQEKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKEDAPRQHVETFFQKMDKNKDGVVTIDEFIESCQKDENIM 206 
STTYAHFLFNAFDTDHNGAVSFEDFIKGLSILLRGTVQEKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKEDAPRQHVETFFQKMDKNKDGVVTIDEFIESCQKDENIM 178 
STTYAHFLFNAFDTDHNGAVSFEDFIKGLSILLRGTVQEKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKEDAPRQHVETFFQKMDKNKDGVVTIDEFIESCQKDENIM 219 
STTYAHFLFNAFDTDHNGAVSFEDFIKGLSILLRGTVQEKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKEDAPRQHVETFFQKMDKNKDGVVTIDEFIESCQKDENIM 215 
               EF-hand 2                                EF-hand 3                                                                                                                          EF-hand 4                                                                                           
 
RSMQLFENVI 250 KChIP4.1 
RSMQLFENVI 216 KChIP4.2 
RSMQLFENVI 188 KChIP4.3 
RSMQLFENVI 229 KChIP4.4 
RSMQLFENVI 225 KChIP4.5 
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The repertoire of KChIPs is further expanded by the presence numerous KChIP splice variants 
(Figure 1.14 and 1.15) (Deschênes et al. 2002, Van Hoorick et al. 2003). In total, twenty two 
isomers have been identified (5 for KChIP1, 9 for KChIP2, 3 for KChIP3, and 5 for KChIP4) , the 
most common difference among these isomers is the deletion or insertion of amino acid sequences 
near the N-terminus. In particular, KChIP1.2 and KChIP3.2 isoforms which have a deletion of the 
metal binding loop of EF-hand 2. Interestingly, a minimal KChIP2 isoform has been discovered, 
in which only EF-hand 3 and 4 are present; this isoform was shown to still effectively regulate 
potassium currents (Patel, Campbell & Strauss 2002).  
Figure 1.16. Cartoon representation of a hypothetical potassium channel macromolecular 
complex, dotted lines represent the transmembrane thickness. The model was constructed by 
structural alignment of the full length shaker potassium channel KV1.2 (PDB: 3lut) and the crystal 
structure of the KChIP1-Kv4.3 T1 domain complex (PDB: 2i2r).  (a) Side view: the 
transmembrane domain containing the K+ selectivity pore is shown in green with potassium as 
solid purple spheres. The T1-domain is shown in light blue and KChIP1 bound to Ca2+ (yellow 
sphere) is show in dark blue. The β subunit is shown in orange. (b) Top vie of the same complex. 
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This minimal construct highlights the importance of the C-terminus of KChIPs in K+ channel 
regulation. KChIPs have also been shown to associate with Kv4 channels in many different 
combination of different KChIPs/isomers, which results in a wider range of K+ channel tuning 
(Bourdeau et al. 2011, Kunjilwar, Qian & Pfaffinger 2013b, Liss et al. 2001).  
Figure 1.17. Cartoon representation of the KChIP1:Kv4.3 T1 domain protein complex (PDB: 
2nz0). (a) Octameric cross shaped complex of four KChIP1 (dark blue) and four T1 domain 
monomers (orange). (b) Close up of the interaction between the N-terminus hydrophobic region of 
the T1 domain (“Site 1”) and the hydrophobic surface of KChIP1. Residues 1 to 10 shown in 
yellow and 10 to 20 in red. (c) Contact between the N-terminus of KChIP1 and “Site 2” (residues 
70 to 90, shown in green licorice) of Kv4.3. 
 
Structural studies have shown that KChIP1.1 associates with the cytosolic portion of the α-
subunit of the Kv4 potassium channels, to form octameric complexes (Figure 1.16)  (Pioletti et al. 
2006, Scannevin et al. 2004, Wang et al. 2007). The KChIP1:Kv4 interaction is mediated by 
two surface contacts on KChIP1 and the cytosolic T1 domain of the Kv4 channels (Scannevin et 
al. 2004). The KChIP1:Kv4 protein complex forms an octameric cross shaped organization 
(Figure 1.17) (Pioletti et al. 2006, Wang et al. 2007). The most predominant interaction is 
 25 
between a large hydrophobic surface on KChIP1 and the hydrophobic N-terminus α-helix of the 
Kv4 channel. This hydrophobic interaction buries about 2300 Å2 of exposed surface and involves 
two well conserved bulky residues on the N-terminus of Kv4 channels, Trp8 and Trp19 (Figure 
1.18) (Wang et al. 2007).  
Figure 1.18. (a) Cartoon representation of KhIP1 (PDB: 2nz0) using the same coloring scheme as 
in Figure 1.4 with residues forming the interface with the N-terminus of Kv4.3 shown as licorice 
model. (b) Alpha-helix at the N-terminus of the KV4.3 potassium channel with hydrophobic amino 
acids involved in binding of KChIP1 shown as licorice model. 
 
The hydrophobic surface on KChIP1 is lined by two groups of amino acids at the N- and 
C-terminus. The C-terminus cluster includes Tyr134, Ile150, Val151, Tyr155, Ile154, Phe178, and 
His174, which interact with Trp19 of the Kv4 channel (Figure 1.18). At the N-terminus, residues 
Ile77, Tyr78, Phe74, Leu94, Phe111, Leu115, Leu118, Phe60 and Gly59 are in direct contact with 
Trp8 and Phe11 of the N-terminus of the Kv4 channel. The second contact interface between 
KChIP1 and the T1 domain involves hydrophobic and charged residues at the entering helix of EF-
hand 1 on KChIP1 and residues 70 to 78 of the T1 domain (Figure 1.19) (Scannevin et al. 2004, 
Wang et al. 2007). In this interface Phe73 of the T1 domain interacts through stacking interactions 
with Leu39, Leu42, Leu43, Tyr57 and Phe108 of KChIP1. In addition, two salt bridges between 
Glu77 and Asp78 of the T1 domain and Lys50 and Arg51 on KChIP1 stabilize this interaction.  
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Even though all members of the KChIP group of NCS proteins associate with KV4 
channels, only the structure of KChIP1 has been obtained in complex with these channels (Pioletti 
et al. 2006, Liang et al. 2009). However, all KChIPs share a high sequence homology (58 % 
among residues 60 to 256) at the core domain spanning EF-hands 1, 2, 3, and 4 (Figure 1.20). Thus 
it has been proposed that similar structural organization of the KChIP:Kv4.3 complex may be 
present in other KChIPs (Liang et al. 2009). Indeed, all amino acids involved in stabilizing the 
KChIP1:Kv4 complex are conserved among all KChIP proteins (Figure 1.20, highlighted in 
green).  
Figure 1.19. Cartoon representation of the second interface “Site 2” between KhIP1 and the 
N-terminus of Kv4.3 (PDB: 2nz0) using the same coloring scheme as in Figure 1.4. The T1 domain 
is shown in brown. The inset show the hydrophobic (top) and electrostatic (bottom) interactions. 
 
All members of the KChIP subgroup contain four EF-hand domains, with EF-hand 3 and 4 
showing the strongest affinity for Ca2+, while EF-hand 2 is proposed to bind Mg2+ preferentially 
(Osawa et al. 2005, Lusin et al. 2008). The selectivity for Mg2+ over Ca2+, is believe to arise due 
to the mutation of glutamic acid at position 12 of the EF-hand loop to aspartic acid. However, it is 
not known whether the Ca2+ affinity varies among the member of the KChIP group. Nonetheless, 
calcium binding studies on KChIP3 have revealed that this construct can bind two calcium ions 
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with higher affinity than that observed for other NCS proteins, (Kd ~ 1 to 10 μM) (Osawa et al. 
2005, Craig et al. 2002).  
Figure 1.20. Sequence alignment of human KChIP1, KChIP2, KChIP3, and KChIP4. Turn loops 
of EF-hand 1, 2, 3, and 4 are shown in bold and underlined. the negatively charged amino acids 
involved in metal coordination shown in red. Asterisks indicate identical residues, semicolon 
indicates very similar residues, and the period is for somewhat similar residues. Amino acids 
involved in Kv4 binding are shown in green. 
 
1.5.2 DREAM/KChIP3 
In contrast with other members of the neuronal calcium sensor family, KChIPs are not 
only prominently expressed in the brain, but also in cardiac tissue. In the heart, they play a 
major role in regulation of the fast ITO currents generated by the fast opening of voltage 
gated K+ channels (An et al. 2000). For instance, the expression gradient of KChIP2 in the 
endocardium and epicardium have been implicated in generation of the transmural current 
necessary for proper pacemaking (Rosati et al. 2001). More importantly, KChIP2 has been 
shown to mediate the dose dependent effect of drugs known to regulate heart pacemaking 
(Bett et al. 2006). Thus, KChIPs have been proposed to be an innovative target for the 
treatment of cardiovascular diseases (Calloe et al. 2009, Lundby et al. 2010). In the brain, 
KChIP2 and KChIP3 have been shown to play a major role in regulation of the fast ISA 
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current arising from K+ escape through the Kv4 voltage sensitive channels (Amarillo et al. 
2008, Jerng, Pfaffinger 2008). 
In addition, KChIP3 has been shown to be involved in regulation of gene expression. 
Association of KCHIP3 in the absence of calcium with the downstream regulatory element 
(DRE) of some genes has been directly shown to inhibit expression of downstream genes 
(Carrion et al. 1999). On the basis of the antagonist modulation of gene expression by 
KChIP3, Carrion et al. named this protein as DREAM (downstream regulatory element 
antagonist modulator). Association of Ca2+ with DREAM induces dissociation from the 
DRE DNA sequence and subsequent expression of the downstream gene (Carrion, 
Mellstrom & Naranjo 1998). These findings have set KChIP3/DREAM as the first calcium 
binding protein able to directly associate with DNA and regulate gene expression in a 
calcium dependent manner (Carrion et al. 1999, Carrion, Mellstrom & Naranjo 1998). 
Calmodulin is also known to regulate gene expression, but in this case, regulation is 
indirect since calmodulin must associate with basic helix-loop-helix nucleoproteins 
(Corneliussen et al. 1994). Indirect regulation of gene expression has also been observed 
in DREAM via interactions with α-CREAM and CREB proteins (Ledo et al. 2000, Ledo 
et al. 2002). The DREAM-CREB interactions allows the regulations of genes with 
promoters different than the DRE, thus expanding the role of DREAM in gene regulation. 
Furthermore, the role of KChIP3/DREAM in regulation of additional biological processes 
has been highlighted by the initial findings that this protein was able to associate with 
presenilin and regulate the activity of the γ-secretase protein complex (Buxbaum et al. 
1998). The calcium dependent manner in which KChIP3/DREAM associates with 
presenilin led the authors to name this protein calsenilin. Thus, KChIP3 has been 
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independently found by three groups to associate with three different ligands and has been 
named with three different names, KChIP3/DREAM/calsenilin. It is fortunate that despite 
DREAM being found to interact with and regulate the activity of over 40 other proteins in 
the membrane, cytosol, and nucleus, no additional names have been assigned to the protein 
(Ramachandran et al. 2012). 
Figure 1.21. Cartoon representation of the NMR structures of (a) Ca2+ bound mouse 
DREAM (first 75 amino acids not resolved, PDB: 2jul) and (b) Ca2+ bound human 
DREAM (first 160 amino acids not resolved, PDB: 2e6w). The helices numbers are shown 
for clarity, and the EF-hand 1, 2, 3, and 4 are shown in orange, green, blue, and red, 
respectively. Calcium is shown as a yellow sphere. (c) Amino acid sequence of mouse 
DREAM (residues 76 to 256) following the same coloring scheme as in Figure 1.4. The 
cartoon representation of the secondary structure is shown. 
 
Structural studies of DREAM have provided some insight into the potential 
mechanisms of DNA and potassium channel regulation. The NMR structure of Ca2+ bound 
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mouse DREAM(Δ65) reveals an EF-hand domain organization similar to that of recoverin 
(Figure 1.21) (Lusin et al. 2008). In DREAM, EF-hands 1 through 4 are organized as two 
closely packed domains, where the N–terminus contains the inactive EF-hand 1 and the 
Mg2+ sensitive EF-hand 2, while the C-terminus contains EF-hand 3 and 4. The first helix 
(H1, residues 77 to 89) and last helix (H10, residue 242 to 256) are not part of the EF-
hands, but may be involved in ligand recognition (Lusin et al. 2008). Calcium binds with 
high affinity (1 to 10 μM ) at EF-hand 3 and 4 (Osawa et al. 2005). The coordination of 
Ca2+ by the turn-loop of EF-hand 3 and 4 follows that observed in other NCS protein, as 
shown in Figure 1.6.  
Figure 1.22. Cartoon representation of the proposed DREAM dimer in which Leu155, 
Leu158, Leu159, and Leu251 are shown in licorice model with a diffuse surface. Color 
scheme as in Figure 1.12. 
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In the absence of Ca2+, DREAM has been proposed to form tetramers, whereas upon 
binding of Ca2+ a transition to dimers has been observed (Lusin et al. 2008, Osawa et al. 
2001). The role of dimerization in ligand recognition is not known, but dimerization upon 
binding of calcium is widely present in NCS proteins. Indeed, the crystal structures of 
neurocalcin (Vijay-Kumar, Kumar 1999), recoverin (Weiergräber et al. 2003), VILIP-1 (Li 
et al. 2011), and KChIP1 (Zhou et al. 2004b) reveal the formation of dimers upon Ca2+ 
binding.  
Figure 1.23. Cartoon representation of the NMR structures of (a) Ca2+ bound mouse 
DREAM (PDB: 2jul). Positively charged amino acids proposed to mediate DNA binding 
are shown in licorice and transparent blue surface. 
 
The crystal structure of KChIP1 also shows that a hydrophobic crevice lining one side 
of the protein stabilizes the dimer in the calcium bound form (Zhou et al. 2004b). Similarly, 
a proposed model for the dimer of DREAM also highlights the role of hydrophobic amino 
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acids in stabilizing the dimer (Lusin et al. 2008). In particular, two leucine rich regions at 
the N-terminus (Leu155, Leu158, and leu159) and C-terminus (Leu251) have been 
implicated in dimerization and protein-protein interactions (Figure 1.22) (Lusin et al. 2008, 
Ledo et al. 2000).  
 
 
 
 
 
 
Structural analysis and deletion studies have also revealed the potential role of basic 
amino acids at the entering helix of EF-hand 1 (helix H2) in DNA binding (Osawa et al. 
2005, Lusin et al. 2008, Ledo et al. 2000). These basic amino acids (Lys87, Lys90, Lys91, 
Arg98, Lys101, Arg160, and Lys166) are clustered at the N-terminus protein surface and 
may mediate electrostatic interactions with DNA (Figure 1.23). Furthermore, analysis of 
the DRE DNA sequence to which DREAM binds (Table 1.1) as well as pull down 
experiments have highlighted the role of the core section of the DRE sequence (GTCA) in 
binding of DREAM (Nystedt et al. 2006, Ledo et al. 2000).  
 
1.6 Objectives of this study 
Overall, the studies presented above have highlighted DREAM as a novel type of 
NCS protein with the ability to modulate numerous biological processes. However, the 
precise mechanism by which this protein regulates these processes and the molecular 
Table 1.1 Aligned DRE sequences 
Consensus sequence    ANGTCAAAG  
    G     GG  
NPFF DRE 1 GCTTTGTCAGAGCCAGGC antisense 
NPFF DRE 2 CTCCTGTCAGGATTGAGC antisense 
Human DynDRE CCGGAGTCAAGGAGGCC sense 
Mouse DynDRE CTAGAGTCAGGGTACCT sense 
Human c-fos DRE GAAGAGTCAACGAGCGA inverse sense 
Mouse c-fos DRE GAAGAGTCAACGAGCGA inverse sense 
Adapted from (Nystedt et al. 2006) 
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reorganization triggered by Ca2+ binding which controls these mechanisms remains to be 
discovered.  
The role of KChIPs in regulation of ITO currents in the heart and ISA currents in the 
brain has widespread implications in terms of treatment and understanding of 
cardiovascular and neurological diseases. Moreover, the tissue specific expression of 
KChIPs is in sharp contrast to the widespread expression of Kv4 channels, thus providing 
a novel avenue for the development of drug therapies aimed at treatment of abnormal 
activity in the heart or brain. However, the development of novel therapies is hindered by 
the lack of detailed understanding of the molecular mechanisms controlling the interactions 
of KChIPs and their biological partners. Also, the interaction of KChIPs and NCS protein 
with small synthetic and natural ligands remains unexplored. Similarly, information on the 
molecular mechanisms by which Ca2+ regulates the activity of these proteins remains 
scarce. 
Here, we propose to use KChIP3/DREAM as a model neuronal calcium sensor in order 
to understand the role of Ca2+ in regulating the structural mechanism responsible in 
controlling ligand recognition. First, we seek to characterize the role a hydrophobic surface 
on DREAM in regulating association of small fluorescent ligands. This information is 
further used to identify the mechanism by which small non-fluorescent molecules can 
regulate the activity of DREAM and its ability to interact with biological KV channels. We 
further seek to identify role of the N-terminus of DREAM in regulation of protein-protein 
and protein-DNA interactions, and the mechanism by which the C-terminus mediates 
protein-metal coordination. Lastly, through the use of theoretical and experimental 
biophysics, we seek to identify the role of specific amino acids in regulation of protein 
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activity, stability, and ligand recognition. We envision that the combination of 
experimental and theoretical biophysics would allow us to decipher the precise molecular 
reorganization triggered by Ca2+ binding to DREAM. 
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2. MATERIALS AND METHODS 
2.1 Chemicals and reagents 
 The hydrophobic fluorescent probes 1,8-AN, 2,6-ANS and nile red were purchased 
from Invitrogen and used without further purification. The 1,5-IAEDANS, fluorescein 5-
maleimide, and rhodamine red C2 maleimide were purchased from Invitrogen. DM-
nitrophen was purchased from Invitrogen Life Sciences or Calbiochem as described in the 
text. The caged proton, 2-nitrobenzaldehyde was purchased from sigma and dissolved in 
ultrapure water and protected from light by using light resistive microcentrifuge tubes 
and/or aluminum foil. The compound NS5806 (1-[2,4-dibromo-6-(1H-tetrazol-5-yl)-
phenyl]-3-(3,5-bis-trifluoromethyl-phenyl)-urea) (purity>99%) was purchased from 
Tocris Bioscience. Trifluoperazine (TFP) was purchased from Sigma-Aldrich. All other 
reagents and solvents were purchased from Sigma-Aldrich or Fischer scientific and were 
of analytical grade. Maleimide labeling fluorophores were solubilized in DMSO and stored 
at -20°C. Concentrated TFP, 1,8-ANS, and 2,6-ANS stocks were prepared in ultrapure 
(18.2 MΩ) water and stored at -20°C.  The concentration of NS5806, TFP and 1,8-ANS 
stocks were determined spectrophometrically using the extinctions coefficients listed in 
table 2.1. All reagents required for the synthesis of the ReAsH-EDT2 and FlAsH-EDT2 
biarsenical probes were purchased from the vendors recommended in the 
reference (Adams, Tsien 2008). Arachidonic acid was purchased from Sigma, dissolved in 
DMSO and stored under anaerobic conditions at – 30 °C. Cholesterol, benzafibrate, and 
LS35 were obtained from sigma and stocks were prepared in 20mM MOPS pH 7.4. The 
terbium(III) lanthanide was obtained as a hydrated chloride salt (TbCl3·6H2O) from 
Sigma-Aldrich and was used without further purification. Terbium stocks of ~0.5 M were 
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prepared gravimetrically in decalsified ultrapure 18 MΩ water, the concentration of Tb3+ 
stocks were confirmed by titrations against EDTA standards. 
2.2 Recombinant protein expression and purification 
The DREAM and human Kv4.3 protein constructs were expressed in E. coli 
BL21(DE3) cells and purified according to previously published procedures (Scannevin et 
al. 2004, Lusin et al. 2008, Osawa et al. 2001). The plasmid for mouse DREAM, 
DREAM(Δ65), DREAM(Δ160), DREAM(Δ65, E186Q), DREAM(Δ65, E234Q), 
DREAM(Δ65) with a CCPGCC peptide tag at the C-terminus, DREAM-NCS, and 
Kv4.3(1-152) were purchased from Genecopoeia. The rat calmodulin plasmid (herein 
referred as CaM) was a kind gift of Dr. J. P. Davis (Ohio State University). The CaM 
plasmid was subcloned in BL21(DE3) cells and purified as previously described (George 
et al. 1993). The amino acid sequence of all purchased plasmids is shown in Figure 
2.1. Cells were disrupted by sonication (Fisher Scientific, Model 100).  The DREAM(Δ65) 
with a CCPGCC peptide tag and Kv4.3(1-152) protein constructs were recovered as 
insoluble inclusion bodies which were collected by centrifugation. Inclusion bodies were 
washed extensively with 50 mM Tris buffer pH 8.0, 1 M NaCl, 0.5 % Triton-X100, 0.1 % 
NaN3,1 mM DTT, and 5 mM EDTA followed by a final wash with 50 mM Tris buffer pH 
8.0 and 2.0 M NaCl. Washed inclusion bodies were solubilized in 100 mM Tris buffer pH 
12.5, 2.0 M urea, and 5 mM DTT. Refolding was achieved by fast dilution of solubilized 
inclusion bodies into a 10x volume of 100 mM Tris buffer pH 7.4, 250 mM sucrose, 30 % 
glycerol, 20 mM LDAO, 1 mM 2-mercaptoethanol on an ice bath with constant stirring. 
All proteins were stored as concentrated stocks ranging in concentrations from 250 μM to 
850 μM at -32 °C in 20 mM TRIS pH 7.4.  
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Table 2.1a  List of chromophore, extinction coefficient, and manufacturers 
Chemical λ 
(nm) 
Extinction 
coefficient 
(M-1cm-
1) 
Solvent Reference Manufacturer 
NS5806 295 2200 MOPS pH 7.4  Tocris Bioscience 
TFP 306 3300 Water (Hart et al. 1983) Sigma 
1,8-ANS 350 5000 water (Stryer 1965) Calbiochem/Sigma 
2,6-ANS 350 5000 Water (Diwu et al. 1997) Molecular Probes 
Nile red 552 19600 DMSO (Castro et al. 2005) Molecular Probes 
IAEDANS 332 6100 Phosphate  
pH 7.4 
(Hudson, Weber 1973b) Molecular Probes 
Dansyl chloride 340 3300 Phosphate  
pH 7.4 
(Weber 1952) Sigma 
Rhodamine  
maleimide 
560 52000 DMF (Beija, Afonso & Martinho 2009) Molecular Probes 
Fluorescein  
maleimide 
495 78000 0.1 M NaOH (Bigelow, Inesi 1991) Molecular Probes 
Chromophores without reference to the source of the extinction coefficient were determine in this work.  
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Table 2.1b   List of chromophore, extinction coefficient, and manufacturers 
Chemical λ 
(nm) 
Extinction 
coefficient 
(M-1cm-1) 
Solvent Reference Manufacturer 
FITC 495 80000 0.1 M NaOH (Bigelow, Inesi 1991) Sigma 
FlAsH-EDT2 508 63500 0.1 M NaOH (Adams, Tsien 2008)  
ReAsH-EDT2 5579 63000 0.1 M NaOH (Adams, Tsien 2008)  
DM-nitrophen 350 4330 pH 7.1 (Kaplan, Ellis-Davies 1988) Molecular 
probes 
2-nitrobenzaldehyde 313 1590 water (Galbavy et al. 2010) Aldrich 
Arachidonic acid 369 4.72 DMSO  Sigma 
Benzafibrate 280 660 MOPS pH 7.4  Sigma 
Quin-2 240 42000 MOPS pH 7.4 (Linse et al. 1987) Sigma 
TbCl3·6H2O 265 0.052 MOPS pH 7.4  Sigma 
      
Chromophores without reference to the source of the extinction coefficient were determine in this work.  
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Figure 2.1. Amino acid sequence of plasmid purchased. The mouse DREAM, 
DREAM(Δ65), and DREAM(Δ160) plasmids contain a start methionine residue (verified 
by mass spectrometry) and a C-terminus His-tag (blue) connected by tripeptide linker 
(green). The DREAM(Δ65, C4) plasmid contains an N-terminus His-tag (blue) and a C-
terminus tetracysteine tag. The DREAM-NCS chimera plasmid is identical to the 
DREAM(Δ65) plasmid but residues Leu158, Leu159 and the linker between EF-hand 3 
and 4 were replaced by the amino acid sequence of human NCS-1 (shown in red). Lastly, 
a GST-Kv4.3 T1 domain fusion construct was generated (GST in red). The enterokinase 
cleavage site shown in red and underlined. The T1-domain of human Kv4.3 residues 2 to 
152 shown in black. The biarsenical tag is shown in underlined red color. 
 
Labeling of DREAM(Δ65) containing a CysCysProGlyCyCys amino acid sequence 
at the C-terminus with the biarsenical probe FlAsH-EDT2 was conducted by adding 2x 
stoichiometric excess probe under identical condition as reported before (Adams, Tsien 2008). 
Unbound probe was removed by size exclusion chromatography and  labeled protein was further 
purified through a Ni-NTA followed by extensive dialysis in 20 mM MOPS pH 7.4 100 mM NaCl. 
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The labeling efficiency and stock concentration was determined by comparing the protein 
concentration using the bicinchroninic colorimetric method (Thermo Scientific) to the protein 
concentration determined using the FlAsH and ReAsH absorbance in 0.1 M NaOH. Protein purity 
and proper folding prior to FlAsH labeling was assayed using SDS-page electrophoresis, CD 
spectroscopy, and the Zn2+ and Ca2+ induced oligomerization changes as previously reported. 
 
2.3 Mutagenesis 
 
A CaM(A148C) mutant was obtained by site directed mutagenesis of the CaM 
plasmid using the QuickChange Lightning kit (Agilent Technologies). The specific 
procedure described in detail in the QuickChange Lightning procedure provided by the 
manufacturer was strictly followed. Similarly, a small library of DREAM(Δ65) proteins in 
which specific amino acids were mutated to alanine was generated following the same 
protocols. The primer sequence used for the mutagenesis were selected using results from 
the PrimerX webserver and are shown in Table 2.2. Mutation of the selected amino acids 
was confirmed by DNA sequencing (Eurofins Genomics) of plasmid extracted with the 
Table 2.2 Primers used for site directed mutagenesis 
Mutant name 5’ to 3’ 
CaM(A148C) GCTGACTGAAGAACAGATTTGCGAATTCAAGGAAGCTTTCTC 
DREAM(K87A) CTACAAGCTCAGACCGCGTTCACCAAGAAGG 
DREAM(E92A) CAAGTTCACCAAGAAGGCGCTGCAGTCCCTTTAC 
DREAM(F171A) GAGAAGCTCAAGTGGGCCGCGAATCTCTATGACATTAAC 
DREAM(Y174A) GTGGGCCTTCAATCTCGAGGACATTAACAAGGATGG 
DREAM(F218A) GGAGCATGTGGAGAGGGCGTTTCAGAAAATGGACAG 
DREAM(F219A) GCATGTGGAGAGGTTCGCGCAGAAAATGGACAGG 
DREAM(F235A) GTGGTGACCATTGATGAAGCGCTGGAGACTTGTCAGAAG 
DREAM(F252A) GAACTCCATGCAGCTGGCGGAGAACGTCATCTAC 
 41 
StrataPrep Plasmid Miniprep kit (Agilent). Following sequencing, these plasmids were 
subcloned in BL21(DE3) E. coli cells; protein expression and purifications was carried out 
as described above. We have observed that not all plasmid extractions yield plasmid of 
enough purity for sequencing. For instance, we have observed that large concentrations 
usually larger than 100 ng/mL with absorbance ratios of 1.8>260/280<2.1 and 
1.2<260/240<1.7 usually result in successful sequencing; however, in some instances we 
have obtained good enough sequencing for samples which did not satisfy these conditions. 
In all instances, sequencing allowed unequivocal identification of the mutations being 
introduced (see appendix 2). Overall, almost all plasmid mutations were a success using 
the protocols described, with only one failed transformation. 
2.4 Full length DREAM expression and purification 
We have also developed a CaM and DREAM low temperature co-expression 
protocol which has allowed us to recover milligram quantities of soluble full-length 
DREAM. Briefly, E. coli BL21(DE3) competent cells were transformed with CaM and 
DREAM plasmids and grown in LB medium at 37°C in the presence of 100 μg/mL 
ampicillin until reaching an optical density of 2 at 600 nm. The medium was then quickly 
chilled on an ice bath to 4°C and protein expression was induced by adding 0.2 mM IPTG. 
The medium was placed back in the shaker at 250 rpm for an additional 6 hours at 18°C 
followed by harvest of the cells by centrifugation for 15 minutes at 5000 RPM. The cell 
pellet was resuspended in 100 mM Tris buffer pH 8.0, 0.5 M NaCl, 1 mM CaCl2, 5 mM 
MgCl2, 5 mM imidazole, 1.0 % Triton-X100, 0.5 % Tween 20 supplemented with 20 
μg/mL DNAse, 200 μg/mL lysozyme, and 0.5 mM phenylmethylsulfonyl fluoride and 
sonicated on an ice bath for 30 cycles at 30% duty cycle. The cell lysate was centrifuged 
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at 11,000 g for 50 minutes and the supernatant was loaded on a Ni-NTA column 
equilibrated with buffer A (20 mM Tris pH 7.4, 300 mM NaCl, 0.5 mM CaCl2 and 10 mM 
LDAO). The Ni-NTA column loaded with DREAM was washed extensively with buffer 
A and eluted in buffer B (20 mM Tris pH 7.4 and 10 mM LDAO) supplemented with 250 
mM imidazole. Selected fractions were loaded onto a DEAE-sepharose anion exchange 
column previously equilibrated with buffer B, washed with buffer B and 80 mM NaCl then 
eluted with 180 mM NaCl, the final protein was stored in 5 mM Tris pH 8.0. The purity of 
all protein constructs was assessed using SDS-PAGE. The proper secondary structure and 
tertiary structure of all protein constructs was confirmed by using the known far-UV CD 
transition of DREAM protein as well as changes in tryptophan fluorescence upon calcium 
binding (Osawa et al. 2005, Carrion et al. 1999, Osawa et al. 2001). 
 
2.5 Protein labeling 
 Labeling of CaM(A148C) with 1,5-IAEDANS or rhodamine red C2 (RRC2) 
maleimide was conducted after reduction of cysteine residues with 5 mM TCEP in 200 
mM Tris pH 7.4 followed by extensive purging with argon and addition of (10-50x) excess 
fluorophore freshly prepared in DMF. The reaction was allowed proceed for 24 hours at 
4°C with constant stirring in the dark. Unbound fluorophore was removed by size exclusion 
chromatography through a Sephadex G10 column. Labeled protein fractions were selected 
based on their absorption and fluorescence anisotropy and were extensively dialyzed in 5 
mM Tris pH 7.4. The fraction of labeled protein was determined by dividing the 
fluorophore concentration (1,5-IAEDANS ε336nm = 6100 M-1cm-1 in buffer (Hudson, 
Weber 1973a) or RRC2 ε560nm = 119000 M-1cm-1 in DMSO) by the protein concentration 
 43 
(CaM(A148C) ε280nm = 3140 M-1cm-1) after correction by the absorption of the fluorophore 
at 280 nm. Protein samples were prepared by dilution and the final protein concentration 
was measured using ε280nm = 31,200 M-1cm-1 for DREAM and ε280nm = 19,000 M-1cm-1 for 
DREAM(Δ65).  The extrinsic fluorophore 1,8-ANS was added to protein samples directly 
from a concentrated stock. Calcium was added at 10x excess for DREAM and 1 mM for 
DRE29 samples and 2 mM EDTA was used to remove calcium; 50 mM CaCl2 and 200 
mM EDTA standard stocks at pH 7.4 were used. CaM labeled with IAEDANS or RRC2 
are referred as CaM-IAEDANS and CaMRR2, respectively. The amount of DMSO in the 
protein samples, whenever needed, did not exceed 1.2 % v/v. 
Figure 2.2. Increase in fluorescence intensity of FlAsH-EDT2 and ReAsH-EDT2 upon 
specific covalent attachment to a small CCPGCC peptide. Green trace functions as a 
control to show that there is no direct interaction of the biarsenical probe and DREAM, 
even though 5 cysteine are present in this protein. 
 
The ReAsH-EDT2 and FlAsH-EDT2 synthesis and purification was carried out as 
described in detail by (Adams et al. 2002). The selectivity of the purified products was 
tested by monitoring the fluorescence enhancement upon binding to the CCPGCC test 
peptide. A representative plot of total fluorescence vs. time is shown in Figure 2.2. Proteins 
were labeled with FlAsH and ReAsH following previous protocols (Adams, Tsien 2008). 
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Unbound fluorophores were removed by size exclusion chromatography using a G10 
Sephandex column (Sigma) followed by Ni-NTA purification and extensive dialysis.  
2.6 Protein sample preparation 
 Protein samples were prepared by diluting a concentrated protein stock in buffered 
aqueous solutions at pH and ionic strength as described throughout the text. Final protein 
concentration was measured spectrophotometrically using ε280nm = 19,000 M-1cm-1 for 
DREAM(Δ65), ε280nm=10,500 M-1cm-1 for DREAM(Δ160), ε280nm=71,500 M-1cm-1 for 
GST-Kv4.3(1-152), and ε508nm =63,500 M-1cm-1 for DREAM(Δ65) labeled with FlAsH or 
ReAsH (Adams, Tsien 2008). All samples were prepared and measured at room 
temperature, unless specified otherwise. Protein stocks were kept in small concentrated 
aliquots  at -30 °C immediately after purification, these stocks were thawed on ice only 
once prior to use. The Ca2+ free or Mg2+DREAM samples were prepared by adding 1 mM 
EDTA or 1 mM EGTA and 5mM MgCl2, respectively. The Ca2+ and Ca2+ Mg2+ samples 
were prepared by adding 1 mM Ca2+ or 1mM Ca2+ and 5mM Mg2+. All EDTA, EGTA, 
CaCl2, and MgCl2 stocks were prepared in ultrapure 18 MΩ water and adjusted to pH 7.4 
using NaOH or HCl. Throughout the text, the metal free protein is referred as Ca2+ free, 
apo-, or apoform. 
 
2.7 Methods used in chapter 3 
2.7.1 Steady-state fluorescence 
Steady-state emission measurements were carried out on a custom PC1 
spectrofluorometer (ISS, Champaign, IL) with bandwidth and slit width for 
excitation/emission set at 8 nm and 0.5 mm, respectively. The emission spectra for 1,8-
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ANS:DREAM(Δ65) and 2,6-ANS:DREAM(Δ65) complexes were measured using λexc = 
350 nm and 319 nm, respectively. Titration were carried out at 20 °C and in a 2 mm x 10 
mm path length quartz cuvette with excitation along the 2 mm path. Dissociation constants 
were determined either by titrating a small amount of concentrated ANS or arachidonic 
acid stock solution into 7 µM DREAM(Δ65) sample or keeping ANS concentration 
constant and adding aliquots of DREAM(Δ65) stock solution. In order to avoid dilution 
effects, ANS or protein was kept in both titrant and titrand at identical concentration. The 
intensity was corrected for the inner filter effect (Lakowicz 2010). The signal from 
unbound dye was subtracted and the emission intensity was determined by integrating the 
emission signal. Titration curves were analyzed using the Hill equation (Hawe, Sutter & 
Jiskoot 2008): 
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where, Kdss is the dissociation constant, n represents the Hill coefficient, and yo is an offset 
associated with small uncorrected light scattering.  
2.7.2 Fluorescence decay lifetime 
Frequency-domain fluorescence lifetime and anisotropy decay measurements were 
performed using a ChronosFD spectrofluorimeter. The samples containing 1,8-ANS or 2,6-
ANS were excited with a 305 nm diode or 370 nm laser diode and the emission was 
collected using a 400-600 nm band pass filters (Andover). The lifetime reference used 
was 1,4-bis(5-phenyloxazol-2-yl)benzene (POPOP) in ethanol (τ = 1.35 ns) with polarizers 
set at a magic angle configuration (Spencer, Weber 1970). Modulation ratio and phase 
change data were analyzed using GlobalsWE software and the χ2 parameter was used as 
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criterion for goodness of the fit (Lakowicz 2010). Fluorescence intensity decays were 
analyzed using a multiple-exponential decay model and multiple frequency-domain data 
from at least three different protein batches were simultaneously fitted using the global 
analysis approach with the lifetime parameters set as linked variables. The theory behind 
frequency-domain depolarization has been described elsewhere (Badea 1979, Lakowicz et 
al. 1993). We implemented a triple associative decay model since multiple correlations 
lifetimes due to oligomerization equilibrium of DREAM(Δ65) and due to heterogeneous 
binding of the ANS probes. The validity of the model was judged on the basis of the 
closeness of the χ2 value to 1. Frequency-domain depolarization data were analyzed using 
global analysis between data sets obtained with 305 nm and 370 nm excitation while 
keeping the rotational time as a linked-variable.  
2.7.3 Calculation of Förster distances and energy transfer  
The energy transfer efficiency between Trp donor and 1,8-ANS acceptor was 
determined according to Eqn. 2.7.2 (Blackman, Piston & Beth 1998, Runnels, Scarlata 
1995)  
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where E represents efficiency of energy transfer and D is the distance between the donor 
and acceptor (D). The variable R0 describes the critical distance at which rate of energy 
transfer equals the rate of fluorescence decay can be readily calculated using (Steinberg 
1971): 
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where κ is the dipole orientation factor (set to 2/3), ФD is the quantum yield of the donor, 
N is Avogadro’s number, n is the index of refraction of water, FD(λ) is the normalized 
fluorescence emission of the donor and ε(λ) is the extinction coefficient spectra of the 
acceptor.  
2.7.4 ANS displacement studies  
For experiments investigating the displacement of 1,8-ANS by arachidonic acid, 
aliquots of the arachidonic acid stock solution (1.6 mM arachidonic acid in 20 mM Tris, 
pH 7.4, and 100 mM NaCl) were titrated into 7 μM apo- or Ca2+DREAM solubilized  in 
20 mM Tris, pH 7.4, and 100 mM NaCl, 1 mM DTT and 20 μM 1,8-ANS. The change in 
1,8-ANS fluorescence intensity as a function of arachidonic acid was analyzed by a single 
binding site model as described by (Epps, Raub & Kezdy 1995).   
2.7.5 Molecular docking modeling 
 The ANS binding sites on DREAM surface were identified using AutoDock 4.2 
software (http://autodock.scripps.edu/) (Morris et al. 1998). The structure of Ca2+ bound 
DREAM (PDB: 2jul) was used as a rigid macromolecule (Lusin et al. 2008). The most 
plausible docking model was selected on the basis of the energetic ranking provided by 
AutoDock 4.2. 
 
2.8 Methods used in chapter 4 
2.8.1 Steady-state fluorescence 
  Steady-state emission spectra were recorded using a PC1-ChronosFD 
spectrofluorometer (ISS, Illinois). Tryptophan emission spectra were measured using a 295 
nm excitation, and titrations were carried out in a 0.1 x 1 cm path length quartz cuvette 
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with excitation along the 0.1 cm path. The DREAM(Δ65):NS5806 dissociation constants 
were determined by non-linear fit of the change in integrated fluorescence (310 nm to 400 
nm) using a single binding site model: 
           Eqn. 2.8.1 
 
where ΔF is the intensity change, Kd is the dissociation constant, n is the number of binding 
sites, Pt is the total protein concentration, Lt is the total ligand concentration, and c is a 
proportionality constant. For 1,8-ANS displacement studies, the excitation wavelength was 
set at 350 nm along the 2 mm path of a 0.2 x 1 cm cuvette, and the integrated emission 
intensity (410 nm to 500 nm) of 1,8-ANS bound to DREAM(Δ65) was used to calculate 
the extent of displacement. The dissociation constant of NS5806 for DREAM(Δ65) was 
recovered using a single binding site displacement equation (Chuang et al. 2008): 
 
       Eqn. 2.8.2 
 
where, α and β are proportionality constants, Ki is the dissociation constant of 1,8-ANS 
(measured separately), It is the total concentration of NS5806 and Kd is its dissociation 
constant. 
  To investigate the association between DREAM(Δ65) constructs and KV4.3(2-22) 
“Site 1” or KV4.3(70-90) “Site 2”, fluorescently labeled peptides were purchased from 
ThinkPeptides (Sarasota, FL, USA). The peptides with the sequence of the Site 1 of human 
KV4.3 (Dansyl-Ahx-EKEFFFNEDTKEYFFDRDPEV) and Site 2 of human KV4.3  
(FITC-Ahx-AAWLPFARAAAIGWMPV) were received at higher than 98 % purity. The 
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fraction of FITC-Ahx-KV4.3(2-22) bound to DREAM(Δ65) constructs was determined 
based on the increase in steady state anisotropy and corrected for the increase in total 
intensity upon complex formation using: 
        Eqn. 2.8.3 
 
where fB is the fractional concentration of peptide bound, r is the measured anisotropy, rF 
and rB are the anisotropy of the free and fully bound peptide, respectively (Lakowicz 2010). 
As a consequence of the large change in fluorescence intensity of Dansyl-Ahx-KV4.3(70-
90) peptide upon binding to DREAM(Δ65) constructs the fraction bound was determined 
by the change in integrated fluorescence intensity (450 nm to 650 nm) normalized by the 
maximum intensity change. The resulting titration curves were analyzed using a single site 
binding model, Eqn. 2.8.1. 
  For the determination of the calcium dissociation constants, a sample containing 1 
μM of DREAM(Δ65) containing the biarsenical binding sequence (CCPGCC) at the C-
terminus and labeled with FlAsH was prepared in 20 mM MOPS pH 7.4, 100 mM NaCl, 1 
mM DTT, 1 mM EGTA, and 1 mM NTA. All solutions were previously decalsified by 
treatment with CHELEX resin (BioRad). The amount of residual calcium was determined 
using Quin-2 and calculated to be ~ 200 nM. Calcium binding was monitored by the change 
in integrated fluorescence emission (510 nm to 580 nm) upon calcium binding to 
DREAM(Δ65)-FlAsH. Calcium was added from a buffered 50 mM CaCl2 stock prepared 
from a 100 mM CaCl2 standard (Fisher Scientific) and the free calcium concentration was 
determined by obtaining the saturation curves for the calcium indicators Quin-2 (Kd = 120 
nM ), Calcium Green-5N (Kd = 14 μM) and CaGreen-2 (Kd = 550 nM). The determined 
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free calcium concentrations were in agreement with the values calculated using the pCa 
calculator software (Dweck, Reyes-Alfonso Jr. & Potter 2005). The macroscopic calcium 
binding constants in the presence of NS5806 were obtained under identical conditions. The 
FlAsH labeled DREAM(Δ65) was excited with a 470 nm laser diode and the change in 
fluorescence intensity was used to probe the extent of calcium binding. The resulting 
titration curves were analyzed using a double-Hill equation: 
        Eqn. 2.8.4 
 
where fbound is the fraction of proteins bound to calcium calculated from the intensity 
change, f is the fraction of sites B with dissociation constant kB and showing a Hill 
coefficient nb, with remaining sites showing a dissociation constant of kA and Hill 
coefficient na. 
2.8.2 Fluorescence and anisotropy decay 
  Tryptophan fluorescence decay lifetimes were measured using a ChronosFD 
spectrofluorometer (ISS, Champaign Illinois) in the frequency domain mode. Tryptophan 
was excited with a frequency modulated light ( 280 nm diode) and emission was collected 
using a 305 nm long pass filter and 400 nm short pass filter (Andover). The modulated 
anisotropy of tryptophan was calculated from the amplitude ratio of the parallel and 
perpendicular components of the modulated emission. The fluorescence decay lifetime of 
1,8-ANS was determined by excitation with a 370 nm output of a frequency modulated 
laser diode and the emission was collected through a 400-600 nm wide pass filters 
(Andover). Modulation-phase data were best fitted by a multiple-exponential decay model 
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using GlobalsWE software and the χ2 parameter was used as criterion for goodness of fit 
(Beechem 1989).  
2.8.3 Isothermal Titration Calorimetry (ITC) 
  Thermodynamic parameters for NS5806 binding to DREAM(Δ65) and 
DREAM(Δ160) were determined using a VP-ITC titration calorimeter (Microcal Inc. 
Northampton, MA). The ITC buffer (20 mM MOPS pH 7.4, 0.25 mM DTT, and 100 mM 
NaCl) was prepared using decalcified water filtered through Chelex-100 resin (Bio-Rad). 
The protein stock solution was dialyzed against ITC buffer overnight. To minimize artifacts 
from mismatched buffers, stock NS5806 solutions were prepared in the final ITC dialysate 
buffer. The cell sample and injection syringe were extensively cleaned with decalcified 
water and then with ITC buffer. The reaction cell was loaded with 10 µM DREAM(Δ65) 
or DREAM(Δ160) solution and the concentration of NS5806 in syringe was 473 µM. 
Thirty injections (9 µL each) of NS5806 were titrated into protein solution with 2 min 
intervals between injections. Parallel experiments were carried out for titration of NS5806 
into the dialysate buffer as a control for heats of dilution of ligand. The temperature was 
kept at 25 o C and stirring speed was at 307 rpm. ITC data were analyzed using Origin 7 
ITC data analysis software (OriginLab Corp. Northampton, MA). The data obtained for 
NS5806 binding to both KChIP3 constructs were analyzed using a two binding site model 
(Jelesarov, Bosshard 1999).  
2.8.4 Molecular modeling 
 The NS5806 binding sites on DREAM(Δ65) surface were identified using AutoDock 
4.2 software (http://autodock.scripps.edu/) (Morris et al. 1998). The structure of Ca2+ 
bound DREAM(Δ75) (PDB: 2jul, conformation # 1) and DREAM(Δ160) (PDB: 2E6W) 
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were used as a rigid macromolecule and docking grids were set to cover the entire protein 
surface (Lusin et al. 2008, Yu et al. 2007b). The most favorable docking site among 200 
docking simulation was selected based on their energy rankings. The structure of the 
NS5806- DREAM(Δ65) complex was further refined by running 10 ns of molecular 
dynamic simulation using AMBER03 force fields on the YASARA interface at 298 K, 
with a dynamic time step of 1.25 fs and trajectories recorded every 25 ps for further analysis 
(Krieger, Koraimann & Vriend 2002). The molecular model for the DREAM:KV4.3 T1 
domain was constructed by combining the crystal structure of KChIP1:KV4.3 T1 domain 
(PDB: 2NZ0) (Wang et al. 2007) and the DREAM(Δ75) or the NS5806:DREAM(765) 
complex prior to molecular dynamic simulation.  The energy minimized 
DREAM(Δ75):KV4.3 T1 domain or NS5806:DREAM(Δ75):KV4.3 T1 domain complexes 
were then subjected to a 10 ns molecular dynamics simulation. The resulting protein and 
drug-protein complexes were aligned using the MUSTANG algorithm on the YASARA 
interface. 
 
2.9 Methods used in chapter 5 
2.9.1 Steady-state fluorescence measurements 
 Fluorescence emission measurements were recorded using a custom PC1 
spectrofluorimeter (ISS, Illinois). Tryptophan emission spectra were measured using 295 
nm excitation, and titrations were carried out in a 0.2 x 1 cm path length quartz cuvette 
with excitation along the 0.2 cm path. The dissociation constants for CaM binding to 
DREAM were determined by a non-linear fit of the change in normalized fluorescence 
emission spectra at 370 nm using a single binding site model (Equation 2.8.1). 
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 To study the interaction between CaM and the N-terminus of DREAM we employed 
a fluorescently labeled peptide homologous to DREAM(29-44) and the fluorescence 
anisotropy increase upon complex formation was used to determine the affinity. A peptide 
homologous to DREAM(29-44) with a FITC label at the N-terminus 
(SIKWQRPRFTRQALMRK-FITC) was purchased from ThinkPeptides, USA. Additional 
titrations of apo and Ca2+CaMRR2 and DREAM(29-44)-FITC peptides were conducted by 
monitoring the quenching of FITC fluorescence by rhodamine through energy transfer. 
Equation 2.8.1 was used for fitting of the anisotropy and quenching data. 
 The effect of CaM on DREAM interaction with the DRE sequence of human 
prodynorphin was probed by steady-state fluorescence anisotropy. A synthetic 
oligonucleotide analogous to the DRE sequence (5-GAAGCCGGAGTCAAGGAGGCCC 
CTG-3) labeled at the 5’ end with FITC was purchased (Eurofins, USA) and used without 
further purification, the complementary strand was not labeled. Samples were prepared as 
previously reported (Osawa et al. 2005), in the absence of LDAO. 
 2.9.2 Circular dichroism measurements 
 All CD spectra were measured using a Jasco J-815 CD spectropolarimeter. The far 
UV-CD spectra were measured at 10 μM protein concentration through a 1 mm path in 5 
mM Tris buffer pH 7.4. Near-UV CD spectra were measured along a 1 mm path using 160 
μM DREAM and 560 μM DREAM(Δ65) in 20 mM Tris pH 7.4 and 10 mM LDAO. All 
measurements were conducted at 16 °C and traces represent an average of 20 scans. 
2.9.3 Stopped-flow kinetics  
 A PC1 spectrofluorometer (ISS, Illinois) with an SFA-20 stopped-flow kinetics 
accessory (Hi-Tech, Salisbury, UK) was used to determine the dissociation rate constants 
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by monitoring the change in anisotropy upon complex dissociation. Experiments between 
CaM and DREAM(29-44)-FITC, as well as CaMRR2 and DREAM, were conducted by 
mixing 1:1 volumetric ratio of the protein complexes in the presence of 100 μM calcium 
with 2 mM EDTA in 20 mM Tris pH 7.4. Samples were excited using 470 nm for 
DREAM(29-44)-FITC and 520 nm excitation for CaMRR2. The change in fluorescence 
anisotropy upon complex dissociation was determined by collecting the fluorescence at 
520 ± 10 nm for FITC and 600 ± 10 nm for RRC2 using a T-format configuration. The 
dissociation of Ca2+ from CaM was monitored using 285 nm excitation and the intrinsic 
tyrosine fluorescence in the L-format through a 305 nm long pass filter.  The temperature 
was controlled using a circulating water bath (Fisher, Isotemp M9100) and measured at the 
sample holder to ± 0.5 °C. Dissociation kinetic data were best described by single or 
double-exponential decay equations using Origin 8.0 software (OriginLab Corp.). 
2.9.4 Fluorescence lifetime and anisotropy decay measurements 
 Fluorescence decay data were obtained using a ChronosFD spectrofluorometer 
(ISS) in the frequency domain mode. Fluorescence decay lifetime of IAEDANS or FITC 
complexes was determined by excitation with a 370 nm and 470 nm modulated laser diode, 
respectively. Fluorescence was collected through a 400 nm long pass filter for IAEDANS 
samples or 500 nm long pass filter for FITC samples. POPOP (1,4-bis(5-phenyloxazol-2-
yl)benzene) in ethanol (τ = 1.35 ns) or rhodamine B in water (τ = 1.35 ns) were used as 
lifetime references;  polarizers were set at magic angle configuration. Anisotropy decay 
measurements were conducted under identical conditions. Modulation-phase data were 
fitted using GlobalsWE software and the χ2 parameter was used as a criterion for goodness 
of fit (Beechem 1989).  
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2.9.5 Molecular modeling and dynamic simulations 
 The initial structure of Ca2+ bound DREAM(Δ75) (PDB: 2jul, conformation # 1) 
was employed as a starting model of the core domain of the full-length protein(Lusin et al. 
2008). The secondary structure of the N-terminal residues of DREAM not resolved in the 
NMR structure and those comprising helix 1 (residues 76-86) were predicted by a 
combination of six secondary structure prediction software (Jpred, Porter, PSIPRED, 
PredictProtein, PROF – secondary structure prediction, and CFSSP). To decrease the 
variability of the helix prediction, a helical conformation was only accepted if it was 
predicted by at least 4 of the algorithms. A model for the full-length protein was constructed 
by modeling the first 90 residues as an extended helix or loop according to the secondary 
structure prediction followed by 10 ns molecular dynamics simulation to equilibrate the 
structure. The helical structure of residues 76-86 (helix 1) was used to align the peptide to 
the published NMR structure to obtain the structure of DREAM from residue 1 to 256.  
 The DREAM model was solvated and ionized as described below (resulting in a 
total of 122639 atoms) followed by classical and accelerated molecular dynamics 
simulations (cMD and aMD, respectively) to identify the dynamics and folding of the N-
terminus. The parameters for the aMD were determined from the total energy and dihedral 
energy from a cMD simulation (<Etotal>= -330141.1 kcal/mol and <Edihed>= 973.1 
kcal/mol). The dihedral boost was applied above a threshold energy set to 1993.1 kcal/mol 
with a dihedral alpha value of 204 kcal/mol. All-atom explicit solvent molecular dynamics 
simulations were obtained using the molecular dynamics simulation package NAMD 
(Phillips et al. 2005)  with the CHARMM27 force fields (Brooks et al. 1983). All simulated 
systems were solvated in a periodic TIP3P water box with 10 Å margins and ionized with 
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150 mM NaCl (Humphrey, Dalke & Schulten 1996). Long range interactions were treated 
with the PME method (Essmann et al. 1995) with a 12 Å cutoff. Energy was minimized 
with a conjugate gradient algorithm, followed by heating at 1 K/ps from 0 to 310 K. After 
reaching 310 K, a 100 ps equilibration step in the NVT ensemble using Langevin dynamics 
with a 1 fs integration time was conducted. Production runs were in the NPT ensemble (1 
atm and 310 K) both with Langevin coupling and with a 2 fs integration time. All 
simulations were performed on a i7-4770/ GTX-780Ti system using NAMD 2.9. 
Trajectory files were saved every 20 ps for further analysis. The initial structure used for 
cMD and aMD in the absence of Ca2+ was modeled as coarse grained spheres using the 
VMD plugin and MARTINI parameters (Marrink et al. 2007). The structure was 
minimized and simulation were run in the NPT ensemble. Solvation, ionization and force-
field parameters were identical to those utilized in cMD and aMD simulation, but with an 
increase time step of 20 fs. 
  
2.10 Methods used in chapter 6 
2.10.1 Photophysics of the DREAM:Tb3+ complex 
 Fluorescence experiments were conducted on a custom PC1-ChronosFD 
instrument (ISS, Champaign, IL) in steady-state mode for excitation and emission spectra 
and in frequency domain mode for fluorescence decay measurements. The intrinsic protein 
fluorescence arising from tyrosine residues in CaM and tryptophan on DREAM(Δ65) was 
obtained by exciting the sample with 280 ± 2 nm and 295 ± 2 nm light, respectively. The 
fluorescence of 1,8-ANS was monitored by exciting the sample with 350 ± 4 nm light, 
through a vertically oriented polarizer. The sensitized emission spectra of terbium(III) 
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bound proteins were obtained by exciting the sample at 280 ± 4 nm while collecting the 
emission through a 400 nm long pass filter to minimize contribution of the protein intrinsic 
fluorescence and the 2nd harmonic peaks. Displacement of Ca2+ from DREAM(Δ65) was 
monitored by adding small aliquots of a 2.0 mM Tb3+ in 20 mM Tris pH 7.4 stock solution 
into 10-20 μM DREAM(Δ65) construct in the same buffer with 5 mM Mg2+ and/or 100 
μM Ca2+. The resulting spectra were normalized by dividing the intensity at each 
wavelength by the background value at 530 nm and the resulting titration plots were fitted 
using a non-cooperative n-site quadratic equation which assumes similar affinity for all the 
sites (see Chapter 4). All spectra were corrected for the PMT wavelength dependent 
response as well as the lamp wavelength dependent changes in intensity. The intrinsic 
fluorescence lifetime of DREAM(Δ65) was measured by exciting the sample with the 
modulated light of a 280 nm diode and the fluorescence collected through a 320 nm long 
pass filter with 2,5-diphenyloxazole (PPO) in ethanol (τ = 1.40 ns) used a lifetime 
reference. 
 Circular dichroism measurements were conducted in a Jasco J-815 CD 
spectrometer along the 1 mm path of a quartz cuvette (J-815 Jasco, Easton, MD). 
Luminescence measurements were conducted on a custom-built instrument where the 
sample was placed in a 2x10 mm quartz cuvette in a temperature controlled sample holder 
(Quantum Northwest, Liberty Lake, WA) and excited along the 10 mm path. The 355 nm 
line of a Nd:YAG laser (Minilite II Continuum, San Jose, CA) was used to directly excite 
Tb3+ ions while the luminescence was measured perpendicularly through a 550 ± 10 nm 
band pass filter and detected by a H7360-01 PMT (Hamamatsu, Japan). The signal was 
digitized by a 400 MHz oscilloscope (WaveSurfer 42Xs, Teledyne Lecroy, NY) and the 
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initial 100 μseconds of each trace were deleted to eliminate contribution from scattered 
light and PMT recovery time. The fluorescence modulation-phase plots and luminescence 
decay traces were fit using Globals for spectroscopy software (LFD, Irvine CA). 
2.10.2 Thermodynamics of the DREAM:Tb3+ complex 
  Isothermal calorimetry titrations were employed to determine the thermodynamics 
of Tb3+ displacement of Ca2+ from DREAM(Δ65) or CaM and they were carried out using 
a VP-ITC isothermal calorimeter (Microcal Inc. Northampton, MA). Protein constructs 
were dialyzed overnight in 5 mM Tris pH 7.4, 100 mM NaCl, 100 μM CaCl2 with/without 
5mM MgCl2. The use of 10 mM EDTA during purification of calmodulin required multiple 
overnight dialysis steps to ensure complete removal of contaminating EDTA. Terbium 
stock solutions were prepared in ITC dialysate buffer. The reaction cell was loaded with 
~10 µM protein solution, determined spectrophotometrically prior to the ITC experiment, 
the concentration of Tb3+ in the syringe (297 µL) was 1.00 mM. Thirty injections of 
increasing volume were titrated into the protein solution with increasing time intervals 
between injections. Isotherms were corrected for the heat of dilution of ligand and all ITC 
experiments were conducted in triplicates. The recovered thermodynamic parameters were 
obtained by fitting the isotherms modeled either with an N-set-of-sites model or a 
sequential model using the Microcal ITC analysis plug in Origin 7.0. 
2.10.3 Trapped ion mobility spectrometry—mass spectrometry studies (TIMS-MS) 
2.10.4 Experimental:  
Details regarding the TIMS operation and specifics compared to traditional IMS 
can be found elsewhere (Fernandez-Lima, Kaplan & Park 2011, Fernandez-Lima et al. 
2011, Molano-Arevalo et al. 2014, Hernandez et al. 2014). Briefly, in TIMS, the mobility 
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separation is achieved by holding the ions stationary with an electric field against a moving 
gas. The separation in a TIMS device can be described by the center of the mass frame 
using the same principles as in a conventional IMS drift tube (McDaniel, Mason 1973). 
The TIMS analyzer was coupled to a maXis Impact Q-UHR-ToF (Bruker Daltonics Inc., 
Billerica, MA). Data acquisition was controlled using in-house software, written in 
National Instruments Lab VIEW (2012, v. 12.0f3), and synchronized with the maXis 
Impact acquisition program. The TIMS separation was performed using nitrogen as a bath 
gas at ca. 300 K and typical P1 (pressure at the ramp electrode) and P2 (pressure at the 
outlet electrode) values are 1.8 and 0.6 mbar, respectively. The pressure difference drives 
the input of the sample into the analyzer. The same RF (880 kHz and 200–350 Vpp) was 
applied to all electrodes including the entrance funnel, the mobility separating section, and 
the exit funnel. The purpose of the voltage potentials is to generate an electromagnetic field 
able to trap the ions in the TIMS analyzer and minimize loos of the charged ions through 
diffusion. Protein samples were prepared at 15 μM concentration protein and 15 μM 
TbCl3·6H20 using HPLC grade solvents from Thermo Fisher Scientific Inc. (Waltham, 
MA) in 10 mM ammonium acetate at pH = 6.7. A custom built, nano electrospray 
ionization source was coupled to the TIMS-MS analyzer and  was used for all analyses. A 
typical source voltage of 600-1200 V was used and analyses were performed in positive 
ion mode. 
2.10.5 Theoretical 
Theoretical CCS were calculated for the previously reported 2JUL NMR structure 
of DREAM (Lusin et al. 2008) using the IMoS (v1.04b) (Larriba, Hogan Jr 2013, Larriba, 
Hogan 2013, Ouyang et al. 2013) software with nitrogen as a bath gas at ca. 300K. In the 
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IMoS calculations, 100 total rotations were performed using the diffuse hard sphere 
scattering method with a Maxwell distribution. In addition, I have also developed a 
MATLAB script designed to extract the average peak intensity, calculate calibration 
constants, and convert mobility to collisional cross sections for multiple peaks. This script 
was designed in order to expedite and facilitate the analysis of multiple ion species. For 
instance, using TIMS-MS we are able to identify the apo, 1 Ca2+, and 2 Ca2+ bound 
DREAM produces. In the presence of NS5806, the same peaks with additional peaks 
corresponding to NS5806 + 1 Ca2+ and NS5806 + 2 Ca2+ can be identified. Thus, if the 
charge states from +6 to +22 are identified (which is common), this would result in a total 
of 80 peaks. In addition, TIMS experiments require the use of different ramp times (often 
a set of five ramp times are used), resulting in a total of 400 peaks to be analyzed. It 
becomes obvious that a large amount of time could be spent analyzing the data. The details 
about this script (which is not used in the presented work) are listed in appendix 2. 
 
2.11 Methods used in chapter 7 
2.11.1 Caged compounds 
The DM-nitrophen samples were prepared by dissolving DM-nitrophen in buffers 
as described in the text. The Ca2+-DM-nitrophen samples were prepared by adding CaCl2 
to DM-nitrophen sample to achieve a desirable ratio of [DM-nitrophen]total:[Ca2+]total. The 
sample preparation and measurements were carried out in a dark room to prevent unwanted 
uncaging and release of the chelated ligand (H+, Ca2+, or Tb3+). Absorption spectra were 
recorded using a single beam UV-vis spectrophotometer (Cary 50, Varian) and the DM-
nitrophen concentration was determined from the absorbance value at 350 nm.  
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The synthesis of the H2Cage and Cu(OH2)Cage compounds were performed in the 
laboratory of Dr. Konstantinos Kavallieratos at FIU and were done according to the 
procedure reported by Ciesienski et al. (2008). The purity was verified by H1 NMR (400 
MHz Bruker NMR spectrometer) and IR (Nicolet Magna-IR 560 spectrometer) 
spectroscopy. For all trials and experiments, both the ligand and complex were dissolved 
in a MOPS buffer mixture (5mM MOPS buffer, pH 7.10) and then transferred to a 1 x 0.5 
cm quartz cuvette. To minimize unwanted photo cleavage all samples were prepared and 
measured in a dark room. Absorptions spectra for both compounds were collected using a 
single beam UV-Vis spectrophotometer (Cary 50, Varian). 
2.11.1 Isothermal Titration Calorimetry (ITC) 
 Thermodynamic parameters for Terbium binding to DM-nitrophen or EDTA were 
determined using a VP-ITC titration calorimeter (Microcal Inc. Northampton, MA). The 
ITC buffer (20 mM MOPS pH 6.5 with and without 1 mM CaCl2) was prepared using 
ultrapure 18 MΩ water which was decalcified by filtering through a Chelex-100 resin (Bio-
Rad). The cell sample and injection syringe were extensively cleaned with decalcified 
water and then with ITC buffer. The reaction cell was loaded with ~120 µM DM-nitrophen 
solution and the concentration of Tb3+ in syringe was 2 mM. Thirty injections (10 µL each) 
of Tb3+ were titrated into a protein solution with 2 min intervals between injections. Parallel 
experiments were carried out for titration of Tb3+into buffer as a control for heats of 
dilution. The temperature was kept at 25 oC and stirring speed was at 307 rpm. The ITC 
results were analyzed using Origin 7 ITC data analysis software (OriginLab Corp. 
Northampton, MA).  
 62 
2.11.2 Photothermal beam deflection instrument 
All photothermal beam deflection (PBD) measurements were performed on a 
custom-built instrument described in detail elsewhere (Mikšovská, Day & Larsen 2003). 
The sample was held in a 1.0x0.5 cm cuvette which was placed inside a temperature 
controlled holder (TC 125, Quantum Northwest). Illumination of the sample was done with 
a Nd: YAG laser (355 nm, 5 ns pulse, Minilite, Continuum, CA) passed through the 1.0 
cm path length of the cuvette. A diode probe beam (635 nm, 5 mW output from He-Ne 
Laser, Edmund Optics) was aligned so that it is nearly collinear to the pump beam and 
crossed in the center of the sample cell. A mirror on the opposite side was used to align the 
probe beam onto the center of a split diode, so the intensity of the Gaussian laser beam is 
equally distributed between the two photodiodes. The detector is of our own design and 
the signal output was digitized by a 400 MHz digitizer (WaveSurfer, LeCroy). All data 
analysis was performed off line in Origin 8.0 data analysis software (OriginLab Corp. 
Northampton, MA or Microsoft Excel. 
 
2.12 Methods used in chapter 8 
2.12.1 Modeling of DREAM 
The initial structure of Ca2+ bound DREAM(Δ75) (PDB: 2jul, conformation # 1) 
was employed as a starting model of the core domain of DREAM protein (Lusin et al. 
2008). This core domain contains helix 1 through 10 and 2 calcium ions bound at EF-hand 
and 3 and 4. All DREAM mutants were generated by the mutate residue plug in of VMD 
using the conformation #1 of DREAM as the initial structure (Humphrey, Dalke & 
Schulten 1996). The DREAM models were then solvated using TIP3P waters and ionized 
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with Na+ ions to neutrality using the ionize plug in of VMD. The complete system 
consisted of about 29800 atoms in a 81.5 Å x 68.6 Å x 58.1 Å rectangular box, which is 
big enough to prevent the protein from interacting with its own periodic image.  
The dimeric form of DREAM was generated by overlaying the monomeric 
Ca2+ bound structure of DREAM (pdb: 2jul, conformation #1) on each subunit of the 
dimeric structure observed in the structure of KChIP1 (pdb: 1s6c) obtained by x-ray 
crystallography (Zhou et al. 2004b). This dimeric form of DREAM is in good agreement 
with the dimer structure proposed previously (Lusin et al. 2008), the dimeric structure was 
subsequently solvated and ionized as described above. 
2.12.2 All atom molecular dynamic simulations 
Classical molecular dynamics (cMD) and accelerated molecular dynamics (aMD) 
simulations have been widely employed to study the conformational dynamics and folding 
of proteins at the atomic level (Liu et al. 2005, Zhou et al. 2004a, Hamelberg, Mongan & 
McCammon 2004, Kern, Zuiderweg 2003). In this work, we have carried out cMD and 
aMD simulations using the NAMD (Phillips et al. 2005) simulation software and the 
CHARMM27 force field including the phi, psi, cross term map (CMAP) correction 
(MacKerell, Feig & Brooks 2004). These forcefield have been shown to be able to 
reproduce experimental NMR and unfolding data of the neuronal calcium sensor-1 protein 
(Bellucci et al. 2013, Heidarsson et al. 2013, Zhu et al. 2014). Accelerate MD simulations 
have also been shown to enhance the conformational space sampled by proteins within 
shorter simulation times (Hamelberg, Mongan & McCammon 2004). This method has been 
used to provide insight into the allosteric mechansims of calcium binding in calcium 
binding proteins (Kekenes‐Huskey et al. 2012).  
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In both simulation approaches, the long range interactions were treated with the 
PME method (Essmann et al. 1995) with a 12 Å cutoff. The system described above was 
energy minimized with a conjugate gradient algorithm, followed by: 1) heating at 1 K/ps 
from 0 to 155 K, 2) 200 ps of simulation using constant pressure, temperature, and number 
of particles (NPT), and 3) a second heating step from 155 K to 310 K at 1 K/ps. We have 
noticed that performing the short NPT equilibration step between the heating steps 
eliminates the formation of vacuum bubbles during the simulation. After reaching 310 K, 
a 100 ps equilibration step in the NVT ensemble using Langevin dynamics with a 1 fs 
integration time was conducted. Production runs were in the NPT ensemble (1 atm and 310 
K) both with Langevin coupling and a 2 fs integration time. All simulations were performed 
on a i7-4770/ GTX-780Ti system using NAMD 2.10. Trajectory files were saved every 20 
ps for further analysis.  
Accelerated molecular dynamics (aMD) is an enhanced sampling technique in 
which the energy of the system is modified throughout the simulation in order to allow the 
protein to transition into structural conformations not readily sampled by classical 
molecular simulations (cMD). The acceleration in aMD arises from introduction of a non-
negative energy to the dihedral angles of all amino acids in the protein whenever the total 
dihedral energy of the system goes below a predefined threshold (Miao et al. 2015). This 
concept of acceleration can be best explained by the following equations: 
𝑉𝑉𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏(𝑡𝑡) =  𝑉𝑉(𝑡𝑡)      𝑖𝑖𝑖𝑖     𝑉𝑉(𝑡𝑡) ≥ 𝐸𝐸𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟   Eqn. 2.12.1 
𝑉𝑉𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏(𝑡𝑡) =  𝑉𝑉(𝑡𝑡) + ∆𝑉𝑉(𝑡𝑡)     𝑖𝑖𝑖𝑖     𝑉𝑉(𝑡𝑡)  < 𝐸𝐸𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟  Eqn. 2.12.2 
In which V(t) is the potential of the system at simulation time t, Ereference is the reference 
threshold potential, and Vboost(t) is the modified potential. In our case, the Ereference value 
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has been obtained from a 10 ns simulation of the system using classical molecular 
dynamics using: 
𝐸𝐸𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟 = [𝑉𝑉𝑑𝑑𝑑𝑑ℎ𝑟𝑟𝑑𝑑𝑟𝑟𝑒𝑒𝑒𝑒] + 𝑎𝑎 ∗ 𝑁𝑁𝑟𝑟𝑟𝑟𝑏𝑏𝑑𝑑𝑑𝑑𝑟𝑟𝑟𝑟   Eqn. 2.12.3 
Where [Vdihedral] is the average dihedral energy of the cMD simulation, Nresidue is the 
number of amino acids in the protein, and a is an empirically determined constant usually 
near 4.  The parameter ΔV(t) represents the boost potential, which takes the form of: 
∆𝑉𝑉(𝑡𝑡) = �𝐸𝐸𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟−𝑉𝑉(𝑏𝑏)�2
𝛼𝛼+𝐸𝐸𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟−𝑉𝑉(𝑏𝑏)   Eqn. 2.12.4 
In which the α value has been introduced as an acceleration factor that must be either 
adjusted based on simulation results. In our work, we have set the α value as previously 
reported using (Miao et al. 2015): 
𝛼𝛼 = 𝑒𝑒
5
∗ 𝑁𝑁𝑟𝑟𝑟𝑟𝑏𝑏𝑑𝑑𝑑𝑑𝑟𝑟𝑟𝑟    Eqn. 2.12.3 
We have observed that setting value for a near 4 would result in the N- and C-terminus 
helices of DREAM to become unstable, thus in our simulations we have used a value of a 
= 3.26. The scripts used are described in detail in appendix 3. 
2.12.3 Coarse grained simulations 
 In order to explore conformational changes in DREAM which may occur on longer 
timescales, we have performed coarse-grained molecular dynamics simulations (cgMD). 
In this approach, the atomic composition of amino acids in DREAM is reduced by 
clustering of atom into larger bead models. These models have been optimized to maintain 
the biophysical characteristics of the protein, while reducing the computational cost of 
performing long simulations. We have performed simulation on DREAM using the same 
model described above, in which the all atom representation was reduced from about 29800 
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atoms to about 6900 beads. The model was protonated using the pdb2pqr webserver 
(Dolinsky et al. 2004), solvated with  WT4 waters and neutralized with NaW sodium-water 
coarse-grained ion representations.  These simulations were performed on the GROMACS 
5.0.7 software package (Hess et al. 2008) and the SIRAH coarse-grained force fields (Darré 
et al. 2015). The simulations protocol included 100000 minimization steps using the 
steeped descent algorithm, followed by 250000 steps of equilibration with 10 fs time step 
and positional restrain applied to all the protein beads. Production runs were performed in 
the NPT ensemble at 20 fs time step for 1 μs (Darré et al. 2015).  
 
2.4 Analysis methods 
Analysis of the cMD, aMD, nd cgMD simulations were carried using the VMD 
1.9.2 software. Root mean square deviations (RMSD) were calculated for the alpha carbon 
of the whole protein (residue 76 to 256) using the structure of DREAM after minimization 
and equilibration as the frame of reference.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
ge of 500 frames (10 ns) of the alpha carbons of selected amino acids. The amino acids 
included in calculation of the N-terminus RMSF included residues 86 to 160 and residues 
163 to 242 for the C-terminus included. The solvent accessible surface of Trp169 was 
calculated using a rolling sphere of 1.4 Å radius.  
Analysis of the conformational dynamics of DREAM were analyzed by community 
network analysis of trajectories in which the equilibration time was deleted. We compared 
the RMSD of all simulations (apo and Ca2+ bound separately) and observed that all 
simulations were equilibrated within 20 ns. Therefore, we deleted the first 1000 frames of 
every simulation, in order to analyze only the dynamic networks present in the equilibrated 
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apo or Ca2+ bound DREAM. The network analysis was performed using the VMD plug in 
NetworkSetup and visualized using Network View (Sethi et al. 2009). In this 
representation, each node represents the alpha carbon of an amino acids, and the edges 
connecting non-neighboring alpha carbons represents atoms which interacted over 75 % of 
the time within 4.5 Å. The thickness of the edges represents the degree of correlation 
between the nodes. These networks were further classified by the Girvan-Newman 
algorithm in order to split the networks into communities of dynamically coupled residues 
(Girvan, Newman 2002). In these communities, amino acids belonging to one communities 
are more correlated to each other than to amino acids of other communities. Furthermore, 
the connection between these communities, represent dynamic hubs through which most 
dynamic fluctuations propagate from one community to the rest of the protein. 
2.12.2 Circular dichroism and Emission spectra 
All CD spectra were measured using a Jasco J-815 CD spectropolarimeter. The far 
UV-CD spectra were measured at 10 μM protein concentration through a 1 mm path in 5 
mM phosphate buffer pH 7.4. Near-UV CD spectra were measured along a 1 mm path 
using 160 μM DREAM and 560 μM DREAM(Δ65) in 20 mM Tris pH 7.4 and 10 mM 
LDAO. All measurements were conducted at 16 °C and traces represent an average of 20 
scans. 
2.12.3 Tryptophan fluorescence  
 The tryptophan fluorescence of DREAM was monitored by placing 20 μM to 40 
μM DREAM protein in 20mM MOPS pH 7.4 and 1 mM DTT buffer in a 2x10 mm quartz 
cuvette. The sample was placed in the sample holder of a ChronosFD-PC1 custom 
spectrofluorometer, with 295 nm excitation along the short 2 mm path and emission 
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collected along the 10 mm path. The bandwidth was set at ± 4 nm. All measurements were 
conducted at room temperature. 
2.12.4 Ca2+ binding experiments 
 The binding of Ca2+ to all the DREAM constructs was carried out in a ChronosFD-
PC1 custom spectrofluorometer (ISS). A protein concentrations between 4 μM to 6 μM 
was used throughout, and the sample was prepared by dilution of a concentrated DREAM 
stock (concentrations ranging from 450 μM to 800 μM) stored in 20mM Tris pH 7.4. No 
more than 50 μL of DREAM was added to 3 mL of 20 mM MOPS pH 7.4 supplemented 
with 1 mM EGTA and 1mM NTA. This buffer was prepared by dilution of 100 mM EGTA 
and 100 mM NTA standard solution prepared separately to an accuracy of ± 2 %, as 
determined by electrochemical titration using a Ca2+ electrode. In the event that the 
DREAM stock was highly concentrated, an additional volume of 20mM Tris pH 7.4 was 
added so that the total volume added to the 3mL EGTA-NTA buffer solution was always 
50 μL. The addition of 50 μL of solution to all samples ensured that any dilution of EGTA 
and NTA was constant throughout all the experiments. The protein in EGTA-NTA buffer 
was placed in a 1x1 cm quartz cuvette and the sample was kept at room temperature 
throughout (~ 17 °C). The excitation wavelength was set to 295 nm with a bandwidth of ± 
4 nm, while the emission was collected through a monochromatic with bandwidth of ± 
4nm. The emission spectra was collected from 305 nm to 450 nm at a step of 2 nm. A total 
of twenty two samples were prepared, ranging from 0 mM to 1 mM CaCl2, with injection 
volumes ranging from 0.9 μL to 33 μL. The contribution associated with dilutions were not 
corrected, as we observe that this correction induced an erroneous increase in fluorescence; 
however, this effect should only be present in the last 3 to 4 point as most, since the dilution 
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of the first 18 points was not more ~ 3 % in total. Each injection was added with a Hamilton 
syringe (Sigma-Aldrich). The change in tryptophan fluorescence was determined by 
integrating the emission spectra between 309 nm to 423 nm. The data were analyzed by a 
NLLS fit to the data using origin 8.0 software and a simple one site HILL equation. 
 
2.12.5 DREAM stability studies  
The guanidium hydrochloride (GuHCl) induced protein unfolding was monitored 
by measuring the tryptophan fluorescence spectra as a function of increasing GuHCl 
concentration. The samples for fluorescence measurements were prepared by solubilizing 
a 80 μM DREAM protein stock in 20 mM MOPS pH 7.4, 1 mM DTT  to a final 
concentration of 5 μM. The samples were then  incubated in the presence of GuHCl for 18 
to 24 hours prior to measurements. A total of twenty four samples were measured, each 
sample (~100 μL) was placed in a 3x3x5 (width-length-height) quartz cuvette. The 
emission spectra were recorded using a FluoroMax-3 spectrofluorometer (Horiba, Japan)  
at room temperature (~17 °C). The excitation was set a 295 nm with an excitation and 
emission bandwidth of 4 nm. A total of three scans were average for each sample. DREAM 
unfolding traces were analyzed as a one-step or two-step process involving an intermediate 
state:  
N ↔U    Eqn.   8.2 
N ↔ I ↔U   Eqn.   8.3 
where N corresponds to the native state, I to the intermediate state, and U to the unfolded 
state. The unfolding curves were fit using the following equation (Hung et al. 2003, 
Santoro, Bolen 1988):  
 70 
RT
DmGDmG
RT
DmG
RT
DmGDmG
RT
DmG
GuHCl
UII
UI
U
I
IN
UII
UII
])[][(
exp
])[(
exp1
])[][(
exp
])[(
exp
)(
−∆+−∆−
+
−∆−
+
−∆+−∆−
+
−∆−
+
= 

λλλ
λ  
         Eqn. 8.4 
where λ(GuHCl) is the wavelength of the emission maxima of the tryptophan fluorescence, 
ΔG is the standard free energy for the transition, m is the dependence of the free energy on 
the denaturant concentration, T is the temperature (T = 290 K), [D] is the concentration of 
GuHCl and R is the ideal gas constant, R = 8.314 JK-1 mol-1. The parameters λ N, λ I, and 
λ U represent the wavelength of the tryptophan emission maxima of each molecular species 
at zero GuHCl concentration. 
2.12.6 Site 2 peptide binding to DREAM constructs 
 Binding of DREAM to the site 2 peptide of the voltage gated potassium channel 
KV4.3 were carried out using the same spectrofluorometer as in section 2.12.3. In these 
experiments a 10 μM solution of Kv4.3 peptide (described in section 2.8.2) was solubilized 
in 20mM Tris pH 7.4 supplemented with 1mM DTT in the presence of 1mM EDTA or 500 
μM CaCl2. The sample was placed in a 2x10 mm quartz cuvette and the dansyl chloride 
covalently bound to the peptide was excited with 330 nm light. The dansyl fluorescence 
was collected through a 400 nm longpass filter and a vertically oriented polarizer placed in 
front of a monochromator. The presence of the polarizer in the configuration described 
above eliminates strong contribution from scattering as well as the Wood’s anomaly of our 
instrument, which happens at 500 nm. The DREAM construct was added to the sample 
from a concentrated stock at concentration ranges between 0 and 100 μM, without 
exceeding 10 % of the total volume of the sample (450 μL). Dilution effects were corrected. 
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3. ROLE OF THE HYDROPHOBIC CAVITY AT THE C-TERMINUS DOMAIN 
OF DREAM IN LIGAND BINDING AND RECOGNITION 
3.1 Background and significance 
The function of DREAM and its interactions with various target proteins are 
strongly dependent on its cellular localization. In the nucleus, DREAM functions as an 
agonist transcriptional modulator of the specific DRE (downstream regulatory element) 
sequence found in prodynorphin and c-fos genes (Carrion et al. 1999, Carrion, Mellstrom 
& Naranjo 1998, Ledo et al. 2000). DREAM regulates gene expression in a Ca2+ dependent 
manner with apoDREAM binding to DRE sequence as a tetramer whereas Ca2+ bound 
DREAM forms a stable dimer with a decreased affinity for DRE sequence (Osawa et al. 
2005, Carrion et al. 1999). In the cytoplasm, DREAM binds to the Kv4 voltage channels 
through the N-terminus in a calcium independent fashion (An et al. 2000, Bowlby et al. 
2005). In addition, in vitro and in vivo studies have proposed DREAM involvement in 
regulating apoptotic processes, accumulation of amyloid β peptides, and N-cadherin 
processing through interactions with presenilin 1 (Buxbaum et al. 1998). It was recently 
also shown that DREAM forms a heterodimer with calmodulin in a Ca2+ dependent manner 
and regulates calmodulin function (Ramachandran et al. 2012). 
However, the molecular basis of DREAM - target proteins/DNA association and 
the mechanism of how Ca2+ binding modulates DREAM – target protein/DNA interactions 
remains unclear. Based on the NMR structure of Ca2+ loaded DREAM, it has been 
proposed that solvent exposed basic residues located at the DREAM N-terminal domain 
may form the DNA binding pocket and that solvent exposed leucine residues stabilize the 
Ca2+DREAM dimer (Lusin et al. 2008). The leucine residue rich domain found close to 
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EF-hand 2 may also mediate DREAM interactions with leucine zipper proteins such as α-
CREM (Ledo et al. 2000). The structure of the Ca2+ bound DREAM reveals the presence 
of a large hydrophobic cavity located between EF-hand 1 and EF-hand 2 which extends 
into the C-terminal domain. In addition, solvent exposed hydrophobic residues were shown 
to be involved in DREAM interactions with Kv4 channels and possibly with other 
intracellular partners. For example, the structure of the KChIP1–Kv4.3 complex reveals 
two binding sites for the T1 domain; the first binding site on KChIP1 is formed by a 
hydrophobic cavity extending from the N-terminal domain to the C-terminal domain. The 
second binding site has a more polar character and contains residues located at the N-
terminal domain (Scannevin et al. 2004). In addition, the functional properties of the 
KChIP-Kv4 complexes have been observed to be modulated by association of small 
hydrophobic molecules, such as arachidonic acid (Holmqvist et al. 2001) and NS5806 
(Witzel, Fischer & Bähring 2012).  
Considering the multifunctional role of DREAM in neuronal cells and its 
interactions with diverse intracellular targets, we have investigated the structural 
transitions induced by Ca2+ and/or Mg2+ binding to DREAM. In particular, we are 
interested in identifying the hydrophobic binding sites that may be involved in stabilization 
of DREAM oligomers, specific recognition of intracellular partners, and providing binding 
sites for small hydrophobic molecules. Using the extrinsic fluorescent probes 8-anilino 1-
naphathalene sulfonate (1,8-ANS) and 6-anilino 2-naphthalene sulfonate (2,6-ANS), both 
of which are highly sensitive to their immediate environment, two distinct  hydrophobic 
sites with high affinity for ANS probes were identified. These sites were located at the C-
terminal domain and were characterized using time-resolved fluorescence and docking 
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studies. In addition, 1,8-ANS displacement studies show that site 2 located between helix 
7, 8, and 10 serves as a binding site for arachidonic acid and possibly for other hydrophobic 
modulators of Kv4:KChIP complexes. The identification of high affinity hydrophobic sites 
on DREAM surface may provide the structural insight necessary for development of small 
molecules for modulation of DREAM interactions with other proteins.  
 
3.2 Results 
3.2.1 Ca2+ triggers changes in DREAM surface hydrophobicity 
Figure 3.1. Normalized fluorescence emission spectra of 1,8-ANS (left panel) and 2,6-
ANS (right panel) bound to DREAM. Conditions: 40 µM DREAM in 20 mM Tris pH 7.4 
and 1 mM DTT. The excitation wavelength was 350 nm and 319 nm for 1,8-ANS and 2,6-
ANS, respectively. 
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Figure 3.2 Calcium titration to 7 μM DREAM in the presence of 10 μM 1,8-ANS. Calcium 
titration into Mg2+ bound DREAM (squares) and apostate DREAM(circles). Samples were 
prepared in 20mM Tris pH 7.4, 100mM NaCl, and 1mM DTT which was decalsified by passing 
through an equilibrated CHELEX resin column (BioRad) and delivered into a decalsified 
1cmx1cm quartz cuvette. The average of three trials is shown, and nonlinear fit with a Hill 
equation (solid lines) yields Kd= 8.0 ± 0.9 μM with a Hill coefficient of n=1.22. 
The ANS emission intensity increases in the presence of DREAM due to ANS 
association to the protein, a further increase in intensity is observed upon Ca2+ addition to 
both apo- and Mg2+DREAM indicating that ANS binds to hydrophobic cavities on the 
DREAM surface (Figure 3.1). The identical emission spectra for 1,8-ANS bound to 
Ca2+DREAM and Mg2+Ca2+DREAM suggest that the change in surface polarity due to 
Ca2+ binding to apo or Mg2+ DREAM are identical. On the other hand, association of Mg2+ 
to apoDREAM leads to a small but reproducible increase in the 1,8–ANS emission 
compared to the apoform. This change is consistent with a more stable tertiary structure of 
Mg2+ bound DREAM, which may induce slight changes of the ANS binding sites (Osawa 
et al. 2005). Nonetheless the hydrophobic core is not fully exposed in the Mg2+ bound form 
of the protein. The results for 2,6-ANS are consistent with those obtained using 1,8-ANS 
probe. We further observes that ANS association to DREAM does not impair the binding 
of Ca2+, since the Kd value determined for Ca2+ association to DREAM-ANS complexes, 
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Kd = 8.0 ± 0.9 µM (Figure 3.2) is comparable to that determined by ITC, Kd = 1 - 10 µM 
(Osawa et al. 2005). 
 
Figure 3.3. Titration of 10 µM 1,8-ANS by apoDREAM (squares), Mg2+DREAM (circles), 
Ca2+DREAM (up-triangles), and Mg2+Ca2+DREAM (down triangles). The solid lines 
correspond to the fit of experimental data.  
 
Affinity of the ANS probes for DREAM was determined by conducting a series of 
titrations, with ANS titrated into a constant amount of protein (data not shown) or with 
protein titrated into a constant amount of ANS (Figure 3.3). Both approaches provided 
identical Kd values, within the experimental error. The titration curve shown in Figure 3.3 
were analyzed using a single binding site model according to eqn. 2.7.1. Approximately 
three times higher affinity for 1,8-ANS was observed for Ca2+ bound DREAM (Table 3.1) 
than in the apoform or in the presence of Mg2+. The affinity of 2,6-ANS for apoDREAM 
(Kdss~330 µM) is significantly lower than that for 1,8-ANS but it  is also promoted by Ca2+ 
association to DREAM (Kdss~154 µM) (Figure 3.4). Dynamic light scattering and gel 
filtration studies have shown that in the absence of calcium, DREAM adopts a tetrameric 
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conformation whereas Ca2+ bound DREAM forms dimers (Carrion et al. 1999, Osawa et 
al. 2001).  
 
Table 3.1 Equilibrium dissociation constants for 1,8-ANS binding to DREAM  
DREAM Kdss 
(µM)a 
nSSb Kdα1 
(µM)c 
Kdα2 
 (µM)c 
Kdtetramer  
(µM) 
Kddimer 
(µM) 
apo 195 ± 20 1.10 235 ± 36 158 ± 27 46 ± 5  
Mg2+ 198 ± 28 1.00 217 ± 20 131 ± 30 59 ± 9  
Ca2+  62 ± 4 1.09 68 ± 13 63 ± 12  31 ± 3 
Mg2+Ca2+ 60 ± 3 1.11 107 ± 16 49 ± 30  30 ± 2 
(a) Dissociation constants calculated from steady-state fluorescence. (b) Errors are 
less than 0.1 units. (c) Calculated from fluorescence decay parameters α1 and α2. 
 
Figure 3.4. Titration of 2,6-ANS by DREAM. The concentration of 2,6-ANS was kept 
constant (10 µM) and emission was collected from 405 nm to 600 nm using excitation 
wavelength of 319 nm. The data were corrected for scattering as described in Material and 
Methods section. The solid lines correspond to the fit of experimental data using a hill 
equation.  
 
The dissociation constants show a stronger ANS binding to DREAM monomer in the 
dimeric Ca2+ bound form than in the tetrameric Ca2+ free form of the protein. The increased 
accessibility of ANS binding sites could be due to a conformational change in each 
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monomer and/or due to the tetramer dissociation into individual dimers. The equilibrium 
constants were also determined by plotting the ANS emission intensity as a function of the 
tetramer concentration (for apo- and Mg2+DREAM) and dimer concentration (for Ca2+- and 
Ca2+Mg2+DREAM) (Table 3.1). The affinity of the DREAM dimer for 1,8-ANS is 
approximately two times larger than that of the DREAM tetramer which is consistent with 
an increased accessibility of the ANS binding sites upon tetramer dissociation into the 
individual dimers.  
3.2.2 Ca2+ association to the EF-hand 3 and EF-hand 4 increases accessibility of ANS 
binding sites 
Figure 3.5: Frequency-domain intensity decay of ANS bound to apoDREAM (squares), 
and Mg2+(circles), Ca2+ (up-triangle), and Mg2+Ca2+ (down triangle). Phase delay is shown 
as empty symbols, modulation ratio as solid symbols and the solid lines represent the 
calculated fitting curves. Protein concentration was 47.5 µM with 30 µM 1,8-ANS or 
30µM 2,6-ANS. 
 
The lifetimes for 1,8-ANS and 2,6-ANS DREAM complexes were determined  using 
frequency domain fluorometry (Figure 3.5), and the decay parameters are summarized in 
Table 3.2. The lifetime of 1,8-ANS  in 20 mM Tris pH 7.4 was measured to be 0.27 ns  
with a minor fraction (~ 2%) of a 4 ns lifetime due to the non-planar excited state decay 
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(Upadhyay et al. 1995, Someya, Yui 2010). The lifetime of 2.6-ANS was determined to be 
0.35 ns in agreement with a previously determined value (León et al. 2009). 
 In the presence of DREAM(Δ65), two additional lifetimes were resolved and 
attributed to ANS bound to at least two binding sites with distinct polarity. Heterogeneous 
binding is common and was reported for other ANS-protein systems (Parul et al. 2000, 
Togashi, Ryder 2008, Gasymov, Glasgow 2007). We associate the longer lifetime (~ 16 
ns) to 1,8-ANS bound to a nonpolar solvent restricted binding site, labeled site 2, that 
promotes the decay of the excited state by populating the long lived non-planar 
conformation of 1,8-ANS (Upadhyay et al. 1995). The faster lifetime can be attributed to 
the 1,8-ANS probe bound to a partially solvent exposed binding surface, site 1, which 
facilitates  rotation of the ANS aniline group into a lower energy planar configuration with 
respect to the naphthalene group (Gao, Mammen & Whitesides 1996).  
 
The fluorescence decay parameters are also sensitive to structural changes 
associated with Ca2+ binding to DREAM(Δ65). 1,8-ANS bound to Ca2+Mg2+ or 
Table 3.2 Decay parameters for ANS–DREAM complexes 
1,8-ANS τ1(ns) α1(%) τ2(ns) α2(%) χ2 
apo 5.9 ± 0.1 13.1 ± 0.5 16.2 ± 0.7 22.5 ± 0.3 1.16 
Mg2+ 5.7 ± 0.2 13.9 ± 0.6 16.2 ± 0.9 26.1 ± 0.4 1.13 
Ca2+  5.9 ± 0.2 17.9 ± 0.9 17.6 ± 0.5 41.9 ± 0.6 1.13 
Mg2+Ca2+  5.9 ± 0.2 17.8 ± 0.9 17.5 ± 0.5 44.5 ± 0.5 0.95 
2,6-ANS τ1(ns) α1(%) τ2(ns) α2(%) χ2 
apo 4.6 ± 0.2 9.8 ± 0.3 10.3 ± 0.3 39.9 ± 0.3 0.87 
Mg2+ 4.5 ± 0.9 9.6 ± 0.6 10.5 ± 0.6 42.5 ± 0.4 0.83 
Ca2+  4.6 ± 0.9 9.9 ± 0.1 10.6 ± 0.3 60.0 ± 0.7 1.44 
Mg2+Ca2+  4.9 ± 1.1 11.1 ± 0.5 10.7 ± 0.9 56.0 ± 0.6 0.98 
Data recovered from Globals software using a sum of three discrete exponential 
decays with fixed 1,8-ANS lifetime (τ0 = 0.27 ns) and 2,6-ANS lifetime (τ0 = 0.35 
ns). Phase and modulation errors were set at ≤0.2⁰ and ≤0.002 respectively. 
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Ca2+DREAM(Δ65) shows a small increase in its long lifetime and almost twofold increase 
in the pre-exponential parameter α2 compared to the apoprotein or Mg2+DREAM(Δ65). 
The fact that the individual 1,8-ANS lifetimes are not significantly altered by Ca2+  
association to DREAM(Δ65)  is consistent with 1,8-ANS binding to identical binding sites 
in the Ca2+ free and Ca2+ bound DREAM(Δ65). The small increase of the longer lifetime, 
τ2, indicates that Ca2+ induced structural changes in the vicinity of site 2 further restrict the 
rotation of the aniline ring. We associate the increase in the pre-exponential factors (Table 
3.2) with an increased accessibility of the ANS binding sites due to Ca2+ triggered change 
in the DREAM(Δ65) monomer structure and concomitant tetramer dissociation into 
dimers. Minor changes in the lifetime or pre-exponential factor values were measured for 
Mg2+ addition to either apoDREAM(Δ65) or Ca2+ bound DREAM(Δ65), supporting the 
idea that Mg2+ association to DREAM(Δ65) does not significantly alter surface 
hydrophobicity and the structural changes due to Mg2+ association are localized in the 
vicinity of the EF-2. Two lifetimes were also resolved for 2,6-ANS bound to 
apoDREAM(Δ65) (Table 3.2) in agreement with two different binding environments for 
hydrophobic ANS probes. The increase in the pre-exponential parameters for 2,6-ANS-
Ca2+DREAM(Δ65) complexes is smaller compared to those for  1,8-ANS-
Ca2+DREAM(Δ65) complexes. This is expected since the elongated structure of 2,6-ANS 
could represents a larger steric hindrance for binding to hydrophobic pockets on the protein 
surface.  
The phase and modulation data presented in Figure 3.5 were also analyzed using a 
phasor approach (Figure 3.6) (James et al. 2011). The resulting phasor plots clearly show 
a significant change in the signal between ANS in Tris buffer solution and in the presence 
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of apoDREAM and Ca2+ bound DREAM. Interestingly, a small difference was observed 
between experimental data for apoDREAM(Δ65) and Mg2+DREAM(Δ65); this shift is 
consistent with the small increase in the emission intensity due to the Mg2+ binding to 
DREAM(Δ65). The phasor plot for 2,6-ANS bound to DREAM(Δ65) shows similar results 
as those observed for 1,8-ANS DREAM(Δ65) complex (data not shown). 
Figure 3.6. Phasor plot representation of frequency domain data for 1,8-ANS (solid 
symbols) and 2,6-ANS (open symbols) bound to by apoDREAM (squares), Mg2+DREAM 
(circles), Ca2+DREAM (up-triangles), and Mg2+Ca2+DREAM (down triangles). 
Conditions: 64 µM DREAM and 30 µM ANS, modulation frequency (ω) was 70 MHz. 
 
The pre-exponential parameters (α0, α1, α2) corrected by their quantum yields 
correlate with the concentration of unbound ANS (α0) and ANS associated to individual 
binding sites (α1, α2) with lifetimes τ1 and τ2, respectively. These pre-exponential factors 
can be used to calculate the fraction of ANS bound to site 1 and site 2 (Robinson et al. 
1978, Kosower, Kanety 1983) and  determine  ANS binding constants for individual 
binding sites. Since titrations of DREAM into 28 µM ANS solution resulted in very small 
deviations in individual lifetimes (< 0.5 ns), the lifetime data obtained  at different 
DREAM(Δ65) concentrations were analyzed using the global analysis approach, i.e. the 
lifetimes corresponding to ANS bound to protein were treated as linked variables and the 
lifetime for unbound ANS was fixed. The plots of α1, α2 as a function of 
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Ca2+DREAM(Δ65) concentration are shown in Figure 3.7 and the recovered dissociation 
constants are presented in Table 3.1.  
Figure 3.7. Titration curves for 1,8-ANS binding to site 1 and site 2 of Ca2+DREAM. The 
concentration of the free 1,8-ANS bound to site 1 (τ1 ~ 6 ns) and binding site 2 (τ2 ~ 17 
ns) was determined based on the pre-exponential parameters α0, α1, and α2. The solid line 
corresponds to the fit using a Hill equation.  
 
Figure 3.8. Titration of 28.2 µM 1,8-ANS by DREAM using pre-exponential factors. The 
concentration of ANS bound to site 1 (a) and site 2 (b) was determined based on the pre-
exponential parameters α0, α1, and α2. 
 
The plots for the titrations of apoDREAM, Mg2+DREAM and Ca2+Mg2+DREAM 
are provided in Figure 3.8. Interestingly, the binding constants for 1,8-ANS binding to 
apoDREAM are similar with Kd = 235 µM for site 1 and Kd = 158 µM for site 2.  The Ca2+ 
bound DREAM exhibits an approximately 2-3 times increase in affinity for 1,8-ANS 
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binding to both sites which is in agreement  with the overall binding constants determined 
in steady-state emission measurements.  
Figure 3.9. Differential angle and modulation ratio data for 1,8-ANS (left) and 2,6-ANS 
(right) in complex with DREAM. The solid lines correspond to the NLLS fit of the data as 
described in the text. Conditions were the same as in Figure 3.5. 
 
3.2.3 Changes in DREAM oligomerization 
We have taken further advantage of the long fluorescence lifetime of 1,8-ANS and 
2,6-ANS DREAM complexes by monitoring the changes in DREAM oligomerization by 
probing the rotational diffusion of the ANS-DREAM complexes in time-resolved 
anisotropy measurements. The frequency-domain anisotropic decay of ANS-DREAM 
complexes in the presence of Mg2+ and/or Ca2+ are shown in Figure 3.9. Results from the 
non-linear least square analysis of the differential angle and amplitude ratio are listed in 
Table 3.3. The differential angle plots show a transition towards negative values at high 
modulation frequencies. This is characteristic for complexes with a fluorophore located in 
dissimilar environments with distinct depolarization contributions (Szmacinski et al. 
1987). Under our experimental conditions, ANS is bound to at least two binding sites on 
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the surface of DREAM, while residual unbound ANS also contributes to the observed 
signal.  
 
 
 
 
 
 
 
 
 
 
 
Nearly identical experimental data were observed for 1,8-ANS bound to Ca2+DREAM and 
Ca2+ Mg2+DREAM, whereas data for 1,8-ANS-Mg2+DREAM complex shows minor 
deviations from 1,8-ANS bound to apoDREAM. Non-linear analyses of experimental data 
yielded satisfactory χ2 values only when a triple associative decay model was used with 
the rotational lifetime for freely rotating 1,8-ANS or 2,6-ANS being fixed at Φ0 = 0.105 
ns. This value was determined independently and is consistent with the value of 0.092 ns 
reported previously (Szmacinski et al. 1987). In addition to the rotational correlation time 
for unbound 1,8-ANS or 2,6-ANS, two rotational correlation times, Φ1 and Φ2, were 
resolved and are associated with a global and a local motion of the ANS-DREAM 
complexes, respectively, and are reported in Table 3.3. The rotational lifetimes of 1,8-ANS 
Table 3.3. Anisotropy decay parameters of 1,8-ANS-
DREAM(Δ65) and 2,6-ANS-DREAM(Δ65) 
1,8-ANS Φ1a (ns) ƒ1b Φ2a (ns) ƒ2b χ2 
apo 55.0 ± 6.1 0.29 13.9 ± 0.6 0.38 1.15 
Mg2+ 57.6 ± 5.8 0.25 12.3 ± 0.4 0.38 0.96 
Ca2+  26.4 ± 0.7 0.48 6.7 ± 0.4 0.17 0.99 
Mg2+Ca2+ 23.8 ± 0.5 0.51 5.2 ± 0.4 0.11 1.16 
2,6-ANS Φ1a (ns) ƒ1b Φ2a (ns) ƒ2b χ2 
apo 55.8 ± 7.7 0.20 9.4 ± 1.7 0.39  0.83 
Mg2+ 54.9 ± 6.9 0.13 12.1 ± 1.9 0.39  0.97 
Ca2+  22.3 ± 1.5 0.69 5.7 ± 2.4 0.23  1.17 
Mg2+Ca2+ 21.8 ± 1.2 0.43 6.9 ± 2.1 0.15  1.71 
Conditions: 40 µM ANS and 53 µM DREAM(Δ65), rotational 
correlation for unbound ANS was fixed, Φ0 = 0.105 ns. (a) 
Recovered rotational correlation lifetime. (b) Recovered 
fractional depolarization, errors are less than 0.05 units.  
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bound to DREAM closely matches those for 2,6-ANS, confirming that the measured 
correlation times reflect properties of the macromolecule. The rotational correlation times 
Φ1~56 ns and Φ2~13 ns are similar for apoDREAM and Mg2+DREAM complexes with 
the fractional depolarizations, f1 and f2 accounting for 29% and 38 % of the total 
depolarization. Upon Ca2+ binding, the longer rotational correlation time decreases to ~26 
ns for Ca2+DREAM and to ~24 ns for Ca2+Mg2+DREAM complexes and accounts for ~ 
50% of the anisotropy decay. The faster rotational time, Φ2,  reaches 6.7 ns and 5.2 ns for 
1,8-ANS bound to Ca2+DREAM and Ca2+Mg2+DREAM, respectively. Analogous values 
were determined for the 2,6-ANS-DREAM complexes (Table 3.3).  
The experimentally determined rotational correlation times can be compared to 
expected values for a spherical protein calculated by using the Stokes-Einstein equation 
(Φ1calc= ηV/RT) (Lakowicz 2010) where η is the viscosity of water (η = 1.02 cP) (Korson, 
Drost-Hansen & Millero 1969), V is the hydrodynamic molecular volume, R is the ideal 
gas constant, and T is the temperature (20° C). Based on the molecular mass of 23 kDa for 
truncated mouse DREAM, and accounting for protein hydration we estimate the rotational 
correlation time for DREAM tetramer and dimer to be 48 ns and 24 ns, respectively. The 
rotational correlation time observed  for Ca2+DREAM and Ca2+Mg2+DREAM matches well 
the estimated rotational time for the DREAM dimer confirming that Ca2+ binding to either 
apoDREAM or Mg2+DREAM stabilizes the protein in its dimeric form. The measured 
correlation rotational time for apo- and Mg2+DREAM, Φ1~56 ns, indicates that in the 
absence of Ca2+, the protein adopts a tetrameric form. The observed rotational correlation 
times are somehow larger than the rotational correlation time calculated for the DREAM 
tetramer and the discrepancy between the observed and calculated values indicates that the 
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spherical model approximation applied here may not accurately describe the properties of 
the DREAM tetramer. 
Figure 3.10. Fractional depolarization recovered from NLLS analysis of the anisotropy 
decay of 1,8-ANS-DREAM complexes at different protein concentration, with 28.2µM 
1,8-ANS. The rotational correlation times (Φ) were fixed to those shown on Table 3 for 
the dimer, tetramer, and free dye; while the fractional depolarization and limiting 
anisotropy were the variable parameters. In all cases the global chi squared was less than 
2, the phase and modulation error set to ≤0.2 and ≤0.002, respectively.  
 
To probe the impact of protein concentration on the DREAM oligomerization state, 
we have determined f1 and Φ1 values for the 1,8-ANS–Mg2+DREAM(Δ65) and 1,8-ANS–
Ca2+DREAM(Δ65) complex in the protein concentration range from 5 µM to 300 µM 
(Figure 3.10). Both values remain constant with Φ1 = 58 ns confirming that Mg2+ 
DREAM(Δ65) retains tetrameric conformation in a broad concentration range and that the 
tetramer dissociation into individual dimers and/or monomers occurs at sub-micromolar 
concentration. On the other hand, the time-resolved anisotropy study of Ca2+DREAM(Δ65) 
as a function of protein concentration revealed an additional rotational correlation time that 
corresponds to the rotational correlation time of the tetramer (~ 55 ns) appearing at 
DREAM(Δ65) concentrations above 170 µM. These data indicate that the Kd value for the 
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Ca2+DREAM(Δ65) dimer to Ca2+DREAM(Δ65) tetramer transition occurs around 170 µM 
DREAM(Δ65). This is consistent with pre-exponential parameters recovered from ANS 
titration data showing a decrease in ANS affinity at Ca2+DREAM(Δ65) concentration 
above 170 µM (data not shown).  
The shorter rotational correlation time, Φ2 ~ 6 ns determined for 
Ca2+DREAM(Δ65) and Ca2+Mg2+DREAM(Δ65), is too short to be attributed to the 
DREAM(Δ65) monomer (Φcalc = 12 ns). Considering the molecular mass of the C-terminal 
domain to be 12 kDa and the  location of ANS binding sites on the C-terminal domain of 
the protein (see below) we associate this rotational correlation time to the local  motion of 
an isolated C-terminal domain of Ca2+DREAM(Δ65). In the case of apoDREAM(Δ65) and 
Mg2+DREAM(Δ65), the value of Φ2 was determined to be similar, 14 ns and 12 ns, 
respectively. This value may reflect either the presence of the monomeric form of 
apoDREAM or Mg2+DREAM(Δ65) in addition to the tetramer or it may indicate the slower 
rotation of the C-terminal domain in the DREAM(Δ65) tetramer. DREAM(Δ65) was 
detected as a monomer, dimer and tetramer in the nuclear extract, and as a dimer and 
tetramer in cytosolic extract using Western blot (Buxbaum et al. 1998). On the other hand, 
dynamic light scattering studies revealed that apoDREAM(Δ65) adopts a tetrameric form 
in the absence and presence of DRE sequence (Osawa et al. 2001). Thus we associate the 
slower rotational correlation time observed for both, Ca2+ bound and Ca2+ free 
DREAM(Δ65) to the local motion of the C-terminal domain. This motion becomes slower 
in the tetrameric form of DREAM(Δ65) due to the interaction of the individual monomers.  
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3.2.4 Identification of ANS binding sites 
In order to identify the ANS binding site(s) we have performed ligand docking 
simulations using AutoDock software version 4.2 (Morris et al. 1998). The NMR structure 
of Ca2+ bound DREAM(Δ75) was used in the simulations and treated as a static 
macromolecule whereas ANS ligands were treated as flexible molecules. Dockings were 
conducted with binding grids covering the whole protein surface to include all possible 
binding sites. The ANS binding sites were selected based on the lowest binding energy as 
well as on favorable ANS interactions with protein such as the presence of hydrogen bonds 
between the sulfonate group and amino acids or hydrophobic interactions. Additional low 
affinity sites identified in docking simulations represent nonspecific ANS binding and are 
unlikely to be populated under experimental concentrations.  
Two sites for 1,8-ANS and for 2,6-ANS were identified in the C-terminal domain 
and one site was found at the interface of the EF-hand 1 and EF-hand 2 (Figure 3.11 and 
Figure 3.12). In the case of 1,8-ANS one site is located between the entering and exiting 
helix of EF-hand 4, and shows a high affinity (Figure 3.11). This site is buried within the 
protein matrix and 1,8-ANS is surrounded by several hydrophobic residues (Try174, 
Ile182, Ile190, Ile194, Val215, Phe218, and Phe252). In addition to hydrophobic residues, 
three polar residues (M187, M191, and H214) form the binding site. The ANS sulfonate 
group points towards the solvent and forms a hydrogen bond with H214. 
The second binding site was identified at the interface of EF-3 and EF-4. This site 
is more polar and the ANS molecule is surrounded by V163, L167, C239, N247 and Q250 
and the ANS sulfonate group forms a salt bridge with K166. The third binding site 
identified in the docking study partially overlays with the solvent exposed hydrophobic 
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cavity between EF-2 and EF-1. However, in the model structure of DREAM dimer this 
hydrophobic cavity is part of the dimerization interface and may not be accessible for 1,8-
ANS binding. Identical binding sites were found for 2,6-ANS (Figure 3.12). 
 
Figure 3.11. Position of three docking site for 1,8-ANS on the surface of Ca2+ bound 
DREAM as predicted using AutoDock 4.2 (Panel A). The binding sites were found in the 
vicinity of EF-4 (panel B, left), at the interface between EF-3 and EF-4 (panel B, middle) 
and at the hydrophobic crevice between the EF-1 and EF-2 (panel B, right). Cartoon 
representation of monomeric calcium bound DREAM (pdb: 2JUL) with EF-1 shown in 
green, EF-2 in orange, EF-3 in blue and EF-4 in red while calcium is shown as solid spheres 
and 1,8-ANS as licorice model. 
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Figure 3.12. Position of three docking site for 2,6-ANS on the surface of Ca2+ bound 
DREAM as predicted using AutoDock 4.2 (Panel A). The binding sites were found in the 
vicinity of EF-4 (panel B, top), at the interface between EF-3 and EF-4 (panel B, middle) 
and at the hydrophobic crevice between the EF-1 and EF-2 (panel B, bottom).  
 
3.2.5 RET from Trp to 1,8-ANS 
Taking advantage of the spectral overlap between the emission spectrum of Trp169 
and the absorption spectrum of 1,8-ANS (Figure 3.13), the distance between the 1,8-ANS 
binding sites and Trp residue can be determined based on the efficiency of the Förster 
energy transfer between the excited Trp169 donor and the 1,8-ANS acceptor. The emission 
intensity of Trp 169 is efficiently quenched upon addition of 1,8-ANS (Figure 3.14). The 
FRET efficiencies at saturating 1,8-ANS concentrations were determined to be ~0.97 for 
both, apoDREAM:1,8-ANS complex and the  Ca2+DREAM: 1,8-ANS complex. Using Eq. 
2.7.3 the Förster distance, Ro, between Trp169 in Ca2+ free and Ca2+ bound DREAM and 
1,8-ANS was determined to be 25 Å.   
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Figure 3.13. Normalized absorption spectrum of 1,8-ANS bound to Ca2+DREAM, 
normalized emission spectrum of Ca2+DREAM and the  overlap integral for the Trp169 - 
1,8-ANS FRET pair.  
 
Based on the FRET efficiency and accounting for the degree of flexibility of both 1,8-ANS 
and Trp 169 (Eq. 2.7.2 and Figure 3.14), we estimate the distance between 1,8-ANS and 
Trp169 to be between 8 Å and 16 Å, which matches well the position of the 1,8-ANS sites 
determined in docking studies. The flexibility of ANS and Trp 169 was determined from 
the steady state anisotropy and the limiting anisotropy as described in Figure 3.14. Notably, 
the Eff50 value matches the value of Kd for 1,8-ANS biding to apo- and Ca2+DREAM 
suggesting that the FRET efficiency is determined by the 1,8-ANS site occupancy. Also 
the similar distance between bound 1,8-ANS and the Trp residue in apo and Ca2+DREAM  
indicates that the size and overall shape of DREAM monomer is similar in the apo and 
Ca2+ bound form of the protein.  
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Figure 3.14. (Top left) Quenching of the DREAM fluorescence emission by addition of 
1,8-ANS (Top right) resulting efficiency plot calculated using the decrease in fluorescence 
emission at 328 nm as a function of 1,8-ANS concentration. Protein concentration was kept 
at 53 µM and aliquots containing 53 µM protein and 260µM 1,8-ANS were added to the 
solution. (Bottom left) Equations used for the analysis of the ANS-W169 distances, where 
ri represents the steady state anisotropy of the fluorophore in the absence of rotational 
diffusion and r0 represents the limiting anisotropy determined from the modulated 
anisotropy extrapolated a high frequencies. (Bottom right) Steady state anisotropy 
determined and limiting anisotropy determined for the ANS-W169 FRET pair used to 
calculate the lower and upper limits for the kappa squared parameter. 
 
3.2.6 Hydrophobic probe displacement studies  
 To determine if the hydrophobic sites occupied by ANS molecules can serve as 
binding sites for small hydrophobic modulators of Kv channels:KChIP complexes, the 
emission intensity of 1,8-ANS:DREAM(Δ65) complex was monitored upon addition of 
arachidonic acid. Addition of the fatty acid results in a decrease in the emission intensity 
in Ca2+DREAM(Δ65) and in apoDREAM(Δ65), although to a smaller extent in the 
apoform (Figure 3.15). Also, the emission maximum of 1,8-ANS:DREAM(Δ65)  complex 
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undergoes a bathochromic shift from 467 nm to 475 nm suggesting that the arachidonic 
acid preferentially displaces 1,8-ANS bound to a hydrophobic site 2. This was confirmed 
by the docking studies which show that the fatty acid molecule is positioned between α-
helices 7, 8, and 9 with the carboxy group oriented towards the guanidino group of Arg217 
(Figure 3.15c). The titration curves were analyzed using a competitive binding model 
(Epps, Raub & Kezdy 1995). Arachidonic acid binds to Ca2+DREAM with a dissociation  
constant of 19 ± 1 μM, whereas an approximately 10 time smaller affinity was determined 
for arachidonic acid association to the apo protein (Ki =160 μM).  
Figure 3.15: Decrease in the emission intensity of 1,8-ANS bound to Ca2+DREAM upon 
addition of  arachidonic acid (a). The change in 1,8-ANS fluorescence intensity as a 
function of arachidonic acid concentration. The solid line corresponds to the fit of the 
experimental data using a single binding site model (solid line) (b). The position of the 
docking site for arachidonic acid in the C-terminal domain of DREAM (c).  
3.3 Discussion 
In consideration of its multifunctional role in neuronal tissue, DREAM represents 
a unique model to study the mechanism of calcium signal transduction by neuronal calcium 
sensors. Unlike other members of the NCS family, DREAM adopts distinct 
oligomerization states depending on the Ca2+/Mg2+ occupation of the EF-hands and 
possibly on DREAM interactions with other intracellular proteins. Fluorescence properties 
of hydrophobic probes such as 1,8-ANS and 2,6-ANS offer several advantages in studying 
conformational changes in proteins that undergo oligomerization. Besides the traditional 
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application of ANS probes to identify putative hydrophobic binding sites on the protein 
surface, the long fluorescence lifetime of ANS-protein complexes allows a direct 
characterization of the DREAM oligomerization by probing the rotational correlation time 
in time-resolved anisotropy studies.  
Previous studies reported that DREAM forms a monomer, dimer, and tetramer in 
nuclear extracts, and as a dimer and tetramer in cytosolic extract (Carrion et al. 1999). In 
vitro, Ca2+ association to EF-hands stabilizes the dimeric form of DREAM (Osawa et al. 
2001); however, a discrepancy about the oligomeric state of Mg2+ bound DREAM remains. 
Initially, Carrion et al. proposed that in the absence of Ca2+, DREAM forms a stable 
tetramer with a high affinity for DNA (Carrion et al. 1999). On the other hand, using size 
exclusion chromatography, Ames et al. have reported that Mg2+ stabilizes DREAM in the 
monomeric form and that the presence of Mg2+ facilitates the specific recognition of the 
DRE sequence (Osawa et al. 2005). The long fluorescence life-time of ANS:DREAM 
complexes enable us to probe the DREAM oligomerization state in solution as a function 
of protein concentration. The time-resolved anisotropy data presented here demonstrate 
that Mg2+DREAM forms a stable tetramer at the concentrations range from 8 µM to 230 
µM and  the Mg2+DREAM tetramer dissociates into dimers or monomers at concentrations 
below 8 µM indicating a strong affinity between the individual dimers or monomers of 
Mg2+DREAM. Indeed, attempts to separate Mg2+ bound DREAM tetramer into individual 
monomers or dimers using low concentration of denaturant (up to 1M GuHCl), high salt 
concentrations (up to 200 mM), or a temperature increase (up to 33°C) were unsuccessful. 
The concentration of free Mg2+ in the nuclei and cytoplasm of neuronal cells was 
determined to be ~ 110 µM and close to 1 mM, respectively (Gotoh et al. 1999). 
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Considering the Kd value for Mg2+ binding to DREAM of 13 µM (Osawa et al. 2005), in 
vivo Mg2+ would constitutively bind to DREAM in the cytoplasm as well as in the nuclei 
and stabilizes its tetrameric structure.  
Using fluorescence and computational studies, two ANS binding sites of 
comparable affinity were identified in the DREAM C-terminal domain; namely, in the 
vicinity of EF-hand 4 (site 2) and between EF-hand 3 and EF-hand 4 (site 1). The C-
terminal domain carries both Ca2+ binding EF-hands in DREAM and other KChIPs and 
this domain was reported to be essential for  the KChIP1 binding to phosphatidylserine as 
well as for protein association to the membrane (Liao, Chen & Chang 2009). In addition, 
the crystal structure of Kv4.3 channel in complex with KChIP-1 reveals that the site 1 of 
the T1 domain of the Kv4.3 channel interacts with several hydrophobic residues in the C-
terminal domain of KChIP-1 including Tyr144, Ile150, Ile154 and Tyr155 (Pioletti et al. 
2006) and the replacement of Tyr144 by Glu prevents KChIP1 association to Kv4.3 
channels (Wang et al. 2007). Tyrosine 144  in KChIP1 is analogous to Tyr174 in DREAM, 
an amino acid which we found to be in direct contact with 1,8-ANS bound at the 
hydrophobic site. This observation confirms the role of the hydrophobic site 2 (Figure 3.11) 
in interactions with the N-terminus of Kv4 channels. Interestingly, the 1,8-ANS 
displacement study shows that arachidonic acid binds to the hydrophobic site 2 between 
helix 7, 8 and 10 in the C-terminal domain in presence of Ca2+. Previously it was shown 
that arachidonic acid modulates inactivation kinetics of Kv4 channels in complex with 
KChIPs (Boland, Drzewiecki 2008). Both the N-terminus of the T1 domain and 
arachidonic acid bind at the hydrophobic crevice at the C-terminus of DREAM. We 
hypothesize that the association of arachidonic acid to the hydrophobic C-terminus of 
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KChIPs triggers reorientation of the contacts between the T1 domain and the KChIP 
leading to modulation of the inactivation kinetics.   
Figure 3.16. A cartoon model depicting DREAM interactions with Mg2+ and Ca2+ ions and 
arachidonic acid. Association of the Mg2+ ions to apoDREAM tetramer does not lead to 
substantial changes in DREAM structure (step 1). Subsequent binding of Ca2+ to EF-hand 
3 and EF-hand 4 promotes tetramer dissociation and concomitant exposure of the 
hydrophobic cavity located in the C-terminal domain by repositioning of the C-terminal α-
helix (step 2) allowing binding of the arachidonic acid to the C-terminus hydrophobic 
cavity (step 3). 
 
To understand the mechanism of the Ca2+ triggered increased occupancy of the site 
2 by hydrophobic molecules, we have overlaid the structure of Ca2+DREAM with the 
structure of recoverin in its apoform (Tanaka et al. 1995). The C-terminal helix of recoverin 
partially restricts the solvent exposure of site 2 whereas this site is more solvent accessible 
in the Ca2+ bound form of DREAM. We propose that a similar displacement of the C-
terminal helix occurs in DREAM and thus concomitant reorganization of the C-terminal 
hydrophobic cavity contributes to the increase in 1,8-ANS and arachidonic acid binding to 
Ca2+DREAM. Since the hydrophobic cavity in the DREAM C-terminal domain serves as 
a binding sites for the N-terminus of the T1 domain, we propose that Ca2+ induced exposure 
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of the hydrophobic cavity modulates interactions within the T1 domain:DREAM complex 
and such structural rearrangement represent an initial step in Ca2+ dependent regulation of 
current amplitudes and kinetics properties of KV4- DREAM complexes (Zhou et al. 
2004b). Also, the Ca2+ triggered increase in the exposure of the DREAM C-terminal 
hydrophobic cavity may control the affinity of DREAM for other small hydrophobic 
molecules such as NS5806 or CL-888 (Bowlby et al. 2005). 
3.4 Summary 
Members of the NCS family including DREAM share a cluster of highly conserved 
hydrophobic residues that form solvent exposed hydrophobic patches at the N-terminal 
domain and at the interface between the N- and C-terminal domains. The solvent exposure 
of hydrophobic patches regulated by Ca2+ association to the active EF-hands may represent 
a key factor for NCS interactions with target proteins. Based on the fluorescence lifetime 
data, two 1,8-ANS binding sites were identified in the apo and Ca2+ bound form of 
DREAM with site 2 being more accessible in Ca2+DREAM and Ca2+Mg2+DREAM 
compared to apo and Mg2+DREAM. Unlike other NCS members, Ca2+ association to 
DREAM and possibly other KChIP proteins regulates solvent exposure of hydrophobic 
patches located on the C-terminal domain. Such limited exposure of the hydrophobic 
patches may represent a molecular mechanism used to fine tunes specificity for 
intracellular target proteins as well as small modulators of KChIP-Kv4 function.  
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4. REGULATION OF DREAM ACTIVITY BY THE NOVEL ITO CURRENT 
ACTIVATOR NS5806 
4.1 Background and significance 
Potassium is the most abundant ion in vertebrate cells, and its concentration is highly 
regulated by the coordinated activation and inactivation of Na+/K+ pumps and other K+ 
transporters, including voltage sensitive K+ channels. In excitable tissue such as brain and heart 
tissue, the higher intracellular concentration of K+ is used to restore the resting membrane potential 
after depolarization; this makes the regulation of K+ ions of utmost relevance to cell survival. 
Consequently, voltage-gated K+ channels are the most diverse and widespread cation-conducting 
membrane proteins, and have been found to be involved in numerous biological processes such as 
apoptosis (Szabò, Zoratti & Gulbins 2010), neuron signaling (Song et al. 1998), cell volume 
(Lang et al. 2007), and cardiac action potential (Niwa, Nerbonne 2010). In neurons and 
cardiomyocytes the KV4 subfamily of voltage gated K+ channels regulate the fast-inactivating 
components of the ISA and ITO currents, respectively (Liss et al. 2001). These channels form 
octameric transmembrane complexes with accessory subunits such as potassium channel 
interacting proteins (KChIPs) (An et al. 2000), dipeptidyl-peptidases (DPPs) (Nadal et al. 2003), 
and KVβ proteins (Martens, Kwak & Tamkun 1999) . Interaction of KChIP2 with KV4 channels 
in the heart results in an increase in current density, acceleration of recovery from inactivation, and 
slower inactivation kinetics (An et al. 2000). Similar effects on the biophysical properties of neural 
fast inactivating K+ currents have been observed for KChIP1 (Bourdeau et al. 2011) and KChIP3 
(Witzel, Fischer & Bähring 2012). Even though the molecular structures of the KV4 T1 domain 
in presence and absence of the regulatory KChIP1 is known, the mechanism by which these 
auxiliary proteins mediate channel gating remains unknown. Patch clamp studies using 
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heterologous expressed KV4 channels highlight the relevance of the T1 domain in gating and 
mediating ancillary subunit interaction. Two regions on the KV4 T1 domain (amino acids 7-11 
“site 1” and 71-90 “site 2”) have been identified as being necessary for KChIP1 current regulation 
(Scannevin et al. 2004). 
  KChIP3 also known as DREAM or calsenilin is expressed in the brain/testis and heart and 
has been shown to interact with presenilin (Buxbaum et al. 1998), DNA (Carrion et al. 1999) 
and KV4.3 (An et al. 2000). KChIP3DREAM contains four calcium binding domains “EF-
hands”, of which EF-3/4 binds Ca2+ with high affinity, EF-2 binds Mg2+ preferentially, and EF-1 
is inactive (Craig et al. 2002). Similarly to other KChIPs this protein contains a relatively polar 
surface while the opposite side is predominantly hydrophobic with a large nonpolar cavity (Lusin 
et al. 2008). The formation of the KV4-KChIP complex has been shown to be necessary for proper 
regulation of the fast component of the ITO currents in the heart (Niwa, Nerbonne 2010) and ISA 
in the brain (Bourdeau et al. 2011). Demodulation of ITO currents is a characteristic trait in 
hypertrophied and failing hearts (Kääb et al. 1998) as well as in Brugada syndrome (Calloe et 
al. 2009). Normal functioning heart tissue displays an increasing ITO current density gradient from 
endocardium to epicardium, which has been shown to correlate with a transmural KChIPs density 
(Zicha et al. 2004).  Studies using canine models of failing hearts have shown that heart failure 
results in a decrease of phase 1 repolarization due to a decrease in ITO current as well as a 
remodeling of the gating kinetics of this current (Cordeiro et al. 2012). Although numerous drugs 
have been shown to down regulate the amplitude or modify the gating kinetics of ITO current, drugs 
that directly upregulate the ITO current amplitude have not been reported. 
 Recently, Calloe et al. have introduced a new compound named NS5806 (Calloe et al. 2009) 
which was shown to modulate the ITO current kinetics and reverse the ITO current decrease induced 
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by heart failure in canine models (Calloe et al. 2010). Interestingly, this ITO activator has also 
been shown to decrease ISA currents in cultured hippocampal neurons where its effects on gating 
kinetics are comparable to those observed in heart tissue (Witzel, Fischer & Bähring 2012). 
Moreover, the induced  potassium current modulation by NS5806 has been shown to depend on 
the presence of KV4 auxiliary KChIP protein (Witzel, Fischer & Bähring 2012, Lundby et al. 
2010). 
  In this study we investigate the mechanism of NS5806 ITO/ISA current regulation by 
determining the interaction between NS5806 and KChIP3 (herein referred as DREAM), and how 
this interaction modulates the DREAM-KV4.3 association.  We show that the ITO  activator 
NS5806 binds to the KV4 auxiliary protein DREAM at the C-terminus near the calcium binding 
sites, EF-hand 3 and EF-hand 4, with an affinity comparable to the previously determined EC50 
for current potentiation. We also characterize the association constants between DREAM and 
peptide fragments of the T1 domain of KV4.3 to show that calcium binding induces an increase in 
the affinity between DREAM the T1 domain of KV4.3. In the presence of NS5806, the interaction 
between DREAM and the hydrophobic N-terminus of KV4.3 is enhanced and the calcium 
dependency of this interaction is abolished. Furthermore, anisotropy data suggest that the complex 
between DREAM  and the T1 domain adopts an altered quaternary structure in the presence of 
NS5806. Kinetic data indicates that NS5806 decreases the rate of dissociation between DREAM 
and site 1 of KV4.3, which results in an overall increasing in affinity. These results support the idea 
that NS5806 binds at the interface between the hydrophobic N-terminus of KV4.3 and the 
hydrophobic cavity at the C-terminus of DREAM and stabilizes the protein complex. These results 
are further supported by docking, molecular dynamic simulations and site directed mutagenesis. 
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Overall, the studies shown here provide a roadmap for the elucidation of the precise mechanism by 
which KV4 current kinetics are regulated by KChIPs and NS5806. 
Figure 4.1. (a) Fluorescence emission of 15 μM apoDREAM(Δ65) and 15 μM Ca2+ 
DREAM(Δ65) in the absence and presence of 30 μM NS5806, λexc = 295 nm. (b) Titration of 
DREAM(Δ65) with NS5806 by monitoring the change in tryptophan fluorescence in the apo and 
calcium bound form. The recovered dissociation constants were determined using Eqn. 2.8.1 (solid 
lines)  and are listed in Table 4.1. (c) Average tryptophan fluorescence lifetime of 15 μM 
DREAM(Δ65) and 15 μM DREAM(Δ160) in the Ca2+ bound state as a function of NS5806. Solid 
lines represent the best non-linear fit using a single site Hill equation.  
 
4.2 Results 
4.2.1 NS5806 binds at the C-terminus of DREAM  
  The KV4 mediated current amplitude increase and slowing of inactivation induced by 
NS5806 have been reported to be enhanced or dependent on the presence of the auxiliary KChIP 
proteins (Witzel, Fischer & Bähring 2012, Lundby et al. 2010). In this study we probe whether this 
dependency is due to direct interaction between NS5806 and the neuronal calcium sensor 
DREAM(Δ65). The interaction of NS5806 with DREAM(Δ65) was initially characterized by 
monitoring the steady-state tryptophan fluorescence emission of DREAM(Δ65) upon addition of 
NS5806. The single tryptophan residue (Trp169) found in the DREAM(Δ65) protein is located at 
the interface between EF-hand 3 and EF-hand 2 and thus its emission may probe NS5806 
association to either N- or C-terminal domains. Upon addition of two -fold excess of NS5806, a 
significant decrease in tryptophan emission intensity was observed (Figure 4.1a). The quenching 
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effect was present in the apo-state as well as in the calcium bound state of DREAM(Δ65). The 
absorption spectrum of NS5806 in 20 mM MOPS buffer shows an absorption peak at 340 nm with 
an extinction coefficient of 105 M-1cm-1. This absorption band overlaps with the Trp169 emission 
spectrum suggesting that resonance energy transfer (RET) between Trp169 and NS5806 is 
responsible for the observed Trp emission quenching.  
Figure 4.2. (a) Quenching of the tryptophan fluorescence of DREAM(Δ65) and DREAM(Δ160)) 
in the apo-state as a function of NS5806, analyzed using a modified Stern-Volmer equation (inset). 
The linear fit recovered a slope of 45 ± 2 μM and intercept of 1.0 ± 0.2 for DREAM(Δ65) and 
slope of 80 ± 4 μM and intercept of 1.8 ± 0.2 for DREAM(Δ160). The inverse of the intercept for 
DREAM(Δ160) indicates that only 56 % of the tryptophan residues are quenched at saturating 
amounts of NS5806. After correction for the fraction quenched, both constructs result in identical 
dissociation constant values of ~40 μM in the apoform. (b) The tryptophan fluorescence of 5 μM 
Zn2+Kv4.3(1-152)-GST decrease due to binding of NS5806, inset shows the structural formula of 
NS5806. (c) Fluorescence intensity change as a function of NS5806 concentration, solid line 
represents best fit using eq. 1 with recovered Kd=11 ± 2 μM.  
  
To determine the DREAM(Δ65) affinity for NS5806, the Trp emission intensity was plotted as a 
function of NS5806 concentration of DREAM(Δ65) (Figure 4.1b), the dissociation constants were 
recovered using Eq. 2.8.1 and are listed on Table 4.1. The stoichiometry of the model was set to 
one since analysis of the tryptophan fluorescence by the continuous variation method yielded a 
stoichiometry of one to one (data not shown). The recovered dissociation constants implies that in 
the Ca2+ bound form, DREAM(Δ65) binds NS5806 with a dissociation constant of 4.4 ± 0.3 μM. 
Separate experiment using the truncated C-terminus domain, DREAM(Δ160), shows roughly a 
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two-fold affinity increase to Kd = 2.7  ± 0.3 μM (data not shown). Upon Ca2+ removal, the affinity 
of DREAM(Δ65)  for NS5806 decreases, Kd = 30 ± 2 μM, similarly the affinity of DREAM(Δ160) 
is reduced to Kd = 26 ± 4 μM. Since both constructs show similar affinities for NS5806 in the 
calcium bound form and apo-state we propose that the C-terminus of DREAM is the binding site 
for NS5806.  
  It is interesting to note that the decrease in fluorescence of apoDREAM(Δ65) upon 
addition of NS5806 is about twice as large as that observed for apo DREAM(Δ160) (data not 
shown), we hypothesize that this could be due to a structurally different conformation of the isolated 
C-terminus in the apo-state. To investigate if this is the case, the quenching data was analyzed using 
a modified Stern-Volmer equation which accounts for the presence of tryptophan residues which 
may not be quenched by NS5806 (Figure 4.2a). The results show that both DREAM(Δ65)  and 
DREAM(Δ160) in the apo-form bind to NS5806 with the same affinity, and that the observed 
differences in the extent of quenching are due to the fact that in the apo-state, DREAM(Δ160) 
populates a second conformation (~40 %) which is not quenched by NS5806. This additional 
population may be  present due to a lower stability of the truncated C-terminus domain. 
 To probe if RET is responsible for the observed fluorescence quenching we measured the 
tryptophan fluorescence lifetime of both DREAM constructs in the calcium bound form. The 
average lifetime of Trp169 decreases from 3.3 ns to approximately 1.3 ns in Ca2+ DREAM(Δ65) 
and from 4.3 ns to 3.2 ns in Ca2+ DREAM(Δ160) as the concentration of NS5806 is increased 
(shown in Figure. 4.1c). The fluorescence lifetime decrease indicates that the quenching 
mechanism happens during the excited state of tryptophan, and correlates well with a dynamic 
quenching process such as RET.  
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  Furthermore, it is possible to use the fluorescence emission spectra of both DREAM 
constructs, the tryptophan fluorescence quantum yield, and the absorbance spectra of NS5806 
while assuming a random NS5806-Trp169 orientation to obtain the overlap function and calculate 
the Förster distance between the NS5806-Trp169 pair for DREAM(Δ65) and DREAM(Δ160). 
The Förster distances were calculated to be 12 Å and 14 Å for the apo-form DREAM(Δ65)  and 
DREAM(Δ160), respectively, while a Förster distance of 12 Å was recovered for the Ca2+ bound 
form of DREAM(Δ65) and 13 Å  for Ca2+ DREAM(Δ160), (Table 4.1). Due to the location of 
Trp169 within the protein matrix, a random orientation value for κ2 is not appropriate. However, 
an upper (κ2max) and lower (κ2min) limit for the orientation factor can be obtained from measurement 
of the frequency modulated anisotropy of Trp169 for both DREAM construct (data not shown). 
These values were used to calculate the upper and lower limits for NS5806-Trp169 distances as 
shown in Table 4.1. The recovered NS5806-Trp169 distances using fluorescence emission and 
fluorescence lifetime of Trp169 range from 5 Å to 13 Å and 8 Å to 20 Å, respectively. The larger 
values for the lifetime measurements support the presence of an additional static quenching process 
induced by binding of NS5806 which results in smaller distances being resolved in the steady state 
Table 4.1 Overlap integrals and Förster distances between DREAM and NS5806 
 J(λ)  
(M-1cm-
1nm4) 
R0 
(Å) 
Ф(a) κ2min κ2max r (b) 
(Å) 
r(c)  
(Å) 
apoDREAM(Δ65) 2.44 x1012 11 0.039 0.096 2.76 5-9 - 
Ca2+ DREAM(Δ65) 2.36 x1012 11 0.037 0.076 2.87 7-12 8-15 
apoDREAM(Δ160) 8.38x1011 12 0.190 0.063 2.96 7-13 - 
Ca2+DREAM(Δ160) 1.57x1012 12 0.125 0.055 3.00 7-13 11-20 
(a) Quantum yield of Trp169 determined relative to L-Tryptophan. Experimental 
distance “r” determined using the energy transfer efficiency at saturating NS5806 
concentration (150 μM) using the tryptophan fluorescence intensity. 
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quenching measurements. Additional contribution due to quenching of residual tyrosine 
fluorescence cannot be ruled out. Overall, these results show that NS5806 binds at the C-terminus 
of DREAM near EF-hands 3 and 4 and quenches the single tryptophan residue through resonance 
energy transfer. NS5806 also showed binding and quenching of tryptophan residues on a 
GST-Kv4.3(1-152) fusion protein; however, the dissociation constant for binding to this 
construct was 11 ± 2 μM (Figure 4.2b and 4.2c). The low solubility of the full T1 domain 
prevented us from further characterization of this interaction and from unequivocally 
showing that NS5806 binds at the T1 domain. Nonetheless, based on the more favorable 
binding of NS5806 with DREAM, it is likely that the site on DREAM is populated before 
binding at the T1 domain.  
4.2.2 NS5806 binding on DREAM displaces 1,8-ANS bound at the hydrophobic cavity 
near EF-hand 4  
  Previously, we have identified two binding sites for the solvent sensitive 
fluorophore 1,8-ANS at the hydrophobic cavities located on the C-terminus of 
DREAM(Δ65) as well as on DREAM(Δ160) (Chapter 3). In order to determine the nature 
of interactions between NS5806 and DREAM, displacement studies were carried out in the 
presence of the hydrophobic fluorophore 1,8-ANS. Upon binding of 1,8-ANS to calcium 
bound DREAM(Δ65) an intense fluorescence emission at 475 nm is observed. The 
emission intensity of bound 1,8-ANS decreased sharply as the concentration of NS5806 is 
increased, indicating that NS5806 displaces 1,8-ANS from the hydrophobic cavity. The 
decrease in 1,8-ANS emission intensity is accompanied with a redshift of the emission 
maxima from 475 nm to 484 nm (Figure 4.3a). Using the decrease in fluorescence intensity 
and the previously determined affinities of 1,8-ANS for DREAM(Δ65) the affinities for 
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NS5806 binding to DREAM(Δ65) were determined  (Eq. 2.7.6) to be Kd = 23  ± 7 μM in 
the apo-form and Kd = 2.5  ± 0.3 μM in the Ca2+ bound form (Figure 4.3b), which are in good 
agreement with the quenching data.   
Figure 4.3. (a) Fluorescence emission of 1,8-ANS:DREAM(Δ65) complexes as a function 
of increasing concentrations of NS5806, inset shows the shift in emission spectra maximum 
as a function of NS5806. (b) Replacement curves for the 1,8-ANS- DREAM(Δ65) complex 
in the apo and calcium bound states as a function of NS5806 concentration. The 
dissociation constants recovered using Eq. 2.8.2 are Kd =  23 ± 7 μM and Kd =  2.5 ± 0.3 
μM for apo and calcium bound forms, respectively. Conditions: 95 μM 1,8-ANS, 10 μM 
Ca2+ DREAM(Δ65) in 20mM MOPS, pH 7.4, and  100mM NaCl. (c) Change in 
fluorescence lifetime pre-exponential parameters α1 and α2 as a function of NS5806 
concentration. Pre-exponential parameters were recovered using a triple discrete 
exponential decay model from analysis of emission decay data of  10 μM 1,8-ANS bound 
to 10 μM DREAM(Δ65) in the apoform and Ca2+ bound state. The lifetime of unbound 
ANS was set as a fixed value at 0.28 ns (measured separately), while the second and third 
decay lifetimes were set as linked variables with lifetimes of 5.7 ± 0.4 ns and 15.4 ± 0.9 ns 
in the apoform (χ2=2.7)and 6.3 ± 0.5 ns and 16.7 ± 0.5 ns in the calcium bound state 
(χ2=1.7). 
 Previously, we have identified that 1,8-ANS binds to at least two different hydrophobic 
sites on DREAM, each bound 1,8-ANS being characterized by distinct lifetimes. Therefore 
it is possible to employ the fluorescence lifetime of 1,8-ANS in the presence of 
DREAM(Δ65)  and the associated pre-exponential factors to pinpoint the NS5806 binding 
site. The 1,8-ANS:Ca2+DREAM(Δ65)  complex exhibits a fluorescence decay that is best 
modeled by the sum of three exponential decays. We associated the fastest lifetime (τ0 = 
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0.28 ns) as corresponding to unbound 1,8-ANS. The two additional decay lifetimes 
correspond to 1,8-ANS binding to a partially polar cavity on the protein surface with 
lifetime τ1 ~ 6 ns and 1,8-ANS bound to a predominantly  hydrophobic site/cavity on the 
KChIP3 surface with a lifetime of τ2 ~ 16 ns. Addition of NS5806 to the 1,8-ANS: Ca2+ 
DREAM(Δ65) complex did not alter the 1,8-ANS lifetimes. However, a systematic 
decrease in the pre-exponential factor for the long lifetime (α2) and an increase of the pre-
exponential parameter for 1,8-ANS in solution (α0) were observed. The pre-exponential 
factor for 1,8-ANS bound at the site with 6 ns lifetimes (α1) remained fairly constant 
(Figure 4.3c). These results indicate that NS5806 binds to the hydrophobic site/cavity on 
DREAM, which results in a displacement of 1,8-ANS bound at that site.  
 
 
 
 
 
4.2.3 NS5806 binding to DREAM is enthalpically driven  
  The thermodynamic properties associated with the formation of NS5806- DREAM 
complexes were probed using isothermal calorimetry. Isotherms for the titration of NS5806 
into Ca2+ DREAM(Δ65) and Ca2+ DREAM(Δ160) in presence of 5 mM Mg2+ are shown 
in Figure 4.4.  The isotherms were analyzed using a two-site binding model (solid line). 
The binding of NS5806 to DREAM was characterized with two dissociation constants with 
the specific binding site associated with a Kd of 0.8 µM and a non-specific binding site 
which showed a very weak affinity with Kd ~ 150 µM (data not shown). This weak binding 
Table 4.2. Thermodynamic parameters for NS5806 binding to 
Ca2+KChIP3 constructs determined using ITC 
 
 
Kd 
(μM) 
ΔH 
(kcal/mol) 
-TΔS 
(kcal/mol) 
DREAM(Δ65) 0.8 ± 0.4 -4.4 ± 0.8 -3.9  
DREAM(Δ160) 2.5 ± 1.0 -6.9 ± 0.7 -1.3 
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site was not observed in the Trp169 quenching and 1,8 ANS displacement studies, probably 
due to an inefficient quenching or different binding site than that of 1,8-ANS. ITC 
thermodynamic parameters for NS5806 specifically binding to DREAM constructs are 
summarized in Table 4.2. 
Figure 4.4. ITC binding isotherms for NS5806 association to 
Mg2+Ca2+DREAM(Δ65)(left) and to Mg2+Ca2+DREAM(Δ160) (right). The upper panels 
of each profile reflects the thermal power expressed in units of µcal·s-1. The lower panel 
shows integrated reaction heats (ΔH) normalized for bound NS5806 and expressed in units 
of kcal·mol-1. The solid lines represent fitting curves using the two-set of sites model. 
Conditions: 10 µM Mg2+Ca2+DREAM in  20 mM MOPS, pH 7.4, and  100 mM NaCl, 
1mM CaCl2 and 5 mM MgCl2. 
 
The association of NS5806 to DREAM(Δ65) and DREAM(Δ160) exhibited an 
exothermic binding with ΔH = -4.4 kcal mol-1 and ΔH = -6.9 kcal mol-1, respectively.  
Association of NS5806 to DREAM(Δ65) showed different enthalpic and entropic 
contributions than DREAM(Δ160), which may indicate that the structural rearrangements 
induced by NS5806 are not localized solely on the C-terminus domain. An exothermic 
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interaction indicates that the overall interaction may involve a structural reorganization of 
the protein-drug complex upon association with the NS5806. 
 
4.2.4 NS5806 increases the affinity between Kv4.3 Site 1 and DREAM and abolishes its 
calcium dependency   
Figure 4.5. Titration curve for (a) Site 1 (Kv4.3(2-21)) binding to apoDREAM(Δ65) (open 
symbols) and apoDREAM(Δ160) (solid symbols) in the absence (circles) and presence of 
200 μM NS5806 (up triangle). Conditions: 0.5 μM Kv4.3(2-22) and 200 μM NS5806 in 20 
mM MOPS, pH 7.4, and  100 mM NaCl. (b) Titration curves of Ca2+ (open symbols) or 
NS5806 (solid symbols) binding to the DREAM-site 1 complex in the presence of NS5806 
or Ca2+. Solid lines represent fits to a Hill equation, with dissociation constants for NS5806 
binding to Ca2+DREAM-site 1 of Kd = 51 ± 2 μM and to apoDREAM-site 1 Kd = 21 ± 1 
μM. The recovered Ca2+ dissociation constants do not reflect the actual apparent calcium 
affinities since EDTA was present in the samples. Conditions: 1 μM Kv4.3(2-22) and 20 
μM DREAM(Δ65) in 20mM MOPS, pH 7.4, 100mM NaCl with 1mM Ca2+ or 100 μM 
EDTA. (c) Time profile of the change in fluorescence intensity of 100 nM Kv4.3(2-22) 
peptide upon binding to 5 μM Ca2+ DREAM(Δ65) in the absence and presence of 200 μM 
NS5806. Solid line represents the NLLS fit using a double exponential decay model, 
recovered parameters listed on Table 4.  
 
  Previous structural and electrophysiological studies have identified the T1-domain 
at the N-terminus of Kv4 mediates binding of KChIPs (An et al. 2000, Bahring et al. 2001). 
The association of KChIP1 was also shown to involve two binding sites on the Kv4.2 T1 
domain, site 1 comprising mainly nonpolar residues 2-22 and the more polar site 2 on the 
T1 domain surface consisting of residues 70-90 (Callsen et al. 2005). Due to the poor 
solubility of the T1 domain of Kv4.3 (residues 1-152), we decided to investigate the 
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interactions by employing the fluorescently labeled peptides FITC-Ahx-Kv4.3(2-22) and 
Dansyl-Ahx-Kv4.3(70-90). A representative titration curve for DREAM(Δ65) binding to 
site 1 is shown in Figure 4.5a, with the recovered parameters listed on Table 4.3.   
  Binding of site 1 to Ca2+ DREAM(Δ65) was marked by an increase in anisotropy 
from r = 0.072 to r = 0.238 and a strong calcium dependency with a dissociation constant 
for Kv4.3 site 1 in the apoform of Kd = 70 ± 3 μM and Kd = 2.7 ± 0.1 μM in the calcium 
bound form. A stronger calcium dependency was observed for binding of site 2 to 
DREAM(Δ65), with a dissociation constant of ~ 500 μM in the apo-state and Kd = 10 ± 1 
μM upon calcium binding. Similarly, binding of Site 1 to the DREAM(Δ160)  construct, 
which lacks the N-terminus domain, showed an increase in anisotropy to r = 0.230 in the 
presence of calcium as well as a strong calcium dependency with Kd ~450 μM in the apo-
form to Kd = 24 ± 1 μM in the calcium bound form. On the other hand, binding of site 2 to 
calcium bound DREAM(Δ160)  was weak (Kd ~390 μM), indicating that binding of this 
peptide is specific  
to the N-terminus domain as proposed previously (Pioletti et al. 2006, Wang et al. 2007).  
  Furthermore, upon addition of 150 μM of NS5806, the binding affinity of 
DREAM(Δ65) and DREAM(Δ160) for site 1 becomes calcium independent and the Kd 
values decrease to 1.9 ± 0.2 μM (r = 0.289) and 5.3 ± 0.3 μM (r = 0.249), respectively 
(Table 4.3). The NS5806 induced affinity increase is dose dependent and was observed in 
the apo and Ca2+ bound forms (Figure 4.5b). Interestingly, in the presence of Ca2+ and site 
1 peptide, the affinity for NS5806 decreased significantly likely due to a restricted access 
to the hydrophobic cavity (Figure 4.5 and legend). On the other hand, addition of Ca2+ to 
the apo DREAM(Δ65)-NS5806-site 1 complex did not result in any change in anisotropy.  
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In the apoform, the affinity between site 2 and DREAM(Δ65) was not observed to be 
modulated by NS5806. These results support the idea that the interactions between 
DREAM(Δ65)- and the Kv4.3 T1 domain are regulated by calcium and that in the presence 
of NS5806, DREAM(Δ65) undergoes structural rearrangements that favor the association 
of the hydrophobic N-terminus of Kv4.3. 
 
 
 
 
 
 
 
 
 
 
 
 
  
4.2.5 NS5806 modulates Kv4.3 site 1 binding to KChIP3 by decreasing the rate of 
dissociation 
  To better understand the mode of action of NS5806 we investigated its effect on 
the kinetics of binding between DREAM(Δ65)  and site 1 of Kv4.3. Association of the 
fluorescently labeled peptide analogous to site 1 of Kv4.3 with DREAM(Δ65)  in the apo-
Table 4.3 Dissociation constant for Kv4.3(2-22) “site 1”and Kv4.3(70-90) 
“site 2” binding to DREAM constructs 
  NS5806  
Kd (μM)a 
Site 1  
Kd (μM)b 
Site 2   
Kd 
(μM)c 
  -  
NS5806 
+ 150 µM 
NS5806 
 
DREAM(Δ65) apo 30 ± 2 70 ± 3 1.9 ± 0.1 ~500 
 Ca2+ 4.4 ± 0.3 2.7 ± 0.1 1.9 ± 0.2 10 ± 1 
DREAM(Δ160) apo 26 ± 4 ~450 5.6 ± 0.2 n.d. 
 Ca2+ 2.7± 0.3 24 ± 1 5.3 ± 0.3 ~390 
DREAM(Y174A) apo 17 ± 0.8 90± 16 25 ± 3 n.d. 
 Ca2+ 8.3± 0.8 6.9 ± 0.4 3.1 ± 0.2 n.d. 
DREAM( F218A ) apo 28 ± 3 90 ± 31 130 ± 28 n.d. 
 Ca2+ 13 ± 1.3 2.1 ± 0.2 7.8 ± 0.3 n.d. 
(a) Determined by the integrated intensity decrease of Trp169 and fitted using 
equation 1. (b) Determined using steady state anisotropy change and corrected 
for change in fluorescence intensity using equation 3 (c) determined by the 
integrated intensity increase of dansyl labeled peptide upon binding. 
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form or calcium bound form resulted in an approximately 18 % increase in total 
fluorescence intensity. The fluorescence intensity increase can be attributed to a decrease 
in solvent accessibility of the fluorophore upon binding. The change in fluorescence 
intensity was used to probe the binding kinetics of Kv4.3 site 1 to DREAM(Δ65) and 
DREAM(Δ160), a representative trace is shown on Figure 4.5c. The kinetic traces were 
best analyzed using a double exponential decay, and the recovered parameters are listed in 
Table 4.4. The association rate for the fast and slow phase of site 1 binding to KChIP3(65-
256)  were similar in the apo and calcium bound state, with konfast= 17 ± 5 mM-1s-1 and 
konslow= 2.5 ± 0.3 mM-1s-1 in the apo-state and konfast= 28 ± 8 mM-1s-1 and konslow = 2.6 ± 
0.7 mM-1s-1 in the calcium bound form. However, the pre-exponential factors associated 
with the slow (α2) phase showed an increase upon binding of calcium from 0.02 in the 
apostate to 0.13 in the calcium bound state. The parameters most influenced by binding of 
calcium were the dissociations rates of both phases, decreasing from kofffast = 1170 ± 30 
x10-3 s-1 and koffslow = 2.9 ± 0.7 x10-3 s-1 in the apoform to kofffast = 77 ± 20 x10-3 s-1 and 
koffslow = 0.2 ± 0.06 x10-3 s-1 in the calcium bound form. Upon addition of 150 μM of 
NS5806, the observed association rate for the fast and slow phase decreased approximately 
twofold; consequently, the association rate decreased but remained independent of calcium 
, konfast = 12 ± 2 mM-1s-1 and konslow = 1.1 ± 0.8 mM-1s-1 in the apo-state and konfast = 9 ± 
0.8 mM-1s-1 and konslow = 1.1 ± 0.3 mM-1s-1 in the calcium bound form. The pre-exponential 
factor associated with the slow phase increased were the dissociations rates of both phases, 
decreasing from kofffast = 1170 ± 30 x10-3 s-1 and koffslow = 2.9 ± 0.7 x10-3 s-1 in the apoform 
to kofffast = 77 ± 20 x10-3 s-1 and koffslow = 0.2 ± 0.06 x10-3 s-1 in the calcium bound form.  
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Table 4.4. Kinetic parameter recovered for Kv4.3(2-21) “site 1” binding to DREAM constructs in the 
presence of NS5806 
 
DREAM(Δ65) 
τ1 
(s) 
α1 τ2 
(s) 
α2 konfast 
(mM-1s-1)  
konslow 
(mM-1s-1) 
kofffast 
(s-1) x10-3 
koffslow 
(s-1) x10-3 
apo 12 ± 3 0.98  81 ± 5 0.02 17 ± 5 2.5 ± 0.3 1170± 30 2.9 ± 0.7 
Ca2+ 7 ± 2 0.87  76 ± 2 0.13 28 ± 8 2.6 ± 0.7 77 ± 20 0.20 ± 0.06 
apo + NS5806 16 ± 2 0.92 181 ± 13 0.08 12 ± 2 1.1 ± 0.8 24 ± 3 0.03 ± 0.01 
Ca2++ NS5806 22 ± 2 0.67 191 ± 6 0.33 9 ± 0.8 1.1 ± 0.3 17 ± 2 0.02 ± 0.01 
DREAM(Δ160) 
apo 18 ± 3 0.85 156 ± 43 0.15 11 ± 2 1.3 ± 0.4 5050 ± 90 6.5 ± 1.2 
Ca2+ 31 ± 2 0.64 270 ± 18 0.36 6.5 ± 0.9 0.74 ± 0.05 150 ± 10 0.11 ± 0.01 
apo + NS5806 21 ± 2 0.78 516 ± 33 0.22 9.5 ± 0.4 0.39 ± 0.03 53 ± 5 0.02 ± 0.01 
Ca2++ NS5806 36 ± 4 0.67 480 ± 43 0.33 5.6 ± 0.6 0.42 ± 0.04 29 ± 3 0.01 ± 0.01 
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  Upon addition of 150 μM of NS5806, the observed association rate for the fast and 
slow phase decreased approximately twofold; consequently, the association rate decreased 
but remained independent of calcium , konfast = 12 ± 2 mM-1s-1 and konslow = 1.1 ± 0.8 mM-
1s-1 in the apo-state and konfast = 9 ± 0.8 mM-1s-1 and konslow = 1.1 ± 0.3 mM-1s-1 in the 
calcium bound form. The pre-exponential factor associated with the slow phase increased 
from 0.08 in the apo-form to 0.33 in the calcium bound form. The calculated dissociation 
rates decreased upon addition of NS5806 and became partially calcium independent with 
kofffast = 24 ± 3 x10-3 s-1and koffslow = 0.03 ± 0.01 x10-3 s-1 in the apo-form and kofffast = 17 
± 2 x10-3 s-1and koffslow = 0.02 ± 0.01 x10-3 s-1 in the presence of calcium.  
  The change in fluorescence intensity associated with binding of Kv4.3 site 1 to 
DREAM(Δ160) were also best modeled with a double exponential function, Table 4.4. 
Similarly DREAM(Δ65), the association rate constants for the fast phase were mainly 
unaffected by binding of calcium. An increase in the pre-exponential factor associated with 
the slow phase (α2) upon binding of calcium to DREAM(Δ160) was also observed. The 
calculated dissociation rates were affected by calcium binding to a larger extent than in the 
case of DREAM(Δ65), with the fast phase decreasing from kofffast= 5050 ± 90 x10-3 s-1 to 
kofffast= 150 ± 10 x10-3 s-1 and the slow phase decreasing from koffslow= 6.5 ± 1.2 x10-3 s-1 
to koffslow= 0.11 ± 0.01 x10-3 s-1.  
  Addition of NS5806 resulted in a decrease in the association rate of the slow phase 
to konslow = 0.39 ± 0.03 mM-1s-1 in the apo-form and konslow = 0.42 ± 0.04 mM-1s-1 in the 
calcium bound form; as well as, a decrease in the dissociation rate of the fast and slow 
phases to kofffast = 53 ± 5 x10-3 s-1and koffslow = 0.021 ± 0.002 x10-3 s-1 in the apoform and 
kofffast = 29 ± 3 x10-3 s-1and koffslow = 0.012 ± 0.001 x10-3 s-1 upon calcium binding. Unlike 
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DREAM(Δ65), the pre-exponential parameters for the slow phase were unaffected by 
addition of NS5806 to apo or Ca2+ bound DREAM(Δ160). Together, these results indicate 
that the observed increase in affinity between Kv4.3 site 1 and DREAM(Δ65) or 
DREAM(Δ160) due to NS5806 binding can be attributed to a decrease in the dissociation 
rate of the site 1 peptide.   
Figure 4.6. (a) Docking site for NS5806 on DREAM(Δ65) and (b) DREAM(Δ160). Solid 
line indicates the distance between tryptophan 169 and the dibromophenyl ring of NS5806. 
The initial NMR structures of DREAM(Δ65) (pdb: 2JUL) and DREAM(Δ160) 
(pdb:2E6W) were used as docking macromolecules, EF-1 shown in green, EF-2 in orange, 
EF-3 in blue, EF-4 in red and NS5806 shown as licorice model. (c) Mutation of Tyr174 or 
Phe218 to alanine completely abolishes the affinity enhancement observed in the absence 
of calcium upon binding of NS5806. Conditions as described in figure 4.5a. 
 
4.2.6 NS5806 binds at the hydrophobic cavity near EF-hand 4  
  To identify the NS5806 binding site, docking simulations using AutoDock 4.2 
algorithm were employed. Identical docking sites for NS5806 were identified on both 
constructs of DREAM (Figure 4.6). The most prominent NS5806-DREAM(Δ65) 
interactions are hydrophobic, between the nonpolar brominated phenyl ring on NS5806 
and Phe218, Tyr174 and Ile194 on DREAM, whereas the more electrophilic fluorinated 
phenyl ring faces the solvent. We have previously used a similar approach to identify the 
docking site of 1,8-ANS to DREAM(Δ65) and DREAM(Δ160), and found that the same 
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hydrophobic cavity at the C-terminus was the most favorable binding site (Chapter 3). The 
fact that docking simulations identify the same docking site for 1,8-ANS and NS5806 
correlates well with the 1,8-ANS displacement studies shown above. The direct role of 
Phe218 and Tyr174 in binding of NS5806 was confirmed by independent mutation of these 
residues to alanine. We observed that mutation of either residues results in a 2 to 3-fold 
decrease in the affinity of NS5806 in the calcium bound state, whereas the affinity in the 
apostate for the Tyr174 mutant increases about 2 fold to 17 ± 0.8 μM (Table 4.3). The 
binding affinity in the presence of calcium of the Kv4.3 site 1 peptide decreased 3-fold for 
the Tyr174 mutant while remaining unchanged for the Phe218 mutant. In the presence of 
NS5806, DREAM(Y174A) showed an increased affinity for the site 1 peptide in the apo 
and calcium bound forms, but still weaker than DREAM(Δ65). On the other hand, 
DREAM(F218A) in the presence of NS5806 showed lower affinity for the site 1 peptide 
in both apo and calcium states. Overall, these results support the docking simulation and 
the idea that these hydrophobic residues play an important role in NS5806 binding and its 
observed effect on Kv4.3 site binding. 
  Furthermore, given that the binding site of NS5806 is located in the vicinity of the 
EF-hand 3 and 4 we tested whether drug association alters the DREAM interactions with 
Ca2+. Titration curves for Ca2+ binding to DREAM(Δ65)-FlAsH and NS5806- 
DREAM(Δ65)-FlAsH are shown in Figure 4.7, the resulting titration curves were best 
analyzed using a model that assumes two protein populations in the apo-state, each with at 
least two calcium binding sites (Eq. 2.7.8). The recovered parameters show a dual 
population of DREAM(Δ65)-FlAsH in the apo-state with the larger population (f = 0.82) 
having macroscopic binding constant Kd = 170 ± 20 nM (Hill coefficient nA= 1.5) and the 
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minor population having a Kd = 10 ± 2 μM (Hill coefficient nB =1.1). The apparent 
dissociation constants are comparable to the calcium binding constants reported in previous 
studies, ranging from 0.1 μM to 10 μM (Craig et al. 2002),(Osawa et al. 2005), indicating 
that addition of the amino acid sequence CCPGCC at the C-terminus and labeling with the 
biarsenical fluorophore FlAsH did not alter the calcium affinity.  Titration of calcium into 
DREAM(Δ65)-FlAsH in the presence of 150 μM of NS5806 resulted in titrations curves 
which were also best fitted with a double Hill equation. The macroscopic binding constant 
recovered for the high affinity sites was Kd = 120 ± 20 nM (Hill coefficient nA= 1.1) with 
f = 0.66, and a dissociation constant for low affinity sites of Kd = 21 ± 4 μM (Hill 
coefficient nB=1.4), indicating that the overall calcium affinity of DREAM(Δ65) is 
marginally affected by binding of NS5806.   
Figure 4.7. Titration curve for calcium binding to 1μM DREAM(Δ65) labeled with the 
biarsenical fluorophore FlAsH-EDT2 in the absence (squares) and in the presence (circles) 
of NS5806. The solid line represents the NLLS fitting using equation 4. Conditions: 1μM 
DREAM(Δ65), 200 μM NS5806 in 20 mM MOPS, pH 7.4, and  100 mM NaCl. 
 
4.3 Discussion 
  The precise mechanisms underlying the gating regulation of Kv4 mediated K+ 
currents are yet to be completely understood; however, it is widely accepted that these 
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channels do not undergo open state inactivation involving the N-terminus (Gebauer et al. 
2004, Bähring, Covarrubias 2011). It has also been shown that association of KChIPs at the 
N-terminus of Kv4 channels impairs open-state inactivation (Beck et al. 2002). 
Electrophysiological studies support the idea that both the N- and C-terminus of KV4 
channels interact in order to regulate the inactivation kinetics (Jerng, Covarrubias 1997, 
Jerng, Shahidullah & Covarrubias 1999), opening the possibility that such interactions are 
modulated by binding of KChIPs at the N-terminus (Bahring et al. 2001),(Gebauer et al. 
2004). It is also proposed that the N-terminus functions as a membrane transport control, 
which in the absence of KChIPs, anchors Kv4 channels near the perinuclear region of the 
cell (Foeger, Marionneau & Nerbonne 2010, Cui, Liang & Wang 2008). Association of 
KChIPs at the T1 domain of Kv4 results in translocation to the membrane and a 
concomitant increase in total K+ current. In addition, the presence of KChIPs is necessary 
for recovery of K+ current with similar biophysical properties as those found in vivo.   
  Recent reports by Calloe and coworkers on the ITO activating properties of a novel 
diphenyl urea compound (NS5806) whose activity depends on the presence of KChIPs has 
highlighted the role of these auxiliary proteins in regulation of ITO currents (Calloe et al. 
2009). This drug was shown to reverse the effect of induced heart failure in canine models 
(Calloe et al. 2009, Cordeiro et al. 2012). On the other hand, Witzel and coworkers 
hypothesized that the observed current inhibition in hippocampal neuronal cells was likely 
due to a higher concentration of NS5806 being used (20 μM) compared to the concentration 
used in canine cardiomyocytes (Witzel, Fischer & Bähring 2012). Indeed, at NS5806 
concentrations above 100 μM a reversal of activation was observed in HEK293 cells. This 
highlights the possibility of multiple binding sites of NS5806 on the Kv4-auxiliary subunit 
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complex. Nonetheless, NS5806 still resulted in a slowing of inactivation and accelerated 
recovery from inactivation in both cardiac and neuronal cells at concentrations below 20 
μM .  
  Given the dependency K+ current modulation by NS5806 on the presence of 
KChIPs, in this report we investigated whether KChIPs could be a target binding partner 
for NS5806. Titration experiments show that both the apo and calcium bound forms of 
DREAM(Δ65) were quenched by NS5806 with an affinity fivefold lower in the apoform. 
The hydrophobic nature of NS5806 supports the idea that the binding site on DREAM is 
located in a solvent restricted hydrophobic cavity, and that calcium binding to DREAM 
increases accessibility of the drug to this cavity. Moreover, the similar dissociation 
constants recovered for both DREAM constructs indicate that in the calcium bound and 
calcium free state of the protein, the binding site of NS5806 is located at the C-terminus. 
Interestingly the dissociation constants recovered for NS5806 binding to Ca2+ 
DREAM(Δ65) is very similar  to the EC50 value observed for current potentiation in CHO-
K1 cells expressing Kv4.3/KChIP2 (EC50 = 5.3 μM) (Lundby et al. 2010) as well as  in 
HEK293 cells expressing Kv4.2/KChIP3 (EC50 = 6.9 μM) (Witzel, Fischer & Bähring 2012). 
Similarly, the affinity of NS5806 for the Ca2+ free form of DREAM (Kd ~ 25 μM) is 
identical to the EC50 determined for NS5806 induced accelerated recovery from 
inactivation (EC50 = 26 25 μM) (Lundby et al. 2010). Displacement studies of the extrinsic 
fluorophore 1,8-ANS bound to DREAM(Δ65) confirm that NS5806 binds at a hydrophobic 
cavity. The emission spectrum of 1,8-ANS bound to DREAM shows a maxima at 475nm. 
Addition of NS5806 to 1,8-ANS:DREAM complexes  resulted in a fluorescence intensity 
decrease in the presence or absence of calcium as shown in Figure 4.3b. Interestingly, upon 
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addition of ~40 μM NS5806 the total emission intensity of 1,8-ANS:DREAM complex is 
identical in the presence or absence of calcium. A fluorescence signal is still detected even 
at saturating amounts of NS5806 (150 μM). This is likely due the presence of  additional 
1,8-ANS bound to a site distinct than that occupied by NS5806. Furthermore, the emission 
maxima of 1,8-ANS bound to calcium or apoform DREAM(Δ65) in the presence of 150 
μM NS5806 shows a maxima at 485 nm (Figure 4.3a inset). These results are in agreement 
with fluorescence lifetime data, which show that addition of NS5806 results in a 
concomitant decrease in the pre-exponential parameter α2 associated with 1,8-ANS bound 
at the solvent restricted cavity (Figure 4.3c), while the pre-exponential parameter that 
corresponds to 1,8-ANS bound to a solvent exposed site with emission maximum at 485 
nm remains constant. These results suggest that 1,8-ANS binds at a physiologically active 
hydrophobic cavity on DREAM. These observations also support the idea that 
displacement of 1,8-ANS could be used as a fluorescence based high throughput method 
for the discovery of new drugs that bind at this hydrophobic cavity and could induce similar 
effects to that observed for NS5806. Indeed, an analogous 1,8-ANS screening assay has 
been previously reported for other drug targets (Martin et al. 2012).  
 Isothermal calorimetric titrations of NS5806 into DREAM further confirm the strong 
association between NS5806 and DREAM. The recovered thermodynamic parameters 
show that both enthalpic and entropic contributions stabilize the complex formation, with 
the enthalpic contribution becoming dominant in the DREAM(Δ160) construct. The large 
enthalpy contribution is in contrast to the idea that the binding site of NS5806 on DREAM 
is mainly hydrophobic (entropy driven binding); however, it is likely that binding of 
NS5806 triggers larger exothermic structural rearrangements on the protein. 
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  Characterization of the interaction of DREAM and peptides homologous to 
Kv4.3(2-22) and Kv4.3(70-90) indicate that the interactions between site 1/site 2 and  
DREAM are modulated by calcium, Table 4.3. In the presence of calcium, DREAM(Δ65) 
showed a 26-fold increase in affinity for site 1, whereas, DREAM(Δ160) showed an 18-
fold increase compared to the apoform. Furthermore, the dissociation constant recovered 
for site 1 binding to DREAM(Δ160) in the presence of calcium was about tenfold weaker 
than that of site 1 binding to DREAM(Δ160). The determined dissociation constants can 
be utilized to calculate the role of the N- and C-terminus domains of DREAM on binding 
of site 1 of Kv4.3. The energetic contribution of the N- and C-terminus of DREAM to the 
association with site 1 calculated from the dissociation constants in the calcium bound state 
are -1.3 kcal mol-1 and -6.1 kcal mol-1, respectively. The larger contribution of the C-
terminus highlights the role of this domain on DREAM as mediator in protein-protein 
interaction. Interestingly, the Y134E mutation on KChIP1 (Y174E on DREAM) has also 
been shown to completely abolish current modulation by KChIP1 (Wang, Chai 2009). 
However, the contribution of the N-terminus hydrophobic cavity of KChIPs is necessary 
for Kv4 translocation to the membrane and KChIP-Kv4 complex formation (Zhou et al. 
2004b, Kunjilwar, Qian & Pfaffinger 2013a). This is in agreement with structural studies, 
where the N-terminus of Kv4.3 was determined to bind across the hydrophobic face of 
KChIP1 contacting residues spanning both the N- and C-terminus of KChIP1 (Pioletti et 
al. 2006, Wang et al. 2007). The dissociation constant for site 2 binding to DREAM(Δ65) 
was also dependent on calcium, with an approximately 50-fold increase in affinity but still 
weaker than the site 1 interaction. The fact that calcium binding at the C-terminus EF-3 
and EF-4 of DREAM modulates binding of site 2 is remarkable, suggesting that the 
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structural changes associated with the calcium binding to the C-terminal domain are 
propagated into the N-terminal domain of the protein. However, it is also possible that the 
calcium induced dimerization of DREAM is responsible for the increase in affinity. 
  Addition of saturating amounts of NS5806 completely abolished the calcium 
dependency of site 1 association with DREAM as well as further increased its affinity. 
These results are surprising, given that the experiments above support the idea that NS5806 
and site 1 share the same binding site at the C-terminus of DREAM. Furthermore, a clear 
dose dependent increase in DREAM-site 1 association is observed upon addition of 
NS5806 in the absence of calcium (Kd = 21 ± 1), but no further increase is observed upon 
addition of excess calcium. On the other hand, at saturating amounts of calcium addition 
of NS5806 induces a further increase in anisotropy. Suggesting that in the presence of 
NS5806 the DREAM-site 1 complex adopts an altered tertiary structure, as evident from 
the larger anisotropy upon binding in the presence of NS5806 (Figure 4.5b). These results 
are comparable to those obtained for the Kv4.3(1-143)-KChIP1 complex using size 
exclusion chromatography in the presence of the diphenyl-urea compound CL-888 
(Bowlby et al. 2005). A similar effect due to the presence of NS5806 for site 1 bound to 
DREAM(∆65) on anisotropy was observed, indicating that structural rearrangement are 
localized on the C-terminus domain of DREAM. 
  A better understanding of the mechanism by which NS5806 modulates the affinity 
of site 1 peptide binding to DREAM construct is gained from the kinetics associated with 
binding, Table 4.4. The biphasic nature of the binding kinetics is potentially due to the 
presence of DREAM proteins which populate partially distinct conformations or 
oligomerization state. Overall, these results revealed that saturating amounts of NS5806 
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decreased the rate of dissociation between DREAM and site 1 of Kv4.3, independent of 
calcium. A possible explanation for the stabilization of the protein peptide complex, is that 
binding of NS5806 at the C-terminus cavity destabilizes this domain and increases the 
accessibility of the hydrophobic residues to interact with hydrophobic residues on site 1. 
Also, the fact that the affinity of Ca2+ free DREAM for NS5806 is lower than in the 
presence of calcium indicate that there is a larger energy barrier for access to the 
hydrophobic cavity at the C-terminus. However, once NS5806 binds at the hydrophobic 
cavity in the apoform, the resulting structural changes are comparable to those present in 
the calcium bound form. This results in similar affinity and dissociation constants for the 
N-terminus of Kv4.3. On the other hand, the observed decrease in dissociation rate in the 
presence of NS5806 seem to indicate that the DREAM-NS5806 reorganizes into a 
conformation which is different from that of the apoform or calcium bound KChIP3 and 
which forms a more stable complex with site 1 of Kv4.3.  
  Computational simulation allowed us to pinpoint the potential docking site for 
NS5806 as being at a hydrophobic cavity between EF-3, EF-4 and the H10 helix. This 
docking site is also in good agreement with the distances from Trp169 determined using 
RET and with the displacement studies. However, previous docking studies of a similar 
diphenyl-urea compound (CL-888) identified a site on the hydrophilic surface of KChIP1 
(Bowlby et al. 2005). The proposal that this is the docking site for NS5806 is not supported 
by the fact that similar dissociation constants were recovered for DREAM(∆65) and 
DREAM(∆160), even though the C-terminus construct lacks half of the residues involved 
in the proposed docking site for CL-888. We also conducted docking simulation with 
NS5806 where we limited the docking grid to cover only the previously proposed binding 
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site at the hydrophilic surface. The predicted association energy of this site was 4 kcal mol-
1 weaker than predicted energy for the docking at the hydrophobic cavity near EF-3 and 
EF-4. Indeed, the role of Tyr174 and Phe218 identified in docking simulation as being 
involved in stabilization of NS5806 and Kv4.3 site 1 peptide interactions is supported by 
site directed mutagenesis studies, which show that mutation of either residue to alanine 
completely abolishes the effect of NS5806 (Figure 4.6c). We also have observed that a 
DREAM(F252A) mutant readily forms aggregates (data not shown), supporting the idea 
that this residue plays an important role in the stability of the protein. Thus, displacement 
of this amino acid by NS5806 could potentially play a major role in restructuring of the 
DREAM structure. 
  With these results in mind, we propose that binding of NS5806 at the C-terminus 
hydrophobic cavity results in an increase in flexibility of the H10 helix, which is likely 
facilitated by displacement of the hydrophobic residues on this helix (Fig. 4.8). This is 
supported by molecular dynamic simulations which show that in the absence of NS5806 
the aromatic residue Phe252 on the H10 helix is stacked between Tyr174 and Phe218, 
inherently reducing the flexibility of this helix (Fig. 4.8). In contrast, simulations in the 
presence of NS5806 show a displacement of Phe252 residue and concomitant motion of 
the H10 helix in order to accommodate NS5806 in the hydrophobic cavity. Furthermore, 
simulation of the Kv4.3-DREAM complex show that Trp19 of Kv4.3 is positioned in an 
identical stacking position between Tyr174 and Phe218 as that found for Phe252 and 
NS5806; whereas, in the presence of NS5806 the cavity at the C-terminus of DREAM 
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expands in order to accommodate both NS5806 and the hydrophobic N-terminus of Kv4.3 
while pushing Trp19 deeper into the hydrophobic cavity (Fig. 4.8).  
Figure 4.8.  Reorganization of the hydrophobic pocket in the DREAM C-terminus upon 
binding of NS5806 and/or site 1. Top left: Position of helix-10 (shown in yellow) in the C 
terminus hydrophobic pocket of DREAM(Δ65) is stabilized by stacking interactions 
among F218, F252 and Y174. Top right:  Binding of NS5806 to the DREAM(Δ65) leads 
to the displacement of F252 and NS5806 is stabilized by hydrophobic interactions with 
F218 and Y174. Bottom left: Orientation of site 1 in the C-terminus hydrophobic pocket of 
DREAM(Δ65) with focus on the interaction of W19 from site 1 with hydrophobic residues 
from DREAM(Δ65). Bottom right: The reorientation of the hydrophobic domain at the 
DREAM C-terminus upon concomitant binding of site 1 and NS5806. 
 
The motion of Trp19 into the hydrophobic cavity of DREAM C-terminal may contribute 
to the slower rate of dissociation of the hydrophobic site 1 peptide in the presence of 
NS5806. The structural rearrangement observed using molecular dynamics are consistent 
with the idea that binding of NS5806 induces structural rearrangements in the Kv4.3-
DREAM protein complex. Whether these structural changes are isolated on DREAM and 
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the N-terminus of Kv4.3 or they propagate across the T1 domain remains to be determined. 
Previous studies favor the idea that such structural changes could propagate towards the 
K+ channel inner vestibule near the pore and modulate the K+ currents (Wang, Covarrubias 
2006, Cushman et al. 2000).  
 
4.4 Summary 
  The results presented here could potentially explain the observed increase in K+ 
current and the slowing of inactivation in the presence of NS5806 in cardiac, neuronal, and 
heterologous expression studies. The elimination of the calcium dependency of association 
between DREAM and site 1 of Kv4.3 as well as the increase in affinity in the presence of 
NS5806 support the idea that the observed increase in K+ current amplitude is due to an 
enhanced translocation of Kv4.3-DREAM protein complexes to the cell membrane 
induced by the presence of NS5806. We further hypothesize that the resulting decrease in 
inactivation kinetic is due to the decrease in accessibility of the N-terminus of Kv4.3 
channel to interact with the cytoplasmic C-terminus of Kv4. Indeed, this interaction has 
been shown to be necessary for modulation of gating currents of Kv4.2 (Callsen et al. 
2005). The fact that the dissociation constant was reduced in the presence of calcium also 
highlights the potential role of Ca2+ in regulation of K+ currents.  In support of the role of 
calcium in regulating K+ current are studies which have shown that in rat stellate cells, a 
protein complex is formed involving the voltage-gated calcium channel Cav3, the 
potassium channel Kv4.2 and the auxiliary protein DREAM (Anderson et al. 2010). 
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5. MODEL OF DREAM PROTEIN AND IMPLICATION IN PROTEIN AND 
DNA INTERACTIONS  
5.1 Background and significance 
 One of the most widely studied calcium binding proteins is calmodulin (CaM), a 
small and ubiquitous (148 residues) acidic protein, with four active EF-hand motifs able to 
bind calcium with affinities between 1 to 10 μM (Crivici, Ikura 1995). The structure of 
calcium bound CaM has been shown to follow a dumbbell arrangement of the N- and C-
terminus domain, while removal of calcium induces local rearrangement of the EF-hands 
and an increase in flexibility of the N- and C-terminus (Chattopadhyaya et al. 1992, Zhang, 
Tanaka & Ikura 1995). The interaction of CaM with proteins as well as with their peptide 
fragments often surpass the affinity for calcium(Rhoads, Friedberg 1997). The mechanism 
of calcium induced protein binding to CaM can be simplified as a calcium triggered 
exposure of hydrophobic surfaces which facilitates the association of the target protein. 
The protein fragments involved in CaM association often function as an autoinhibitory 
domain or are directly involved in protein activity. These CaM recognition sequences are 
amphipathic in nature with numerous positive and bulky hydrophobic residues forming 
electrostatic and hydrophobic contacts. CaM binding sequences can be often grouped by 
those that are enhanced by calcium or are calcium independent (Rhoads, Friedberg 1997). 
The fact that CaM has been shown to constitute about 0.1 % of total cytosolic protein, also 
highlights the role of this signal transducer in calcium signaling (Chin, Means 2000). 
DREAM is a relatively new member of the group of EF-hand calcium binding 
proteins and it has been shown to be one of the first proteins to regulate gene expression in 
a calcium dependent manner (Carrion et al. 1999). Additionally, this protein was identified 
 127 
to be involved in presenilin fragmentation (Buxbaum et al. 1998), as well as regulation of 
the KV4 subfamily of voltage gated potassium channels (An et al. 2000). DREAM is a 256 
amino acid long, 29 kDa protein highly expressed in the brain (An et al. 2000) and belongs 
to the superfamily of neuronal calcium sensors (NCS) with close homology to NCS-1 and 
recoverin (Burgoyne, Weiss 2001). Similarly to other NCS, DREAM contains four EF-
hand motifs of which EF-hand 1 is unable to bind calcium, EF-hand 2 binds preferentially 
magnesium and the two EF-hands at the C-terminus bind calcium with affinities between 
1 to 10 μM (Osawa et al. 2005). Three other homologous proteins with close homology to 
DREAM (KChIP1, KChIP2 and KChIP4) have also been identified, and together form the 
KChIP subgroup of NCS proteins (An et al. 2000). Despite the high homology of KChIPs 
at their C-terminus, the N-terminus region and tissue expression are highly divergent. 
A recent report by Ramachandran and coworkers showed that DREAM and CaM 
form a complex and enhance the activation of calcineurin (Ramachandran et al. 2012). 
Additionally, over 40 protein partners were identified to interact with DREAM in a calcium 
dependent and independent manner, further highlighting the role of DREAM as a calcium 
sensor involved in numerous cell processes (Ramachandran et al. 2012). Consequently, 
given the wide spectrum of processes regulated by CaM and the multifunctional activity of 
DREAM, a better understanding of the molecular mechanism by which these two proteins 
interact will provide insight into the regulation of calcium signaling in neuronal cells.  
Recent studies have addressed the molecular structure of DREAM and how calcium 
induced changes are translated into regulation of protein-protein and protein-DNA 
interactions (Lusin et al. 2008, Ramachandran et al. 2012, Osawa et al. 2001). NMR 
structures of the calcium binding C-terminus domain (EF-hand 3 and EF-hand 4, residues 
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161-256, PDB: 2e6w) (Yu et al. 2007b) and of the core domain (EF-hand 1 to 4, residues  
76-256, PDB: 2jul) (Lusin et al. 2008) have been resolved. Interestingly, DREAM has been 
shown to be cleaved at Aps61-Asp64 by caspase-3, which indicates that inside the cell 
there may be a subpopulation DREAM with structure analogous to that resolved by 
NMR(Choi et al. 2001). However, no model for the full-length DREAM protein is 
currently available. 
In this report, we seek to identify the amino acid sequence at the N-terminus of 
DREAM involved in CaM binding. We further characterize the secondary and tertiary 
structure of DREAM N-terminus using a combination of theoretical and experimental 
techniques to build a molecular model for the full-length protein. Finally, we propose a 
mechanism by which CaM associates to DREAM and sequesters its N-terminus domain 
which could potentially modulate DREAM’s interaction with binding targets. Altogether, 
the results presented here provide us with a molecular understanding of the CaM:DREAM 
interaction and underline the implication of this protein complex in  calcium signaling and 
gene expression.   
5.2 Results  
5.2.1 Calmodulin stabilizes the N-terminus of DREAM and increases the solubility of the 
protein complex. 
 Previous reports have shown that DREAM readily forms inclusion bodies when 
overexpressed in BL21(DE3) E. coli cells, whereas DREAM(Δ65) was recovered in 
moderate yields as a soluble protein (Lusin et al. 2008, Osawa et al. 2001). Indicating that 
residues 1-65 in DREAM destabilize the protein under conditions used for recombinant 
protein expression. It has also been shown that the association between DREAM and CaM 
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is mediated by an amino acid sequence within the N-terminal 94 residues of DREAM 
(Ramachandran et al. 2012). We hypothesized that binding of CaM could stabilize 
DREAM and lead to an increase in solubility during recombinant expression. To test this 
hypothesis we co-expressed CaM and DREAM in BL21-DE3 E. coli at low temperature 
(see materials and methods).  Under such conditions, DREAM was recovered as a soluble 
protein with yields of ~40 mg. Interestingly, we have observed that 10 mM LDAO 
abolishes the CaM:DREAM interaction and prevents DREAM aggregation in the presence 
of saturating calcium, which facilitates the purification of soluble DREAM. We envision 
this protocol being more robust than the previously employed method of inclusion body 
refolding (Osawa et al. 2001) or GST fusion tags (Ramachandran et al. 2012). These results 
support the role of CaM as a protein cofactor that stabilizes the N-terminus of DREAM 
and potentially facilitates its translocation in the cell. 
 
5.2.2 Residues 29-44 at the N-terminus of DREAM mediate CaM binding in a calcium 
dependent manner. 
 Bioinformatics analysis of the N-terminus of DREAM revealed the presence of 
numerous basic, acidic and hydrophobic residues. Of particular interest is a short 
amphipathic 16-residue peptide segment (residues 29-44, sequence: 
SIKWQRPRFTRQALMR) with a high density of positively charged residues and 
hydrophobic residues (Figure 5.1).  
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Figure 5.1. (a) Bioinformatics analysis of the first 100 residues at the N-terminus of mouse 
DREAM indicating regions of helical structure and charge distribution. Proposed sites for 
posttranslational modification and ligand interactions are shown. (b) Helical plot analysis 
of residues 29 to 44 of DREAM. (c) DREAM amino acid sequence disorder prediction 
using the PONDR-FIT and VL3 prediction servers. (c) Potential energy surface of 
apoDREAM (lacking the first 77 residues) calculated using the published NMR structure 
and the APBS plugin of the VMD software with CHARMM parameters at 150 mM mobile 
ion concentration. 
 
This short amino acid sequence shows close similarity with the 1-8-14 Type A binding 
motif associated with other calmodulin binding peptides(Rhoads, Friedberg 1997); with a 
total charge of +5 and bulky hydrophobic residues Ile30, Trp32, Phe37, Leu42 and Met43. 
Secondary structure prediction also shows this sequence as having a moderate helical 
propensity. Helical wheel diagram of DREAM(29-44) shows an arrangement of dispersed 
positively and hydrophobic residues (Figure 5.1b). This small helical region is surrounded 
by extended disordered domains (Figure 5.1c), which may enhance the flexibility of the N-
terminus. The core domain of DREAM (residues 76 to 256) exhibits a strong 
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electronegative surface opposite to a hydrophobic groove which has been shown to be 
involved in ligand binding (Chapter 3 )  (Figure 5.1d).   
Figure 5.2. Titration curves for calmodulin binding to (a) 100 nM of a FITC labeled 
peptide analogous to residues 29-44 of mouse DREAM “DRE29” in the absence (circles) 
or present (squares) of 1mM calcium (Kd = 136 ± 10 nM) and in the presence of calcium 
and 30 μM Trifluoperazine (up triangles).  (b) Fluorescence emission spectra of 5 μM 
DRE29 peptide in the presence or absence of 10 μM Ca2+CaM, sample was excited at 300 
± 4 nm which resulted in negligible contribution from tyrosine on CaM. Buffer background 
emission was subtracted to decrease Rayleigh, Raman and 2nd harmonic peaks contributing 
to the signal. (c) Observed shift and increase in tryptophan fluorescence upon calmodulin 
binding. (d) Normalized tryptophan fluorescence change at 370 nm  of DREAM(1-256) 
upon addition of calmodulin in the absence (circles) and presence (squares) or 1mM 
calcium (Kd = 3.3 ± 0.9 μM). 
 
 Calmodulin is well known to bind positively charged amphipathic protein segments 
in a calcium dependent manner; therefore, we hypothesize that a similar binding 
mechanism is present on DREAM. To test this hypothesis we studied binding of CaM to a 
fluorescently labeled peptide homologous to residues 29 to 44 of DREAM (herein named 
DRE29). Upon addition of calcium bound CaM to DRE29 a large increase in fluorescence 
anisotropy was measured, indicative of binding. The binding curves show a clear calcium 
dependent binding of the DRE29 peptide to calmodulin, with a dissociation constant in the 
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calcium bound form of Kd = 136 ± 10 nM and negligible binding in the absence of calcium 
(Figure 5.2a). Similar results were obtained using FRET experiments between DRE29 and 
CaMRR2, with a dissociation constant of 132 ± 16 nM (Figure 5.3a-b). The binding of 
CaM to DRE29 was inhibited in the presence of the antipsychotic drug and known 
calmodulin inhibitor trifluoperazine (TFP). Analysis of the binding using a competitive 
model in the presence of 30 μM TFP, using the reported affinity of TFP for CaM of 1 
μM,(Levin, Weiss 1977) shows that a single bound TFP is sufficient to inhibit binding of 
the peptide (Figure 5.3c). Since the stronger affinity binding sites of TFP on CaM are at 
the C-terminus domain, the data shows that this domain is mainly responsible for binding 
the DRE29 peptide(Cook, Walter & Walter 1994).  
Figure 5.3. (a) Fluorescence intensity quenching of 1 μM DRE29 upon association to 
Ca2+CaMRR2. (b) Plot of the FRET efficiency between DRE29 and Ca2+CaMRR2 
complex, a dissociation constant of 134 ± 16 nM was recovered using a Hill equation. (c) 
Fluorescence anisotropy of 100 nM DRE29 versus calculated TFP free calmodulin. The 
drug free calmodulin concentration was determined assuming that a single TFP molecule 
is bound to calmodulin with an affinity of 1 μM, 30 μM TFP was held constant while the 
concentration of CaM was increased. 
 
 The emission spectra of DRE29 in the presence or absence of Ca2+CaM show two 
peaks corresponding to Trp32 and FITC (Figure 5.2b). The weak fluorescence of Trp32 is 
due to an efficient energy transfer to the FITC label; however, upon association with CaM 
an increase in fluorescence and blue shift from 351 nm to 329 nm is observed. The increase 
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in  FITC emission is expected based on the increase in quantum yield of Trp32. It is also 
possible that restructuring of the DRE29 peptide in the CaM:DRE29 complex increases the 
energy transfer efficiency. Overall, these results identify the amphipathic region in the N-
terminus of DREAM spanning residues 29 to 44 as mediating the calcium dependent 
binding of CaM. It also shows that upon association with Ca2+CaM the solvent accessibility 
of Trp32 decreases. 
  
5.2.3 The N-terminus domain of DREAM does not block its hydrophobic cavity. 
 The intrinsic tryptophan fluorescence of DREAM decreases upon calcium binding, 
a transition similar to that observed for DREAM(Δ65) (Carrion et al. 1999, Pham et al. 
2015). Upon association of Ca2+CaM to DREAM a 5 nm blue shift from 337 nm to 332 
nm is observed along with an increase in fluorescence intensity (Figure 5.2c). Similar to 
our peptide studies, CaM interacts with DREAM only in the presence of calcium (Kd = 3.4 
± 0.9 μM) with no detectable interaction in the absence of Ca2+ (Figure 5.2d), in good 
agreement with the previously reported value of 3 μM (Ramachandran et al. 2012). The 
decreased affinity of CaM for the N-terminus of DREAM compared to the affinity of the 
isolated residues 29 to 44 may indicate that the N-terminus is not completely solvent 
accessible. This could be easily explained by a model in which the N-terminus collapses 
on the DREAM core domain (residues 76 to 256) and reduces the affinity of CaM. Indeed, 
a similar folding was observed in the structure of calcium bound KChIP4 and Mg2+ bound 
caldendrin (Liang et al. 2009),(Reddy et al. 2014). Therefore, to test whether the N-
terminus of DREAM (residues 29-44) physically interacts with the core domain we 
conducted titrations of DRE29 with DREAM(Δ65). We observe an interaction between 
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DRE29 and DREAM(Δ65) with Kd ~30 μM; however, a similar affinity with DREAM 
was observed (Figure 5.4). In the presence of 100 mM NaCl, the affinity of the DRE29 
peptide with DREAM(Δ65) decreased to Kd ~0.3 mM. These results indicate that the 
observed association between residues 29-44 and the core domain of DREAM are 
nonspecific and mediated by electrostatic interactions.  
Figure 5.4. Anisotropy change upon addition of DREAM and DREAM(Δ65) to 1 μM 
DRE29 peptide in the presence of CaCl2 (solid symbols) or EDTA (open symbols). Line 
represent the best fit using Eqn. 1, with dissociation constant for DREAM of 57 μM while 
DREAM(Δ65) resulted in a Kd ~ 30 μM in the absence of salt and Kd ~ 0.3 mM in the 
presence of 100 mM NaCl. 
 
 DREAM(Δ65) protein has been shown to interact with small hydrophobic ligands 
such as arachidonic acid, the K+ current activator NS5806 and the hydrophobic probes 1,8-
ANS and 2,6-ANS (Chapter 3). These ligands associate with a hydrophobic cavity at the 
C-terminus of DREAM whose accessibility increases upon Ca2+ association to EF-3 and 
EF-4. Association of the hydrophobic N-terminus of KV4 channels with DREAM and other 
KChIPs is also mediated by a hydrophobic groove which extends from C- to the N-
terminus (Gonzalez, Pham & Miksovska 2014, Pioletti et al. 2006, Li et al. 2014). 
Therefore, we investigated whether the presence of residues 1 – 65 in DREAM can affect 
the binding of these hydrophobic ligands. Titrations of a peptide homologous to the 
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hydrophobic N-terminus of Kv4.3 (residues 2-22) show that the affinity is not only 
independent of calcium but also identical to the previously reported value for binding to 
the Ca2+ bound DREAM(Δ65) construct (Figure 5.5) (Gonzalez, Pham & Miksovska 
2014). Similarly, the hydrophobic probe 1,8-ANS and NS5806 compound showed 
interactions with DREAM which are similar to those observed for DREAM(Δ65) 
(Gonzalez, Miksovska 2014, Gonzalez, Pham & Miksovska 2014) .  
Figure 5.5. (a) Modified Stern-Volmer analysis of tryptophan fluorescence quenching 
upon binding of NS5806 to apo and Ca2+DREAM, solid lines illustrate the expected traces 
for complete quenching and dashed lines show the intercept a 2.83 ± 0.12. (b) Association 
of Kv4.3(1-22)-FITC with apo and Ca2+DREAM monitored using fluorescence anisotropy; 
solid lines represent the best fit to the data using a Hill binding model with the recovered 
parameters shown in the inset. (c) Fluorescence spectra of 1,8-ANS bound to apoDREAM 
with λmax = 478 nm and Ca2+DREAM with λmax = 475 nm. These results support the idea 
that the accessibility of the hydrophobic cavity at the C-terminus of DREAM is not 
compromised by the presence of the N-terminus residues 1-65. 
 
These results support the idea that the N-terminus of DREAM does not function as 
an autoinhibitory domain of the hydrophobic cavity as observed for the isoform 4 of 
KChIP4(Liang et al. 2009). Analysis of the NS5806 tryptophan quenching data using a 
modified Stern-Volmer plot shows that unlike DREAM(∆65), where Trp169 is completely 
quenched (see Chapter 4), only one out of three tryptophans is quenched in DREAM 
(Figure 5.5a). This observation can easily be explained if the N-terminus of DREAM is not 
near the hydrophobic C-terminus where Kv4.3 N-terminus, 1,8-ANS or NS5806 bind or if 
the association of the hydrophobic ligand induces the displacement of the N-terminus. 
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5.2.4 Calcium binding to DREAM induces a structural rearrangement at the N-terminus 
 The structure of the N-terminus of DREAM (residues 1-75) has not been resolved 
and based on NMR results, it has been proposed to form a random coil (Lusin et al. 2008). 
In order to better understand the mechanism of CaM binding, we set forth to identify the 
potential secondary structure of the N-terminal residues of DREAM using structure 
prediction tools and CD. The N-terminus of DREAM show the potential formation of two 
alpha helices between residues 4 and 11 and between residues 27 and 53, herein named α-
1 and α0 (Fig 1). Two additional alpha helices comprising residues 76-85 and 88-102 were 
also identified, these helices correspond to α1  and α2 previously identified by NMR (Lusin 
et al. 2008). Further analysis of the N-terminus of DREAM using protein disorder 
prediction tools also shows residues surrounding α0 as having high propensity to form 
disordered regions (Xue et al. 2010, Obradovic et al. 2003). Molecular dynamics 
simulations support that both N-terminus helices retain their secondary structure and are 
flexible relative to each other (Figure 5.6), with  α0 showing an expected bend at Pro36. 
Overall, these bioinformatics analyses and simulations of the N-terminus domain of 
DREAM indicate that this domain forms a disordered region with a small helical structure 
connected to the core of DREAM by a 21 residues long disordered region rich in small 
hydrophilic residues (residues 54-75).  
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Figure 5.6.  Eight 10 ns MD simulation at 313 K of DREAM N-terminus (residues 1-66) 
showing the overall stability of the predicted α0 helix. Bulky hydrophobic residues which 
form part of the CaM binding region (shown in red) are drawn as licorice model.  
 
 To gain insight into the secondary structure of DREAM and its N-terminus, we also 
performed near and far UV circular dichroism measurements on DREAM and 
DREAM(Δ65). The far-UV CD signal for both constructs show the characteristic spectra 
of alpha-helical proteins, with negative peaks at 220 nm and 207 nm and a larger positive 
peak near 190 nm (Figure 5.7a). The magnitude of the CD signal was dependent on Ca2+ 
for both constructs with an increase in 190 nm and decrease in 220/207 nm peaks upon 
calcium binding (data not shown). However, the magnitude of the positive and negative 
peaks of DREAM in the absence or presence of calcium was smaller than that of 
DREAM(Δ65), indicative of less alpha-helical content in the full-length construct. 
Analysis of the far-UV CD spectra with the K2D secondary structure prediction tools 
shows 68% and 50% alpha-helical content for calcium bound DREAM(Δ65) and DREAM, 
respectively. A fully unfolded N-terminus domain in DREAM would result in a 47% alpha-
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helical content, which is slightly lower than the value determined here. Therefore, the N-
terminus domain of DREAM likely forms a disordered domain with a small region of 
alpha-helical structure near the CaM binding sequence. 
Figure 5.7.  (a) Far-UV CD spectra of DREAM(Δ65) and DREAM in the presence of 10
0 μM calcium in 5mM phosphate buffer pH 7.4. (b) Near-UV CD spectra of DREAM(Δ6
5) and (c) DREAM in the absence and presence of calcium. 
 
 On the other hand, the near-UV CD spectra for both DREAM constructs showed 
complex and distinct positive and negative peaks. In the absence of calcium, DREAM 
showed a broad negative band with fine structured positive and negative peaks. The peaks 
between 256 nm and 272 nm are likely due to phenylalanine residues whereas the peak 
between 275 nm and 305 nm are associated with tyrosine and tryptophan 
residues (Strickland 1974, Woody 2012). Calcium binding resulted in an increase in 
ellipticity signal between 256 nm and 295 nm (Figure 5.7b), without a significant shift of 
the observed vibronic structures. The near UV CD spectra of DREAM(Δ65) in the absence 
of calcium showed many similarities in the phenylalanine and tyrosine peaks to DREAM, 
whereas a larger peak at 290 nm was observed in the tryptophan region. Binding of calcium 
to DREAM(Δ65) did not induce major changes in the spectra, with the exception of a 
decrease in ellipticity near 305 nm (Figure 5.7c). The presence of only three additional 
aromatic residues in DREAM compared to the construct lacking the first 65 residues 
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indicates that the increase in the ellipticity between 270 nm and 290 nm likely arises from 
Phe37, Trp32 and/or Trp50. Additionally, the broad changes in ellipticity upon binding of 
calcium in DREAM but not in DREAM(Δ65) indicates that the N-terminus residues 
undergo a structural rearrangement which restricts solvent accessibility of Trp32 and/or 
Trp50 (Nagai et al. 2012). These results support the idea that the conformation of the N-
terminal residues of DREAM may be affected by calcium binding.  
 
5.2.5 The core domain of DREAM facilitates dissociation of the CaM:DREAM complex 
 To better understand the mechanism of CaM:DREAM interaction, we determined 
the kinetics of CaM:DREAM complex formation by monitoring the fluorescence change 
of CaM and CaMRR2 upon dissociation from DRE29 and DREAM. Initial attempts to 
resolve the association rate by mixing 1:1 volumetric ratio of 10 μM Ca2+CaM and 0.5 μM 
DRE29 or 10 μM apoDREAM and 0.5 μM CaMRR2 with 1 mM CaCl2  showed that the 
protein complex was formed within the dead time of our stopped-flow instrument (~ 20 
ms), indicating that similarly to other CaM binding peptides and proteins (Brown, Martin 
& Bayley 1997, Kasturi, Vasulka & Johnson 1993), the bimolecular association rate 
constant is near the diffusion limit, with kon in excess of 108 M-1s-1. Dissociation of Ca2+ 
from 2.5 μM CaM by 1 mM EDTA monitored using tyrosine fluorescence showed a 
monophasic decay with koff  = 7.9 ± 0.6 s-1 at 25 °C, as previously reported (Brown, Martin 
& Bayley 1997). The calcium dissociation from 0.5 μM CaMRR2 determined by 
monitoring the anisotropy change of the rhodamine label at Cys148 was four times slower 
than that observed for CaM, with koff = 1.9 ± 0.1 s-1 at 25 °C. The slow Ca2+ dissociation 
from CaMRR2 could be likely due to stabilization of the calcium exposed hydrophobic 
 140 
cavity at the C-terminus by the rhodamine label or due to measurement of a structural 
change sequential to calcium dissociation.  
Figure 5.8. Dissociation kinetics of (a) 10 μM CaM and 1 μM DRE29 and (b) 1 μM 
CaMRR2 and 10 μM DREAM upon addition of 1mM EDTA monitored using T-format 
fluorescence anisotropy as a function of temperature. (c) Eyring plot analysis of the 
dissociation constant as a function of temperature, solid lines represent best linear fit to the 
data. 
 
 On the other hand, mixing of Ca2+CaM:DRE29 and Ca2+CaMRR2:DREAM with 2 
mM EDTA resulted in a well-resolved decrease in fluorescence anisotropy indicative of 
complex dissociation upon Ca2+ removal (Figure 5.8a-b). The dissociation of CaM:DRE29 
and CaMRR2:DREAM were best fitted by a double and single exponential decay 
functions, respectively, Table 5.1. The dissociation rate of CaM with the DRE29 peptide 
and DREAM protein were koff = 2.3 ± 0.2 s-1 and koff = 1.5 ± 0.1 s-1, respectively.  The 
amplitude of the lag phase observed in the CaM:DRE29 accounted for about 22 % of the 
signal change with koff = 8.3 ± 3.5 s-1.  The dissociation of Ca2+ from CaM and CaMRR2 
as well as CaM:DRE29 and CaMRR2:DREAM complexes was measured in the 
temperature range of 6.5 °C to 24.7 °C and the  decay times are listed in Table 5.2. Analysis 
of the dissociation rates as a function of temperature using Eyring plots(Eyring 1935) 
shows a larger contribution of the enthalpic component to the activation parameters of Ca2+ 
dissociation from CaM and CaM:DRE29, Table 5.1.  
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Table 5.1. Activation parameters for CaM:DRE29 and 
CaMRR2:DREAM dissociation 
 
 
koff 
(s-1)a 
ΔH‡ 
(kcal/mol) 
TΔS‡ 
(kcal/mol)* 
CaM 7.9 ± 0.6 12.9 ± 0.5 -3.5 ± 0.5 
CaM-DRE29fast 8.3 ± 3.5 13.8 ± 0.4 -2.7 ± 0.2 
CaM-DRE29slow 2.3 ± 0.16 16.1 ± 0.3 -1.1 ± 0.2 
    
CaMRR2 1.9 ± 0.1 8.6 ± 0.6 -8.6 ± 0.6 
CaMRR2:DREAMb 1.5 ± 0.1 13.5 ± 1.2 -4.0 ± 0.7 
(a) At 298 K (b) Activation enthalpy and entropy corrected for 
the fraction of DREAM bound, fb = 0.57 based on the 
concentration of DREAM of 5 μM and a Kd = 3.3 μM. 
Table 5.2 Dissociation kinetics of calcium bound CaM:DRE29 and 
CaMRR2:DREAM complexes upon addition of EDTA as a function of 
temperature 
 CaM CaM:DRE2
9 
fast 
CaM:DRE2
9 
slow 
CaMRR2 CaMRR2 
DREAM 
 
Temp. 
(°C) 
τoff 
(ms) 
τoff 
(ms)a 
τoff 
(ms)a 
τoff 
(ms) 
τoff 
(ms)  
24.7 127 ± 9 121 ± 51 438 ± 30 532 ± 19 675 ± 31  
20.4 184 ± 8 179 ± 26 645 ± 25 713 ± 32 960 ± 36  
16.1 235 ± 9 260 ± 64 992 ± 43 898 ± 38 1247 ± 41  
12.0 328 ± 18 355 ± 71 1514 ± 53 1066 ± 44 1823 ± 55  
6.5 555 ± 16 586 ± 26 2590 ± 59 1442  ± 74 2336 ± 92  
a Decay parameters recovered by using a double exponential decay function, where 
the fast and slow decay lifetimes correspond to Ca2+ and peptide dissociation, 
respectively. 
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The activation parameters for Ca2+CaM (ΔH‡ = 12.9 ± 0.5 kcal/mol and TΔS‡ = -3.5 ± 0.5 
kcal/mol) and the fast phase of Ca2+CaM:DRE29 (ΔH‡ = 13.8 ± 0.4 kcal/mol and TΔS‡ = 
-2.7 ± 0.2 kcal/mol) are identical, and likely correspond to the same process. On the other 
hand, Ca2+ dissociation activation parameters for CaMRR2 show enthalpy and entropy 
contributions of ΔH‡ = 8.6 ± 0.6 kcal/mol and TΔS‡ = -8.6± 0.6 kcal/mol. The slow phase 
of Ca2+ dissociation observed in the presence of the DRE29 peptide also shows a large 
enthalpy barrier with ΔH‡ = 16.1 ± 0.3 kcal/mol and TΔS‡ = -1.1 ± 0.2 kcal/mol. In the 
presence of the full-length DREAM protein, the dissociation kinetics from CaMRR2 were 
not significantly different (Table 5.1) than those in the absence of DREAM.  
Figure 5.9. Frequency-domain fluorescence decay of apo and Ca2+CaM-IAEDANS (b) Fr
equency-domain anisotropy decay of  Ca2+ bound CaM-IAEDANS in the absence and pre
sence of DREAM. Phase delay and modulation ratio are shown as open and solid symbols
, respectively. Solid lines represent the best fit using multi-exponential decay models, rec
overed parameters are listed in Table 5.3 and 5.4. 
 
Therefore, the recovered CaMRR2 activation parameters likely arise from a combination 
of Ca2+ and protein dissociation activation barriers. The protein dissociation activation 
parameters can be approximated by subtracting the activation barrier for CaMRR2 from 
those of CaMRR2:DREAM, which result in ΔH‡ = 4.9 ± 0.5 kcal/mol and TΔS‡ = 4.6 ± 
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0.8 kcal/mol. These results show that the core domain of DREAM facilitates the 
dissociation of residues 29-44 from CaMRR2 by lowering the enthalpic dissociation 
activation barrier.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.2.6 The DREAM-CaM protein complex forms a near spherical heterotetramer. 
 We employed time-resolved fluorescence anisotropy decay to recover the rotational 
correlation time of calmodulin and DRE29 as well as the CaM:DREAM complex. 
Fluorescence emission spectra and fluorescence lifetime decay of FITC labeled 
DREAM(29-44) show no changes upon binding of calmodulin. Analysis of the frequency 
domain fluorescence decay using a Gaussian model yields satisfactory fits for the DRE29 
peptide and CaM:DRE29 complex, frequency domain data and decay parameters shown in 
Figure 5.9 and Table 5.3, respectively. A bimodal model was necessary to accurately fit 
Table 5.3. Photophysical properties of DRE29 and CaM-IAEDANS upon 
complex formation 
 
 
rss 
 
λmax 
(nm) 
τ1 
(ns) 
α1 
(%) 
τ2 
(ns) 
α2 
(%) 
χ2 
DRE29 a 0.010 517 3.6    1.0 
DRE29:CaM a 0.090 516 3.9    0.7 
IAEDANS 0.006 505 4.1 14 10.5 86 1.7 
apoCaM 0.049 495 10.8 80 16.9 20 1.1 
Ca2+CaM 0.081 484 10.6 55 18.9 45 1.3 
apoCaM:DREAM 0.113 486 10.6 89 21.1 11 0.9 
Ca2+CaM:DREAM 0.132 475 11.3 51 21.9 49 0.9 
Recovered parameters from global analysis of at least three independent 
measurements of the phase delay and modulation ratio using a Gaussian or 
double exponential decay model. The lifetime parameters (τ1 and τ2) were set as linked 
variables, and the pre-exponential parameters (α1 and  α2) as free variables; χ2 represents the goodness of the 
fit. (a) A Gaussian lifetime distribution was used, with recovered width of 0.5 ns for DRE29 and 1.0 ns for 
DRE29:CaM complex. Sample concentrations were: 0.5 μM DRE29 and 10 μM CaM 
or 10 μM CaM-IAEDANS and 20 μM DREAM. 
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the anisotropy decay data and the recovered rotational correlation times for the 
CaM:DRE29 complex are listed in Table 5.4. The fast rotational correlation time of 0.57  
ns for DRE29 accounts for 57 % of the depolarization and can be attributed to a local 
motion of the fluorophore. The second rotational correlation time of 2.0 ns for the DRE29 
peptide is about twofold larger than that expected for a spherical peptide of 1.0 ns, 
calculated using the Einstein-Stokes equation (2.6 kDa and  0.3 mL/g hydration) (Einstein 
1905).   
 
 
 
 
 
 
 
 
 The CaM:DRE29 complex shows a similar local rotational time of 0.61 ns while 
the global motion increased to 10.8 ns. The expected rotational time of a sphere with 
molecular weight similar to that of the CaM:DRE29 complex (19 kDa  and 0.30 ml/g 
hydration) yields a rotational diffusion time of 8.0 ns. The discrepancies observed could be 
due to deviations from a spherical conformation and/or a higher protein hydration. These 
results show that CaM binds to DRE29 as a monomer to form a complex with nearly 
spherical shape, likely similar to the often observed wrap around conformation of 
CaM:peptide complexes (Yamniuk, Vogel 2004). 
Table 5.4. Anisotropy decay parameters of DRE29 and CaM-
IAEDANS upon complex formation 
 
 
θ1 
(ns) 
f1 
 
θ 2 
(ns) 
f 2 
 
θ 3 
(ns) 
f 3 
 
χ2 
DRE29 0.57 0.72 2.0 0.28    
Ca2+CaM: DRE29 0.61 0.42 10.8 0.58   0.6 
apoCaM 0.51 0.80 6.7 0.20   1.0 
Ca2+CaM 0.64 0.52 8.1 0.48   0.7 
apoCaM:DREAM 0.59 0.79 8.1 0.20 56 0.01 0.7 
Ca2+CaM:DREAM 0.62 0.31 8.9 0.31 47 0.38 0.8 
Recovered from global analysis of at least three independent 
measurements of the phase and modulation data using a double 
exponential decay model. Decay parameters (θ1, θ2 and  θ3) were set as linked 
variables, and the fractional depolarization (f1,  f2 and  f3) were set as free variables, χ2 
represents the goodness of the fit. Sample conditions identical to those on Table 
2. 
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To investigate the oligomerization state of calmodulin bound to full-length 
DREAM we employed a fluorescently labeled CaM-IAEDANS construct. The long 
fluorescence lifetime decay and solvent sensitivity of IAEDANS allow us to resolve slower 
correlation times as well as changes in the probe environment(Hudson, Weber 1973b). The 
fluorescence emission spectra of CaM-IAEDANS upon calcium binding shows an increase 
in fluorescence and a blue shift from 495 nm to 484 nm (Figure 5.9a). A modest increase 
in the steady-state anisotropy can be observed upon Ca2+ binding to CaM-IAEDANS, from 
rss= 0.049 to rss= 0.081. Additional information is obtained from lifetime measurements, 
which show a small increase in lifetime from 16.9 ns for apoCaM to 18.9 ns Ca2+ bound 
CaM  and a change in pre-exponential factor α2 of 25%, likely due to a decrease in solvent 
accessibility of the probe, Table 1. Analysis of χ2 surface of the phase/modulation fits also 
reveal that in the absence of Ca2+, the C-terminus domain of CaM is more heterogeneous 
and solvent exposed based on the smaller τ2, Figure 5.9b. The rotational correlation times 
recovered from the fit of the anisotropy decay yield values of 0.51 ns and 0.64 ns for the 
local motion of IAEDANS attached to apo and calcium bound CaM, respectively, and 6.7 
ns and 8.1 ns for the global motion of the apo and calcium bound CaM, respectively. The 
increase in θ1 is significant (Figure 5.9c) and correlates with a decrease in local flexibility 
of the Cys148 region. On the other hand, increase in θ2 upon Ca2+ binding is likely due to 
a more rigid and elongated structure of Ca2+CaM in solution. Nonetheless, the rotational 
correlation times are in good agreement with the expected rotational time for CaM-
IAEDANS of 7.1 ns (17.2 kDa and 0.3 mL/g hydration). Overall, these results indicate that 
association of calcium induces the region near Cys148 to become less flexible and solvent 
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restricted, which is in good agreement with the rearrangement of CaM structure upon Ca2+ 
binding (Chattopadhyaya et al. 1992, Kuboniwa et al. 1995).  
Figure 5.10. (a) Fluorescence emission spectra transition of 5 μM CaM-IAEDANS upon 
association with 20 μM DREAM. (b) Global fluorescence decay lifetime χ2 surface for th
e two component exponential decay of CaM-IAEDANS in the presence (red) or absence (
black) of Ca2+ and Ca2+CaM-IAEDANS:DREAM (blue) and Ca2+ free complex (green). R
otational correlation time χ2 surface from the global analysis of the anisotropy decay data 
using a two component exponential decay for CaM-IAEDANS  and triple exponential dec
ay model for the CaM-IAEDANS:DREAM complex, color scheme as in panel b.  
 
 We also investigated the effects of CaM-IAEDANS association with DREAM and 
found that the emission of Ca2+ bound CaM-IAEDANS increases two-fold upon addition 
of DREAM with a maximum at 475 nm (Figure 5.10a). A small increase in intensity and 
blue shift to 486 nm was also observed for apoCaM-IAEDANS in the presence of DREAM. 
The fluorescence decay lifetime of Ca2+CaM-IAEDANS was affected by association with 
DREAM, showing an increase in the long fluorescence decay lifetime from τ2 = 18.9 ns to 
τ2 = 21.9 ns. A larger increase in τ2 was observed for Ca2+ free CaM-IAEDANS upon 
addition of DREAM (from 16.9 ns to 21.1 ns); however, the amplitude of this decay was 
about four-fold lower than that of the Ca2+ CaM-IAEDANS:DREAM complex. Further 
analysis of the fluorescence of CaM-IAEDANS using anisotropy decay shows that in 
addition to the local and global rotation of apo and Ca2+CaM-IAEDANS, a third rotation 
with correlation time of 56 ns and 47 ns is present (Figure 5.10c and Table 5.4). The 
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rotational correlation time for the Ca2+CaM-IAEDANS:DREAM complex is similar to that 
expected for a spherical CaM:DREAM heterotetramer (calc. 40 ns at 0.3 ml/g hydration). 
The larger rotation for the apoCaM-IAEDANS:DREAM complex could be due to the 
presence of a mixture of oligomers. Analysis of the χ2 surface reveals that the rotation of 
the CaM-IAEDANS:DREAM complex is heterogeneous, ranging from 43 ns to 52 ns and 
51 ns to 61 ns in the presence and absence of Ca2+, respectively (Figure 5.10c). Such a 
heterogeneity likely arises from an extended and flexible conformation of the protein 
complex. These results indicate that not only calcium bound CaM can interact with 
DREAM but also the apo form, likely with a significantly lower affinity. The solvent 
accessibility of IAEDANS decreases upon protein complex formation, suggesting that 
Cys148 forms part of the protein interface. It also supports a model where a Ca2+DREAM 
dimer associates with two Ca2+CaM to form a near spherical heterotetramer. 
5.2.7 Molecular dynamics simulations support a model in which the N-terminus of 
DREAM interacts with an electrostatic patch on the surface of DREAM. 
Figure 5.11. Initial structure of DREAM built using the protocol described in the Materia
l and Methods section, where the structure derived from the published NMR is shown in g
reen and the predicted structure of residues 1 to 75 is shown in orange with the CaM bindi
ng site highlighted in red licorice model. Calcium atoms are shown as yellow spheres. 
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To improve our understanding of the interaction between the N-terminus and the core 
domain of DREAM, we conducted multiple molecular dynamics simulations of using three 
different strategies starting with the initial structure shown in Figure 5.11. Our initial 
approach to model the N-terminus of DREAM as an extended domain with partial alpha-
helical structure followed by 80 ns cMD simulation resulted in structures which are shown 
on Fig. 5.12a.  
Figure 5.12. Molecular dynamics simulation of DREAM using an initial model construct
ed by combining a peptide model for residues 1 to 76 with the published NMR structure o
f DREAM (residues 76 to 256) shown in green. The alpha-helical section of the N-termin
us domain was predicted using secondary prediction tools and shown in orange, the CaM 
binding region corresponding to residues 29-44 is shown in red licorice. All structures are 
aligned using residues 76 to 256; calcium is shown as yellow spheres. (a) Two final struct
ures of DREAM after 80 ns classical MD simulations. (b) Three final structures of DREA
M after 30 ns accelerated MD simulations. (c) Three independent structures of DREAM a
fter 1000ns of coarse grained molecular dynamics simulation in the absence of Ca2+, show
ing a collapsed N-terminus. The hydrophobic surface known to mediate ligand binding on 
DREAM is highlighted by a blue ellipse, the electronegative surface identified on Figure 
5.1 is highlighted in black. 
 
We observed that during the simulation most of the alpha helices are retained and 
there is a partial contraction of the structure. The extended conformation of the N-terminus 
likely arises from insufficient simulation time. To overcome the computational cost of 
longer cMD simulations, we performed three additional aMD simulations where an 
additional energy was applied to the dihedral angles. This type of simulation results in 
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larger conformational space sampling, and as can be seen in Figure 5.12b the N-terminus 
of DREAM adopts a more unfolded and collapsed structure. Nonetheless, the CaM binding 
region is still significantly accessible to solution. Finally, we modeled DREAM using a 
residue based coarse grained approach, which significantly decreases computational costs 
and increases sampling time. In Figure 5.12c, we show three representative all-atom 
structures obtained from coarse grained simulations which clearly show a collapse of the 
N-terminus. Furthermore, all of our simulation resulted in a collapse of the N-terminus near 
the electronegative surface of DREAM (shown as black ellipse)  and away from the 
hydrophobic cavity (blue ellipse).  
 
5.2.8 CaM modulates the Ca2+ dependent association of DREAM and DNA 
 It has been well reported that DREAM interacts with the DRE promoter sequence 
of many genes, including c-fos, c-jun, and prodynorphin (Osawa et al. 2005, Carrion et al. 
1999, Ledo et al. 2000). It was proposed that the interaction between DREAM and its target 
DNA is mediated by basic residues residing on the entering helix of EF-hand 1 (Lys101, 
Arg98, Lys91 and Lys90) which form an electropositive region at the N-terminus (Figure 
5.1d). Additionally, DREAM(Δ65) binds DNA with about two-fold lower affinity than the 
full-length DREAM(Osawa et al. 2005). We hypothesize that the presence of numerous 
basic residues at the N-terminus of DREAM enhance its interaction with DNA and that 
association with CaM may result in a decrease in DNA binding affinity.  
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Figure 5.13. Fluorescence anisotropy increase due to 0.5 μM FITC labeled dsDNA 
homologous to the DRE sequence of human prodynorphin gene binding to 5 μM DREAM 
in the presence or absence of Ca2+. Addition of CaM in increasing concentrations (0 μM, 
20 μM, 40 μM and 60 μM) results in a concomitant decrease in fluorescence anisotropy. 
Chelation of Ca2+ by 2 mM EDTA results in an increase in anisotropy due to dsDNA 
association with DREAM, even in the presence of 60 μM CaM. 
 
We employed a fluorescently labeled dsDNA homologous to the DRE sequence of the 
human prodynorphin gene and monitored the change in fluorescence anisotropy in the 
presence of DREAM and CaM. As shown in Figure 5.13, addition of 5 μM DREAM results 
in a sharp increase in fluorescence anisotropy in the presence or absence of Ca2+. 
Furthermore, upon addition of increasing concentrations of CaM a decrease in anisotropy 
is observed, only in the presence of Ca2+. Addition of 2 mM EDTA results in the reversal 
of the CaM induced decrease in anisotropy, to a value identical to that observed for 
DREAM in the absence of CaM. These results support the idea that in the presence of the 
N-terminus, Ca2+ bound DREAM interacts with DNA, unless CaM is present to sequester 
its N-terminus domain. 
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5.3 Discussion 
 The principal goal of this study is to present a model for the interface between the 
CaM:DREAM protein complex. Based on our results, it is clear that residues 29-44 of 
DREAM associate with CaM in a Ca2+ dependent manner with Kd ~ 136 nM. Association 
of CaM at the N-terminus results in a blue shift and increase in tryptophan fluorescence on 
DREAM as well as on the DRE29 peptide, likely due to solvent restriction of Trp32 (Figure 
5.2). The calcium dependency of CaM association with DRE29 peptide is similar to that 
of the intact DREAM protein; however, the affinity is decreased to Kd = 3.3 ± 0.9 μM.  
This indicates that the core domain of DREAM (residues comprising helix 1 to 10) 
contribute to a decrease in binding energy of about 1.8 kcal/mol. Such a decrease in the 
free energy of the complex could be due to larger steric hindrance of residues 29 to 44 in 
the presence of the rest of the protein, or due to a direct interaction between the N-terminus 
residues and the core domain of DREAM. Indeed, titration of residues 29 – 44 with 
DREAM(Δ65) or DREAM shows the formation of a complex, with Kd ~ 0.3 mM (~ -3 
kcal/mol). Such a low affinity for the N-terminus domain with the core domain of DREAM 
is not irrelevant. The local concentration of the N-terminus can be calculated to be ~3 mM, 
assuming an extended conformation of DREAM of about 100 Å (0.5x10-21 L), which would 
result in approximately 91 % of the N-terminus being associated with the core domain of 
DREAM. However, it is likely that the interaction between DRE29 and DREAM is favored 
by increased peptide flexibility. Therefore, using a Kd ~ 5 mM would be more appropriate 
(calculated from the decrease in binding energy of 1.8 kcal/mol), which yields that only 
about 60 % of the N-terminus domain is accessible to bind CaM. The collapse of the N-
terminus seems to be nonspecific and mainly driven by electrostatic interactions. This 
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conclusion explains why the hydrophobic cavity of DREAM at the C-terminus is not 
compromised and can efficiently bind small hydrophobic ligands such as 1,8-ANS and 
NS5806 as well as large peptides such as the N-terminus of Kv4.3 (Figure 5.5). Moreover, 
the puzzling calcium independent association of DREAM with Kv4.3, indicates that the N-
terminus of DREAM is able to modify the accessibility of the hydrophobic groove. A 
similar effect was observed for NS5806 (Chapter 4), and it is possible that the presence of 
the N-terminus results in a destabilization of the hydrophobic groove which facilitates 
association with large hydrophobic peptides such as Kv4.3. A calcium independent binding 
of KChIPs and Kv4 channels has been observed using full-length proteins (An et al. 2000, 
Pioletti et al. 2006). However, we and others have reported a calcium dependent association 
of KChIP1 (which lacks the extended N-terminus domain) and DREAM(Δ65) with 
fragments of Kv4 (Gonzalez, Pham & Miksovska 2014, Li et al. 2014, Gonzalez, 
Miksovska 2013). Therefore, the results presented here support a mechanism where 
presence of the N-terminus in DREAM enhance association with KV4 channels, whereas 
its truncation by caspase-3 likely results in disruption of the DREAM:KV4 complex in the 
absence of calcium (Choi et al. 2001). 
 Despite the observed flexibility of the N-terminus domain, far and near UV CD 
spectra support a model where the first 65 residues do not form a random coil, but rather a 
partial helical structure. This is supported by bioinformatics analysis which highlights a 
region of high helical propensity, here named α0 (residues 27-53). Additionally, analysis 
of the disorder propensity of the DREAM amino acid sequence reveals that the N-terminus 
is comprised of two disordered regions connected by a structured segment, identified as 
α0. The N-terminus tryptophan (Trp32 and Trp50) within α0 undergo a structural 
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reorganization upon calcium binding which correlates with an increase in solvent 
polarity(Nagai et al. 2012). However, contribution to the observed near-UV ellipticity 
change upon Ca2+ binding being due to the disulfide bond between Cys45 and Cys46 
cannot be ruled out(Woody 2012, Kelly, Jess & Price 2005a).  We hypothesize that upon 
Ca2+ binding the surface charge reduction on DREAM as well as structural rearrangements 
may lead to a decrease in the collapse of the N-terminus, thus inducing an increase in 
solvent exposure of the N-terminus. Near-UV data also does not support a model where 
the N-terminus collapses into the hydrophobic cavity, which would result in a reversal of 
the observed transition.  
 Similarly to other CaM binding peptides, the association between CaM and the N-
terminus of DREAM is fast and close to the diffusion limit(Brown, Martin & Bayley 1997, 
Kasturi, Vasulka & Johnson 1993). On the other hand, dissociation of CaM from DRE29 
proceeds only after dissociation of Ca2+ from CaM. Whether the dissociation requires 
dissociation of all Ca2+ ions or only those at the CaM C-terminus domain is not revealed 
by these experiments. However, the observed displacement of the DRE29 peptide by TFP 
bound at the C-terminus highlights the possibility that this domain plays a major role in 
complex formation. The fluorescence anisotropy change upon Ca2+ dissociation from 
CaMRR2 shows a much slower kinetics than that observed using tyrosine residues located 
at the C-terminus domain. The position of the rhodamine label at the C-terminus on the 
exiting helix of EF-hand 4 near the hydrophobic pocket may allow the xanthene group to 
stabilize the open conformation which results in much slower transition of CaM to the 
closed apo form. Furthermore, the temperature dependence of the dissociation kinetics 
allows us to extract the activation enthalpy and entropy for the dissociation of DRE29 and 
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DREAM from apoCaM. These thermodynamic parameters reveal that the presence of the 
core domain of DREAM resulted in approximately 3-fold lower enthalpy of activation than 
dissociation of DRE29 (16.1 kcal/mol versus 4.9 kcal/mol). We hypothesize that this 
difference arises from an electrostatic attraction of the N-terminus domain involved in CaM 
binding to the electronegative side of DREAM, Figure 5.1. On the other hand, the positive 
4.0 kcal/mol activation entropy for CaMRR2 dissociation from DREAM compared to -1.1 
kcal/mol for the DRE29 dissociation shows that the dissociation transition states are not 
identical. These results support our hypothesis that there is an electrostatic interaction 
between the N-terminus domain and the core domain of DREAM, as well as the idea that 
CaM decreases the disorder of the N-terminus which likely explains the increase in 
solubility of DREAM. 
 DREAM has been shown to undergo an oligomerization change upon binding of 
calcium; however, there seems to be some disagreement among the reported 
oligomerization states. We have recently reported that in the absence of calcium, the 
DREAM(Δ65) construct forms a stable tetramer in solution and a dimer upon calcium 
binding (Chapter 3). In contrast, Ramachandran and coworkers observed a dimer to 
monomer transition upon calcium binding to DREAM (Ramachandran et al. 2012), which 
is contrary to the initial finding favoring a tetramer to dimer transition (Osawa et al. 2001). 
The disagreement could be likely due to different expression methodologies (GST fusion 
vs inclusion body refolding), and/or sample conditions (high salt versus low salt and 10 
mM LDAO). Therefore, to understand the impact of CaM association with DREAM we 
determined the structural arrangement and oligomerization of CaM:DRE29 and 
CaM:DREAM complexes using steady-state and time-resolved spectroscopy.  
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Figure 5.14. Carton representation of the proposed model for a heterotetrameric 
DREAM:CaM complex. The DREAM dimer is shown  in cyan and calmodulin is shown 
in orange, calcium is shown as yellow spheres. 
 
 The fluorescence properties of the IAEDANS labeled CaM shows a clear transition 
upon Ca2+ binding which include an increase in fluorescence, a blue shift in emission as 
well as slower decay lifetime and rotational correlation time of the protein. These results 
are in good agreement with the known transition of CaM from a flexible conformation in 
the apo form to a more rigid and elongated structure in the presence of calcium with 
concomitant exposure of a hydrophobic surface at the C-terminus (Chattopadhyaya et al. 
1992, Kuboniwa et al. 1995). Association of CaM-IAEDANS with DREAM results in an 
even more dramatic increased fluorescence, a larger blue shift and increased decay lifetime 
as well as a more complex rotational decay. Noticeably, CaM and DRE29 form a spherical 
heterodimer whereas a heterotetramer was observed for the CaM-IAEDANS:DREAM 
complex, which supports a stoichiometry of 1:1. Moreover, the fact that Ca2+DREAM 
forms a dimer in the presence of CaM supports the idea that CaM association does not 
disrupt the dimer interface which is partially solvent protected in calcium bound DREAM 
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dimer and likely does not affect the accessibility of the hydrophobic groove on DREAM 
or its interaction with hydrophobic partners(Gonzalez, Miksovska 2014, Gonzalez, Pham 
& Miksovska 2014, Lusin et al. 2008). With these result in mind, we propose that in the 
presence of Ca+, DREAM and CaM form heterotetrameric complex as shown in figure 
5.14.  
 Multiple simulations of a DREAM model derived from bioinformatics analysis 
(Figure 5.13) show that the N-terminus of DREAM likely collapses on a negative surface 
adjacent to the hydrophobic surface. The interaction between the core domain and the N-
terminus of DREAM is mainly mediated by Asp and Glu residues on the exiting helix of 
EF-2 and EE-4 and entering helix of EF-3 as well as on the loop of EF-4. The position of 
the N-terminus also does not conflict with the proposed structure of KChIPs bound to the 
T1-domain of Kv4 channels (Pioletti et al. 2006, Wang et al. 2007). It is well known that 
the drosophila shaker channels (homologous to Kv4 in humans) can inactivate through pore 
occlusion mediated by a long and flexible positively charged N-terminus (Antz et al. 1997). 
The positive charge and conformational flexibility of the N-terminus domain of DREAM 
could highlight the role of this domain in modulation of Kv4 channels through a 
mechanism similar to that of shaker channels. Moreover, the divergent amino acid 
sequence among the KChIP subfamily of Ca2+ binding proteins could explain the observed 
variation in modulation of K+ currents by KChIPs. 
 Finally, binding of CaM to DREAM shows a clear effect on the DREAM 
interactions with the DRE sequence of the prodynorphin gene, an effect which likely 
translates to other DRE promoted genes regulated by DREAM (Ledo et al. 2000). Our 
observation that DREAM associates with DNA independent of calcium is in contrast to 
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previous work (Osawa et al. 2005). However, we believe that the discrepancy arise from 
different experimental conditions since previous ITC experiments were conducted in the 
presence of LDAO. We observed that both LDAO and CaM increase the solubility of 
DREAM, and it is possible that LDAO association with DREAM modulates the 
interactions between DRE and DREAM and potentially inhibits the interaction between 
Ca2+DREAM and DNA. Indeed, we have observed inhibition of the CaM:DREAM 
interaction by LDAO as well as a strong interaction between DRE29 peptide and DRE 
dsDNA with LDAO (data not shown). The EC50 for Ca2+CaM induced DREAM DNA 
dissociation observed here is relatively high, ~20 μM. However, the high intra-cellular 
concentrations of CaM, the known Ca2+ induced translocation of CaM from the cytosol to 
the nucleus as well as the Ca2+ induced increase in the freely diffusing CaM concentration 
could facilitate the formation of DREAM:CAM complex and dissociation of DREAM from 
DNA(Deisseroth, Heist & Tsien 1998, Zaidi et al. 2004).  It is also possible that post-
translational modification such as myristoylation/palmytoylation at Cys45/Cys46 could 
enhance the affinity between CaM and DREAM and decrease the observed EC50, an effect 
which has been observed in other CaM binding proteins(Takasaki et al. 1999).  
5.4 Summary 
 We have shown that an alpha-helical region at the N-terminus of DREAM 
comprising residues 29 to 44 contains a CaM binding surface. The Ca2+ dependent 
association of CaM with DREAM increases its solubility in the presence of calcium. We 
also demonstrate that the N-terminus of DREAM forms a flexible Ca2+ sensitive domain, 
which can collapse on the core domain of DREAM, but does not block the hydrophobic 
cavity at the C-terminus. The protein complexes between CaM and DRE29 or DREAM 
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follow a 1 to 1 stoichiometry, in good agreement with a heterodimer and heterotetramer 
oligomerization. Overall, our biochemical studies provide insight into the molecular 
mechanism of the CaM:DREAM complex and the impact of CaM association to DREAM 
and open up the possibility of CaM:DREAM complex being involved in gene regulation. 
The complex behavior of the N-terminus in DREAM highlights the functional diversity of 
members of the KChIPs group of calcium binding proteins, which share low homology in 
this region. These results also provide a roadmap for the design of a molecular model of 
CaM:DREAM complex, which may shed light on the understanding of these 
multifunctional proteins, and how they affect downstream binding partners such as Kv4 
channels, DNA, and presenilin. 
 159 
6. CHARACTERIZATION OF THE PHOTOPHYSICAL, 
THERMODYNAMIC AND STRUCTURAL PROPERTIES OF THE 
TERBIUM(III)-DREAM COMPLEX 
6.1 Background and significance 
DREAM, is a 29 kDa multifunctional Ca2+ sensing protein found in different 
neuronal cell compartments (Carrion et al. 1999). Outside the nucleus, DREAM interacts 
with presenilin to regulate amyloid precursor protein processing and with potassium 
channels to regulate their membrane translocation and gating (An et al. 2000, Buxbaum et 
al. 1998). Moreover, DREAM represents a new class of Ca2+ sensing protein able to 
translocate to the nucleus and directly bind DNA (Carrion et al. 1999). In the nucleus, it 
regulates prodynorphin and c-fos gene expression by binding to the DRE regulatory 
sequence of those genes (Carrion et al. 1999, Cheng et al. ). Association of DREAM with 
the DRE promoter regions in the absence of calcium leads to inhibition of gene 
transcription. These genes have been shown to be involved in apoptosis, cell homeostasis, 
and pain modulation (Costigan, Woolf 2002, Fontán-Lozano et al. 2009). The role of 
DREAM in pain sensing, memory retention, learning and Alzheimer’s disease highlight 
the multifunctional properties of this protein (Fontán-Lozano et al. 2009). As a calcium 
signal transducer, DREAM does not possess endogenous catalytic activity and its 
regulatory effect in biological processes arises from interaction with numerous binding 
partners. Therefore, understanding how calcium and other metals trigger structural changes 
on DREAM, and how this protein reorganization controls target recognition, would provide 
important insight into its mechanism of action.  
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 The three dimensional structure of Ca2+ bound DREAM has been obtained through 
NMR and is presented in Figure 6.1a (Lusin et al. 2008). DREAM has four EF-hand motifs 
of which EF-hand 3 and EF-hand 4 are able to bind Ca2+, while EF-hand 1 is unable to bind 
either Mg2+ or Ca2+. The coordination of calcium/magnesium in the EF-hand motif has 
been widely studied and it has been shown to form hexa- or hepta-coordination with 
oxygen atoms of proteins in order to form a pentagonal bipyramidal coordination (Figure 
6.1b and c) (Gifford, Walsh & Vogel 2007a, da Silva, Kendrick-Jones & Reinach 1995). 
The oxygen-donating amino acids of the calcium selective metal binding loop in EF-hands 
follow a common organization such that the 1st, 3rd, 5th, positions are either an aspartic or 
an asparagine amino acid, while the amino acid at position 12th is a well conserved glutamic 
acid (Figure 6.1b). Modulation of metal affinity and selectivity arises from distinct 
combinations of negatively charged amino acids at these positions. For instance, the EF-
hand 2 of DREAM has been proposed to selectively bind Mg2+ due to Glu  Asp mutation 
at the 12th position, which eliminates the hepta-coordination necessary for strong binding 
of Ca2+ (Kretsinger, Nockolds 1973, Craig et al. 2002). Similarly, the presence of a lysine 
at the 1st, proline at the 5th, and aspartic acid at the 12th position render the EF-hand 1 of 
DREAM unable to bind most metals (Craig et al. 2002, Osawa et al. 2001). 
 Association of calcium at the metal binding loop of the active EF-hand pair at the 
C-terminus of DREAM, induces a structural rearrangement which leads to exposure of a 
hydrophobic surface as well as changes in oligomerization state (Gonzalez, Miksovska 
2014, Osawa et al. 2001). However, details about the underlying molecular mechanism by 
which calcium binds and induces structural changes on DREAM are not known. 
Nonetheless, experiments using NMR to monitor the glycine residues in the EF-hand loops 
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and the associated chemical shift broadening upon metal binding would provide insight 
into the role of amino acids of DREAM. Of particular interest is the use of lanthanide ions, 
which have been shown to possess similar physical properties to calcium ions, and have 
been widely applied to study the metal binding properties of EF-hands (Mustafi et al. 
2004),(Martin, Richardson 1979). Additionally, lanthanide-protein complexes have been 
shown to undergo magnetic alignment during NMR experiments, which is of great help in 
elucidating the three dimensional structure of protein-metal and protein-protein complexes 
(Pintacuda et al. 2006)The advantage of employing lanthanides to understand the 
mechanism of calcium binding is their unique luminescent properties as well as their ability 
to effectively displace calcium from EF-hand loops. Replacement of Ca2+ by Tb3+ has also 
been shown to induce structural changes on the EF-hand loops which are highly 
homologous to those observed upon calcium binding (Rao et al. 1996).  
In this chapter, we implement a combination of fluorescence, luminescence, TIMS-
MS , and calorimetric techniques to show that Tb3+ binds at the EF-hands of DREAM and 
functions as a calcium biomimetic. Moreover, we show that association of Tb3+ at EF-hand 
3 and 4 of DREAM leads to a calcium-like conformation with similar hydrophobic surface 
exposure, oligomeric transition, and ion-neutral collisional cross section (CCS) as that 
observed for the Ca2+ bound protein. Nonetheless, we observe small deviations in the 
dynamics of the environment near Trp169 as well as secondary structure organization, 
indicating that not all aspects of Tb3+ binding are identical to Ca2+. Using ITC and the 
fluorescent properties of Tb3+ we are able to gain insight into the role of Mg2+ and ligand 
binding to DREAM.  
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Figure 6.1. (a) NMR structure of DREAM monomer with highlighted hydrophobic 
residues (gray mesh) and charged residues (red mesh) (pdb entry 2JUL)7. The four EF-
hand of DREAM are shown in green (EF-hand 1), orange (EF-hand 2), blue (EF-hand 3), 
and red (EF-hand 4). Calcium are shown as an orange sphere. (b) Coordination geometry 
of calcium bound to EF-hand 3 (left) and EF-hand 4 (right). Residues involved in 
coordination of Ca2+ are shown in licorice model. EF-hand 3 shows a clear pentagonal 
bipyramidal coordination whereas EF-hand 4 is distorted. (c) Geometry and consensus 
sequence of EF-hand binding loops as well as sequence homology between neuronal 
calcium sensors and calmodulin at the metal binding loops. 
 
6.2 Results 
 The well-known calcium biomimetic behavior of europium(III), terbium(III), and 
neodymium (III) as well as the unique spectroscopic properties of protein:lanthanide 
complexes have been widely employed to characterize the sequence of metal binding to 
calcium binding proteins (Mulqueen, Tingey & Horrocks 1985, Chaudhuri et al. 1997, 
Kilhoffer, Gerard & Demaille 1980), to observe protein conformational heterogeneity 
(Austin, Stein & Wang 1987), to determine water coordination of metals bound at the EF-
hand motif (Horrocks, Sudnick 1979), and as binding assays (Hagan, Zuchner 2011). 
 163 
Therefore, we envisioned that the properties of lanthanides could be employed to obtain 
information on the biophysical properties of DREAM protein. However, the association of 
lanthanides with the KChIP subfamily of calcium binding proteins has not been extensively 
studied. Thus, we first set forth to determine whether Tb3+is able to directly associate with 
the EF-hand of DREAM. This is important, since previous studies on DREAM(Δ65) using 
mass spectrometry and studies on NCS-1 using sensitized emission have presented 
contradicting results on whether Tb3+ can bind to neuronal calcium sensors (Craig et al. 
2002, Fisher et al. 2000). Additionally, we are interested in investigating whether Tb3+ 
binding induces structural changes on DREAM homologous to those observed for calcium. 
 
6.2.1 Terbium(III) binds to DREAM and is sensitized by energy transfer from W169  
 Calmodulin and DREAM are well known to undergo distinct structural changes 
upon binding of calcium, these structural changes are accompanied by changes in 
fluorescence of tyrosine and tryptophan residues, respectively (Carrion et al. 1999, 
Drabikowski, Brzeska & Venyaminov SYu 1982). These fluorescence transitions of these 
proteins are shown in Figure 8.2a and 8.2b. Upon calcium binding the tyrosine fluorescence 
of CaM increases whereas the tryptophan fluorescence of DREAM decreases, in agreement 
with previous reports. Of particular interest is the observation that in the presence of Tb3+, 
at molar ratios of 4:1 for CaM and 2:1 for DREAM, the fluorescence emission are nearly 
identical to that observed in the presence of saturating calcium (Figure 6.2a, b).  
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Figure 6.2: Intrinsic fluorescence changes of  40 μM (a) CaM and (b) DREAM(Δ65) upon 
binding of 1 mM calcium or 160 μM Tb3+ on CaM or 80 μM Tb3+ for DREAM(Δ65), 
excited at 280 ± 4 nm. The observed tyrosine fluorescence change upon Tb3+ binding to 
CaM shows a small deviation from that observed for Ca2+, likely due to quenching of the 
fluorescence by energy transfer to Tb3+. The Tb3+ induced transition for DREAM(Δ65) is 
identical to that observed in the presence of Ca2+.  Sensitized emission of (c) 160 μM 
Tb3+ bound to CaM and (d) 80 μM Tb3+ bound to DREAM(Δ65), excited at 280 nm with 
and without 2mM EDTA. The background emission of the Tb3+:EDTA complex is shown 
as reference. The observed sensitized emission of Tb3+ shows the characteristic sharp bands 
at 489, 544 (major), 586 and 622 nm due to 
the 5D4–7F6, 5D4–7F5, 5D4–7F4, 5D4–7F3 transitions of Tb3+, respectively. The major peak 
at 545 nm for DREAM(Δ65) is 40 % smaller than that observed for CaM. Addition of 2 
mM EDTA to either CaM or DREAM(Δ65) resulted in an emission identical to that of Tb3+ 
in solution.  
 
The slightly lower tyrosine fluorescence of CaM in the presence of Tb3+ is likely due to an 
efficient quenching of Tb3+ by aromatic amino acid, or due to incomplete binding of this 
ion. We also investigated whether binding of Tb3+ on DREAM leads to energy transfer 
from nearby aromatic residues toward the metal ligand, as previously observed for CaM 
(Kilhoffer, Gerard & Demaille 1980). The presence of the characteristic sharp emission 
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bands in the sensitized emission spectra of the DREAM(Δ65):Tb3+ complex supports the 
idea that aromatic residues, likely at the C-terminus of DREAM, are able to transfer energy 
to bound terbium (Figure 8.2c and 8.2d). The sensitized emission intensity of terbium 
bound to DREAM(Δ65) is about half of that observed for CaM, which is likely due to the 
presence of only two Tb3+ ions bound to EF-hand 3 and 4 of DREAM(Δ65), whereas four 
Tb3+ ions are bound to CaM (Craig et al. 2002). Nonetheless, it is also possible that the 
presence of Tyr-100 at position 7 of the EF-hand 3 binding loop and Tyr-139 at position 
10 of EF-hand 4 on CaM provide a more efficient energy transfer to Tb3+ (Hogue et al. 
1992). 
 Detailed analysis of DREAM(Δ65) excitation spectra due to the 5D4  7F5 
transition at 545 nm shows a broad peak with maximum at 280 nm and 32 nm FWHM 
(Figure 6.3a). The ratio of terbium luminescence intensity when exciting at 295 nm and 
280 nm is 0.40, which indicates that tyrosine and tryptophan residues are able to transfer 
energy (Brittain, Richardson & Martin 1976). The excitation spectra of DREAM(Δ160), 
DREAM(E186Q), and DREAM(E234Q) are identical to those of DREAM(Δ65), with a 
broader FWHM of 36 nm and larger 295/280 ratio of 0.52 for DREAM(Δ160). Analysis 
of the C-terminus domain of DREAM shows the presence of three tyrosine residues (Y174, 
Y195 and Y203); however, only Y174 is within the range of 5 to 10 Å necessary for an 
efficient energy transfer to Tb3+ bound at EF-hand 3 and 4 (Figure 8.3b) (Kleinerman 1969, 
Wallace et al. 1982). Therefore, to quantify the energy transfer contribution of Y174 we 
constructed a DREAM(Y174A) mutant and determined the effect of this mutation on the 
sensitized emission and excitation spectra. This mutant shows identical circular dichroism 
transition and amplitude as well as the same Tb3+ induced tryptophan fluorescence change, 
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as the DREAM(Δ65) construct (data not shown). On the other hand, the efficiency of 
energy transfer in the DREAM(Y174A) mutant is decreased by ~60 %, judging from the 
decreased sensitized emission at 545 nm (Figure 6.3a). The excitation spectra of this 
construct also shows a 5 nm blue shift to 275 nm with a FWHM of 38 nm and 295/280 
ratio of 0.41. 
Figure 6.3: (a) Excitation spectra of DREAM constructs bound to Tb3+, 20 μM protein 40 
μM  Tb3+. The spectra was normalized so that the intensity corresponding to backbone to 
Tb3+ energy transfer at 240nm is the same for DREAM(Δ65), DREAM(Δ160), and 
DREAM(Y174A) while the magnitude is half for DREAM(E186Q) and DREAM(E234Q). 
(b) Calcium/terbium binding sites of EF-hand 3 and 4, only EF-hand 3 is shown (in blue) 
for clarity. (c) Titrations of Tb3+ into DREAM(Δ65) and DREAM(Δ160) in 20 mM TRIS 
pH 7.4 and 100 μM Ca2+ with and without 5 mM Mg2+. (d) Titration of Tb3+ into 
DREAM(E186Q) and DREAM(E234Q) under identical conditions as panel (c). Solid lines 
represent the best fit using the quadratic equation for N-binding sites.  
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The decrease in sensitized emission and blue shift of the excitation spectra support the role 
of Y174 as an energy donor, while the identical 295/280 ratio for DREAM(Δ65) and 
DREAM(Y174A)  is indicative of Tyr  Trp  Tb3+ being the predominant energy 
transfer pathway. The similar Tb3+ sensitization observed in DREAM(Δ160) and 
DREAM(Δ65) constructs indicates that aromatic amino acids at the N-terminus do not 
transfer energy to Tb3+ and that the observed luminescence arises from terbium bound at 
EF-hand 3 and 4. For comparison, the excitation spectra of CaM is also shown and a 
characteristic maxima at 277 nm with FWHM of 24 nm and 295/280 ratio of 0.07 is 
observed, which is in good agreement with a Tyr  Tb3+ energy transfer. Moreover, the 
lack of vibronic structures on the excitation spectra on all constructs indicates that 
phenylalanine residues do not play a major role in energy transfer.  
 The closer proximity of Tyr174 to EF-hand 3 than EF-hand 4 (10.5 Å vs 13.5 Å) 
supports the idea that monitoring the binding of Tb3+ using the sensitized emission may 
allow us to identify whether aromatic amino acids on DREAM can transfer energy to Tb3+ 
bound at both EF-hands. To confirm this hypothesis, we employed two DREAM constructs 
in which glutamic acid at position 12 of the calcium binding loop has been mutated to 
glutamine thus inactivating either EF-hand 3 in DREAM(E186Q) or EF-hand 4 in 
DREAM(E234Q)(Osawa et al. 2005). As expected, the excitation spectra of Tb3+ bound at 
EF-hand 3 in the DREAM(E234Q) mutant shows about 39 % larger fluorescence than that 
of Tb3+ bound at EF-hand 4 in the DREAM(E186Q) mutant (Figure 6.3a). 
Titration of Tb3+ into Ca2+ bound DREAM(Δ65) or DREAM(Δ160) shows that 
both construct have similar affinity for Tb3+ in the presence of calcium. The dissociation 
constant obtained using the quadratic equation shows identical affinity for Tb3+ in the 
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presence of Ca2+ with Kd = 1.8 ± 0.6 μM for DREAM(Δ65) and Kd=1.6 ± 0.2 μM for 
DREAM(Δ160). Interestingly, in the presence of 5 mM MgCl2 the sensitized emission of 
Tb3+ is decreased by 53 % for DREAM(Δ65) but no significant changes are observed for 
DREAM(Δ160) (Figure 4.3c). To better understand the binding mechanism of Tb3+ to EF-
hand 3 and 4 of DREAM,  we have also conducted titrations in the presence of Ca2+ or 
Mg2+ and Ca2+ using the DREAM(E186Q) and DREAM(E234Q) protein mutants (Figure 
6.3d). Displacement of Ca2+ from DREAM(E186Q) by Tb3+ shows a weaker dissociation 
constant of Kd = 11 ± 1 μM compared to DREAM(E234Q) with Kd = 5.9 ± 0.5 μM. 
However, a similar decrease in sensitized emission upon addition of 5 mM MgCl2 as that 
for DREAM(Δ65) was observed, with an emission decrease of 55 % and 80 % for 
DREAM(E234Q) and DREAM(E186Q), respectively (Figure 6.3d). Under the conditions 
used for these titrations (500 μM CaCl2 or 500 μM CaCl2 and 5 mM MgCl2), Tb3+ binds 
first to the inactivated EF-hand (see ITC experiments below). Therefore, the data shown in 
Figure 6.3d, highlights that Mg2+ binding to EF-hand 2 induces structural rearrangements 
which have a larger impact on EF-hand 3. This is in good agreement with the fact that EF-
hand 2 is adjacent to EF-hand 3, and that the exiting helix of EF-hand 2 is in direct contact 
with entering helix of EF-hand 3 (Figure 6.1a). Tryptophan 169 and tyrosine 174, both of 
which are shown to play a major role in energy transfer, both reside on the entering helix 
of EF-hand 3. The presence of Mg2+ also enhanced the binding of Tb3+, with dissociations 
constants of 5.8 ± 1.9 μM for DREAM(E186Q) and 2.7 ± 0.4 μM for DREAM(E234Q). 
This increase in apparent affinity is likely due to a decrease in nonspecific binding of Tb3+ 
to secondary sites or to EF-hand 2. Together these results support a model in which terbium 
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displaces Ca2+ from EF-hand 4 and EF-hand 3 as well as highlight the role of Mg2+ binding 
at EF-hand 2 as a structural cofactor in DREAM. 
 
6.2.2 Terbium(III) binding to DREAM leads to similar structural rearrangement as those 
observed for Ca2+. 
 The terbium(III) induced tryptophan emission quenching observed in Fig. 6.2b 
indicates that Tb3+ is able to mimic the structural changes induced by Ca2+ binding to EF-
hand 3 and 4. To test whether Tb3+ binding to DREAM induces a structural transition 
analog to that of Ca2+, we monitored the fluorescence and anisotropy decay of Trp169, the 
fluorescence of the extrinsic hydrophobic probe 1,8-ANS bound at the C-terminus of 
DREAM(Δ65) (see Chapter 3), and changes in secondary structure. Detailed information 
regarding the environment and dynamics of Trp169 and how they are affected by metal 
binding can be obtained by measuring the fluorescence and anisotropy decay lifetimes. As 
previously reported (Pham et al. 2015), the fluorescence decay of Trp169 on DREAM(Δ65) 
was best fitted by a Gaussian-discrete bimodal decay model, whose parameters are listed 
in Table 1 and Figure 6.4a. The small discrepancies between our results and those 
published previously likely arise from the lack of LDAO detergent under our conditions. 
Nonetheless, we observe that addition of Ca2+ or Tb3+ results in a decrease in the average 
excited state lifetime from 4.8 ns to 3.8 ns, which is due to a decrease in fractional intensity 
contribution of the long lifetime and a slightly faster Gaussian decay from 1.8 ns to 1.5 ns. 
The lack of significant lifetime quenching of Trp169 by Tb3+ is likely due to the poor 
efficiency of this energy transfer process. 
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Moreover, anisotropy decay measurements were conducted to identify whether binding of Tb3+ induces dimerization of DREAM 
as observed for Ca2+. The frequency domain anisotropy decay data was best fitted with a double discrete model, in which the 
fast Θ1 is associated with fast local fluctuations of tryptophan and the slow Θ2 corresponds to the global rotation of the protein 
(Table 1). A clear transition from 15 ns to 29 ns upon binding of Ca2+ and 27 ns in the presence of Tb3+ is observed. These 
rotational correlation times match well with the values of 14 ns for a monomeric and 28 ns for a dimeric DREAM(Δ65) protein 
approximated by the Einstein-Stokes equation at 17 °C, η=0.0100 P, and 0.73 g/mL hydration.  Differences in rotational 
correlation times of the fast local tryptophan motion can be observed between Ca2+ and Tb3+ bound DREAM(Δ65), where a two-
fold faster local motion is measured in the presence of terbium (0.52 ns vs 0.23 ns). 
Table 6.1. Fluorescence and anisotropy decay parameters of DREAM(Δ64) bound to Ca2+ or Tb3+ 
 τ�𝟏𝟏 (f1) 
(ns) 
w1 
(ns) 
τ2 (f2) 
(ns) 
<τ> 
(ns) 
Θ1 (f1) 
(ns) 
Θ2 (f2) 
(ns) χ
2 
apoDREAM(Δ64) 1.8 (0.39) 0.69 5.7 (0.61) 4.2 0.40 (0.35) 15 (0.65) 0.5 
Ca2+DREAM(Δ64) 1.5 (0.48) 0.60 5.9 (0.52) 3.8 0.52 (0.40) 29 (0.60) 0.9 
Tb3+DREAM(Δ64) 1.5 (0.47) 0.64 5.8 (0.53) 3.8 0.23 (0.58) 27 (0.42) 1.5 
Values in parentheses represent the fraction intensity and fractional depolarization. τ1 is the mean 
decay time of the Gaussian distribution with a width of distribution w1. The lifetime of the discrete 
single exponential term is denoted as τ2. The average lifetime <τ> was calculated using Eq.1 and 
Eq.2 in Supplemental Material section. α1 and α2 are normalized pre-exponential decay and f1 and f2 
are exponential decay fractions. 
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In the metal-free DREAM(Δ65), the local flexibility accounts for 35% of the depolarization 
while in the Ca2+ and Tb3+ bound DREAM(Δ65) form, this rotation contributes 48 % and 
58 % in depolarization, respectively. Altogether, excited state and anisotropy decay of 
Trp169 reveal that even though binding of Tb3+ can induce dimerization of DREAM(Δ65) 
this metal also induces a more dynamic structure near the Trp169 compared to Ca2+.  
 
Figure 6.4. (a) Tryptophan fluorescence lifetime distribution of DREAM(Δ64) in the 
presence of Ca2+ or Tb3+, decay data was modeled as a Gaussian distribution and a discrete 
decay, parameters listed in Table 1. (b) Circular dichroism spectra of 40 μM DREAM(Δ64) 
in the presence of 1 mM Ca2+, 2 mM EDTA or 160 μM Tb3+ in 5mM TRIS pH 7.4. (b) 
Binding of Tb3+ or Ca2+ to 10 μM DREAM(Δ64) in the presence of 40 μM 1,8-ANS.  
 
 As shown in Figure 6.4b, the CD spectra of metal-free DREAM(Δ65) shows a 
characteristic profile with minima at 222 nm and 208 nm (maxima at 190 nm is not shown) 
in good agreement with an alpha helical structure. Upon binding of Ca2+, an ellipticity 
decrease at 200 – 225 nm and increase at 190 nm is observed, which can be explained by 
an increase in alpha helical content and/or rearrangement of the alpha helices. On the other 
hand, in the presence of Tb3+ a CD spectra intermediate to that measured for apo and Ca2+ 
bound DREAM is observed. This intermediate structure was also observed when 2-fold 
excess of terbium was added to a sample containing 100 µM calcium (not shown). The 
largest deviation in CD spectra between the Ca2+ and Tb3+ bound DREAM(Δ65) is 
observed near the 208 nm minima. Thus, the CD data indicates that Tb3+ is able to displace 
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Ca2+ and induce a structural change distinct from those observed for metal free and Ca2+ 
bound DREAM(Δ65).  
 Despite the small differences in the protein dynamics near Trp169, as well as 
deviation in secondary structure upon binding of Tb3+, we observed similar binding of 1,8-
ANS at the C-terminal hydrophobic cavity of DREAM(Δ65) (Gonzalez, Miksovska 2014) 
. The fluorescence emission of this probe has been extensively shown to be sensitive to the 
immediate environment, and while the total intensity upon Ca2+ binding is observed to 
increase, no changes in fluorescence of 1,8-ANS were observed upon displacement of Ca2+ 
by Tb3+ (Fig. 4c). Moreover, frequency domain analysis of the excited state of 1,8-ANS as 
well as the depolarization time reveal no significant differences between Ca2+ or Tb3+ 
bound DREAM(Δ65) (data not shown). Overall, the indication is that the hydrophobic 
cavity exposure induced by calcium is also triggered by terbium.  
 
6.2.3 DREAM binds Tb3+ through an entropy driven mechanism. 
 To complement the Tb3+:DREAM binding studies using sensitized emission we 
also conducted calorimetric studies where the heat associated with Tb3+ displacement of 
Ca2+ bound at the EF-hands of CaM and DREAM is measured. Isothermal calorimetry 
reveals that displacement of Ca2+ from CaM is endothermic and can be best modeled as a 
sequential process (Figure 6.5a). The profile of the ITC isotherm for Tb3+ displacement of 
Ca2+ bound to CaM is similar to that obtained for calcium binding to a plant-mammalian 
CaM chimera (Gilli et al. 1998), albeit with slightly different thermodynamic parameters. 
The association of Tb3+ ions with CaM at EF-hand 1 through 4 have slightly lower 
association constants than those determined for Ca2+ binding, which is likely due to 
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competition effects. We associate the site with K1 parameters as representing the 
displacement of Ca2+ by Tb3+, while the two other observed binding processes (K2 and K3) 
likely arise from a convolution of specific and nonspecific association of Tb3+ ions. The 
presence of nonspecific binding of Tb3+ ions is supported by the fact that addition of 5 mM 
Mg2+ results in drastic changes in the thermodynamic parameters associated with K2 and 
K3. The observed decrease in enthalpy and entropy of ~160 kcal·mol-1 and ~ 280 kcal·mol-
1 for K2 and K3 also support the idea that these supplementary sites are strikingly different 
and may involve different ligands and/or ion displacement. We associate the 
thermodynamic values recovered in the presence of Mg2+ with the displacement of Ca2+ 
specifically bound at the loops of EF-hands 1 thru 4, convoluted with any additional protein 
rearrangement to accommodate Tb3+. It can be observed that in the presence of Mg2+ there 
is a three-fold decrease in affinity for the K1 site, with a minimal change in enthalpy and 
entropy; whereas sites K2 and K3 show similar affinity, with K2 having two-fold larger 
enthalpy and entropy than K3 sites. Altogether, these values can be interpreted as 
corresponding to Tb3+ displacement of Ca2+ ions from four EF-hands with K1 representing 
the weakest Ca2+ binding hand and K2 and K3 corresponding to the remaining three EF-
hands. Following previous studies in which calmodulin was shown to follow a sequential 
filling of EF-hands 1  2  3 and 4 by Tb3+ and Ca2+, we associate the K1 binding site to 
that of Tb3+ binding to EF-hand 4 (Kilhoffer, Gerard & Demaille 1980, Wang et al. 1982). 
Interestingly, EF-hand 4 in calmodulin shows the presence of glutamic acid at position 11 
near the –z metal coordination (Figure 6.1), which may explain the lower enthalpic and 
entropic contribution upon displacement of Ca2+ by Tb3+.
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Figure 6.5: ITC isotherms for Tb3+ displacement of Ca2+ from CaM, DREAM(Δ64) and DREAM(Δ160). The upper panels of each 
profile reflects the thermal power expressed in units of µcal·s-1. The lower panel shows integrated reaction heats (ΔH) expressed in 
units of kcal·mol-1. The solid lines present the best fitting curve with parameters shown in Table 6.2. 
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Table 6.2. ITC parameters recovered for Tb3+ displacement of Ca2+  from  EF hands of CaM and DREAM using a sequential 
model 
 K1 x 104 
K2 x 
104 
K3 x 
104 ΔH1 ΔH2 ΔH3 TΔS1 TΔS2 TΔS3 
CaM 29 ± 4.2 0.7 ± 0.4 5.1 ± 8.4 12 ± 5  212 ± 38 
-307 ± 
127 
19 ± 3.9 217 -302 
CaM + Mg2+ 
 
8.9 ± 1.8 1.9 ± 0.2 1.4 ± 0.2 13 ± 1.5 47 ± 0.6 23 ± 7 20 ± 1.4 52 ± 0.6 28 ± 7 
DREAM(Δ64)  
 
22 ± 1.3 8.1 ± 1.6 2.8 ± 0.2 13 ± 9.0 18 ± 0.6 -2.5 ± 2.7 20 ± 9.1 24 ± 0.4 3.6 ± 2.7 
DREAM(Δ64) + 
Mg2+ 
16 ± 2.5 11 ± 1.1 6.0 ± 0.5  12 ±1.3 18 ± 6.0 3.4 ± 3.2 19 ± 1.3 25 ± 5.9 9.9 ± 3.1 
DREAM (Δ160) 
 
6.9 ± 3.2 8.9 ± 9.2  13 ±1.7 8.2 ± 1.3  19 ± 1.5 15 ± 1.1  
DREAM (Δ160) + 
Mg2+ 6.8 ± 1.4 1.8 ± 0.6  11 ± 2.2 7.7 ± 2.4  17 ± 2.1 14 ± 2.4  
DREAM (E186Q) 
+ Mg2+ 
14.0 ± 0.9 8.6 ± 1.3 8.8 ± 2.2 7.5 ±1.2 15 ± 1.7 2.2 ± 2.6 14 ± 0.8 22 ± 1.8 9 ± 2.7 
DREAM (E234Q) 
+ Mg2+ 
5.7 ± 0.9 27 ± 1.5 16 ± 6.2 11 ± 1.9 3.6 ± 2.7 4.0 ± 1.3 18 ± 1.9 9.6 ± 2.5 11 ± 0.9 
All Experiments conducted in triplicate at 25 °C, errors are standard deviations. Enthalpy and entropy changes shown in 
kcal·mol-1, association constants in M-1.  
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The Tb3+ binding sites corresponding to K2 show thermodynamic parameters for ΔH2 and 
ΔS2 which are about two-fold larger than those of ΔH3 and ΔS3, which is likely due to two 
Tb3+ binding sites being reported by the K2 parameters. This allows us to approximate a 
value of ΔH ~ 23 kcal·mol-1 and TΔS ~ 27 kcal·mol-1 for Tb3+ displacement of Ca2+ bound 
at EF-hands 1, 2, and 3 and ΔH = 13 kcal·mol-1 and TΔS = 28 kcal·mol-1 for EF-hand 4. 
 Furthermore, displacement of Ca2+ bound to DREAM(Δ65) by Tb3+ shows a 
simpler isotherm (Figure 6.5b), which is similar to that obtained for Ca2+ displacement by 
Tm3+ in the Entamoeba histolytica calcium binding protein(Mustafi et al. 2004). Despite 
the ability to model the isotherm using the simpler one-set of sites model, we decided to 
present the results obtained from a three sites sequential model based on three accounts. 
First, it is expected that binding of Tb3+ is not associated with a cooperative behavior since 
the protein transitions from a calcium bound structure to a calcium-like structure. Second, 
replacement of glutamic acid at position 12 of the loop in EF-hand 3 resulted in an isotherm 
which could not be fitted by a one-set of sites model. Lastly, displacement of Ca2+ by Tb3+ 
in other calcium binding proteins with known calcium cooperativity have been observed 
to follow a sequential mechanism (Mustafi et al. 2004, Gilli et al. 1998). The recovered 
parameters using the sequential model are shown in Table 6.2. Interpretation of the data 
reveals that three Tb3+ ions can bind to DREAM(Δ65), with slightly different affinities, 
such that K1>K2>K3. Interestingly, the associated enthalpy and entropy of sites K1 and K2 
are similar to those found for Ca2+ displacement of K1 sites on CaM, while the enthalpy 
and entropy of the site corresponding to K3 shows significantly lower enthalpic and 
entropic contributions. Titration of Tb3+ in the presence of Ca2+ and 5 mM Mg2+ in 
DREAM(Δ65) increase ΔΔH3 and TΔΔS3 by ~ 6 kcal·mol-1 while the enthalpy and entropy 
 177 
of sites K1 and K2 remain unchanged. Unlike CaM, in which all four EF-hands are believed 
to have binding preference for Ca2+ over Mg2+ (Wang et al. 1982); EF-hand 2 on DREAM 
is proposed to bind Mg2+ preferentially(da Silva, Kendrick-Jones & Reinach 1995, Craig 
et al. 2002). Therefore, we assign the recovered thermodynamic parameters for sites with 
K1 and K2 association constants as representing Ca2+ displacement from EF-hand 3 or 4, 
while those recovered for site with K3 being representative of Tb3+ binding to EF-hand 2. 
The assignment of K3 to EF-hand 2 is also supported by the displacement of Ca2+ by Tb3+ 
in a DREAM(Δ160) construct lacking the Mg2+ binding EF-hand 2, which shows only two 
sites with affinities and thermodynamic parameters similar to those of K1 and K2 on 
DREAM(Δ65). The recovered association constant and thermodynamic parameter for Tb3+ 
binding to DREAM(Δ160) are also independent of Mg2+, in agreement with the sensitized 
emission titrations. However, despite the similarities, a decrease of ~10 kcal·mol-1 in the 
enthalpy and entropy for the K2 site is observed for DREAM(Δ160) compared to 
DREAM(Δ65). This decrease in energetics could be due to a distinct metal coordination or 
loss structural rearrangement at the missing N-terminus. It is tempting to assign the K2 
parameters of DREAM(Δ160) as representing binding of Tb3+ to EF-hand 3, due to closer 
proximity to the now deleted N-terminus domain, but these results do not permit 
unequivocal assignment. Together, the recovered thermodynamic parameters for 
DREAM(Δ65) and DREAM(Δ160) show that Tb3+ can efficiently displace Ca2+ from the 
C-terminus EF-hand 3 and 4, and that deletion of the N-terminus amino acids (1 to 160) 
results in modification of the metal binding properties of EF-hand 3 and 4. Thus, we can 
approximate a value of ΔH ~ 15 kcal·mol-1 and TΔS ~ 22 kcal·mol-1 for Tb3+ displacement 
of Ca2+ bound at EF-hand 3 and 4 of DREAM(Δ65). 
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 Additional experiments in which we monitored the thermodynamics of Tb3+ 
association with Ca2+ bound DREAM(E186Q) with inactivated EF-hand 3 and 
DREAM(E234Q) with inactivated EF-hand 4 were also conducted and the recovered 
parameters are listed in Table 2. Displacement of Ca2+ by Tb3+ on the DREAM(E186Q) 
construct is best modeled as a three site sequential binding process, in which the K1 site 
has the highest affinity, while ΔH1 and ΔS1 are ~ 5 kcal·mol-1 lower than those obtained 
for DREAM(Δ65). The Tb3+ binding at site with K2 shows identical affinity as the observed 
for K2 on DREAM(Δ65) in the presence of Mg2+, and similar enthalpic and entropic 
contributions. The third site, K3, shows similar parameters as those recovered for Tb3+ 
binding at the EF-hand 2 of DREAM(Δ65) and likely corresponds to the same binding 
process. The decrease in enthalpy and entropy upon binding of Tb3+ at site with K1 as well 
as its stronger binding affinity compared to K2 and K3, seem to indicate that this site likely 
corresponds to the inactivated EF-hand 3. The fact that only small changes are observed 
upon mutation of glutamic acid at position 12 (-z coordination) to glutamine supports the 
idea that this site may still be weakly bound to either Ca2+ or Mg2+. Interestingly, these 
results also show that the E186Q substitution does not affect the binding of Tb3+ at EF-
hand 3 which is interesting, but not unexpected. This effect is likely due to weaker binding 
of Ca2+ which in turn facilitates Tb3+ association. 
 The DREAM(E234Q) construct, in which EF-hand 4 is inactivated, is also able to 
bind three Tb3+ ions with ranges of affinities similar to those obtained for the 
DREAM(Δ65) in the presence of Mg2+. In this construct, the site with association constant 
K2 binds stronger, followed by K3 and then K1 sites. However, the enthalpy for site K2 on 
DREAM(E234Q) is five-fold lower than those obtained for K2 on DREAM(Δ65). The sites 
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with K3 association constant show identical enthalpy and entropy as the site corresponding 
to K3 on DREAM(Δ65). In fact, the enthalpy and entropy for sites K2 and K3 are much 
closer to those obtained for Tb3+ binding to the EF-hand 2 of DREAM(Δ65) in the presence 
of Mg2+, with ΔH ~ 4 kcal·mol-1 and ΔS ~ 10 kcal·mol-1. These results suggest that 
inactivation of EF-hand 4 likely results in a weak binding of Ca2+ or Mg2+, both of which 
can be easily displaced by Tb3+ (based on higher K2 and K3) with a concomitant lower 
enthalpic and entropic contribution. Overall, ITC demonstrates that in the presence of 
saturating amounts of calcium, the Glu  Gln mutation at position 12 of the EF-hand metal 
binding loop actually facilitates binding of Tb3+. 
 
6.2.4 Luminescence decay of Tb3+ bound DREAM is sensitive to ligand binding. 
 Sensitized emission studies show that Mg2+ is able to induce changes in the 
emission of bound Tb3+; to further study this effect, we decided to determine if Mg2+ can 
induce structural changes within the coordination sphere of Tb3+. We employed direct 
excitation of Tb3+ using the 355 nm line of a Nd:YAG pulsed laser and measured the 
luminescence decay of terbium bound to the EF-hands of CaM and DREAM constructs. 
This approach permits analysis of the local environment at the binding site of Tb3+ ions, 
namely the EF-hand loops. Additionally, this method has been widely used to monitor 
changes in the coordination sphere of lanthanides as well as the effects of water 
coordination (Hungerford et al. 2010). Following the studies above, we first characterized 
the luminescence decay of Tb3+ bound to CaM; and as expected, the luminescence decay 
shown in Figure 6.6a follows a mono-exponential decay with τ1 = 1.38 ms. A single 
exponential decay of approximately 1 ms has been reported for the Tb3+: CaM complex 
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and double exponential decays has been observed for complexes of Eu3+ and calmodulin 
(Mulqueen, Tingey & Horrocks 1985, Austin, Stein & Wang 1987).  
Figure 6.6: (a) Luminescence decay of Tb3+ bound to CaM and constructs of DREAM, 
with stoichiometric ratios of 4:1 Tb3+:CaM and 2:1 Tb3+:DREAM. Solid lines represent the 
best fit using Globals software analysis, recovered parameters listed in Table 3. (b) 
Luminescence intensity decay profiles as a function of Tb3+ binding to 10 μM 
DREAM(Δ64). The luminescence decays in (b) were analyzed using a triple discrete model 
and the fractional intensity contribution of the two slowest lifetimes is shown in (c). The 
fastest decay component had a lifetime of ~80 μs with less than 10 % contribution and is 
not shown. (d) Luminescence decay Tb3+ bound to DREAM and DREAM(Δ64) as a 
function of the hydrophobic molecules TFP (top) bound to DREAM and NS5806 (bottom) 
bound to DREAM.  
 
 Luminescence decay of Tb3+ bound to DREAM(Δ65) shows lifetimes of τ1 = 0.86 
ms (59 %) and τ2 = 2.20 ms (14 %), whereas Tb3+ bound to DREAM(Δ160) decays with 
lifetimes of τ1 = 0.74 ms (54 %) and τ2 = 2.16 ms (29 %). The faster lifetime likely 
corresponds to contribution from partially coordinated Tb3+ ions, and is similar to the 780 
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μs decay obtained for Tb3+ bound to NTA in water (Horrocks, Sudnick 1979). We and 
others have determined the lifetime of Tb3+ in buffer at pH 7.4 to be 450 ± 30 μs; therefore, 
we associate τ1 to represent Tb3+ bound to a low coordination site on DREAM (Bunzli, 
Eliseeva 2011). The second lifetime is much longer than that determined for Tb3+ bound to 
parvalbumin (1.3 ms) or CaM (1.38 ms) but is similar to that of Eu3+ bound to these proteins 
or complexes of Tb3+ and bimetallic ligand in which no water coordination is observed 
(Mulqueen, Tingey & Horrocks 1985, Horrocks, Sudnick 1979, Deiters et al. 2009). Long-
lived excited state decays are observed for lanthanides with little phonon quenching which 
often is due to limited water access (Bunzli, Eliseeva 2011). Interestingly, addition of 100 
mM NaCl reduces the fast lifetime to values similar to those of Tb3+ in water and increases 
the fractional intensity of the long lifetime component ~three-fold (Table 6.3). The 
luminescence decay of Tb3+ was not significantly affected by LDAO, a detergent which 
has been proposed to stabilize DREAM in a single conformation (Osawa et al. 2001).  
Titration of Tb3+ into DREAM(Δ65) in the presence of 100 mM NaCl and 10 mM LDAO 
shows that the fractional intensity of the τ2 lifetime increases in a dose dependent manner 
and saturates at a stoichiometric ratio of two to one, whereas the fractional intensity of τ1 
decreases (Figure 6.6b and 6.6c). 
 Additional measurements of the luminescence decay of DREAM construct with 
inactivated EF-hands show similar bimodal exponential decays. One of the most salient 
observations is that the decay lifetime of DREAM(E234Q) is significantly shorter than that 
observed for DREAM(E186Q), τ2 = 1.75 ms (27 %) vs τ2 = 2.02 ms (46 %), respectively. 
This indicates that binding of Tb3+ at EF-hand 4 induces a restructuring of the coordination 
sphere similar to that induced when both EF-hand 3 and 4 are bound to Tb3+. On the other 
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hand, the structural arrangement of the binding loop at EF-hand 3 when Tb3+ is bound at 
this site is significantly different, with a much more solvent exposed Tb3+ ion. However, it 
could also be possible that these two lifetimes cannot be separately resolved in the 
DREAM(Δ65) decays.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6.3. Terbium(III) luminescence decay parameters 
recovered upon binding to DREAM and DREAM constructs 
 τ1 (ms) f1 τ2 (ms) f2 
CaM 1.38 1.00   
CaM + TFP* 0.46 0.31 1.36 0.69 
DREAM(Δ64)  0.86 0.59 2.22 0.14 
DREAM(Δ64) + Mg2+ 0.74 0.54 2.05 0.24 
DREAM(Δ64)(a) ‡ 0.58 0.27 2.00 0.69 
DREAM(Δ64)(b) ‡ 0.46 0.17 2.04 0.77 
DREAM(Δ64)(c) ‡ + 
NS5806 
0.43 0.58 1.83 0.39 
DREAM (Δ160) 0.75 0.47 2.16 0.29 
DREAM (Δ160) + Mg2+ 0.63 0.41 2.03 0.37 
DREAM (E186Q) 0.62 0.50 2.02 0.27 
DREAM (E186Q) + Mg2+ 0.48 0.47 1.58 0.42 
DREAM (E234Q) 0.63 0.27 1.75 0.46 
DREAM (E234Q) + Mg2+ 0.45 0.31 1.70 0.48 
All shown parameters were recovered using a triple or double 
discrete exponential decay, the error of the reported values is 2.5 
% on average. All Experiments conducted at room temperature 
(~20°C) at protein concentration of 20 μM with addition of 80 μM 
Tb3+ for CaM and 40 μM Tb3+ for DREAM constructs. An 
additional lifetime of ~ 80 μs// was resolved for all DREAM 
construct, likely due to parasitic light or PMT recovery delay, and 
it is not shown. *Measured in the presence of 131 μM TFP.  ‡ 
Protein concentration for these experiments was 10 μM in the 
presence of (a) 100 mM NaCl, (b) 100mM NaCl and 10 mM 
LDAO, or (c) same as (b) + 31 μM NS5806. 
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The lifetime of Tb3+ bound at the solvent exposed site is identical on both constructs, with 
τ1 = 0.62 ms (50 %) for DREAM(E186Q) and τ1 = 0.63 ms (27 %) for DREAM(E234Q), 
but faster than that observed for the fully active proteins. Interestingly, in the presence of 
5 mM Mg2+ a decrease in the decay lifetimes and increase of intensity contribution of the 
long-lived decay is observed for all constructs, except for DREAM(E234Q). The observed 
changes are largest for DREAM(E186Q) where a decrease of 0.44 ms in τ2 is also 
accompanied by a 15 % increase in contribution of this decay component. The decay 
lifetimes of τ1 = 0.74 ms for DREAM(Δ65) and τ1 = 0.63 ms for DREAM(Δ160) are still 
longer than for Tb3+ in water, while those of DREAM(E186Q) and DREAM(E234Q) are 
identical to that of Tb3+ in water. The effect of Mg2+ on the luminescent data is in good 
agreement with the changes observed in the sensitized emission titrations (Figure 6.3d). 
 Finally, we examined whether Tb3+ luminescence decay would be sensitive to 
structural changes induced on CaM and DREAM upon binding of small hydrophobic 
ligands.  To test this hypothesis we chose trifluoperazine (TFP) and a novel biphenyl-urea 
compound named NS5806. These compounds have been shown to bind at hydrophobic 
cavities on CaM and DREAM, respectively, in a calcium dependent manner (Gonzalez, 
Pham & Miksovska 2014, Cook, Walter & Walter 1994). Upon titration of each ligand into 
Tb3+ bound CaM and DREAM(Δ65) we observe a strong dose dependent modulation of 
the luminescence decay (Figure 6.6d). Global analysis of the luminescence decay of the 
Tb3+CaM and Tb3+DREAM(Δ65) complexes reveals that binding of these small 
hydrophobic ligands induces a decrease in intensity contribution from τ2 on both construct 
while also decreasing the long lifetime on DREAM(Δ65). Plotting the change in f2 as a 
function of TFP or NS5806 yields dissociation constants of ~37 μM for both ligands (data 
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not shown), which is larger than those observed in the Ca2+ bound form of these proteins 
(Kd ~ 1 μM for TFP and Kd = 5  μM for NS5806). The discrepancies could be due to 
secondary sites being populated (TFP has been shown to bind at four sites on CaM with 
dissociation constants between 1 μM and 5 mM), as well as due to distinct conformation 
of the hydrophobic cavity of the proteins in the Tb3+ bound form.  
 
6.2.5 Displacement of Ca2+ by Tb3+ induces minimal changes in collisional cross section 
of DREAM 
 To further study the displacement of Ca2+ ions from the EF-hand domains of 
DREAM, as well as to determine the magnitude of the structural differences between the 
Ca2+ and Tb3+ bound DREAM structures, ion mobility measurements were conducted to 
determine the ion-neutral collisional cross section using a TIMS-MS analyzer (see Table 
6.4).  
 
 
 
 
 
 
 
 
The mass spectrum of DREAM(Δ65) under native nanoESI conditions shows a narrow 
charge state distribution( +7 - +9), with multiple Ca2+ and Tb3+ adducts. A closer look at 
Table 6.4. Experimental and theoretical ion-neutral 
collision cross section for the DREAM(Δ64):Ca2+/Tb3+ 
molecular ions. 
Theoretical a +7  (Å2) 
+8 
(Å2) 
+9  
(Å2) 
DREAM(Δ64):Ca2+ Ca2+ 2773 2798 2825 
Experimental    
DREAM(Δ64):Ca2+ Ca2+ 2225 2243 2297 
DREAM(Δ64):Ca2+  Tb3+ 2205 2231 2260 
DREAM(Δ64): Tb3+ Tb3+ 2200 2228 2238 
a) Calculated using the IMoS software as described in 
the material and methods section. 
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the charge distribution shows the presence of the apo form [M+nH]+n as well as three 
adduct series: [M + Ca2+x=1-3 + (n-x)H]+n, [M + Ca2+x + Tb3+y + (n-x-y)H]+n and [M + 
Tb3+x=1-2 + (n-x)H]+n.(see example of the +8 charge state distribution of DREAM(Δ65) in 
the presence of Ca2+, Ca2+ and Tb3+, and Tb3+ in Figure 6.7a).  Inspection of the mobility 
profiles for each adduct series show that as the charge state increases from +7 to +9, a 
decrease in mobility (and increase in CCS) is observed as a consequence of the interaction 
of the molecular ion with the external electric field, and not necessarily an indication of 
conformational changes. 
Figure 6.7: (a) Typical nanoESI mass spectra of DREAM(Δ64) in the presence of Ca2+ 
and of DREAM(Δ64) in the presence of Ca2+ and Tb3+. The isotopic distribution of the 
DREAM(Δ64):2Ca2+ and DREAM(Δ64):2Tb3+ are shown for clarity. (b) NanoESI TIMS 
mobility spectra of DREAM(Δ64) bound to Ca2+ and/or Tb3+.  
 
 However, small changes in the CCS are observed as a function of the adduct series 
within each charge state. For example, a decrease in the CCS is observed for DREAM(Δ65) 
bound to Tb when compare to DREAM(Δ65) bound to Ca2+ and DREAM(Δ65) bound to 
Ca2+ + Tb3+ (see Figure 6.7b). Comparison of the observed CCS profiles (CCS+7-+9 = 2200- 
2300 Å2) to that of a previously reported 2JUL NMR structure of DREAM (Lusin et al. 
2008) (CCStheo = 2773 Å2) suggest that the gas-phase conformations are more compact to 
that observed in solution, probably as a consequence of the adduct interaction with the EF-
hands domains in the absence of the solvent. In addition, the higher affinity of Tb3+ when 
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compared to Ca2+ may induce a more compact structure (smaller CCS) for the 
DREAM(Δ65) bound to Tb3+ when compare to DREAM(Δ65) bound to Ca2+ and 
DREAM(Δ65) bound to Ca2+ + Tb3+ in the absence of the solvent.  
6.3 Discussion 
In this report we present conclusive evidence that Tb3+ is able to bind at the C-
terminus of DREAM and displace Ca2+ from the binding loop at the EF-hands 3 and 4. 
Using circular dichroism as well as fluorescence intensity and anisotropy decay of intrinsic 
fluorescent probes, we demonstrate that Tb3+ is able to induce identical structural changes 
on DREAM as those observed upon Ca2+ binding. Circular dichroism shows a small 
deviation of the spectra near 208 nm, a region which is sensitive to the presence of anti-
parallel β-sheets (Kelly, Jess & Price 2005b). DREAM is mainly alpha helical, and the only 
region where a small antiparallel β-sheets are formed is between the metal binding loops 
of each EF-hand pairs (Lusin et al. 2008). Therefore, it is possible that association of Tb3+ 
induces structural changes at the metal binding loop results in loss of these short β-sheet 
regions. Small differences between Tb3+ and Ca2+ bound DREAM, were also observed by 
anisotropy decay measurements. Anisotropy decay revealed that dimers are formed either 
in the Ca2+ or Tb3+ bound form of DREAM, but binding of Tb3+ induces a more dynamic 
environment near Trp169. Using molecular dynamics, we have previously shown that 
Trp169 in DREAM(Δ65) can populate two rotamers, and it is possible that Tb3+ binding 
could enhance this rotamer transition, which would result in an increase of local dynamics 
(Pham et al. 2015).  
Similarly to other calcium binding proteins, we observe that aromatic amino acids 
at the C-terminus are able to transfer energy to the bound Tb3+. Specifically, we show that 
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mutation of Y174 to alanine results in a significant reduction (~60 %) in the sensitized 
emission of Tb3+ at 545 nm, while maintaining identical 280/295 ratios compared to 
DREAM(Δ65). Together, these results highlight the presence of an antenna effect, in which 
W169 is the main donor to Tb3+. Attempts to use sensitized emission and Tb3+ titrations in 
order to elucidate the lanthanide binding sequence to EF-hands 3 and 4 on DREAM 
indicate that both EF-hands bind Tb3+ with similar affinity (DREAM(E234Q) with Kd = 
5.9 μM and DREAM(E186Q) with Kd = 11 μM). Since these experiments were conducted 
in the presence of excess calcium and magnesium, inactivation of each EF-hand actually 
favors binding to the mutated loop (see ITC results). Therefore, we are unable to identify 
whether the slightly lower affinity of Tb3+ with the DREAM(E186Q) mutant is due to 
inherent lower affinity to this hand or because a metal ion (Ca2+ or Mg2+) is loosely bound 
at this mutated site. Nonetheless, one of the most salient observations of these Tb3+ titration 
experiments is that in the presence of Mg2+, the sensitized emission of Tb3+ decreases by 
more than 50 %. This decrease in intensity at 545 nm, could be due to either Mg2+ induced 
structural rearrangements of the environment near Trp169 or to rearrangement of the Tb3+ 
binding loop at EF-hands 3 and 4. Indeed, we observe that EF-hand 3, which is next to EF-
hand 2, is more sensitive to magnesium binding. These results support the idea that Mg2+ 
plays a structural role on DREAM and that at physiological concentrations it may act as a 
functional cofactor through interaction with EF-hand 2.  
Isothermal calorimetry experiments show that Tb3+ displacement of Ca2+ from EF-
hands 3 and 4 on DREAM(Δ65) in the presence of 5 mM Mg2+ is associated with a ΔG = 
-14 kcal·mol-1, while the displacement energy for the DREAM(Δ160) construct is ΔG = -
12 kcal·mol-1. The same displacement process for EF-hands 1 through 4 in CaM is 
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associated a free energy of ΔG = -18 kcal·mol-1. The more favorable displacement of Ca2+ 
from CaM EF-hands compared to DREAM(Δ65) highlights the stronger association of 
Ca2+ in the latter (Osawa et al. 2005). Throughout this report we correlate the K1 
thermodynamic parameters with displacement of Ca2+ from EF-hand 3 and K2 with 
displacement from EF-hand 4 in the DREAM(Δ65), DREAM(E186Q), and 
DREAM(E234Q) constructs. Even thought, these correlations are not unequivocally 
proven by our results, they are supported by the associated changes in enthalpy and entropy 
under different conditions. Following this assignment, we can approximate the enthalpy 
and entropy associated with coordination of Tb3+ by Glu at position 12 of EF-hand 3 and 4 
by calculating ΔHGlu (Mutant) = ΔHiDREAM(Δ65) – ΔHiDREAM(Mutant) and TΔSGlu (Mutant) = 
TΔSiDREAM(Δ65) – TΔSiDREAM(Mutant). Where the subscript i is 1 for DREAM(E186Q) and i 
= 2 for DREAM(E234Q). These calculations reveal that coordination of Tb3+ by Glu186 
of EF-hand 3 is associated with ΔHGlu (E186Q) = 4.5 kcal·mol-1 and TΔSGlu (E186Q) = 5.0 
kcal·mol-1. In contrast, Glu234 of EF-hand 4 has a three-fold larger enthalpy and entropy 
contribution, with ΔHGlu (E234Q) = 14 kcal·mol-1 and TΔSGlu (E234Q) = 15 kcal·mol-1. In both 
cases, coordination of the metal ion is driven by favorable entropy contributions, likely due 
to release of a water molecule upon coordination of Glu at position 12. These results are 
similar to those observed for Ca2+ binding to CaM and DREAM(Δ65) in which entropy 
was observed to be the main driving force (Osawa et al. 2005, Osawa et al. 2005, Gilli et 
al. 1998).  In contrast, the enthalpic contribution due to metal binding to the EF-hands of 
CaM and DREAM(Δ65) has been shown to be very small. It is possible that the unfavorable 
endothermic process observed here, is due to additional structural changes associated with 
Glu-12 coordination. The larger enthalpy and entropy associated with coordination of Glu-
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12 on EF-hand 4 highlights the role of this EF-hand in controlling the activation of 
DREAM. Indeed, Glu-12 is positioned on the exiting helix of EF-hand 4 which is 
immediately adjacent to a hydrophobic cavity that mediates the calcium regulated co-
assembly with potassium channels and small ligands (Gonzalez, Pham & Miksovska 2014, 
Pioletti et al. 2006, Wang et al. 2007).  
Figure 6.8: Plot of T∆S versus ∆H for Tb3+ displacement of Ca2+ from DREAM(Δ64), 
DREAM(Δ160), DREAM(E186Q), DREAM(E234Q) and CaM. Solid line represents the 
best linear fit to the data.  
 
Another interesting aspect of the recovered thermodynamic parameters shown in 
table 2 is that the enthalpy and entropy recovered for all the titrations are highly correlated. 
This correlation has been observed before for Ca2+ binding to CaM (Gilli et al. 1998) as 
well as in other systems (Kuroki, Yutani 1998). More importantly, the linear relationship 
of TΔS as a function of ΔH allow us to extrapolate the entropy associated with 
displacement of Ca2+, prior to any structural change induced by Tb3+(Figure 6.8). This is 
based on the idea that displacement of Ca2+ by Tb3+ is not associated with the formation or 
breakage of any new bond since the coordination of Ca2+ and Tb3+ in bulk water are 
identical. Extrapolating the linear relationship yields a value of TΔSdisplacement = 6.9 ± 0.2 
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kcal·mol-1, which is similar to the value obtained for Ca2+ binding to metal free CaM in 
which TΔSbind = 7.2 ± 0.1 kcal·mol-1 (Gilli et al. 1998). A possible explanation for the 
entropic gain, could be due to an increase in the dynamics of the protein, something which 
is supported by the anisotropy decay data. The correlation of enthalpy and entropy can also 
be explained by a process which involves the release of water following the association of 
two ions of opposite charges in solution. The resulting charge neutralization would 
facilitate the mobilization of solvent molecules from the surface of the protein into the bulk 
water (Bowman-James, Bianchi & García-Espana 2012). This release of water molecules is 
associated with an unfavorable endothermic process (breakage of water-protein hydrogen 
bonds) and favorable positive change in entropy. Indeed, Ca2+ bound DREAM(Δ65) (net 
charge -3 at pH 7.4) and Ca2+ bound CaM (net charge -16 at pH 7.4) would be neutralized 
by 2 and 8 units upon Tb3+ displacement, respectively. This charge neutralization effect, 
could also partially account for the decreased enthalpy and entropy contribution of the 
DREAM(E186Q) and DREAM(E234Q) mutants, both of which have one less negative 
charge compared to DREAM(Δ65). 
Sensitized emission, circular dichroism, TIM-MS, and ITC experiment provide 
information on global structural changes of the protein upon displacement of Ca2+ by Tb3+. 
On the other hand, luminescent studies allow us to gain a better insight into the immediate 
coordination sphere of Tb3+ ion, and how this environment is affected by inactivation of 
EF-hands, Mg2+ binding, ionic strength, and/or ligand binding. Measurements of the 
luminescent decay of Tb3+ bound to different constructs highlight the idea that Tb3+ bound 
at EF-hand 3 is more solvent exposed than Tb3+ bound at EF-hand 4. Nonetheless, the 
decay observed for DREAM(Δ65) is much slower than that observed for CaM, indicating 
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that the coordination around Tb3+ in DREAM highly restricts the accessibility of water. 
We also observe that the luminescence decays are widely affected by addition of excess 
Mg2+, supporting the idea that binding of Tb3+ at some secondary sites, including EF-hand 
2 on DREAM, are identical to those for Mg2+ binding. The high sensitivity of EF-hand 3 
to Mg2+ binding could also be due to propagated rearrangement of EF-hand 2 upon 
association of Mg2+. It is also possible that binding of Mg2+ at these secondary sites is 
responsible for the observed rearrangement of the EF-hand loops. The overall picture that 
emerges from these observations is that Mg2+ is able to modulate the protein structure and 
that secondary metal sites may play a role in modulating protein conformation. Indeed, 
previous work and our unpublished results support the idea that two Ca2+ specific sites and 
additional secondary sites are found on DREAM(Δ160) (Craig et al. 2002). Lastly, titration 
of small hydrophobic ligands also reveal that the environment near the metal binding loops 
of EF-hand 3 and 4 are sensitive to ligand association with DREAM. Altogether, these 
observations highlight the idea that association of these small molecules at the hydrophobic 
surfaces of CaM and DREAM induce conformational changes which can not only distort 
the coordination geometry of Tb3+ at the binding loops, but could also potentially facilitate 
Tb3+ dissociation from the protein.   
 Finally, ion mobility and mass spectrometry measurement support the hypothesis 
that Tb3+ can  displace Ca2+ from EF-hand 3 and 4 and that the resulting folded 
conformation of the Tb3+ bound DREAM(Δ65) protein is almost identical to that of the 
calcium bound protein during native ESI conditions. Comparison of the observed CCS 
profiles to that of a previously reported NMR structure of DREAM (Lusin et al. 2008) 
suggested that the gas-phase conformations are more compact to that observed in solution, 
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probably as a consequence of the adduct interaction with the EF-hands domains in the 
absence of the solvent. In addition, the higher affinity of Tb3+ when compared to Ca 
resulted in more compact structures (smaller CCS) for the DREAM(Δ65) bound to Tb3+ 
when compare to DREAM(Δ65) bound to Ca2+ and DREAM(Δ65) bound to Ca2+ + Tb3+ 
in the absence of the solvent. 
6.4 Summary 
 In this chapter we show compelling evidence supporting the specific association of 
Tb3+ with the EF-hands 3 and 4 of DREAM. We also demonstrate that replacement of Ca2+ 
by Tb3+ leads to an increase in the dynamics of the protein; however, the structural and 
functional properties between DREAM bound to either metal are highly similar. We show 
that similarly to CaM, Tb3+ bound to DREAM can be sensitized by aromatic amino acids 
at the C-terminus, with tryptophan 169 being the main energy donor. The high affinity of 
the EF-hands for Tb3+ and the fluorescent properties of this lanthanide has allowed us to 
highlight the role of Mg2+ as a structural cofactor, which can bind to EF-hand 2 and modify 
the immediate environment near the calcium binding loops of EF-hands 3 and 4. Isothermal 
calorimetry also highlights the role of EF-hand 4 in mediating calcium regulated ligand 
recognition in DREAM. These findings provide structural information on DREAM and 
will facilitate future structural NMR studies and lanthanide resonance energy transfer 
experiments aimed at studying the association of DREAM with other proteins. 
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7. PHOTOTHERMAL BEAM DEFLECTION TO STUDY THE DYNAMICS OF 
DIVALENT ION-CAGE AND ION-PROTEIN COMPLEXES 
7.1 Background and significance 
 Fluorescence spectroscopy has proven to be exceptionally useful to obtain detailed 
kinetic data for ligand induced structural changes in proteins.  Spectroscopic techniques 
allow the study of processes from a distance, often with minimal perturbation of the system. 
In fact, the use of light in science is so pervasive, that there are few techniques today which 
do not relay on it. Current development in fluorescence microscopy have allowed the study 
of brain processes in freely behaving animal (Ghosh et al. 2011, Markowitz et al. 2015), 
cellular processes beyond the diffraction limit (Betzig et al. 2006), and biomolecular 
dynamic at the single-molecule level (Roy, Hohng & Ha 2008, Lee et al. 2005). 
Nonetheless, the need of efficient fluorophores and their lack of stability are often a major 
limitation in these studies (Cordes, Blum 2013, Schermelleh, Heintzmann & Leonhardt 
2010). A simplified Jablonski-Perrin diagram highlights two competing pathways 
following excitation of a chromophore (Figure 7.1).  
Figure 7.1. Jablonski-Perrin diagram highlighting the two major pathways by which the 
excited state of a chromophore can be depopulated. 
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An ideal fluorophore would not only need to have a large probability of absorbing a photon 
(a large extinction coefficient, ε > 80,000 M-1cm-1), but it would also need to have a large 
probability of emitting this absorbed energy as a photon (a quantum yield near unity). On 
the other hand, photothermal methods, such as thermal grating (TG) (Fayer 1982), 
photothermal beam deflection (PBD) (Jackson et al. 1981b), and photoacoustic calorimetry 
(PAC) (Braslavsky, Heibel 1992) are capable of detecting the non-radiative processes 
following absorption of energy by a chromophore. An obvious advantage of these 
techniques, is that they do not require the use of fluorophores. In fact, the best signal would 
be obtained from a photochemical process in which all the energy absorbed is used only to 
drive a specific reaction, without the production of a photon. Thus, these techniques require 
that the photo-triggered process have a large probability of proceeding forward, as in eqn. 
7.1: 
𝐴𝐴 + 𝐵𝐵 → 𝐴𝐴∗  + 𝐵𝐵 → 𝐶𝐶     Eqn. 7.1 
𝜙𝜙 = 𝐶𝐶
𝐴𝐴∗
 ≤ 1         Eqn. 7.2 
 Where A represents the ground state of the reactant and A* its excited state following laser 
excitation. These methods rely on the premise that the triggered processed would result in 
a detectable amount of heat being removed or added from their immediate environment. 
However, unlike the widely applied isothermal calorimetry titration (ITC) technique, 
photothermal methods have the advantage of being able to measure fast processes 
occurring in nanoseconds to milliseconds (Laman, Falvey 1996). This temporal resolution 
makes these techniques ideally suited to study fast biological processes in proteins with 
endogenous chromophores involved in photosynthesis (Schulenberg, Gaertner & 
Braslavsky 1995) or oxygen transport (Mikšovská, Day & Larsen 2003). Additional 
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approaches to study the activity of proteins have been developed through the use of caged-
compounds (Gurney 1994). In these studies, a fast pulse of light is used to trigger the 
photochemical reaction of a compound whose byproducts are ligands for the protein of 
interest.  
 Despite the fact that all of these techniques measure the heat changes accompanying 
a photochemical process, their main differences arise from the way in which heat is 
measured, which in turn controls the temporal resolution of each technique.  For instance, 
in photoacoustic calorimetry, the change in temperature of the environment results in a 
thermal contraction of the medium which then propagates as an acoustic wave and is 
measured with a tightly coupled microphone (Braslavsky, Heibel 1992, Astudillo et al. 
2010). On the other hand, TG and PBD rely on the use of a probe laser in order to measure 
changes in diffraction patterns arising from the change in index of refraction of the media 
triggered by subtle increases in temperature (Fayer 1982, Falvey 1997). The advantage of 
PBD over TG are twofold: 1) the laser used to generate the transient change in index of 
refraction (pump laser) does not need to be Gaussian in shape, and 2) the probe beam does 
not need to be collinear with the pump laser. Furthermore, in PBD, the use of a probe beam 
allows the measurement of samples at a distance, which allows easy exchange of samples. 
However, in PAC, care must be taken to minimize changes in the interface between the 
piezoelectric microphone and the cuvette containing the sample to be measured. In PBD, 
the time resolution is limited by the detection sensors to be over 10 μs, compared to the 50 
ns resolution of PAC. On long timescales, PBD resolution is limited to less than ~100 ms, 
dues to significant contribution of heat diffusion, air drift, and vibrations as described 
below. However, the time resolution of 10 μs – 100 ms is ideally suited to study the 
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dynamics of structural changes in proteins. Finally, PBD allows the determination of 
thermodynamic parameters (ΔH, ΔV, and activation energies) which are not easily 
determined by other techniques. 
 Of particular interest is the use of PBD and the photosensitive compound DM-
nitrophen to study the thermodynamics and dynamics of metal binding to calcium binding 
proteins. In this chapter, we explore the thermodynamics of ligand release from cage-
compounds following ultrafast (5 ns) illumination. In addition, following our previous 
study on Tb3+ binding to DREAM, we investigate whether this lanthanide can be chelated 
by DM-nitrophen and photo released upon photolysis. These studies are complemented by 
PBD experiment where we monitor the enthalpy and volume changes associated with Ca2+ 
binding to DREAM following photo cleavage of Ca2+DM-nitrophen complexes. 
7.2 Results, theory and instrumentation 
 The instrumental design and theoretical principles of PBD have been reviewed in 
(Laman, Falvey 1996, Falvey 1997, Larsen, Mikšovská 2007, Whinnery 1974). Following 
these reports, here we present a complete derivation of the equations used in PBD as well 
as the design of a photothermal beam deflection instrument. To derive the theoretical aspect 
of PBD, we briefly follow the work by Jackson et al. (1981a) and Falvey (1997). The 
problem involves calculating the deviation of a beam of light passing through a medium in 
which a temperature gradient is present. The distribution of temperature in a medium at 
time t after deposition of heat at distance r can be derived from the conservation of energy 
and the heat conduction equation. 
𝜕𝜕𝜕𝜕(𝑟𝑟,𝑏𝑏)
𝜕𝜕𝑏𝑏
= −𝛻𝛻 ∙ 𝑇𝑇(𝑟𝑟, 𝑡𝑡)𝒖𝒖�⃗   Eqn. 7.4 
𝑇𝑇(𝑟𝑟, 𝑡𝑡)𝒖𝒖�⃗ = −𝐷𝐷𝜵𝜵�𝑇𝑇(𝑟𝑟, 𝑡𝑡)   Eqn. 7.5 
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Where the diffusion constant is D= κ/ρCp, Κ is the thermal conductivity, ρ is the density, 
and Cp is the heat capacity. Thus, the temperature response at point r and time t resulting 
from a δ heat source at the origin at time t=0 yields: 
𝑇𝑇(𝑥𝑥, 𝑡𝑡) = 𝜕𝜕0
2(𝜋𝜋𝜋𝜋𝑏𝑏)12 𝑒𝑒−𝑥𝑥2/4𝐷𝐷𝑏𝑏  𝑎𝑎𝑡𝑡 𝑇𝑇(𝑟𝑟, 0) = 𝑇𝑇0𝛿𝛿(𝑟𝑟)  Eqn. 7.6 
And in radial coordinates: 
𝑇𝑇(𝑟𝑟, 𝑡𝑡) = 𝜕𝜕0
8(𝜋𝜋𝜋𝜋𝑏𝑏)32 𝑒𝑒−𝑟𝑟2/4𝐷𝐷𝑏𝑏 − ∞ < 𝑟𝑟, 𝑥𝑥 < ∞     Eqn. 7.7 
  
However, if the heat source does not follow a δ-function and/or there is an additional heat 
sink or source, then the above equation is not a solution. To include this scenario, the heat 
diffusion must be modified so that: 
𝜕𝜕𝜕𝜕(𝑟𝑟,𝑏𝑏)
𝜕𝜕𝑏𝑏
= 𝐷𝐷𝛻𝛻2𝑇𝑇(𝑟𝑟, 𝑡𝑡) + 𝑖𝑖(𝑟𝑟, 𝑡𝑡)  Eqn. 7.8 
 
Where the f(r, t) is due to the additional heat source/sink. This equation can be rearranged 
so that: 
𝜕𝜕𝜕𝜕(𝑟𝑟,𝑏𝑏)
𝜕𝜕𝑏𝑏
− 𝐷𝐷𝛻𝛻2𝑇𝑇(𝑟𝑟, 𝑡𝑡) = 𝑖𝑖(𝑟𝑟, 𝑡𝑡)   Eqn. 7.9 
 
 
Which allows the use Green’s theorem, so that if 𝑳𝑳𝑢𝑢 = 𝑖𝑖 𝑡𝑡ℎ𝑒𝑒𝑒𝑒 𝑳𝑳𝐺𝐺 = 𝛿𝛿  where 𝑳𝑳 = 𝜕𝜕
𝜕𝜕𝑏𝑏
−
𝐷𝐷𝛻𝛻2 and 𝑢𝑢 = 𝑇𝑇(𝑟𝑟, 𝑡𝑡). This leads to: 
𝑳𝑳𝐺𝐺(𝑟𝑟′, 𝑟𝑟, 𝑡𝑡) = 𝛿𝛿(𝑟𝑟’) 𝛿𝛿(𝑟𝑟’)𝛿𝛿(𝑡𝑡)   Eqn. 7.10 
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Figure 7.2. Boundary conditions used in solving the Green’s function. Yellow represents 
the heat posited including any additional process. 
 
Application of the Fourier transform together with the boundary conditions shown in 
Figure 7.2 leads to: 
𝐺𝐺(𝑟𝑟′, 𝑟𝑟, 𝑡𝑡) = 1(4𝜋𝜋𝜋𝜋𝑏𝑏) 𝑒𝑒−𝑟𝑟2+𝑟𝑟′24𝐷𝐷𝐷𝐷 𝐼𝐼0(𝑟𝑟𝑟𝑟′/𝐷𝐷𝑡𝑡)   Eqn. 7.11 
Since eqn. 7.11 is a solution of eqn. 7.10, then the sum of solutions is also a solution. 
𝑇𝑇(𝑟𝑟, 𝑡𝑡) = 2𝜋𝜋 ∫ 𝑑𝑑𝑡𝑡′ ∫ 𝑑𝑑𝑟𝑟′𝑟𝑟′𝐺𝐺(𝑟𝑟′, 𝑟𝑟, 𝑡𝑡′)𝑖𝑖(𝑟𝑟′, 𝑡𝑡)∞0𝑏𝑏0   Eqn. 7.12 
In order to find a complete solution to this equation, the function f(r’, t) must be defined. 
This can be done if we first assume this function represents the convolution of the energy 
absorbed, the energy of the heat source (i.e. a Gaussian laser pulse), and the heat 
contribution of any additional processes. So that, 𝑖𝑖(𝑟𝑟, 𝑡𝑡) = amount of energy abs x pump 
pulse distribution x heat of others which leads to: 
𝑖𝑖(𝑟𝑟, 𝑡𝑡) = �𝛼𝛼𝐸𝐸𝑒𝑒
ℏ𝜔𝜔
�   2
𝜋𝜋𝜔𝜔0
2 𝑒𝑒
−2𝑟𝑟
2
𝜔𝜔0
2   ∑ 𝑑𝑑𝑑𝑑𝑑𝑑
𝑑𝑑𝑏𝑏
𝑑𝑑
     Eqn. 7.13 
where α is the absorption coefficient, Ea the energy of the photons per mole, ℏ𝜔𝜔 is the 
energy per photon, 𝜔𝜔0 is the full width half maxima, and Q is the heat released. 
Combining eqn. 7.13 and 2.11 into eqn. 7.12 yield: 
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𝑇𝑇(𝑟𝑟, 𝑡𝑡) = 2𝜋𝜋 ∫ 𝑑𝑑𝑡𝑡 ∫ 𝑑𝑑𝑟𝑟′𝑟𝑟′ � 1(4𝜋𝜋𝜋𝜋𝑏𝑏) 𝑒𝑒−𝑟𝑟2+𝑟𝑟′24𝐷𝐷𝐷𝐷 𝐼𝐼0(𝑟𝑟𝑟𝑟′/𝐷𝐷𝑡𝑡)���𝛼𝛼𝐸𝐸𝑒𝑒ℏ𝜔𝜔 �   2𝜋𝜋𝜔𝜔02 𝑒𝑒−2𝑟𝑟2𝜔𝜔02   ∑ 𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑏𝑏𝑑𝑑 �∞0𝑏𝑏0   
Eqn. 7.14 
Which can be integrated 
𝑇𝑇(𝑟𝑟, 𝑡𝑡) = (2𝜋𝜋) � 1(4𝜋𝜋𝜋𝜋𝑏𝑏)� �𝛼𝛼𝐸𝐸𝑒𝑒ℏ𝜔𝜔 � � 2𝜋𝜋𝜔𝜔02� ∫ 𝑑𝑑𝑡𝑡 ∫ 𝑑𝑑𝑟𝑟′𝑟𝑟′𝑒𝑒−𝑟𝑟2+𝑟𝑟′24𝐷𝐷𝐷𝐷 𝑒𝑒−2𝑟𝑟2𝜔𝜔02   𝐼𝐼0 �𝑟𝑟𝑟𝑟′𝐷𝐷𝑏𝑏 �∑ 𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑏𝑏𝑑𝑑∞0𝑏𝑏0  Eqn. 7.15 
𝑇𝑇(𝑟𝑟, 𝑡𝑡) = � 𝛼𝛼𝐸𝐸𝑒𝑒
𝜋𝜋𝜋𝜋𝑏𝑏ℏ𝜔𝜔𝜔𝜔0
2�∫ 𝑑𝑑𝑡𝑡
∑ 𝑑𝑑𝑑𝑑𝑑𝑑
𝑑𝑑𝑏𝑏
𝑑𝑑
𝑒𝑒−
𝑟𝑟2
4𝐷𝐷𝐷𝐷 ∫ 𝑑𝑑𝑟𝑟′𝑟𝑟′𝑒𝑒
−(𝜔𝜔02+8𝐷𝐷𝐷𝐷)𝑟𝑟′2
4𝐷𝐷𝐷𝐷+𝜔𝜔0
2 𝐼𝐼0 �
𝑟𝑟𝑟𝑟′
𝐷𝐷𝑏𝑏
�
∞
0
𝑏𝑏
0
  Eqn. 7.16 
𝐷𝐷 = 𝜋𝜋
𝜌𝜌𝐶𝐶𝜌𝜌
       Eqn. 7.17 
𝑇𝑇(𝑟𝑟, 𝑡𝑡) = � 𝛼𝛼𝐸𝐸𝑒𝑒
𝜋𝜋𝜋𝜋𝑏𝑏ℏ𝜔𝜔𝜔𝜔0
2�∫ 𝑑𝑑𝑡𝑡
∑ 𝑑𝑑𝑑𝑑𝑑𝑑
𝑑𝑑𝑏𝑏
𝑑𝑑
𝑒𝑒−
𝑟𝑟2
4𝐷𝐷𝐷𝐷 ∫ 𝑑𝑑𝑟𝑟′𝑟𝑟′𝑒𝑒
−(𝜔𝜔02+8𝐷𝐷𝐷𝐷)𝑟𝑟′2
4𝐷𝐷𝐷𝐷+𝜔𝜔0
2   ∞
0
𝑏𝑏
0
   Eqn. 7.18 
 
The last term on right hand side is of the form, 
∫𝑥𝑥𝑒𝑒−𝑟𝑟𝑥𝑥
2
𝑑𝑑𝑥𝑥 = − 1
2𝑟𝑟
𝑒𝑒−𝑟𝑟𝑥𝑥
2     Eqn. 7.19 
whose solution is: 
∫ 𝑑𝑑𝑟𝑟′𝑟𝑟′𝑒𝑒−𝑟𝑟𝑟𝑟
′2 =∞
0
(8𝐷𝐷𝑏𝑏+2𝜔𝜔02)𝑟𝑟−(𝜔𝜔02+8𝐷𝐷𝐷𝐷)𝑟𝑟24𝐷𝐷𝐷𝐷+𝜔𝜔02(8𝐷𝐷𝑏𝑏+𝜔𝜔02)    Eqn. 7.20 
which once plugged into eqn. 7.18 gives: 
𝑇𝑇(𝑟𝑟, 𝑡𝑡) = � 2𝛼𝛼𝐸𝐸𝑒𝑒
𝜋𝜋𝜋𝜋𝑏𝑏ℏ𝜔𝜔
�∫ 𝑑𝑑𝑡𝑡 ∑
𝑑𝑑𝑑𝑑𝑑𝑑
𝑑𝑑𝑏𝑏
𝑒𝑒−
𝑟𝑟2
4𝐷𝐷𝐷𝐷𝑑𝑑
𝑟𝑟
−(𝜔𝜔02+8𝐷𝐷𝐷𝐷)𝑟𝑟′2
4𝐷𝐷𝐷𝐷+𝜔𝜔0
2(8𝐷𝐷𝑏𝑏+𝜔𝜔02)𝑏𝑏0     Eqn. 7.21 
In the event that the waist of the Gaussian profile of the pump laser is much larger than the 
diffusion coefficient of the media (water D = 0.282 cm2•s-2, air D=0.176 cm2•s-2) (Cussler 
2009), then (4𝐷𝐷𝑡𝑡 + 𝜔𝜔02)~𝜔𝜔02 and eqn. 7.21 simplifies to:   
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𝑇𝑇(𝑟𝑟, 𝑡𝑡) = � 4𝛼𝛼𝐸𝐸𝑒𝑒
8𝜋𝜋𝜋𝜋ℏ𝜔𝜔
�∫ 𝑑𝑑𝑡𝑡 ∑
𝑑𝑑𝑑𝑑𝑑𝑑
𝑑𝑑𝑏𝑏𝑑𝑑
𝑟𝑟
−
𝜔𝜔0
2(1+𝑟𝑟2)
4𝐷𝐷𝐷𝐷+𝜔𝜔0
2(8𝐷𝐷𝑏𝑏+𝜔𝜔02)𝑏𝑏0   Eqn. 7.22 
Integration over the temperature gives the final solution for the heat diffusion due to a 
Gaussian heat pulse and additional processes. 
𝑇𝑇(𝑟𝑟, 𝑡𝑡) = � 4𝛼𝛼𝐸𝐸𝑒𝑒
8𝜋𝜋𝜋𝜋ℏ𝜔𝜔
�∑ 𝑄𝑄𝑖𝑖
𝑑𝑑 𝑟𝑟
−
2𝑟𝑟
2
8𝐷𝐷𝐷𝐷+𝜔𝜔0
2(8𝐷𝐷𝑏𝑏+𝜔𝜔02)    Eqn. 7.23 
In which the first term is correlated to sample and instrumental parameters such as the 
absorption of the sample, path length of the sample (Z), power of pump laser, and energy. 
The summation term corresponds to the heat deposited by the ith molecule at time t and 
position r, and the last term correlates to the heat diffusion of such heat deposition.  
 Furthermore, to calculate the deflection of the probe beam in PBD we must also 
derive the response of the index of refraction of the media due to changes in temperature. 
This can be done by considering that the change in index of refraction (n) as a function of 
time can be due to at least three factors: i) changes in solvent density due to temperature 
change, ii) change due to photo-products which can affect the index of refraction, iii) and 
changes in molar volumes of the solvated species.  
𝛥𝛥𝑒𝑒𝑡𝑡𝑡𝑡𝑡𝑡𝑎𝑎𝑡𝑡 = 𝛥𝛥𝑒𝑒𝑡𝑡ℎ𝑒𝑒𝑟𝑟𝑒𝑒𝑎𝑎𝑡𝑡R+ 𝛥𝛥𝑒𝑒chemistry+ 𝛥𝛥𝑒𝑒𝑣𝑣𝑡𝑡𝑡𝑡𝑢𝑢𝑒𝑒𝑒𝑒   Eqn. 7.24 
Under conditions such that the probe laser is not sensitive to changes in the chemical 
composition of the media, i.e. the absorption of the sample does not overlap with the 
wavelength of the laser, then 𝛥𝛥𝑒𝑒
chemistry = 0. Under this condition, using: 
𝛥𝛥𝑒𝑒(𝑟𝑟, 𝑡𝑡)𝑡𝑡ℎ𝑒𝑒𝑟𝑟𝑒𝑒𝑎𝑎𝑡𝑡 ~ �𝑑𝑑𝑟𝑟𝑑𝑑𝜕𝜕� ∆𝑇𝑇(𝑟𝑟, 𝑡𝑡)    Eqn. 7.25 
And 
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𝛥𝛥𝑒𝑒𝑣𝑣𝑡𝑡𝑡𝑡𝑢𝑢𝑒𝑒𝑒𝑒 = ∫ 𝑑𝑑𝑟𝑟𝑑𝑑𝑉𝑉 𝑑𝑑𝑉𝑉 = ∫ 𝑑𝑑𝑟𝑟𝑑𝑑𝜌𝜌 𝑑𝑑𝜌𝜌𝑑𝑑𝑉𝑉 𝑑𝑑𝑉𝑉   Eqn. 7.26 
Equation 7.24 simplifies to: 
𝛥𝛥𝑒𝑒𝑡𝑡𝑡𝑡𝑡𝑡𝑎𝑎𝑡𝑡 = �𝑑𝑑𝑟𝑟𝑑𝑑𝜕𝜕� ∆𝑇𝑇(𝑟𝑟, 𝑡𝑡) + ∫ 𝑑𝑑𝑟𝑟𝑑𝑑𝜌𝜌 𝑑𝑑𝜌𝜌𝑑𝑑𝑉𝑉 𝑑𝑑𝑉𝑉  Eqn. 7.27 
The ∆𝑇𝑇(𝑟𝑟, 𝑡𝑡) term on the right has been derived in eqn. 7.23, whereas the second term on 
the right can be derived from the Claussius-Mossoti relation (also known the the Feynman 
relation) (Feynman, Leighton & Sands 1979, Böttcher et al. 1978). 
𝜌𝜌𝛼𝛼 = 3(𝑟𝑟2−1)(𝑟𝑟2+2)      Eqn. 7.28 
𝑑𝑑𝑟𝑟
𝑑𝑑𝜌𝜌
𝑑𝑑𝜌𝜌
𝑑𝑑𝑉𝑉
= −(𝑟𝑟2+2)(𝑟𝑟2−1)
6𝑟𝑟𝑉𝑉
     Eqn. 7.29 
Where the number of particles per unit volume is 𝜌𝜌, 𝛼𝛼 is the polarizability of the particle, 
and n is the index of refraction. Applying the chain rule on eqn. 7.78 leads to 7.29, and 
plugging into eqn. 7.27 together with eqn. 7.23, yields. 
𝛥𝛥𝑒𝑒𝑡𝑡𝑡𝑡𝑡𝑡𝑎𝑎𝑡𝑡 = �𝑑𝑑𝑟𝑟𝑑𝑑𝜕𝜕� � 𝛼𝛼𝜋𝜋ℏ𝜔𝜔� � 𝐸𝐸𝑒𝑒𝜌𝜌𝐶𝐶𝜌𝜌�∑ 𝑄𝑄𝑖𝑖𝑑𝑑 + ∫−(𝑟𝑟2+2)(𝑟𝑟2−1)6𝑟𝑟𝑉𝑉 𝑑𝑑𝑉𝑉  Eqn. 7.30 
In the event that the volume changes are small enough, so that: 
∫
1
𝑉𝑉
𝑑𝑑𝑉𝑉~∆𝑉𝑉𝑉𝑉𝑟𝑟
𝑉𝑉𝑑𝑑
      Eqn. 7.31 
Then eqn. 7.30 simplifies to: 
𝛥𝛥𝑒𝑒𝑡𝑡𝑡𝑡𝑡𝑡𝑎𝑎𝑡𝑡 = �𝑑𝑑𝑟𝑟𝑑𝑑𝜕𝜕� � 𝛼𝛼𝜋𝜋ℏ𝜔𝜔� � 𝐸𝐸𝑒𝑒𝜌𝜌𝐶𝐶𝜌𝜌�∑ 𝑄𝑄𝑖𝑖𝑑𝑑 + −(𝑟𝑟2+2)(𝑟𝑟2−1)6𝑟𝑟 ∆𝑉𝑉  Eqn. 7.32 
Which can be rearranged so that: 
Δ𝑒𝑒𝑏𝑏𝑏𝑏𝑏𝑏𝑒𝑒𝑒𝑒 = 𝐴𝐴𝐸𝐸𝑒𝑒𝜙𝜙 �𝑑𝑑𝑟𝑟𝑑𝑑𝜕𝜕 � 1𝜌𝜌𝐶𝐶𝜌𝜌�∑ 𝑄𝑄𝑑𝑑 + −(𝑟𝑟2+2)(𝑟𝑟2−1)6𝑟𝑟 Δ𝑉𝑉𝑑𝑑 �  Eqn. 7.33 
Where the constant A contains instrumental parameters, such as absorption, alignment and 
path length of the sample. Here it was assumed that 𝑑𝑑𝑟𝑟
𝑑𝑑𝜕𝜕
 does not change with temperature, 
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the quantum yield (𝜙𝜙) of the reaction was also included. For a process in which all the 
energy absorbed is released as heat (𝜙𝜙 = 1), then ∑ 𝑄𝑄𝑑𝑑 = 𝐸𝐸ℎ𝜐𝜐 𝑑𝑑  and if there are no 
associated structural or chemical changes upon photoexcitation of the chromophore, the 
eqn. 7.33 reduces to: 
Δ𝑒𝑒𝑏𝑏𝑏𝑏𝑏𝑏𝑒𝑒𝑒𝑒 = 𝐴𝐴𝐸𝐸𝑒𝑒 �𝑑𝑑𝑟𝑟𝑑𝑑𝜕𝜕 � 1𝜌𝜌𝐶𝐶𝜌𝜌�𝐸𝐸ℎ𝜐𝜐 �    Eqn. 7.34 
Even though the angle of deviation in PBD can be calculate by taking the path integral of 
this equation, a better approach is to measure the deviation of the beam and take the ratio 
of this same signal with a compound satisfying the conditions that lead to eqn. 7.34. In this 
scenario, the compound satisfying eqn. 7.34 is called a reference sample, thus we can write: 
𝑆𝑆 = 𝑆𝑆𝑎𝑎𝑒𝑒𝑆𝑆𝑡𝑡𝑒𝑒 = 𝐴𝐴𝑏𝑏𝐸𝐸𝑒𝑒𝜙𝜙𝑏𝑏 �𝑑𝑑𝑟𝑟𝑑𝑑𝜕𝜕 � 1𝜌𝜌𝐶𝐶𝜌𝜌�∑ 𝑄𝑄𝑑𝑑 + −(𝑟𝑟2+2)(𝑟𝑟2−1)6𝑟𝑟 Δ𝑉𝑉𝑑𝑑 �  Eqn. 7.35 
And, 
𝑅𝑅 = 𝑅𝑅𝑒𝑒𝑖𝑖𝑒𝑒𝑟𝑟𝑒𝑒𝑒𝑒𝑅𝑅𝑒𝑒 = 𝐴𝐴𝑅𝑅𝐸𝐸𝑒𝑒 �𝑑𝑑𝑟𝑟𝑑𝑑𝜕𝜕 � 1𝜌𝜌𝐶𝐶𝜌𝜌�𝐸𝐸ℎ𝜐𝜐 �   Eqn. 7.36 
Where the left hand side is equal to the PBD signal. Under conditions so that the alignment 
of the PBD instrument as well as the absorption at the excitation wavelength of both the 
sample and reference is the same (𝐴𝐴𝑏𝑏 = 𝐴𝐴𝑟𝑟), taking the ratio of eqn. 7.35 and 7.36 leads 
to: 
𝑆𝑆
𝑅𝑅
= Φ𝑠𝑠
𝐸𝐸ℎ𝜐𝜐 �∑ 𝑄𝑄𝑑𝑑𝑑𝑑 + −(𝑟𝑟2+2)(𝑟𝑟2−1)6𝑟𝑟 ��𝑑𝑑𝑟𝑟𝑑𝑑𝜕𝜕� � 1𝜌𝜌𝐶𝐶𝜌𝜌��−1 𝛥𝛥𝑉𝑉�   Eqn. 7.37 
In this equation, 𝐸𝐸ℎ𝜐𝜐  and Φ𝑏𝑏 are temperature independent constants while the term 
��
𝑑𝑑𝑟𝑟
𝑑𝑑𝜕𝜕
� �
1
𝜌𝜌𝐶𝐶𝜌𝜌
��
−1
 is a temperature dependent term which can be calculated from known 
parameter values for water, or other solvents. The term−(𝑒𝑒2 + 2)(𝑒𝑒2 − 1) 6𝑒𝑒𝑉𝑉⁄ = 𝜖𝜖  for 
water can be considered constant as a function of temperature, with a value of 𝜖𝜖 =  −0.365. 
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Thus, a plot 𝑆𝑆
𝑅𝑅
𝐸𝐸ℎ𝜐𝜐  vs  𝜖𝜖 ��𝑑𝑑𝑟𝑟𝑑𝑑𝜕𝜕� � 1𝜌𝜌𝐶𝐶𝜌𝜌��−1follows a linear trend with intercept equal to 
Φ𝑏𝑏 ∑ 𝑄𝑄𝑑𝑑𝑑𝑑  and slope equal to Φ𝑏𝑏𝛥𝛥𝑉𝑉. If the quantum yield of the reaction is known, then the 
enthalpy change Δ𝐻𝐻 = Φ𝑏𝑏 ∑ 𝑄𝑄𝑑𝑑𝑑𝑑  and volume change 𝛥𝛥𝑉𝑉 can be calculated. In addition, the 
temporal dependence of Δ𝐻𝐻 and 𝛥𝛥𝑉𝑉 can be determined in the range of 10 μs to ~ 100 ms.  
The PBD measurements were performed on a home-build instrument described below. The 
samples were held in a 1.0x0.5 cm or 3x3x5 mm cuvette which were placed inside a 
temperature controlled holder (TC 125, Quantum Northwest). Illumination of the sample 
was done with a Nd: YAG laser using the 355 nm line. The pulse of this source lasts about 
5 ns and the power was kept between 600 µJ to 2400 µJ (Minilite, Continuum, CA). The 
laser probe beam (635 nm, 5 mW output from He-Ne Laser, Edmund Optics) was aligned 
so that it is nearly collinear to the pump beam and crossed in the center of the sample cell. 
Mirror were used to reflects and align the probe beam onto the center of a split diode. The 
detector is of our own design and the signal output was digitized by a 400 MHz digitizer 
(WaveSurfer, LeCroy).  
Figure 7.3. Experimental set-up for the photo-thermal beam deflection measurements in 
the collinear configuration.  
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The instrumental design is shown in Figure 7.3, where M1 and M2 represent flat 
mirrors used to focus the probe beam on the center of a position sensitive detector, M355 
represent high energy Nd:YAG laser mirrors, L1 represents a convex lens positioned in 
front of a detector, P1 and P2 represents pinholes to shape the pump and probe beam 
diameter, respectively. a 500 nm long pass filter is represented by F1.  
Figure 7.4. (Top) PBD noise on long timescales with and without air insulation. (Bottom) 
The PBD amplitude distribution of the noise. 
 
The probe beam travels through a refractive index gradient created by a temperature 
gradient in a medium is deflected by an angle α. The deflection angle is measured using a 
position sensitive detector. We have recently modified this set-up to include vibration 
damping columns as well as an acrylic enclosure. These additions have resulted in 
significant decrease in vibration noise and probe beam drifts due to changes in air 
temperature. Air currents, such as those of nearby AC vents, can create temperature 
gradients which can effectively induce deflection of the probe beam. In addition, a strong 
airflow can carry dust particles that when crossing the probe beam laser will reduce the 
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intensity and shape of the beam arriving at the detector. As shown in figure 7.4, these 
artifacts can be significantly reduced by isolation from air current and reduction of 
vibrational noise. 
Figure 7.5. (a) PBD signal amplitude of Na2(CrO4)2 in 20 mM MOPS pH 7.4 and 100 mM 
NaCl as a function of absorbance at 355 nm.  (b) Linear plots of the PBD data as a function 
of  ��𝑑𝑑𝑟𝑟
𝑑𝑑𝜕𝜕
� �
1
𝜌𝜌𝐶𝐶𝜌𝜌
��
−1
 at different optical absorbance at 355 nm. The inset shows the deviation 
from 0-interecept as a function of optical density at 355 nm. (c) PBD signal amplitude of 
the same sample as a function of pump laser power at an absorbance of 0.701 at 355 nm. 
 
Additional experiments were carried out to characterize the linearity of the PBD 
measurements as a function of laser power and optical density of the sample. In figure 7.5a, 
the amplitude of the PBD signal as a function of absorbance at 355 nm is shown. The 
linearity of this plot shows that no multiphoton process is observed for Na2(CrO4)2 at this 
laser power (1200 μJ) and temperature (20 °C). In contrast, plots of the sample signal as a 
function of ��𝑑𝑑𝑟𝑟
𝑑𝑑𝜕𝜕
� �
1
𝜌𝜌𝐶𝐶𝜌𝜌
��
−1
 shows small deviations from zero y-intercept at increasing 
absorbance. This deviation likely arises from changes in ionic strength of the solvent due 
to the large concentrations of Na+ and CrO4- ions. This increase in ionic strength would 
likely need to be corrected by adjusting the 𝑑𝑑𝑟𝑟
𝑑𝑑𝜕𝜕
 value. Lastly, analysis of the PBD signal 
amplitude as a function of pump laser power shows no deviation from linearity in the range 
between 60 μJ and 1400 μJ. Indicating that at these powers, no multiphoton absorption is 
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observed for Na2(CrO4)2 in solution. These experiments highlight the robustness of the 
PBD set-up and must be carried out in the event that a new reference compound if used or 
if high concentrations of analyte are necessary. 
7.3 Results 
7.2.1 Data analysis and calculations 
A typical PBD signal for sodium chromate (Na2(CrO4)2) in aqueous solution is 
shown in Figure 7.6. In this plot, a fast rise upon illumination with the 355nm pump laser 
is observed, followed by a slow decay due to heat diffusion. As the temperature increases, 
the PBD signal increases, and becomes minimal at about ~0 °C. At this temperature the 
�
𝑑𝑑𝑟𝑟
𝑑𝑑𝜕𝜕
� term becomes zero and the first term in eqn. 7.35 is negligible, thus the signal 
measured corresponds to the volume change (𝛥𝛥𝑉𝑉).  
Figure 7.6. (a) PBD signal of Na2(CrO4)2 in 20 mM MOPS pH 7.4 upon excitation with 
1100 μJ power at 355 nm. (b) PBD signal as a function of pump laser repetition rate at 20 
°C. Inset shows the magnitude of the heat diffusion effect as a function of frequency. 
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In the timescales of 10 μs to 10 ms the PBD signal appears to be flat due to the 
negligible heat diffusion and disruption of the transient lens. However, it must be kept in 
mind that the slow diffusion of heat can lead to laser pump pileup. This can be observed in 
Figure 7.6b, where the diffusion effects become larger as the laser pump frequency is 
increased. As the frequency increases, the heat deposited increases due to pump pulse 
pileup and leads to a larger PBD amplitude decrease at times longer than 20 ms. This is an 
important aspect which must be taken into account, especially if the reference and sample 
signals are not measured using identical laser repetition rates or if processes with slow 
kinetics must be measured. Nonetheless, at low pump laser repetition rates and timescales 
shorter than 10 ms, the PBD signal can be assumed to follow a square wave shape. Thus, 
when using eqn. 35 and 36, the difference between the pre-pulse signal and post pulse 
signal is taken to represent the PBD signal, Figure 7.7.  
Figure 7.7. A representative trace highlighting the kinetics of a photo triggered processes 
and the amplitude of the slow and fast phases used to calculate the enthalpy and volume 
changes. 
 
The change in PBD signal can be associated with fast processes (those than happen 
faster than 10 μs) and slow processes (processes with kinetics within 10 μs and 10 ms). In 
this case the volume and enthalpy changes for the process of interest are calculated using: 
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Δ𝐻𝐻𝑟𝑟𝑒𝑒𝑏𝑏𝑏𝑏 = −�𝑄𝑄𝑟𝑟𝑒𝑒𝑏𝑏𝑏𝑏 − 𝐸𝐸ℎ𝜐𝜐 � 𝜙𝜙�    Eqn. 7.38 
Δ𝐻𝐻𝑏𝑏𝑒𝑒𝑏𝑏𝑠𝑠 = −𝑄𝑄𝑏𝑏𝑒𝑒𝑏𝑏𝑠𝑠 𝜙𝜙⁄      Eqn. 7.39 
Δ𝑉𝑉 = Δ𝑉𝑉𝑟𝑟𝑏𝑏𝑟𝑟−𝑏𝑏ℎ𝑟𝑟𝑟𝑟𝑒𝑒𝑒𝑒𝑒𝑒 𝜙𝜙⁄    Eqn. 7.40 
Following Eqn. 7.37, a plot of PBD signal vs 𝜖𝜖 ��𝑑𝑑𝑟𝑟
𝑑𝑑𝜕𝜕
� �
1
𝜌𝜌𝐶𝐶𝜌𝜌
��
−1
for the reference compound 
should be linear with intercept at zero. However, as shown in Figure 7.8, small variances 
in the value of 𝜖𝜖 ��𝑑𝑑𝑟𝑟
𝑑𝑑𝜕𝜕
� �
1
𝜌𝜌𝐶𝐶𝜌𝜌
��
−1
can lead to significant deviations from the linear fit 
intercepting zero. In addition, the presence of salts or organic solvents can result in 
significant deviation from linearity due to large changes on the 𝜖𝜖 ��𝑑𝑑𝑟𝑟
𝑑𝑑𝜕𝜕
� �
1
𝜌𝜌𝐶𝐶𝜌𝜌
��
−1
 term. 
Figure 7.8. (a) Differences in calculated ��𝑑𝑑𝑟𝑟
𝑑𝑑𝜕𝜕
� �
1
𝜌𝜌𝐶𝐶𝜌𝜌
��
−1
 values. In method 1, the values 
are obtained by fitting the �𝑑𝑑𝑟𝑟
𝑑𝑑𝜕𝜕
�, 1
𝜌𝜌
, and 1
𝐶𝐶𝜌𝜌
 terms individually to a polynomial of rank 3. In 
method 2, the values of �𝑑𝑑𝑟𝑟
𝑑𝑑𝜕𝜕
�, 1
𝜌𝜌
, and 1
𝐶𝐶𝜌𝜌
 are first multiplied and the trace fitted with 
polynomial of rank 5. These polynomials are used to calculate the ��𝑑𝑑𝑟𝑟
𝑑𝑑𝜕𝜕
� �
1
𝜌𝜌𝐶𝐶𝜌𝜌
��
−1
 at the 
temperature shown. (b) The deviation from linearity becomes more obvious at lower 
temperatures (near 0 on the x-axis). This plot was obtained using Na2(CrO4)2 in 20mM 
MOPS pH 7.4 100mM NaCl with a laser power of 1100 μJ. (c) Effect on the intercept due 
to increase in ionic strength, conditions are the same as in (b). 
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An alternative approach is to rearrange eqn. 7.35 and 7.37 to obtain a linear 
equation of sample PBD signal as a function of the reference PBD signal as in eqn. 7.41. 
Thus a plot of sample PBD signal vs reference PBD signal divided by the laser energy 
would result in a linear plot with 𝑠𝑠𝑡𝑡𝑡𝑡𝑆𝑆𝑒𝑒 = 𝜙𝜙𝑏𝑏 ∑ 𝑄𝑄𝑑𝑑𝑑𝑑 . The volume change associated with the 
process can be recovered if the parameter 𝐴𝐴𝑏𝑏 is determined, which can be done by plotting 
the reference PBD signal vs 𝜖𝜖 ��𝑑𝑑𝑟𝑟
𝑑𝑑𝜕𝜕
� �
1
𝜌𝜌𝐶𝐶𝜌𝜌
��
−1
. However, in the event that the volume 
changes are not necessary, then eqn. 7.41 provides a convenient approach to determine the 
enthalpy of a process without previous knowledge of the solvent thermal properties. Also, 
determining the enthalpy from the slope of the linear plot leads to less systematic error due 
to extrapolation of the linear fit. Another important advantage of this approach is that the 
linear fit has equal contributions from all temperatures, whereas the linear plot following 
eqn. 7.37 has much larger contribution from lower temperatures where the 
𝜖𝜖 ��
𝑑𝑑𝑟𝑟
𝑑𝑑𝜕𝜕
� �
1
𝜌𝜌𝐶𝐶𝜌𝜌
��
−1
 values show the largest changes. 
𝑆𝑆 = 𝑆𝑆𝑎𝑎𝑒𝑒𝑆𝑆𝑡𝑡𝑒𝑒 = 𝜙𝜙𝑏𝑏 𝑅𝑅𝐸𝐸ℎ𝜐𝜐 ∑ 𝑄𝑄𝑑𝑑 + 𝐶𝐶𝑑𝑑   Eqn. 7.41 
𝐶𝐶 = 𝐴𝐴𝑏𝑏𝐸𝐸𝑒𝑒𝜙𝜙𝑏𝑏 −(𝑟𝑟2+2)(𝑟𝑟2−1)6𝑟𝑟𝑉𝑉 Δ𝑉𝑉  Eqn. 7.42 
In the event that no thermal information is known for the solvent to be used, then it 
is possible to find a temperature at which the 𝜖𝜖 ��𝑑𝑑𝑟𝑟
𝑑𝑑𝜕𝜕
� �
1
𝜌𝜌𝐶𝐶𝜌𝜌
��
−1
 term approaches zero, at 
this point the PBD signal for the reference approaches zero, while that of the sample are 
directly proportional to Φ𝑏𝑏𝛥𝛥𝑉𝑉. This temperature can be determined measuring the PBD 
signal as a function of temperature, as in Figure 7.9c. At this temperature the PBD signal 
for the reference approaches zero, while that of the sample is directly proportional to Φ𝑏𝑏𝛥𝛥𝑉𝑉. 
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Figure 7.9. (a) PBD signal of Na2(CrO4)2 (reference) in 20 mM MOPS pH 7.4 100 mM 
NaCl. (b) Plot of the reference PBD signal as a function of ��𝑑𝑑𝑟𝑟
𝑑𝑑𝜕𝜕
� �
1
𝜌𝜌𝐶𝐶𝜌𝜌
��
−1
 used to 
determine the instrument constant 𝐴𝐴𝐸𝐸𝑒𝑒. (c) Linear fit of the PBD signal as a function 
temperature used to identify the temperature at which the PBD signal for the reference is 
equal to 0. 
 
7.2.2 Time-resolved thermodynamics of Cu2+, Ca2+, Tb3+, and H+ release 
Photo-thermal beam deflection enables the determination of time-resolved volume 
and enthalpy changes for a wide range of  photo-initiated processes, including the release 
of a bioactive molecule from cage compound complexes (Gonzalez, Miksovska 2014, 
Dhulipala et al. 2009). Cage compounds are molecules that are biologically inactive, but 
which can decompose upon irradiation with light to yield a biologically active by-product. 
The ability to control the spatiotemporal release of biologically active compounds has led 
to the development of numerous photosensitive caged compounds. Including caged 
adenosine triphosphate, inositol triphosphate, cyclic adenosine monophosphate, Ca2+, H+, 
and DNA, to name a few (Kaplan, Somlyo 1989, Ellis-Davies 2007). The main advantage 
of such compounds, is their ability to release the biologically active compound within 
milliseconds. Thus, caged compounds offer the opportunity to study ligand induced 
biological processes on timescales not accessible by other techniques. However, to be 
relevant to the study of biological processes, these caged compounds must release their 
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cargo within millisecond timescales and this process must have a relative large quantum 
yield (Gurney 1994). 
 
Table 7.1 Volume and enthalpy following photo-cleavage of caged compounds 
 ∆V1  
(mL mol-1) 
∆H1  
(kcal mol-1) 
∆V2  
(mL mol-1) 
∆H2  
(kcal mol-1) 
2-NBAa 16 ± 3 -36 ± 18   
DM-nitrophen b 12 ± 1 63 ± 6   
Ca2+DM-nitrophen b -12 ± 5 -50 ± 20 9 ± 3 -23 ± 12 
Tb3+DM-nitrophen b -11 ± 2 -53 ± 21   
H2Cage c -29 ± 1  -2 ± 5 17 ± 2 - 65 ± 14 
Cu(OH2)Cage c, d 20 ± 5 -390 ± 94 -15 ± 3  -33 ± 9 
a) Determined in water adjusted to pH 9.8 with NaOH. b) determined at pH 7.4 in 
20mM MOPS and 100 mM NaCl. Determined at pH 7.1 in 5mM MOPS. d) this 
data was obtained from a single PBD trial, errors are from the linear fit to the data. 
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 In this section we use PBD to determine the thermodynamics of H+ release from 
the caged compound o-nitrobenzaldehyde, Ca2+ and Tb3+ from DM-nitrophen, and Cu2+ 
from a pyridyl-amide-nitrophenyl based compound (Scheme 7). The kinetics, enthalpy, 
and volume change associated with photo-cleavage of o-nitrobenzaldehyde to release a 
proton and 2-nitroso benzoic acid have been studied in (Bonetti, Vecli & Viappiani 1997, 
Choi, Hirota & Terazima 2001) using photoacoustic calorimetry and transient grating. 
Through implementation of PBD we have been able to determine the volume and enthalpy 
changes associated with this process, and the results are shown in Table 7.1. The measured 
value of ΔH= -36 ± 18 kcal•mol-1 and ΔV= 16.1 ± 3.2 mL•mol-1 at pH 9.8 are in good 
agreement with those reported by Viapiani et al. (Bonetti, Vecli & Viappiani 1997). 
Following these results, we have also determined the volume and enthalpy associated with 
photo-release of Ca2+ ions from the cage compound DM-nitrophen. As shown in scheme 
7.2, illumination with a 355 nm laser pulse induces the photo-cleavage of a C-C bond to 
yield free Ca2+ and photoproducts. Photo-dissociation of the Ca2+DM-nitrophen leads to a 
prompt (< 15 µs) reaction volume change that can be expressed as:  
Δ𝑉𝑉 =  Δ𝑉𝑉𝐷𝐷𝐷𝐷−𝑟𝑟𝑑𝑑𝑏𝑏𝑟𝑟𝑏𝑏𝜌𝜌ℎ𝑟𝑟𝑟𝑟 + Δ𝑉𝑉𝐶𝐶𝑒𝑒2+°   Eqn. 7.43 
where Δ𝑉𝑉𝐷𝐷𝐷𝐷−𝑟𝑟𝑑𝑑𝑏𝑏𝑟𝑟𝑏𝑏𝜌𝜌ℎ𝑟𝑟𝑟𝑟 corresponds to the volume change associated with the photolysis of 
DM-nitrophen and Δ𝑉𝑉𝐶𝐶𝑒𝑒2+
°
 is the partial molar volume of Ca2+ ion. Using Δ𝑉𝑉𝐷𝐷𝐷𝐷−𝑟𝑟𝑑𝑑𝑏𝑏𝑟𝑟𝑏𝑏𝜌𝜌ℎ𝑟𝑟𝑟𝑟 
= 12 ml•mol-1, the partial molar volume of Ca2+ was determined to be - 24 ± 5 mL•mol-1. 
A value similar to the partial molar volume determined using densometric techniques at 
25 oC, Δ𝑉𝑉𝐶𝐶𝑒𝑒2+
° = - 23 mL•mol-1 (Millero 1971) and - 20 mL•mol-1  as observed in transient 
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grating measurements (Kondoh, Baden & Terazima 2008). Similarly, the enthalpy change 
determined for the fast phase can be described as: 
Δ𝐻𝐻 =  Δ𝐻𝐻𝐷𝐷𝐷𝐷−𝑟𝑟𝑑𝑑𝑏𝑏𝑟𝑟𝑏𝑏𝜌𝜌ℎ𝑟𝑟𝑟𝑟 + Δℎ𝑦𝑦𝑑𝑑𝐻𝐻𝐶𝐶𝑒𝑒2+°   Eqn. 7.44 
where Δ𝐻𝐻𝐷𝐷𝐷𝐷−𝑟𝑟𝑑𝑑𝑏𝑏𝑟𝑟𝑏𝑏𝜌𝜌ℎ𝑟𝑟𝑟𝑟 corresponds to the enthalpy change due to  the DM-nitrophen 
cleavage and Δℎ𝑦𝑦𝑑𝑑𝐻𝐻𝐶𝐶𝑒𝑒2+
°
, corresponds to the enthalpy of hydration for Ca2+. Using 
Δ𝐻𝐻𝐷𝐷𝐷𝐷−𝑟𝑟𝑑𝑑𝑏𝑏𝑟𝑟𝑏𝑏𝜌𝜌ℎ𝑟𝑟𝑟𝑟= 63 ± 6 kcal mol-1, we estimate the enthalpy of hydration to be -113 ± 20 
kcal mol-1for Ca2.  
The 400 µs phase likely corresponds to Ca2+ rebinding to unphotolysed DM-
nitrophen, which leads to a positive volume change of 9 ± 3 mL mol-1 and a negative 
enthalpy change of 23 ± 12 kcal mol-1. The observed volume increase is consistent with 
the positive volume change observed for Ca2+ complexation to EDTA (ΔV = 18.4 mL mol-
1) or EGTA (ΔV = 13.3 mL mol-1) . In addition, the negative change in enthalpy determined 
for Ca2+ binding to un-photolyzed DM-nitrophen matches well the enthalpy change for 
Ca2+ binding to EDTA (ΔH = - 12 kcal mol-1) as determined using ITC (Griko 1999).  
Figure 7.10. Titration curves for Ca2+ and Tb3+ binding to DM-nitrophen. The titrations 
were conducted in 20 mM MOPS pH 6.5 and 100 μM DM-nitrophen. The absorbance at 
350 nm is plotted. 
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In addition, we were interested in determining if DM-nitrophen is able to chelate 
Tb3+ ions and release these ions upon light illumination. Lanthanides have been widely 
reported to have similar coordination as Ca2+ ions, and are often used as Ca2+ biomimetics 
(Martin, Richardson 1979). However, there have been no reports of association between 
DM-nitrophen and lanthanides. To initially identify if such interaction is present, we have 
monitored the change in absorption of DM-nitrophen as a function of Tb3+ concentration 
(Figure 7.10). Addition of Tb3+ resulted in a sharp absorption decrease, up to an equimolar 
concentration. These changes are similar to those observed due to Ca2+ chelation, the 
deviation from 1:1 stoichiometry is likely due to about 5% error in the calculation of the 
Tb3+ stock concentration.  
Figure 7.11. (a) Representative ITC isotherms for displacement of Ca2+ by Tb3+ upon 
binding to DM-nitrophen. (b) Heat due to Tb3+ binding to DM-nitrophen (black symbols), 
Tb3+ displacement of Ca2+ from DM-nitrophen (red symbols), and (c) from EDTA. The 
solid lines represent the best fit to the data using a one-site model. 
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Isothermal titration calorimetry provides further evidence that Tb3+ is not only able 
to directly bind to DM-nitrophen, but that it can also displace Ca2+ ions (Figure 7.11). The 
data for the association of Tb3+ binding to DM-nitrophen shows a one to one stoichiometry 
with an enthalpy of ΔH = 1.9 ± 0.1 kcal•mol-1. The complex isotherm observed in the 
absence of Ca2+ is likely due to contributions of Tb3+ binding to Ca2+ free DM-nitrophen 
(at low molar ratios) followed by Tb3+ displacement of DM-nitrophen bound to 
contaminating Ca2+. In the presence of Ca2+, the stoichiometry of 1:1 is maintained, but an 
increase enthalpy is observed (ΔH = 7.1 ± 0.1 kcal•mol-1). The isotherm was also best fitted 
by a one-site model with n= 1.1 ± 0.1, K = 14 ± 4 x 106 M-1, and TΔS = 16.8 ± 0.3 kcal•mol-
1. The more endothermic enthalpy due to ligand exchange on DM-nitrophen highlights the 
subtle differences between Tb3+ and Ca2+. These differences likely arise from distinct 
solvation shells around Tb3+ and Ca2+ in bulk water as well as a due to a distinct structural 
organization of the Tb3+:DM-nitrophen complex (Martin, Richardson 1979). Similar 
isotherms and thermodynamic parameters were observed for Tb3+ displacement of Ca2+ 
from EDTA (n= 1.2 ± 0.1, K = 6 ± 4 x 107 M-1, ΔH = 4.5 ± 0.1 kcal•mol-1, and TΔS = 15 
± 0.2 kcal•mol-1 in 5 mM TRIS pH 7.4 and 100mM NaCl). Indicating that enthalpic and 
entropic increases upon displacement of Ca2+ by Tb3+ likely arise from solvation effects 
and not structural changes of the chelator. The association constant determined for Tb3+ 
displacement of Ca2+ together with the published affinity of DM-nitrophen for Ca2+ (K = 
2.5 x 106 M-1)(Kaplan, Ellis-Davies 1988), can be used to calculate the affinity of Tb3+ ions 
for DM-nitrophen using (Sigurskjold 2000): 
𝐾𝐾𝜕𝜕𝑏𝑏3+ = 𝐾𝐾𝑒𝑒𝜌𝜌𝜌𝜌(1 + 𝐾𝐾𝐶𝐶𝑒𝑒2+[𝐶𝐶𝑎𝑎2+])   Eqn. 7.44 
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where 𝐾𝐾𝐶𝐶𝑒𝑒2+ is the association constant of Ca2+ to DM-nitrophen, [𝐶𝐶𝑎𝑎2+] is the 
concentration of Ca2+ (1 mM), and 𝐾𝐾𝑒𝑒𝜌𝜌𝜌𝜌 is the association constant of Tb3+ determined in 
the presence of Ca2+. The association constant for Tb3+ binding to DM-nitrophen and 
EDTA is thus calculated to be 𝐾𝐾𝜕𝜕𝑏𝑏3+ = 3.6 x 1010 M-1 and 𝐾𝐾𝜕𝜕𝑏𝑏3+ ~ 1014 M-1., respectively 
The deviation for the association constant of Tb3+ binding to EDTA from the reported value 
(~1016 M-1) likely arises from the tight binding, which may not be easily determined under 
our conditions (Betts, Dahlinger 1959). 
 Furthermore, DM-nitrophen not only is able to chelate Tb3+ with high affinity, but 
PBD experiments show that Tb3+ can be released within microseconds after illumination 
with a 355 nm pulse of light. The PBD traces for the Tb3+DM-nitrophen complex show 
that Tb3+ release from DM-nitrophen happens within 10 μs. Plotting the sample PBD signal 
and reference PBD signal following eqn. 7.37 and eqn. 7.41, allows the calculation of ΔV 
to be -11 ± 2 mL•mol-1 and ΔH = -53 ± 21 kcal•mol-1. These value are in good agreement 
with those obtained for Ca2+ photo-release (Table 7.1). However, unlike Ca2+, the release 
from Tb3+ was not accompanied by a slower rebinding processes. The lack of a slower 
rebinding process in the Tb3+DM-nitrophen complex following photo-cleavage can 
facilitate the interpretation of Ca2+ binding experiment with kinetics within 10 μs and 10 
ms. The results presented here supplement numerous reports highlighting the biophysical 
similarities between Ca2+ and lanthanides. 
 The last cage compound studied is a Cu2+ chelating photosensitive compound 
synthetized by the group of Dr. Kavalieratos at FIU (Ciesienski et al. 2008). The quantum 
yield of photolysis for each compound (ΦH2Cage = 0.73 and Φ[Cu(OH2)(cage)] = 0.32) were 
determined by Ciesienski (Ciesienski et al. 2008). As shown in scheme 7.3, illumination 
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with 355 nm light induces the breakdown of two pyridyl-amide arms which are initially 
connected by the photosensitive nitrophenyl group. The application of this Cu2+ cage for 
fast induction of oxidative stress and trafficking of copper inside of the cell are highly 
dependent on the kinetics photo-release of this cage. Thus, in this section we study the 
kinetics and thermodynamics of breakdown of the ligand free cage (H2Cage) and of the 
copper complex (Cu(OH2)Cage). 
Figure 7.12. (a) PBD signal of H2Cage (dark lines) in 20 mM MOPS pH 7.1 100 mM NaCl 
as a function of temperature. (b) PBD signal of Cu(OH2)Cage at different temperatures. 
The reference PBD signal of Na2(CrO4)2 (light lines) at 30 °C (red) and 10 °C (black) are 
shown for comparison in plots a and b. (c) Plot of the sample to reference PBD signal ratio 
as a function of 𝜖𝜖 ��𝑑𝑑𝑟𝑟
𝑑𝑑𝜕𝜕
� �
1
𝜌𝜌𝐶𝐶𝜌𝜌
��
−1
 for the fast and slow phases of H2Cage and Cu(OH)2Cage 
used to determine ΔH and ΔV, following eqn. 7.37. The solid red lines represent the linear 
fit of the data. Recovered parameters listed in Table 7.1. 
 
Photothermal beam deflection traces for the H2Cage are shown in Figure 7.12a/b 
together with the reference compound. The H2Cage and [Cu(OH2)(cage)] photo-cleavage 
shows two distinct phases in the PBD signal. The fast phase occurs within the 10 µs 
resolution of the instrument, while the slow phase shows a life time of around 850 µs for 
H2Cage and 50 µs for [Cu(OH2)(cage)] at 20 °C. We attribute the fast phase to the rapid 
population of the aci-nito intermediate and the slow phase to the subsequent decay of the 
aci-nitro intermediate, since its kinetics closely matched the aci-nitro intermediate lifetimes 
of both compounds, as determined using transient absorption spectroscopy at 435 nm (data 
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not shown). No additional kinetics were observed up to 100 ms timescale on PBD, 
suggesting that the aci-nitro decay is the rate-limiting step for both H2Cage and 
[Cu(OH2)(cage)] photodissociation. The PBD traces shown in Figure 7.12 confirms that 
chelation of Cu2+ by the H2Cage increases the aci-nitro intermediate 17-fold. 
The thermodynamic parameters were determined from a linear plot using eqn. 7.37 
(Figure 7.12) and are listed in Table 7.1. The formation of the aci-nitro intermediate in the 
H2Cage was accompanied by a contraction of -29 ± 1 mL•mol-1 and near zero enthalpy. 
The decay of this intermediate resulted in an expansion of 17 ± 2 mL•mol-1 and ΔH = -65 
± 14 kcal•mol-1.  These volume and enthalpy changes are consistent with a fragmentation 
of covalent bonds. Fragmentation reactions create larger surface areas for solvent 
molecules to distribute around and the loss of the aci-nitro intermediate anion eliminates 
any electrostriction of the solvation sphere. The Cu(OH)2Cage also shows two phases; 
however, the volume and enthalpy changes are markedly different. The fast phase shows a 
volume expansion of 20 ± 5 mL•mol-1 and a large endothermic process with ~ 400 
kcal•mol-1 of energy. The slow phase results in a contraction of -15 ± 3 mL•mol-1 and 
enthalpy change of -33 ± 9 kcal•mol-1 . Unlike the H2Cage, addition of Cu2+ results in a 
small but measurable absorption band near wavelength of the probe beam (632 nm). 
Absorption of the probe beam by the sample, or changes in the absorption band at this 
wavelength would lead to erroneous determination of the thermodynamic parameters by 
PBD. Thus, it is not possible to assign the ΔV and ΔH values to a chemical process, until 
the contribution of the absorption at 632 nm is verified to be negligible. An alternative 
approach is to employ a probe laser with longer wavelength than 632 nm. Nonetheless, the 
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data obtained from PBD allows facile determination of the activation enthalpy of H2Cage 
(ΔH‡= 7 ± 1 kcal•mol-1) and Cu(OH2)Cage (ΔH‡= 12 ± 01 kcal•mol-1) (Figure 7.13).  
Figure 7.13. Eyring plot of H2Cage and Cu(OH2)Cage aci-nitro intermediate decay as 
determined by PBD. Solid lines represent the best linear fit to the data. 
 
Altogether, the experiments shown here demonstrate that PBD can be used to determine 
the kinetic and thermodynamics of photo-triggered reactions within the 10 μs and 20 ms 
range. The data for DM-nitrophen confirm that this photosensitive compound is able to 
chelate Tb3+ and release it following illumination with a short 355 nm pulse of light. In 
addition, the thermodynamic parameters for release of Tb3+ and Ca2+ are very similar, in 
agreement with the idea that these two ions share similar biophysical properties in solution. 
Lastly, PBD data shows that the chelation of Cu2+ by the H2Cage compound induces a 17-
fold increase in the breakdown rate of this cage following illumination. Further studies are 
needed to fully determine the thermodynamic parameters of the Cu(OH2)Cage compound, 
but the data presented here show that the breakdown of this complex at about 50 μs is well 
within the resolution of PBD. 
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7.2.3 Time-resolved thermodynamics of Ca2+ binding to DREAM constructs 
Following the application of PBD to study the photo-triggered release of Ca2+ from 
DM-nitrophen within 10 μs, this technique is also amenable to investigate the 
thermodynamics and dynamics associated with Ca2+ binding to DREAM. In figure 7.13 
the PBD traces for DREAM( Δ64), DREAM(Δ160), and DM-nitrophen at 20 °C are 
shown. Due to the non-reversibility of the Ca2+ release process, the samples has to be 
exchanged after every pulse. To minimize the sample needed, a 3x3x5 mm (width-length-
height) quartz cuvette was used (45 μL) and ten single shots were averaged. A sample 
concentration of 100 μM for DREAM protein,  795 μM DM-nitrophen, and 780 μM 
calcium in 20mM HEPES pH 7.4, 1mM TCEP, 100 mM NaCl solution was used. Under 
these conditions DM-nitrophen shows a rebinding kinetic of about 350 μs (black trace in 
fig. 7.14). On the other hand, Ca2+ binding kinetics to DREAM(Δ64) and DREAM(Δ160) 
are slower, with τ = 650 μs and τ = 1270 μs, respectively. In the case of DREAM(Δ160) 
the association rate of kon = 4.0 s-1•μM-1 determined here is in good agreement with the 
calculated value of kon = 4.0 ± 0.1 s-1•μM-1 from stopped-flow experiments. These results 
highlight the role of the N-terminus domain in regulating the kinetics of calcium binding 
at the C-terminus. Unfortunately, we observed that the Ca2+ rebinding kinetics to DM-
nitrophen following illumination varied among different manufacturers (Figure 7.14b). 
Thus the overlap of the DM-nitrophen and DREAM kinetics, as well as large variations in 
the DM-nitrophen kinetics prevented further deconvolution of these signals. 
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Figure 7.14. (a) PBD traces for DREAM constructs at 200μM concentration, solid green 
line represent best NLLS fit to an exponential decay. Trace for DREAM(1-256) not shown. 
(b) PBD traces of Ca2+DM-nitrophen from different manufacturers. 
 
7.3 Summary 
 In this section I presented the theory behind photothermal beam deflects as well as 
improvements on the PBD set up which decrease noise levels at longer timescales. The current 
PBD instrument is able to measure processes faster than ~40 ms. However, at these timescales, 
much care must be taken to account for diffusion and vibrational effects. We demonstrate that PBD 
can be used to determine the kinetics and thermodynamics of ligand release from 2-NBA, DM-
nitrophen, and a novel copper cage. In addition, we presented the use of DM-nitrophen to cage and 
photo-release Tb3+. Kinetic analysis of the PBD data supports the idea that Ca2+ can bind to 
DREAM within milliseconds. However, further studies need to be carried out in order to determine 
the thermodynamics of this process.  
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8. ROLE OF AROMATIC AMINO ACIDS IN ALLOSTERIC REGULATION 
OF DREAM ACTIVITY 
8.1 Background and significance 
The neuronal calcium sensors DREAM, KChIP1, KChIP 2, and KChIP 4 co-
assemble with the KV channels to enhance channel surface expression, facilitate channel 
assembly and regulate the functional gating properties of the channels. Despite numerous 
X-ray structures of the KV4 T1 domain in the presence and absence of the regulatory 
KChIPs, the mechanism by which these auxiliary proteins mediate channel gating remains 
unknown. Two fragments on the KV4 T1 domain (amino acids 7-11 “site 1” and 71-90 “site 
2”) have been identified as being necessary for KChIP1 current regulation (Scannevin et 
al. 2004). The “site 1” interaction interface involves a large hydrophobic patch on the 
DREAM surface, while “site 2” interactions involves helix 2 at the KChIP N-terminus 
(Pioletti et al. 2006, Wang et al. 2007). Remarkably, we have shown that in the presence 
of calcium, DREAM(Δ65) exhibits a 26-fold increase in affinity for site 1, and 
approximately 50-fold increase for site 2 (Chapter 4). The fact that calcium binding at the 
C-terminus EF-hand 3 and EF-hand 4 of DREAM(Δ65) modulates binding of site 2 
indicates that the structural changes coupled to calcium association are transmitted towards 
the DREAM N-terminus. The regulation of ligand binding at sites distant from the Ca2+ 
binding is also observed for DNA. However, DREAM interacts with DNA in a manner that 
opposes that of KV4 site 2, that is, Ca2+ induces the dissociation from DNA (Osawa et al. 
2005, Carrion et al. 1999) (Figure 8.1). Nonetheless, these interactions highlight that Ca2+ 
binding to DREAM can induce long range structural reorganizations that can regulate 
ligand binding. The concept of regulation at a distance is not new, and has been widely 
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observed in ligand binding proteins. The regulation of protein activity by binding of a 
ligand (effector) at a distinct site than that of the site involved in activity has been termed 
allosteric regulation. 
 
Figure 8.1. Calcium induced dissociation of DREAM from DNA. The Ca2+ free DREAM 
shown as a tetrameric blue pentagon, upon Ca2+ binding a dimer is formed (green shape). 
The dimeric form of DREAM has lower affinity for DNA. Dissociation of DREAM from 
DNA induces the expression of DRE regulated genes. 
 
Two widely studied models used to explain allosteric regulation in proteins are the 
Monod-Wyman-Changeux (WNC) (Monod, Wyman & Changeux 1965) model and the 
Koshland-Nemethy-Filmer (KNF) model (Koshland Jr, Nemethy & Filmer 1966). Both of 
these models follow the premise that proteins can populate two states, a relaxed state with 
high affinity for the ligand, and a tense state with lower affinity for the ligand. However, 
these models differ on the condition of whether all subunits of a protein actively populate 
only one state upon ligand binding (WNC, concerted) or whether ligand binding only 
results in local structural changes, allowing the protein complex to populate both states 
(KNF, model). However, the growing perspective that protein conformational dynamics 
and fluctuations control allosteric regulation offers a novel paradigm in understanding 
ligand binding. In view presented above, proteins do not behave in a binary fashion, but 
can rather populate a multitude of isoenergetic conformational states (Jardetzky 1996). 
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These conformational states are highly dynamic and sensitive to perturbations resulting 
from ligand binding, which can induce a redistribution of the conformational space 
sampled by the protein (Cui, Karplus 2008, Tsai, Del Sol & Nussinov 2009). However, 
experimental determination of allosteric mechanisms and pathways have proven to be 
elusive. Even after decades of research on the allosteric regulation of hemoglobin, the 
precise mechanism remains unresolved. Nonetheless, significant advances in molecular 
dynamics simulations have opened the opportunity to observe the the dynamic nature of 
proteins at the atomic level. Thus, it is now possible not only to study the role of protein 
dynamics in regulation of activity, but to dissect the pathways by which information 
propagates in these complex systems. The concept of dynamic regulation brings a shift in 
the classical view of the structure-function relationship of protein activity to a new focus 
in which structure-dynamic-function plays a major role.  
Figure 8.2. Association of ligand with DREAM (shown in the center as a cartoon model). 
The electrostatic and hydrophobic regions of DREAM are highlighted in a red surface or 
gray surface, respectively. Ligand known to interact with DREAM are shown,  
(counterclockwise) calcium, terbium(III), 1,8-ANS, NS5806, arachidonic acid, site 1 of 
KV4.3, site 2 of KV4.3, DRE DNA, and magnesium. 
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 In chapter 8, we implement the combination of theoretical and experimental 
techniques with the aim of understanding how calcium modulates DREAM activity. More 
importantly, we seek to decipher how structural changes associated with Ca2+ binding at 
the C-terminus are propagated towards the N-terminus. As presented in the previous 
chapters, DREAM is involved multiple biological events and can interacts with numerous 
small and large ligands (Figure 8.2). Therefore, understanding how structural information 
propagates across this protein would provide a new information which could potentially 
allow the development of approaches to control its activity. Knowledge of the molecular 
mechanism controlling structural changes could also be extrapolated to other neuronal 
calcium sensors and provide a fundamental understanding of Ca2+ binding and allostery. 
Figure 8.3. Cartoon representation of the three dimensional structures of (a) NCS1 (PDB: 
1fpw), (b) recoverin (PDB: 1jsa), and (c) DREAM (PDB: 2jul) in the Ca2+ bound form. 
 
8.2 Results 
8.2.1 Calcium binding regulates structural reorganization of the N-terminus helices of EF-
hand 1 
Elucidation of the structure of DREAM has provided valuable information in 
regards to the molecular organization of this protein. However, the NMR structures of 
DREAM(76-256) (PDB: 2jul) and DREAM(161-256) (PDB: 2e6w) have shown little 
deviation from the structure of recoverin or NCS-1 (Lusin et al. 2008, Yu et al. 2007a) 
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(Figure 8.3). Nonetheless, these proteins are known to regulate different processes inside 
the cell and associate with different protein ligands. Furthermore, despite their similar 
structural organization, DREAM, recoverin, and NCS-1 all bind Ca2+ in different 
configurations. For instance, recoverin binds Ca2+ at EF-hand 2 and 3, KChIPs bind Ca2+ 
at EF-hand 3 and 4; while NCS-1 binds Ca2+ in EF-hands 2, 3, and 4. Nonetheless, close 
analysis of the structural organization of these proteins reveal a high degree of sequence 
and structural homology at the C-terminus containing EF-hand 3 and 4. Therefore, it is 
possible that the C-terminus domain represents a fundamental tertiary organization with 
allows these proteins to convert the biochemical energy of Ca2+ binding to structural 
information. In the hypothesis presented above, EF-hand 3 would play an essential 
structural role while EF-hand 2 and 4 function to relay structural information. We further 
hypothesize that in DREAM (and potentially other NCS proteins) structural information 
propagates in the form of structural and dynamic changes.  
Figure 8.4. (a) Root mean square deviation (RMSD) of the alpha carbon (Cα) DREAM 
(residues 76 to 256) as a function of simulation time. Notice that the classical simulation 
must undergo over 400 ns to reach a deviation similar to that observed using aMD. Heat 
map plot showing the RMSD of the Cα of each residue as a function of simulation time for 
the cMD simulation (b) and for the aMD simulation (c). Note the similar patter or 
reorganization between residue 76 to 96 on both simulations (marked as 1). The region 2 
corresponds to residues connecting the exiting helix of EF-hand 3 and entering helix of EF-
hand 4. 
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 To clearly understand the structural changes associated with Ca2+ binding to 
DREAM, we first must obtain a structural model of the protein in the Ca2+ free form. To 
obtain this model we conducted a 450 ns classical molecular dynamics (cMD) simulation 
and a 100 ns accelerated molecular dynamics (aMD) simulation. These simulations were 
initialized using the Ca2+ bound DREAM structure (PDB: 2jul), in which the Ca2+ ions 
have been removed. As shown in Figure 8.4a, the cMD simulation does not reach 
equilibrium even after 450 ns, while the aMD simulation resulted in an equilibrated 
structure after about 20 ns. The fast equilibration is expected, since the aMD approach 
allows the protein to sample a larger number of conformations by effectively lowering the 
energy barriers separating these states (Hamelberg, Mongan & McCammon 2004). Both 
of the resulting DREAM structures in the absence of Ca2+ show an overall molecular 
reorganization of the N- and C-terminus, with an overall RMSD from the starting structure 
of 4.7 Å for the aMD simulation and 5.5 Å for the cMD simulation. However, analysis of 
the RMSF per residue as a function of simulation time reveal significant reorganization of 
the N-terminus domain near EF-hand 2 and 3 in both simulations (Figure 8.4b and c). Since 
the cMD simulation does not reach an equilibrium structure even after 450 ns, we do not 
include it in further analysis; instead, we focus on the structure obtained from the aMD 
simulation. Following the simulation in the absence of Ca2+, the overall structure of 
DREAM becomes more compact, with an evident collapse of the hydrophobic cavity at the 
N-terminus (Figure 8.5a and b). In addition, a reorientation of the N-terminus with respect 
to the C-terminus is observed, likely triggered by the collapse of the N-terminus 
hydrophobic cavity. 
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Figure 8.5. Global structural changes following 100 ns of aMD simulation. (a) Initial 
structure of DREAM following minimization and equilibration and (b) after 100 ns of 
aMD. (c) Overlaid of the initial structure shown in (a) with the N-terminus of DREAM 
after 100 ns of aMD simulation (b) represented as geometric cartoons. The C-terminus EF-
hand 3 and 4 were used in the alignment. 
 
The most obvious changes at the N-terminus are the reorganization of the entering 
helix of EF-hand 1, changing from a perpendicular orientation to a semi-parallel orientation 
with respect to the initial structure (Figure 8.6a), a similar rearrangement is observed for 
the EF-hand 2 (Figure 8.6b).  
Figure 8.6. (a) Reorientation of the EF-hands of DREAM in the absence of Ca2+ before 
(shown in solid colors) and after 100 ns of aMD simulation (shown in diffuse color with 
solid lines representing the backbone atoms). All alignments were conducted using the first 
12 amino acids of the entering helix (shown horizontal). The EF-hand 1 residues 89 to 122 
(a), EF-hand 2 residues 128 to 160 (b), EF-hand 3 residue 163 to 198 (c), EF-hand 4 residue 
210 to 242 (d), and the H10 helix residues 243 to 256. 
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The reorientation of EF-hand 1 is accompanied by a collapse of the N-terminus 
hydrophobic cavity. However, at the C-terminus, a minimal reorganization of the helices 
is observed compared to the initial structure. The small reorganization is mainly localized 
on the EF-hand 3 and the H10 helix. A small bent of the entering helix of EF-hand 3 is 
observed (Figure 8.6c). The EF-hand 4 on the other hand, shows a minimal change in 
orientation of the entering and exiting helices (Figure 8.6d). As shown in Figure 8.6e, a 
slight shift in EF-hand 4 is also observed.  
Figure 8.7. Structure of the N-terminus domain of DREAM (EF-hand 1 in orange and EF-
hand 2 in green) (a) before simulation and (b) after 100 ns of aMD simulation in the absence 
of Ca2+. Root mean square deviation per residue of the last 10 ns compared to the initial 
structure of Ca2+ bound DREAM (red) and Ca2+ free DREAM (black). The approximate 
positions of the EF-hand helices shown as colored squares, EF-hand 1 in orange, EF-hand 
2 in green, EF-hand 3 in blue, and EF-hand 4 in red. Heat map representation of the RMSD 
per residue as a function of time for Ca2+ bound DREAM during 100 ns of aMD simulation. 
 
 At the residue level, the collapse of the N-terminus hydrophobic surface brings 
together numerous hydrophobic amino acids, namely Leu96, Phe100, Phe114, Ile117, 
Tyr118, Phe121, Phe122, Y151, Leu155, Leu158, and Leu159 (Figure 8.7a and b). 
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Interestingly, the entering helix of EF-hand 1, on which residues known to interact with 
KV4 channels and DNA reside, shows the largest structural change. At the C-terminus, the 
structural changes observed in the presence or absence of Ca2+ are very similar, compare 
Figure 8.4c and 8.7d, with the most prominent change being due to motion of the long loop 
(residues 199 to 209) connecting EF-hand 3 and 4. As shown in Figure 8.6, the entering 
and exiting helices of EF-hands 3 and 4 do not move significantly; however, the metal 
binding loops of each hand undergo significant change in flexibility and structure (Figure 
8.8). This change in structure and increase in flexibility is localized near Asn177 and 
Asp179 of EF-hand 3, which provide the Y and Z coordination to the Ca2+ metal (Figure 
8.7a and b). Similarly, Asp223, Asn225, and Asp227 which provide the X, Y, and Z metal 
coordination of EF-hand 4 become significantly more flexible (Figure 8.8c and d).  
Figure 8.8. (a) Root mean square deviation (RMSD) and root mean square fluctuation 
(RMSF) of the EF-hand 2 (residues 163 to 198. RMSF calculated with a moving window 
of 1 ns with a step of 0.2 ns. The RMSD (c) and RMSF(d) of EF-hand 4. White square 
highlights the N-terminus of the metal binding loop. 
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These findings are in good agreement with a model in which the N-terminus amino 
acids of the EF-hand chelating loop are highly flexible in the absence of Ca2+, while metal 
binding induces a decrease in flexibility and large entropic gain which drives metal binding 
(Gifford, Walsh & Vogel 2007b). Interestingly, the fluctuations in EF-hand 4 are much 
larger than those observed in EF-hand 3, which is in good agreement with the observed 
loss of entropic gain when EF-hand 4 is inactivated by the Glu234Gln mutation as 
discussed in Chapter 6. However, to test whether the the collapse of the N-terminus domain 
is a result of Ca2+ dissociation or the simulation conditions, we also performed  aMD 
simulations of the Ca2+ bound DREAM protein. As shown in Figure 8.7c and d, an increase 
in the N-terminus RMSD similar to that shown in Figure 8.4b and c is observed even in the 
presence of Ca2+. However, the change is not as large as that observed for the Ca2+ free 
protein (compare Figure 8.4c and 8.7d). Nonetheless, in the Ca2+ bound state, DREAM is 
known to form dimers (Lusin et al. 2008), which may indicate that the observed changes 
at the N-terminus arise from intersubunit interactions. To determine if intersubunit 
interactions play a role in stabilizing the N-terminus domain, we conducted additional aMD 
simulations of a DREAM dimer structure. The DREAM dimer structure was generated 
using the dimeric structure of KChIP1 (PDB: 1S6C) (Zhou et al. 2004b), the structure of 
the DREAM dimer is shown in Figure 8.9a. The resulting structure is similar to the 
previously proposed structure, in which Leu155, Leu156, and Leu159 stabilize the dimeric 
structure in a head to tail fashion (Lusin et al. 2008). Following energy minimization and 
equilibration, the dimeric structure of DREAM reaches equilibrium within 10 ns of aMD 
simulation (Figure 8.9b). In addition, the RMSD of the entering helix of EF-hand 1 as well 
as the heat map plot reveal that the overall structure of DREAM is much less flexible in 
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the dimeric conformation (Figure 8.10b and c). These are remarkable results, and they 
clearly indicate that both binding of Ca2+ at EF-hand 3 and EF-hand 4 as well as 
dimerization play a significant role in stabilizing the N-terminus EF-hand 1. More 
importantly, these results provide evidence for the presence of pathways which propagates 
structural signals from the C- to the N-terminus in DREAM. 
Figure 8.9. (a) Cartoon representation of the proposed DREAM dimer in which Leu155, 
Leu158, Leu159, and Leu251 are shown in licorice model with a diffuse surface. The N-
terminus EF-hand 1 and 2 shown in blue and the C-terminus EF-hand 3 and 4 shown in 
red. (b) RMSD of the Cα in EF-hand 1 (residues 89 to 102) as a function of aMD simulation 
time for the Ca2+ free and bound DREAM as well as the dimer of DREAM. (c) Heat map 
of the RMSD per residue as a function of simulation time for each DREAM subunit in  the 
dimer protein. 
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8.2.2 Molecular dynamics simulations reveal the role intersubunit and intrasubunit 
dynamic coupling 
 All members of the NCS subfamily are known to fold in a compact manner similar 
to that observed in recoverin (Figure 8.3), a domain organization significantly distinct than 
that observed in calmodulin. Also, unlike calmodulin, NCS proteins do not bind Ca2+ at the 
most N-terminal EF-hand 1. However, structural information on the Ca2+ free and bound 
recoverin seems to indicate that certain structural changes happen near the N-terminus, 
where a myristoyl group resides (Ames et al. 1997). The similar compact structural 
organization of NCS proteins brings to question whether the ability to transduce signal 
from the C- to the N-terminus is a common feature among these proteins. Based on the 
results of the previous section and chapters, we propose that there are two pathways by 
which Ca2+ binding regulates structural changes at the N-terminus. One is through direct 
intrasubunit structural changes and another which involves intersubunit communications. 
However, the nature of these structural changes are not obvious, since we have observed 
that besides local changes in flexibility (Figure 8.9), Ca2+ binding at EF-hand 3 and 4 does 
not lead to significant changes in the structure of the C-terminus. In this section, we test 
the hypothesis that monitoring of the dynamic fluctuation in DREAM provides useful 
information necessary to understand the mechanism controlling structural reorganization 
in this protein.  
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Figure 8.10. Residue cross correlation analysis of the cMD simulations for the (a) Ca2+ 
bound DREAM monomer, (b) Ca2+ bound DREAM dimer (only one subunit shown), and 
(c) Ca2+ free DREAM monomer. All the structure are based on the last 80 ns of a cMD 
simulation at which point the RMSD changed by less than 2 Å. The structure of the Ca2+ 
free DREAM was obtained after 100 ns of aMD simulation. Regions of interest are marked 
and described in the text. 
 
We propose that the transmission of allosteric signal in DREAM is coupled to 
dynamic fluctuations of amino acids in the protein, these fluctuations effectively propagate 
information and induce structural changes at the N-terminus of DREAM. To test this 
hypothesis we have analyzed the cMD simulations of Ca2+ bound DREAM dimer and 
monomer as well as the Ca2+ free DREAM monomer using dynamic cross correlation of 
the alpha carbons between amino acids as a function of simulation time. The approach 
allows us to monitor all residues and identify cluster of amino acids (communities) in 
which dynamic fluctuations are highly correlated. These communities dissect the DREAM 
structure into segments that allows us to understand the pathways of signal transduction in 
DREAM protein. Figure 8.10 shows the residue-based dynamic cross correlation maps of 
DREAM as a function of metal binding and oligomerization state. These correlation maps 
were obtained by analyzing the equilibrium conformation of each state, namely, the last 80 
ns of the simulation during which the RMSD did not change significantly. Therefore, these 
correlation maps represent fluctuations from equilibrium. Analysis of the cross correlation 
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map of Ca2+ bound DREAM(Δ65) shows the presence of widespread regions of correlated 
and anticorrelated motion, shown as blue and red in Figure 8.10a. In the map shown in 
Figure 8.10a we observe three region; region A connects amino acids at the C-terminus 
and region C connects amino acids at the C-terminus. These two dynamic domains are 
connected by a strong correlation between amino acids 130 to 137 at the N-terminus and 
168 to 174 at the C-terminus, highlighted as region B. 
Furthermore, a clear widespread increase in dynamic coupling can be observed for 
the dimeric DREAM simulation (Figure 8.10b). The increase in correlation is present for 
regions A, B, and C, which were already partially correlated in the Ca2+ bound DREAM 
monomer simulation. For instance, the region marked as C in Figure 8.10b corresponds to 
the C-terminus of DREAM and shows a strong increase in correlation, a similar increase if 
observe for the N-terminus. Interestingly, the anticorrelated  region connecting the entering 
helix of EF-hand 1 (residues 80 to 102) to the exiting helix of EF-hand 4 (residue 230 to 
242) is enhanced in the dimeric form as well, shown as region D. Therefore, these results 
suggest that dimerization strengthens already existing dynamic connections, likely 
enhancing the stability of the protein and transduction of dynamic information. On the 
other hand, the correlation map for Ca2+ free DREAM shows a clear overall decrease in 
correlation, both at the N- and C-terminus (Figure 8.10c). Regions C and N become 
significantly less correlated, while region B becomes completely uncorrelated. These 
results show a clear transition triggered by Ca2+ binding to DREAM, from a disordered 
protein conformation to a highly dynamically organized structure.  
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Figure 8.11. (a) Cartoon representation Ca2+ bound DREAM monomer with the colored 
communities shown as ball and stick colored cartoons. The structure was obtained 
following 100 ns of cMD simulation. (b) Cartoon representation of DREAM with EF-hands 
colored and helices labeled for reference to panel (a). (c) Structure of DREAM with 
overlaid dynamic networks highlighting the critical amino acids connecting the N- and C-
terminus of DREAM (amino acids shown in purple licorice, H10 and gray network not 
shown for clarity). (d) Networks at the C-terminus showing the connection between the 
H10 helix (gray network) and the entering helix of EF-hand 4 (yellow network), critical 
amino acids shown in green licorice model. 
 
 To better illustrate the dynamic organization of DREAM, we have carried out 
analysis of the simulations discussed above using dynamic network analysis. This type of 
analysis allows us to build three dimensional networks which represent the cluster of amino 
acids whose motions are highly correlated. The resulting networks of Ca2+ bound DREAM 
monomer overlaid on the DREAM structure are shown in Figure 8.11. One of the most 
salient observation of Figure 8.11a is the particularly defined organization of the N- and 
C-terminus domains, each of which is subdivided in three communities. At the N-terminus, 
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the blue community spans helix 1 and  the entering helix of EF-hand 1, the orange 
community connects the exiting helix of EF-hand 2 and entering helix of EF-hand 3, while 
the green network contains the exiting helix of EF-hand 2 and the beginning portion of EF-
hand 3. The C-terminus shares a similar organization, with three main communities, the 
largest one being the yellow network connecting the exiting helix of EF-hand 3 and 
entering helix of EF-hand 4. The metal binding loops at the C-terminus also form a highly 
correlate community (shown in gray) which connects both loops and the entering helix of 
EF-hand 3. Lastly, the H10 helix is minimally coupled to the rest of the protein and forms 
a community shown in red. Overall, these communities highlight the role of the entering 
helix of EF-hand 3 in connecting both domains. The entering helix of EF-hand 3 (H6) 
seems to function as a dynamic hub through which fluctuations between the N- and C-
terminus can be propagated. In Figure 8.11c the critical amino acids connecting the N-
terminus (Trp169, Glu165, and Lys87) and the C-terminus (Leu165, Phe171, and Tyr174) 
are shown. Analysis of the amino acids connecting the communities, herein referred as 
critical nodes, identifies Trp169, Phe171, and Tyr174 as playing major roles. The N-
terminus connection is dominated by interactions of Trp169 with Phe138 and Leu134. 
Additionally, the dynamic coupling in this domain is also extended by Glu165 and Lys87 
which make a strong salt bridge spanning the entering helix of EF-hand 3 and entering 
helix of EF-hand 1 (green to blue network). At the C-terminus the predominant connection 
is that of Leu167 and Phe171 on the entering helix of EF-hand 3 interacting with Phe235 
and Ile232 on the exiting helix of EF-hand 4. At the C-terminus, the H10 helix is coupled 
to the C-terminus core (yellow network) by the interaction between Phe252 on the H10 
helix and Phe219 on the entering helix of EF-hand 4. Interestingly, Phe218 is strongly 
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coupled to the EF-hand 3 Ca2+ binding loop, connecting the yellow and the green network. 
Altogether, these dynamics networks highlight the role of hydrophobic amino acids, 
specially aromatic amino acids, in maintaining the dynamic coupling from the N- to the C-
terminus.  
Figure 8.12. (a) Cartoon representation Ca2+ free DREAM monomer with the colored 
communities shown as ball and stick colored cartoons. The structure was obtained 
following 450 ns of cMD simulation. The communities were calculated using the last 80 
ns of the cMD simulation. (b) Cartoon representation of DREAM with EF-hands colored 
and helices labeled for reference to panel (a).  
 
 Analysis of the Ca2+ free DREAM simulation shows that most of the communities 
are maintained, but the thinner edges connecting the nodes (representing alpha carbons) 
highlights a much weaker correlation (Figure 8.12). However, a strong reorganization of 
the networks at the C-terminus is observed, where the yellow and gray networks have 
rearranged. The yellow community now connects the entering and exiting helix of EF-hand 
4 and partially the exiting helix of EF-hand 3. The gray network now connects the H10 
helix and the exiting helix of EF-hand 3 and entering helix of EF-hand 4 while the red 
network is largely localized at the entering helix of EF-hand 3. These results allow us to 
propose that in the absence of Ca2+, the H10 helix becomes dynamically coupled to the 
core domain of DREAM through interactions with EF-hand 3. As described in Chapter 3 
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and 4, binding of small hydrophobic ligands on DREAM is mediated by a hydrophobic 
cavity at the C-terminus. Therefore, it is likely that the mechanism being observed here, in 
which the H10 helix becomes free to move in the presence of Ca2+, but bound to the core 
domain of DREAM in the absence of Ca2+, is what regulates ligand binding. At the N-
terminus, the three communities observed in the Ca2+ bound form of DREAM are 
maintained; however, the correlation strength is decreased significantly (judged by the 
thickness of the edges connecting the nodes). 
Figure 8.13. (a) Cartoon representation of the proposed DREAM dimer on which the 
communities have been overlaid using a ball and stick representation. Subunit A and B are 
highlighted in a dotted square. The figure on the right is rotated 180 degrees. (b) carton 
representation of DREAM with EF-hands colored and Ca2+ metal shown, LxxLL motif 
shown in purple licorice model. (c) Intersubunit salt bridges formed between DREAM 
subunits. 
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 The Ca2+ bound DREAM dimer shows the presence of much more extensive 
communities (Figure 8.13). The communities identified in the dimer are not symmetric, 
but in both subunit three well defined dynamic subdomains can be observed. The red 
community, is predominant in both subunit, and it includes both EF-hand 3, EF-hand 4, 
and the H10 helix. In addition, a community (shown in green) spanning the H1 helix, EF-
hand 1, and EF-hand 2 is found in subunit A. In subunit B, this community is smaller, only 
including the exiting helix of EF-hand 1 and entering helix of EF-hand 2 (shown in green). 
Despite their different organization, both subunits show strong intersubunit correlation 
between the red and green communities which is mediated by the long loop connecting EF-
hands 3 and 4 (Figure 8.13b and c). At the residue level, this intersubunit interaction is 
stabilized by a strong salt bridge between Glu103 on one subunit and Arg200 and Arg2007 
on the adjacent subunit (Figure 8.13c). In addition a cluster of four aromatic amino acids 
(Phe121 and Phe122 on each subunit) form a stable connection between both green 
communities (not shown). 
Analysis of the critical nodes connecting the network on each subunit revealed the 
role of Leu155, Leu156, Leu159, and Leu251 in stabilizing the dimeric structure of 
DREAM (Lusin et al. 2008). However, the interaction between the loop connecting EF-
hands 3 and 4 in one subunit with EF-hand 1 have not been previously identified. Overall, 
the model that emerges from these analyses is that the entering helix of EF-hand 3 plays 
an important role in connecting the dynamic motions of the N- and C-terminus. This 
observation may seem obvious at first, given that this helix is at the middle of the N- and 
C-terminus pair of EF-hands. However, a closer look at the structure of DREAM shows 
that the exiting helix of EF-hand 3 and the entering helix of EF-hand 2 are in adjacent to 
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each other, and yet, no correlations was observed between these helices (Figure 8.11a). 
more importantly, the correlation between the entering helix of EF-hand 3 and the rest of 
the C-terminus is highly remodeled by binding of Ca2+ to EF-hand 3 and 4. Secondly, the 
dimeric DREAM shows enhancement of the dynamic coupling among residues at the C-
terminus (red community in Figure 8.13). These simulation also highlight the role of 
charged residues at the flexible loop connecting EF-hands 3 and 4 in stabilizing the protein 
dimer. Indicating that the dimeric structure of DREAM is not only stabilized by 
hydrophobic interactions but also by the presence of salt bridges. Overall, these simulations 
have allowed us to identify the residues at the entering helix of EF-hand 3 and the flexible 
loop as playing a major role in connecting the N- and C-terminus. But more importantly,. 
The observation that specific aromatic amino acids play a role in connecting the dynamic 
subunits at the N- and C-terminus provides an unique opportunity to investigate whether 
these amino acids are able to modulate the activity of this protein. 
 
8.2.3 Dynamic network analysis reveals the role of key conserved aromatic amino acid at 
the C-terminus of DREAM 
A closer inspection of the dynamic and structural changes triggered by removal of 
Ca2+ from DREAM during the cMD and aMD simulation of DREAM reveal and interesting 
reorganization of the C-terminus. As mentioned in the previous section, Ca2+ binding 
induces a strong reorganization of the C-terminus dynamic networks. These changes in 
dynamics show that upon binding of Ca2+, a strong dynamic coupling between then 
entering helix of EF-hand 3 (Figure 8.14a and b, purple helix) and the exiting helix of EF-
hand 4 (Figure 8.14a and b, cyan helix) is created. As shown in Figure 8.14c and d, we 
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have observed that in the Ca2+ bound form, residue Phe235 is in close contact with Tyr174 
and Phe171 at the entering helix of EF-hand 3. However, upon dissociation of Ca2+, Phe235 
undergoes a rapid change in conformation so that it is closely stacked with Phe218 and 
Phe219 at the entering helix of EF-hand 4. The structural switching behavior of Phe235 is 
subtle, but the induced dynamic coupling is clearly shown by the dynamic network 
analysis.  
Figure 8.14. Dynamic networks at the C-terminus, highlighting the strong dynamic 
coupling between the exiting helix of EF-hand 4 (cyan) and the entering helix of EF-hand 
3 (purple), (a) in the presence of Ca2+ and (b) in the absence of Ca2+. Reorganization of the 
C-terminus aromatic amino acids upon removal of Ca2+ from the EF-hands 3 and 4 of 
DREAM.  
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Figure 8.15. (a) Sequence alignment of mouse NCS-1, recoverin, VILIP-1, GCAP-1, and 
DREAM. Turn loops of EF-hand 1, 2, 3, and 4 are shown in bold and underlined. the 
negatively charged amino acids involved in metal coordination shown in red. The 
conserved aromatic amino acids are shown in bold underlined green letters. Asterisks 
indicate identical residues, semicolon indicates very similar residues, and the period is for 
somewhat similar residues. Amino acids involved in KV4 binding are shown in green. 
 
Analysis of the amino acid sequence of proteins belonging to all five group of NCS 
proteins (recoverin, NCS-1, VILIP-1, GCAP1, and DREAM) shows that these five 
aromatic amino acids are highly conserved among NCS protein (Figure 8.15). Therefore, 
it is possible that the observed conformation shift of Phe235 may represent a fundamental 
conformation transition upon Ca2+ binding in this family of CaBPs. Interestingly, in 
Chapter 4, we describe that the small hydrophobic compound NS5806 interacts with 
DREAM via a stacking interaction between the rings of Phe218 and Tyr174. The stacking 
interaction between N25805, Phe218, and Tyr174 induces a structural change on DREAM 
 244 
which facilitates KV4 channel blinding, even in the absence of calcium. Thus, we speculate 
that stacking of NS5806 between Phe218 and Phe219 would effectively displace Phe235 
and enhance the correlation of this amino acid with the entering helix of EF-hand 3. 
Therefore, it could be possible that the switching mechanism of Phe235 observed in these 
simulation is essential in regulating DREAM activity. 
 
8.2.4 Disruption of intrasubunit and intersubunit communication in DREAM by site 
directed mutagenesis and a DREAM-NCS1 chimera 
The analyses using molecular dynamic simulations have highlighted the role of the 
entering helix of EF- hand 3, the loop connecting EF-hand 3 and 4, and aromatic amino 
acids at the C-terminus of DREAM in regulating Ca2+ induced oligomerization and 
structural changes. These theoretical approaches were carried out to identify the 
mechanism by which Ca2+ regulates binding of ligands at the N- and C-terminus. Dynamic 
network analysis supports a model in which the H10 helix become dynamically coupled to 
EF-hand 3 in the absence of Ca2+, effectively eliminating the flexibility of this helix. This 
mechanism could explain the observed decreased in affinity for hydrophobic ligands 
binding at the C-terminus of DREAM. On the other hand, analysis of the simulation 
trajectory in section 8.2.1 and 8.2.2 show that propagation of structural changes from the 
C-terminus towards the N-terminus could potentially be mediated by intrasubunit and/or 
intersubunit couplings.  
Therefore, to support these findings it is essential to develop experimental 
approaches that could verify the role of specific amino acids on KV4 and drug binding. In 
this section and the next, we present extensive biochemical characterization of a small 
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library of DREAM mutants developed to understand the precise pathways of signal 
transduction in DREAM. Following results from the previous section, we have generated 
DREAM mutants in which Tyr174 and Phe235 were replaced by alanine in order to disrupt 
the intrasubunit pathways spanning the N- and C-terminus. These amino acids were 
identified as critical amino acid coupling dynamic motions between the N- and C-terminus. 
In addition, the single amino acid mutants Phe218Ala, and Phe219Ala have been generated 
to study the role of dynamic coupling at the C-terminus and the role of the transition shown 
in Figure 8.16. 
Figure 8.16. (a) Sequence alignment of mouse NCS-1, recoverin, VILIP-1, GCAP-1, and 
DREAM. Turn loops of EF-hand 1, 2, 3, and 4 are shown in bold and underlined. the 
negatively charged amino acids involved in metal coordination shown in red. The loop 
connecting the EF-hands 3 and 4 are shown in green bold and underlined, the respective 
negatively residue with whom these amino acids interacts is shown in bold underlined 
orange color. The LxxLL motif is shown in blue and the the amino acid with whom they 
interact is shown in orange.  
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 To investigate the role of intersubunit communications, we have generated a 
DREAM-NCS1 chimera in which the loop region connecting EF-hands 3 and 4 as well as 
the leucine rich motif in DREAM have been mutated to those present in NCS1. The 
neuronal calcium sensor-1 protein was selected because it is the only member of the NCS 
subfamily of Ca2+ binding proteins known to form monomers in the presence of Ca2+ (Lian 
et al. 2011). As shown in Figure 8.16, the Leucine charged domain with motif LxxLL is 
present in DREAM and partially in GCAP-1, but not in NCS-1, recoverin, and VILIP-1. 
Also, the hydrophobic amino acid with which the LxxLL motif interacts, is only present in 
DREAM (Leu251), NCS-1, and recoverin. Thus, indicating that the LxxLL motif may not 
be the only regulator of dimerization. However, analysis of the charge density of the loop 
connecting EF-hands 3 and 4 reveal a gradual decrease in total charge, with NCS-1 (charge 
-4), recoverin (charge -3), VILIP-1 (charge -1), GCAP-1 (charge -1), and DREAM (charge 
0). At the N-terminus, the negatively charged residue forming a salt bridge with the charged 
loop is well conserved among all NCS proteins (Figure 8.16 highlighted in orange). 
Therefore, it is probable that NCS-1 would experience a strong repulsion between the 
negatively charged loop connecting EF-hands 3 and 4 and Asp37 at the N-terminus, while 
DREAM would form a favorable salt bridge between Arg200, Arg2007, and Glu103. It is 
interesting to note that Glu103 corresponds to the –Z coordination of the Ca2+ binding loop 
of EF-hand 1. Therefore, it is possible that in NCS proteins, the structural changes induced 
at EF-hand 1 are not regulated by direct Ca2+ binding, but by intersubunit contact. On the 
basis of these observations we hypothesize that replacement of the loop residues of 
DREAM (residues 200 to 207, sequence: RHTYPILR) by the loop of NCS (residues 134 
to 141, sequence: NTVELPEE) and of the LxxLL motif of DREAM by the LxxTS motif 
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of NCS would result in inhibition of dimerization. The purpose of eliminating the 
dimerization of DREAM would serve to identify if whether the structural changes observed 
at the N-terminus of DREAM are triggered by intersubunit communications.   
In, addition we have also expressed and purified a DREAM(Δ160) protein 
construct in which the N-terminus domain (EF-hands 1 and 2) have been deleted. The 
DREAM(Δ160) construct allows us to investigate the role of the N-terminus in modulating 
the stability of the C-terminus. It would also provide insight in the how the presence of EF-
hand 1 and 2 can affect the fluorescence of Trp169 residing at the entering helix of EF-
hand 3. Lastly, a mutant in which Phe252 has been replaced by alanine would allow us to 
investigate whether disruption of the critical node between Phe252 and Phe218 can 
enhance or inhibit association of ligands at the C-terminus hydrophobic cavity. 
 
8.2.5 Mutation of the proposed aromatic amino acids and replacement of the LxLL and 
loop region of DREAM does not induce unfolding of the protein 
 Expression of these DREAM mutants in E. coli results in good protein yields, with 
quantities ranging from 10 to 15 mg of protein per liter of TB media. To ensure that these 
protein mutants are in a folded conformation, we have measured the CD spectra of all the 
mutants (Figure 8.17). These spectra clearly show that all mutants have a significant degree 
of alpha helical content, as expected for a fully alpha helical protein. These data also show 
that addition of Ca2+ induces an increase in alpha helical content, or reorganization of the 
alpha helices, which results in an overall decrease in ellipticity. However, not all mutants 
showed this transition, indicating that these amino acids mutations have effectively 
affected the ability of Ca2+ to reorganize the protein structure. For instance, the 
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DREAM(F235A) mutant (Figure 8.17e and inset) shows a reverse transition to that of 
DREAM(Δ65), in which Ca2+ binding induces a decrease in ellipticity. The small 
deviations in ellipticity likely arise from deviations in protein concentration or small 
differences in the overall structure of the proteins.  
Figure 8.17. Far-UV circular dichroism spectra of DREAM mutants. (a) DREAM(Δ65), 
(b) DREAM(Δ160), (c) DREAM(Y174A), (d) DREAM(F218A), (e) DREAM(F235A), 
and (f) DREAM-NCS. The spectra are shown in the presence of 1 mM EDTA (apo), 5 mM 
MgCl2 and 1 mM EGTA (Mg2+), 1 mM CaCl2 (Ca2+), and 1 mM CaCl2 and 5 mM MgCl2 
(Mg2+Ca2+). The coloring scheme is the same for all spectra. The protein centration was 
kept near 10 μM for all protein constructs in 5 mM TRIS pH 7.4. 
 
8.2.6 Mutation of Phe219, Phe235, or loop replacement induce a reversal of the transition 
in tryptophan fluorescence upon Ca2+ binding to DREAM 
 Another convenient approach to determine the extent of structural reorganization 
upon Ca2+ binding, is to monitor the intrinsic tryptophan fluorescence of these construct. 
All constructs contain a single tryptophan amino acid located at the entering helix of EF-
hand 3. The helix discussed above is important for coupling of the N- and C-terminus 
dynamic motions, and should be highly sensitive to local structural changes as a results of 
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the mutations. As shown in Figure 8.18, all mutants show a clear tryptophan fluorescence 
near ~330 nm; however, there are clear difference in the transition observed upon metal 
binding. The DREAM(Δ65) shows the expected decrease in tryptophan fluorescence upon 
Ca2+ binding, while the DREAM(Δ160) mutant shows a similar decrease transition. In 
addition, the DREAM(Δ160) construct shows an additional sensitivity to Mg2+, which 
induces an increase in fluorescence in the absence of Ca2+.  
In contrast, DREAM(Y174A) (Figure 8.18c), shows a decrease in fluorescence 
upon Ca2+ binding to the apo protein, but a strong increase upon Mg2+ binding. The increase 
in fluorescence observed upon Mg2+ binding is eliminated once Ca2+ is added, indicating 
that both metal share the same metal biding site on this protein, or that the structural 
changes induced by Ca2+ eliminate those induced by Mg2+. The DREAM(F218A) and 
DREAM(F252A) mutants show a transition identical to that observed in the DREAM(Δ65) 
construct, indicating that this mutation does not induce significant changes in the Trp169 
environment upon metal binding. On the other hand, the DREAM(F219A) mutant shows 
a inversed transition upon Ca2+ binding, in which Ca2+ binding to the protein induces an 
increase in tryptophan fluorescence (Figure 8.18e). The reversed transition is also observed 
in the DREAM(F235A) and DREAM-NCS mutants (Figure 8.19f and h). In all cases the 
presence of Mg2+ did not extensively affect the tryptophan fluorescence of the Ca2+ free or 
bound form, with exception of DREAM(Δ160) and DREAM(Y174A) construct. Overall, 
these results reveal that the structural changes near the Trp169 residue are highly sensitive 
to mutations of aromatic amino acids at the C-terminus.  
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Figure 8.18. Tryptophan fluorescence spectra of DREAM mutants. (a) DREAM(Δ65), (b) 
DREAM(Δ160), (c) DREAM(Y174A), (d) DREAM(F218A), (e) DREAM(F219A), (f) 
DREAM(F235A), (g) DREAM(F252A), and (h) DREAM-NCS. The spectra are shown in 
the presence of 1 mM EDTA (apo), 5 mM MgCl2 and 1 mM EGTA (Mg2+), 1 mM CaCL2 
(Ca2+), and 1 mM CaCl2 and 5mM MgCl2 (Mg2+Ca2+). The coloring scheme is the same 
for all spectra. The protein concentration was kept near 10 μM for all protein constructs in 
5 mM TRIS pH 7.4. 
 
 Additionally, using frequency domain fluorescence and anisotropy decay of 1,8-
ANS bound to DREAM-NCS1 as described in chapter 3, we have determined that this 
construct effectively forms monomers in solution. Moreover, addition of Ca2+ or Mg2+ does 
not induce the formation of the dimer. However, an increase  in Ca2+ 1,8-ANS fluorescence 
supports a model in which reorganization of the H10 helix and not dimerization mediate 
binding of small hydrophobic molecules such as 1,8-ANS, arachidonic acids, and NS5806.  
 The emission spectra of DREAM-NCS1 bound to ANS shows a transition towards 
stronger fluorescence upon binding of Ca2+ as well as in the presence of Mg2+. However, 
this increase in fluorescence is not additive, and addition of both metals leads to an 
intermediate fluorescence. Similarly, we observe that the fluorescence lifetime of 1,8-ANS 
bound to the hydrophobic cavity of DREAM (τ3) increase in the presence of Mg2+ or Ca2+ 
Table 8.1).  
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Figure 8.19. Fluorescence emission spectra of 1,8-ANS bound to DREAM-NCS1 in the 
presence of Ca2+, Mg2+, or both. 
 
The pre-exponential parameter (α3) also shows a strong increase from 50 % in the 
metal free state, to about 60 to 70 % upon binding of Ca2+ or Mg2+. The larger fraction of 
1,8-ANS bound at the hydrophobic cavity, compared to that observed for DREAM(Δ65) 
in Chapter 3, indicates that this mutant is able to bind 1,8-ANS more readily than the wild-
type protein. The anisotropy decay of 1,8-ANs bound to DREAM reveals the presence of 
at least three depolarization processes. A fast rotation of about 1.15 ns as well as a ~11 ns 
and 52 ns rotational correlation times are observed regardless of the presence of Ca2+ or 
Mg2+. These rotational correlation times are identical to those observed in the 
DREAM(Δ65) construct and likely represent a local motion (1.2 ns), monomeric (11 ns), 
and tetrameric DREAM-NCS1 (52 ns). Moreover, the fact that these rotations do not 
change, but the intensity of 1,8-ANS increases significantly, indicates that this protein 
construct form monomers in solution and is able to induce exposure of a hydrophobic 
cavity upon Ca2+ binding. 
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Table 8.1 Fluorescence and anisotropy decay parameters of 1,8-ANS bound 
DREAM-NCS1. 
 f1 τ2 f2 τ3 f3 α1 θ2 α1 θ2 χ2 
apo 0.06 5.8 0.41 13.8 0.5 -0.38 6.0 0.3 0.74 0.3 
Mg2+ 0.03 6.3 0.32 16.5 0.64 -0.31 11.2 0.57 0.39 1.19 
Ca2+ 0.02 6.6 0.37 17.5 0.6 -0.2 14.3 0.68 0.4 1.46 
Mg2+Ca2+ 0.02 6.7 0.26 18.2 0.7 -0.2 10.4 0.58 0.55 0.74 
A value of 0.28 ns was fixed for the lifetime of unbound 1,8ANS as described in 
Chapter 3. A rotation of 1.15 ns and a third with 52 ns were set as linked variables 
among all traces. A stoichiometric ration 1:1:, 20 μM DREAM-NCS1 and 20μM 
1,8-ANS in 20mM MOPS pH 7.4 1mM DTT was used throughout. 
 
8.2.7 Aromatic amino acid mutation or loop replacement modulates the affinity of Ca2+ 
binding at EF-hand 3 and 4. 
 To determine whether mutations of the aromatic amino acid or the loop connecting 
EF-hand 3 and 4 affect Ca2+ binding, we have conducted calcium titrations while 
monitoring the change in tryptophan fluorescence. In addition, we have also studied the 
Ca2+ affinity of DREAM(E186Q) and DREAM(E234Q), whose EF-hand 3 and EF-hand 4 
have been inactivated, respectively. Overall, we have observed that the constructs 
presented here either undergo a decrease or increase in tryptophan fluorescence upon Ca2+ 
binding. However, the magnitude of these transitions can be significantly different (Figure 
8.17). In Figure 8.20 we present the normalized change in tryptophan fluorescence intensity 
of all mutants as a function of Ca2+ binding. The group of proteins showing a decrease in 
fluorescence include DREAM(Δ65), DREAM(Δ160), DREAM(Y174A), 
DREAM(F218A), DREAM(F252A), and DREAM(E186Q).  
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Figure 8.20. Calcium binding experiments monitoring the tryptophan fluorescence change 
upon Ca2+ binding to each DREAM mutants. (a) All the titration curves for DREAM 
constructs showing a decrease in tryptophan fluorescence similar to that of DREAM(Δ65) 
and (b) DREAM mutants whose change in fluorescence is reverse to that observed in the 
DREAM(Δ65) protein. Protein samples contained 5 μM DREAM in 20mM MOPS pH 7.4 
1 mM EGTA and 1 mM NTA. The concentration of calcium free was determined using the 
known fluorescence transition and dissociation constants of Quin-2.  
 
They all show a single sigmoidal isotherm, with exception of DREAM(E186Q), which 
shows a monotonous almost linear decrease. In terms of Ca2+ affinity, analysis of the data 
with a simple Hill equation reveals affinities ranging from 400 nM to 2.1 μM, as shown in 
Table 8.2. The DREAM(Δ160) and DREAM(Δ65) construct show the strongest Ca2+ 
affinity, followed by DREAM(Y174A), DREAM(F218A), DREAM(F252A), and 
DREAM(E186Q). The Hill coefficient for all these constructs is near 2. The 
DREAM(E186Q) showed a similar decrease as DREAM(Δ65), but the Ca2+ binding curve 
was markedly different. This construct showed the presence of strong binding site with Kd 
~ 10 μM and n=1 and an additional binding with a dissociation constant in the millimolar 
range. We propose that the additional binding site is due to Ca2+ binding to EF-hand 3 or 
2, which likely happens at high Ca2+ concentrations.  
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Table 8.2 Equilibrium dissociation 
constants for Ca2+ binding to DREAM 
construct Kdss 
(µM)a n 
DREAM(Δ65) 0.4 2.2 ± 0.2 
DREAM(Δ160) 0.7 2.1 ± 0.2 
DREAM(E186Q) ~1.0 0.8 ± 0.1 
DREAM(E234Q) 1.3 4.0 ± 0.4 
DREAM(Y174A) 0.5 1.8 ± 0.2 
DREAM(F218A) 2.1 2.5 ± 0.3 
DREAM(F219A) 6.0 2.4 ± 0.3 
DREAM(F235A)  n.d. n.d. 
DREAM(F252A) 5.8 2.2 ± 0.4 
DREAM-NCS 2.0 3.7 ± 0.2 
CaM 15 2.0 ± 0.1 
(a) Dissociation constants calculated from 
steady-state fluorescence. Errors are less 
than 0.1 units. Not determined (n.d.) 
 
 The group of DREAM construct characterized by an increase in tryptophan 
fluorescence upon Ca2+ binding included DREAM(F219A), DREAM-NCS, and 
DREAM(E234Q) (Figure 8.20b). These mutants show somewhat larger differences in 
affinities (Table 8.2), with dissociation constants ranging from 1.2 μM to 6.0 μM. For 
comparison, the titration curve for calmodulin is shown, with a dissociation constant of 15 
μM and Hill coefficient of 2.0, which are similar to the reported values of 5 to 20 μM 
(Kuboniwa et al. 1995). Remarkably, fitting of the DREAM(E234Q) titration yields a Hill 
coefficient larger than 1, which is not expected on the basis that only one high affinity Ca2+ 
binding site is present. However, it is possible that because of the small change in 
fluorescence observed upon Ca2+ binding in this construct, additional effects such as 
changes in ionic strength and nonspecific binding of Ca2+ may contribute to the signal 
 255 
change. Similarly, fitting of the DREAM-NCS titration data yields a large Hill coefficient 
(n = 3.7 ± 0.2), this mutant also shows a small tryptophan transition upon calcium binding. 
Despite the differences, these Ca2+ binding studies confirm that these protein construct are 
able to bind Ca2+ with affinities in micromolar range and bind Ca2+ with higher affinities 
than calmodulin. This strong binding affinity is a common characteristic among NCS 
proteins, which implicates that these constructs are properly folded (Burgoyne 2007) 
 
8.2.8 Aromatic amino acids at the C-terminus provide significant stabilization of the N- 
and C-terminus domain of DREAM. 
 We carried out unfolding experiments to characterize the role of aromatic amino 
acids at the C-terminus as well as the role of the flexible loop connecting EF-hands 3 and 
4 in stabilizing the structure of DREAM. In these experiments we have monitored the 
intrinsic tryptophan fluorescence of each construct as a function of increasing 
concentrations of GuHCl, a compound known to destabilize the tertiary and secondary 
structure of proteins (Monera, Kay & Hodges 1994). At increasing concentrations of 
GuHCl (up to 6.9 M) all of the DREAM mutants show a clear shift in the emission maxima 
of tryptophan (Figure 8.21). However, the profiles for the unfolding curve are highly 
dependent on metal binding as well as to specific mutations. In the absence of Ca2+ or Mg2+, 
most DREAM construct have an emission maxima near 340 nm, with  the exception of 
DREAM(Δ160) (maxima at 356 nm), DREAM-NCS (maxima at 350 nm), and 
DREAM(Y174A) (maxima at 346 nm).  The differences in emission spectra between 
Figure 8.21 and those shown in Figure 8.18 is because the spectra of Figure 8.18 have not 
been corrected for the PMT response of the instrument. An intermediate unfolded state of 
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the protein is also clearly visible between 2 and 3 M GuHCl, with an emission maxim of 
350 nm. 
Figure 8.21. Unfolding experiment of DREAM constructs, in which the tryptophan 
fluorescence maxima was monitored as a function of guanidium hydrochloride (GuHCl) 
concentration. The protein was kept at 5 μM for all protein construct and at all GuHCl 
concentrations. 
 
Even though it may not be visible in Figure 8.21a, DREAM-NCS also shows the 
presence of an intermediate with maxima at 352 nm, while the DREAM(Δ160) construct 
unfolds without populating an intermediate in the absence of Ca2+. At 6.9 M GuHCl, all 
DREAM construct are in an unfolded state with emission maxima at 358 ± 1 nm. In the 
presence of excess Mg2+, the unfolding traces do not look remarkably different than Figure 
8.21a, and similar emission maxima are observed (Figure 8.21b).  
 Upon binding of Ca2+, significantly different unfolding curves are recovered for 
most of the mutants (Figure 8.21c). The most obvious changes are observed for 
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DREAM(Δ65) and DREAM(F252A), both of which show the presence of an additional 
blue shift upon addition of less than 1M GuHCl. The blue shift is followed by a red shift 
to 352 nm at which point an intermediate unfolded state can be observed. Also, upon 
binding of Ca2+, DREAM(F235A) unfolds through a a two-step process without populating 
a clear intermediate. In addition, upon Ca2+ binding,  DREAM(Δ160) unfolds through a 
three-step process with a partially stable intermediate at between 2 and 3 M GuHCl and 
emission maxima of 356 nm. As observed before, addition of 5 mM Mg2+ to the Ca2+ 
bound proteins did not cause major changes in the unfolding curves (shown in Figure 
8.21d).  
 The presence of an intermediate state becomes more obvious when the intensity of 
the tryptophan fluorescence is monitored as a function of GuHCl. As shown in Figure 8.22a 
and b, a clear redshift and increase in fluorescence is observed upon unfolding of Ca2+ free 
and bound DREAM(Δ65). In the absence of Ca2+, figure 8.22a and c, show that DREAM 
unfolds without a significant increase in fluorescence intensity upon formation of the 
intermediate. In the presence of Ca2+, however, formation of the intermediate state 
(between GuHCl concentrations of 3 M and 5 M) leads to an approximately two-fold 
enhancement in fluorescence intensity compared to the apo protein at the same GuHCl 
concentrations. In addition, in the presence of Ca2+, there is an additional initial process 
which triggers a blue shift of the tryptophan fluorescence, this process is not present in the 
absence of Ca2+. In the mutants, the brighter intermediate was only observed in the 
DREAM(F235A), DREAM(F219A), and DREAM(F252A) in addition to the 
DREAM(Δ65). 
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Figure 8.22. Tryptophan fluorescence emission spectra as a function of GuHCl for (a) Ca2+ 
free and (b) Ca2+ bound DREAM(Δ65). The emission spectra of the native DREAM, 
intermediate, and unfolding protein in the absence of Ca2+ (c) and presence of Ca2+ is 
shown (d). 
 
 Even though there are very clear difference in the unfolding curves in the absence 
and presence of Ca2+, in order to quantify the magnitude of the effects of mutation and 
metal binding on stability, we have fitted the data in figure 8.21 using equation 8.4. 
Equation 8.4 allows the extraction of the energetics associated with unfolding of the 
protein. A representative unfolding dataset with the fitted curve is shown in Figure 8.23a 
and b, and the recovered parameters for all constructs are shown Table 8.3 and 8.4. Most 
unfolding traces show the presence of a three-step unfolding pathways, with the exception 
of the Ca2+ free DREAM(Δ160) construct as well as the Ca2+ bound DREAM(F218A) 
construct. 
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Figure 8.23. Representative unfolding trace of (a) DREAM (Δ65) and (b) DREAM-NCS 
in the apo, Mg2+, Ca2+, and Mg2+Ca2+ bound forms. Solid lines represent the best fit using 
equation 8.4. 
 
As shown in Figure 8.24, the Ca2+ free and Mg2+ bound DREAM(Δ65) unfolding 
curve is well fitted by Eqn. 8.4. However, in the presence of Ca2+, the additional unfolding 
process happening at GuHCl concentrations below 1 M cannot be properly fitted. 
Nonetheless, the initial blue shift of tryptophan fluorescence only occurs when using 
GuHCl, since unfolding DREAM with Urea did not show the presence of an initial blue 
shift (Figure 8.23a inset). It has been proposed that changes in protein structure at low 
concentrations of GuHCl are due to direct binding of GuHCl to the protein, whereas at 
higher GuHCl concertation the unfolding is driven by solvent effects (Zarrine-Afsar et al. 
2006, Mason et al. 2009). Therefore for the traces showing the blue shift at low GuHCl 
concentration, we have decided to not fit the initial blue shift, since it may actually 
represent a binding effect. Thus for the Ca2+ bound DREAM(Δ65) and DREAM(F252A) 
mutants, only the data for GuHCl concentrations above 1 M were fitted.  
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Table 8.3 Parameters recovered from fitting of the unfolding curves of DREAM mutants 
 DREAM(Δ65) DREAM(Δ160) 
 apo Mg2+ Ca2+ Mg2+Ca2+ apo Mg2+ Ca2+ Mg2+Ca2+ 
λNative 339 338 332 333 354 354 353 352 
λIntermediate 352 352 352 352   356 356 
λUnfolded 358 359 358 358 355 358 358 358 
ΔGI 1.3 ± 0.1 2.7 ± 0.1 2.6 ± 0.2 4.4 ± 0.2 2.0 ± 0.3 1.9 ± 0.2 0.7 ± 0.1 0.3 ± 0.1 
mΔGI 1.2 1.8 1.4 2.2 0.7 0.5 1.4 1.3 
ΔGU 4.9 ± 0.8 4.6 ± 0.3 6.2 ± 1.0 5.8 ± 0.6   4.8 ± 0.4 5.4 ± 0.4 
mGU 1.3 1.1 1.2 1.2   1.2 1.2 
ΔGTOTAL 6.3 7.3 8.8 10.2 2.0 1.9 5.5 5.7 
 DREAM(Y174) DREAM(F218A) 
 apo Mg2+ Ca2+ Mg2+Ca2+ apo Mg2+ Ca2+ Mg2+Ca2+ 
λNative 344 341 340 343 340 339 340 339 
λIntermediate 350 350 349 348 350 350   
λUnfolded 358 358 357 357 358 358 358 358 
ΔGI 2.1 ± 0.4 1.5 ± 0.2 0.7 ± 0.4 1.8 ± 0.4 6.4 ± 0.6 3.6 ± 0.4 2.5 ± 0.7 2.5 ± 0.2 
mΔGI 2.2 1.7 0.7 1.5 3.9 2.3 0.7 0.7 
ΔGU 2.6 ± 0.2 2.8 ± 0.2 4.9 ± 0.6 3.5 ± 0.3 4.1 ± 0.2 3.8 ± 0.4   
mGU 0.7 0.7 1.6 0.8 1.1 0.9   
ΔGTotal L 4.7 4.2 5.7 5.4 10.5 7.4 2.5 2.5 
Parameters recovered using equation 8.4 and data shown in Figure 8.  The sum of  ΔGI and ΔGU are used to 
calculate   ΔGTotal . Emission wavelengths are shown n unit of nm, while the ΔG parameters are shown with units of  
kcal·mol-1. 
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Table 8.4 Parameters recovered from fitting of the unfolding curves of DREAM mutants 
 DREAM(F235A) DREAM(F252A) 
 apo Mg2+ Ca2+ Mg2+Ca2+ apo Mg2+ Ca2+ Mg2+Ca2+ 
λNative 342 341 343 343 339 337 333 334 
λIntermediate 349 351 352 351 349 350 351 351 
λUnfolded 358 358 356 356 358 358 358 358 
ΔGI 2.3 ± 0.8 1.4 ± 0.1 2.0 ± 0.1 2.7 ± 0.2 2.6 ± 0.4 2.4 ± 0.4 4.2 ± 0.1 4.2 ± 0.3 
mΔGI 2.1 1.2 1.4 1.8 2.1 1.9 2.0 2.0 
ΔGU 2.4 ± 1.3 3.9 ± 0.6 4.3 ± 0.9 4.3 ± 1.0 2.4 ± 0.5 2.7 ± 1.0 4.7 ± 0.6 4.6 ± 0.7 
mGU 0.7 0.9 0.9 0.9 0.6 0.7 0.9 0.9 
ΔGTOTAL 4.8 5.3 6.3 7.0 5.0 5.1 8.9 8.8 
 DREAM(F219A) DREAM-NCS 
 apo Mg2+ Ca2+ Mg2+Ca2+ apo Mg2+ Ca2+ Mg2+Ca2+ 
λNative 339 340 340 341 346 348 347 348 
λIntermediate 350 339 350 348 353 352 353 353 
λUnfolded 358 363 357 359 358 358 358 358 
ΔGI 2.0 ± 0.1 2.4 ± 0.6 0.8 ± 0.1 1.2 ± 0.1 0.8 ± 0.5 1.7 ± 0.4 0.5 ± 0.6 0.8 ± 0.4 
mΔGI 1.7 2.7 1.0 1.3 1.43 2.29 0.65 1.09 
ΔGU 2.6 ± 0.4 0.4 ± 0.3 2.9 ± 0.3 1.6 ± 0.1 2.7 ± 0.4 2.1 ± 0.3 4.0 ± 1.2 3.5 ± 0.5 
mGU 0.7 0.2 0.6 0.3 0.93 0.80 0.97 0.95 
ΔGTotal 4.6 2.9 3.7 2.8 3.5 3.8 4.5 4.4 
Parameters recovered using equation 8.4 and data shown in Figure 8.  The sum of  ΔGI and ΔGU are used to 
calculate   ΔGTotal . Emission wavelengths are shown n unit of nm, while the ΔG parameters are shown with units of  
kcal·mol-1. 
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We observe that in unfolding of the the Ca2+ free DREAM(Δ65) protein, the first 
unfolding process is associated with a ΔGI of 1.3 ± 0.1 kcal·mol-1 and the second with ΔGU 
= 4.9 ± 0.8 kcal·mol-1. In the presence of Mg2+, the first unfolding transitions shows an 
increase in stability, with ΔGI = 2.7 ± 0.1 kcal·mol-1, while the second remains unchanged 
at ΔGU = 4.6 ± 0.3 kcal·mol-1. A similar, but stronger, increase in stability of the protein is 
observed upon binding of Ca2+ to the apo protein (ΔGI = 2.6 ± 0.2 kcal·mol-1 and ΔGU = 
6.2 ± 1.0 kcal·mol-1) and Ca2+ binding to the Mg2+ bound protein (ΔGI = 4.4 ± 0.2 kcal·mol-
1 and ΔGU = 5.8 ± 0.6 kcal·mol-1). The stabilization provided by metal binding is clearly 
observed on the total energy required to unfold the protein, which increase from 6.3 
kcal·mol-1 in the apoform to 10.2 kcal·mol-1 upon binding of Mg2+ and Ca2+. 
 The DREAM(Δ160) construct in the metal free form unfolds via two-step process 
which is insensitive to the presence of Mg2+ (ΔGI = 2.0 ± 0.3 kcal·mol-1 and ΔGU = 1.9 ± 
0.2 kcal·mol-1). However, this construct is stabilized by about 3 kcal·mol-1 upon binding 
of Ca2+, regardless of the presence of Mg2+. In addition, the Ca2+ bound form unfolds 
though a  three-step process in in which the first step is marginally stable (0.5 kcal·mol-1). 
The different emission maxima of the DREAM(Δ65) and DREAM(Δ160) intermediate 
structures (352 nm vs 356 nm, respectively) as well as the different energetics, indicates 
that the initial NI unfolding process in the Ca2+ bound form of these protein is not the 
same. Furthermore, the total energy required to unfold the EF-hands 3 and 4 present in the 
DREAM(Δ160) construct is identical to the necessary energy to transition from the 
intermediate to the unfolded state of the Ca2+ and Mg2+Ca2+ bound DREAM(Δ65), compare 
ΔGI ~ 6.0 kcal·mol-1 for DREAM(Δ65) and ΔGTotal ~5.6 kcal·mol-1 for DREAM(Δ160).  
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 The DREAM(Y174A) construct was also characterized by a three-step unfolding 
pathway, in which the native, intermediate, and unfolded states have a similar tryptophan 
fluorescence maxima at ~ 340 nm, 350 nm, and 358 nm. The NI transition indicates that 
the native conformation is less stable than that observed in DREAM(Δ65) and only 
marginally affected by the presence of Ca2+ or Mg2+ (apo: 2.1 ± 0.4 kcal·mol-1 , Mg2+: 1.5 
± 0.2 kcal·mol-1 , Ca2+: 0.7 ± 0.4 kcal·mol-1 , Ca2+ Mg2+: 1.8 ± 0.4 kcal·mol-1 ). The 
transition from the intermediate structure to the fully unfolded conformation (IU) shows 
a clear dependence on Ca2+ binding, but not Mg2+. On average,  Ca2+ binding stabilizes the 
transition from the intermediate to the unfolded structure by about 1.2 kcal·mol-1, which is 
much less than that observed for binding of Mg2+ and Ca2+ to DREAM(Δ65). Interestingly, 
the DREAM-NCS and DREAM(F235A) constructs showed similar insensitivity to the 
presence of Mg2+ as that observed in the DREAM(Y174A) mutant as well as a modest 
increase in stability upon Ca2+ binding. The DREAM-NCS construct was also less stable 
than the DREAM(Y174A) mutant, with a total energy of unfolding in the absence of Ca2+ 
of about 3.6 kcal·mol-1 and 4.5 kcal·mol-1 upon Ca2+ binding. On the other hand, 
DREAM(F235A), was slightly more stable in the presence of Ca2+ than the 
DREAM(Y174A) mutant (ΔGTOTAL ~ 5 kcal·mol-1 in the Ca2+ free and ΔGTOTAL ~ 6.7 
kcal·mol-1 in the Ca2+ bound state). The DREAM(F235A) construct had similar tryptophan 
emission wavelength for the native conformation (λNative on average 343 nm), intermediate 
conformation (λIntermediate on average 351 nm), and unfolded state (λUnfolded on average 357 
nm) as the DREAM(Δ65). However, DREAM-NCS had an emission maxima in the native 
state of about 347 nm (also note the plot on Figure 8.21), while the emission of the 
intermediate and unfolded states were similar to those of DREAM(Δ65). 
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 The mutation of Phe218 on the entering helix of EF-hand 4 is characterized by a 
remarkable reversal of the unfolding stabilities compared to the DREAM(Δ65) and 
DREAM(Δ160) constructs. In this case, DREAM(F218A) is more stable in the absence of 
Ca2+ or Mg2+, and Ca2+ binding triggers the transition from a three-state to a two-state 
unfolding pathway. The overall unfolding stability of the Ca2+ free DREAM(F218A) 
construct (ΔGTOTAL = 10.5 kcal·mol-1) is comparable to that of the Mg2+Ca2+ bound 
DREAM(Δ65) protein (ΔGTOTAL = 10.2 kcal·mol-1). However, in DEAM(F218A), the first 
transition from native to intermediate is more stable (ΔGI = 6.4 ± 0.6 kcal·mol-1) than the 
intermediate to unfolded state transition (ΔGU = 4.1 ± 0.6 kcal·mol-1). Binding of Mg2+ to 
this mutant decreases the stability of both transition to about 3.7 kcal·mol-1, while binding 
of Ca2+ to the metal free or Mg2+ bound DREAM(F218A) protein also leads to a significant 
decrease in stability, with ΔGTOTAL = 2.5 kcal·mol-1.  
 
Figure 8.24. Unfolding plot of (a) DREAM (F218A) and (b) DREAM(F219A) in the apo, 
Mg2+, Ca2+, and Mg2+Ca2+ bound forms. Solid lines represent the best fit using equation 
8.4. 
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Table 8.5 Summary of observed unfolding effects on DREAM mutants 
 
DREAM 
(Δ65) 
DREAM 
(Δ160) 
DREAM 
(Y174) 
DREAM  
NCS 
DREAM 
(F218A) 
DREAM 
(F219A) 
DREAM 
(F235A) 
DREAM 
(F252A) 
Unfolding 
path in Ca2+ 
free 
 
NIU IU NIU NIU NIU NIU NIU NIU 
Unfolding 
path in Ca2+ 
bound 
NIU NIU NIU NIU I-->U NIU NIU NIU 
         
Mg2+ effect Stabilize NIU none none none 
Destabilize  
NI 
in apo 
Destabilize 
IU none none 
Ca2+ effect stabilize NU 
Stabilize 
NU 
Stabilize 
IU 
Stabilize 
IU 
Destabilize 
NU 
Destabilize 
NU 
weak 
Stabilize 
NIU 
Stabilize 
NIU 
         
Bright 
Intermediate YES NO NO NO NO YES YES YES 
         
ΔλN-->U 23 4 15 11 19 15 15 22 
 266 
Mutation of the amino acid adjacent of Phe218 in the DREAM(F219A) mutant 
leads to an overall decrease in stability of the protein, compared to the DREAM(Δ65) 
construct, mainly due to a decrease in stability of the IU unfolding pathway. In the 
DREAM(F219A) mutant, we also observe a metal induced decrease in stability similar to 
DREAM(F218A); however, the decrease in stability due to Ca2+ or Mg2+ binding is 
restricted to the NI or the IU transition, respectively. The metal-selective decrease in 
stability seems to be additive, since in the presence of Mg2+ and Ca2+ the overall stability 
of the unfolding process decreases by half (from ΔGTOTAL = 4.6 kcal·mol-1 to ΔGTOTAL = 
2.8kcal·mol-1). 
Lastly, replacement of Phe252 on the H10 helix to alanine partially stabilized the 
transition from NI in the presence of Ca2+, compared to the DREAM(Δ65) construct, 
while Mg2+ had no effect on the stability (apo: ΔGI = 2.6 ± 0.4 kcal·mol-1 , ΔGI = Mg2+: 
ΔGI = 2.4 ± 0.4 kcal·mol-1 , ΔGI = Ca2+: 4.2 ± 0.1 kcal·mol-1 , Ca2+ Mg2+: 4.2 ± 0.3  
kcal·mol-1). The second transition, from IU, was identical to the NI transition in terms 
of energetics and metal binding effect. Overall, the energy required to unfold 
apoDREAM(F252A) (ΔGTOTAL) was similar to that required to unfold the 
apoDREAM(Δ65) construct; however, no increase in stability was observed upon binding 
of Mg2+. The summary of observations described above are listed in Table 8.4. 
 
8.2.9 Amino acid mutations modulate the conformational dynamics of Trp169  
 As show in the previous sections, the position of Trp169 at the entering helix of 
EF-hand 3 is highly sensitive to amino acid mutations, Ca2+ binding, and protein unfolding. 
To better understand how these experiment observations correlate to the molecular 
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organization of DREAM, in this section, we employ extensive biophysical characterization 
of tryptophan dynamics. In particular, we hypothesize that fluctuations of the rotameric 
states of Trp169 may help explain the observed changes in fluorescence due to amino acid 
mutation and calcium binding. In solution, tryptophan has been proposed to populate three 
rotameric states (the g+, g-, and t) (Figure 8.25). More importantly, the fluorescence decay 
of tryptophan has also been correlated to population of different rotameric states (Szabo, 
Rayner 1980, Clayton, Sawyer 1999). In solution, the g+ is the most favored conformation, 
while g- is the least favored (Ross, Jameson 2008). However, in proteins, the structural 
organization of the backbone and other regions of the proteins may hinder or promote a 
specific rotameric conformation. Furthermore, it is possible that dynamic fluctuations in 
protein conformation may allow the population of multiple rotameric conformations 
depending on the protein structure and dynamics. 
Figure 8.25. Rotameric states of tryptophan in proteins. (a) Newman projection of the t 
rotamer and (b) g+ rotamer with view along the Cα-Cβ carbon bond. The corresponding 
indole conformations as observed in the aMD simulation of apoDREAM(Δ160). The 
measured Cα-Cβ and Cβ-Cγ angles are highlighted with black arrows. 
 
Implementation of molecular dynamic simulations is ideal to investigate the 
structural organization of DREAM at the molecular level, and to define whether the 
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experimental observations can be associated with multiple rotameric states of tryptophan. 
However, the rotameric transitions in DREAM may occur in the microsecond to 
millisecond timescales, which are not readily available through classical molecular 
dynamics. To overcome the computational costs of obtaining MD data with temporal 
resolution similar to that observed experimentally, we have employed accelerated 
molecular dynamics (aMD). The aMD simulation method allows us to enhance the 
conformational sampling of the protein by lowering the energy barrier separating multiple 
conformations of the protein (Hamelberg, Mongan & McCammon 2004). The decrease in 
energetic barriers between multiple states is attained by increase of the potential energy 
wells by addition of an external energy. In our approach, the external energy is added to 
the dihedral angles of every amino acids. The energetic addition results in an enhanced 
sampling of rotameric states for all the amino acids as well as an increase in the 
conformational space that the protein can sample. As described in section 8.2.1, aMD 
effectively induced the transition from the Ca2+ bound structure of DREAM to a proposed 
structure of the apoprotein within 20 ns. Therefore, we propose to use this method not to 
only investigate the rotameric state of Trp169 in DREAM in the presence of Ca2+ but also 
in the absence of this metal.  
 In Figure 8.26 and 8.27 we show the population of rotameric states for the Ca2+ free 
and bound state of the DREAM constructs. In these figures we plot the Cβ-Cγ angle as a 
function of Cα-Cβ angle, this was taken from the observation that the benzene of the  indole 
ring of DREAM was able to rotate 180 ° and point towards the nitrogen (angles less than 
180 °, herein referred as D+)  or towards the carboxy group of the peptide bond (angles 
between 180 ° and 360 °, herein referred as D-). In these plots, the g+ rotamer of tryptophan 
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would lay between 120 ° and 239 °, the g- between 240 °and 360 °, and the t rotamer 
between 0 ° to 119 ° on the x-axis. The Cα-Cβ dihedral angle distribution in Figure 8.26 
and 8.27 clearly show that no conformation was present with angles above 240 °. This 
observation is expected, since a g- conformation for tryptophan forming part of an alpha 
helix would result in significant steric hindrance and distortion of the helix.  
 
Figure 8.26. Plots of the Cβ-Cγ as a function of Cα-Cβ dihedral angle of tryptophan 169 in 
the Ca2+ bound (a) DREAM(Δ160), (c) DREAM(Δ65), and (e) DREAM(Y174A), as well 
as the Ca2+ free of the (b) DREAM(Δ160), (f) DREAM(Δ65), and (f) DREAM(Y174A). 
A total of 4000 points representing 20 ps each are plotted, obtained from the aMD 
simulations. The angles at which the t or g+ rotamers are present as well as the orientation 
of the indole ring in the D+ or D- are show in in panel (a). 
 
Thus, in DREAM, only the g+ and t rotamers are present. On the other hand, the 
distribution of Cβ-Cγ angles reveals that a wide range of angles can be populated for the 
dihedral plane between the Cβ and Cγ carbons, with angles between 50 ° to 90 ° and 200 ° 
to 300 ° being most common, depending on the protein construct. For instance, the 
DREAM(Δ160) construct shows the presence of g+ and t rotamers with indole ring in the 
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D+ and D- conformation. In the presence of  Ca2+ the predominant specie is the t rotamer 
with D- indole conformation, while in the absence of Ca2+ the g+ rotamer with D- indole 
conformation is preferred (Figure 8.26a and b). The widespread distribution of Trp169 
rotamers and indole orientation in the DREAM(Δ160) construct is likely because of the 
absence of the N-terminus domain, which significantly decrease the steric hindrance of 
tryptophan. 
Figure 8.27. Plots of the Cβ-Cγ as a function of Cα-Cβ dihedral angle of tryptophan 169 
in the Ca2+ bound (a) DREAM(F218A), (c) DREAM(F219A), and (e) DREAM(F252A), 
as well as the Ca2+ free of the (b) DREAM(F218A), (d) DREAM(F219A), and (f) 
DREAM(F252A). A total of 4000 points representing 20 ps each are plotted, obtained from 
the aMD simulations. 
 
In the DREAM(Δ65) construct, the absence of Ca2+ results in the population of the 
t rotamer and indole in the D- conformation, while upon binding of Ca2+, a clear transition 
to the g+ rotamer with D+ conformation is observed. Interestingly, the D- rotameric state 
of Trp169 places the indole in direct interaction with Phe138 and Leu158, residing at the 
entering and exiting helices of EF-hand 2. The interaction is effectively eliminated when 
 271 
the indole is in the D+ conformation (pointing towards the solvent). Similarly the 
DREAM(Y174A) mutant shows a similar transition, with Trp169 populating the t rotamer 
with D- indole orientation in the absence of Ca2+, and the g+ rotamer with G+ indole 
orientation upon Ca2+ binding. 
 In contrast, the conformational distribution of Trp169 in the DREAM(F218A) 
mutant shows a transition distinct than that observed in the DREAM(Δ65) construct. In 
DREAM(F218A), binding of Ca2+ induces a transition from a single conformation (the g+ 
rotamer and D- conformation) to two conformations of the same rotamer, with indole in 
the D+ and D- conformation. The transition from organized (one conformation) to 
disorganized (two conformations) upon Ca2+ binding is opposite to that observed in the 
DREAM(Δ65) construct. Similarly, the DREAM(F219), DREAM(F235A), and 
DREAM(F252A) show population of mainly the g+ rotamer with indole in the D- 
orientation in the absence of Ca2+. However, upon Ca2+ binding, a small change in 
orientation of Trp169 towards the t rotamer with D- indole orientation is observed for these 
three constructs (Figure 8.27c, d, e, f, and 8.28a and b). As shown in Figure 8.28c and 
8.28d, the t rotamer with D- indole conformation shows a strong hydrophobic interaction 
of Trp169 with the hydrophobic N-terminus, while the g+ rotamer with the D+ indole 
orientation shows the most solvent exposure. Analysis of the simulation trajectory also 
reveals that rotation of the indole ring induces the largest change solvent accessible surface 
area, from ~365 Å2 in the D+ conformation to ~345 Å2 in the D- conformation. Even 
though the transition from a D- to a D+ conformation in the DREAM(Δ160) construct is 
not obvious, an increase in population with the D+ can be observed. However, in the 
 272 
DREAM(Δ65), DREAM(Y174A), and DREAM(F218A) constructs a clear transition from 
D- to the D+ conformation can be observed upon Ca2+ binding.  
Figure 8.28. Plots of the Cβ-Cγ as a function of Cα-Cβ dihedral angle of tryptophan 169 
in the Ca2+ bound (a) and Ca2+ free (b) of the DREAM(F235A). Solvent exposure of 
Trp169 in the (c) t rotamer with D- indole orientation and in the (d) g+ rotamer with D+ 
indole orientation. Inset shows the change in SASA as a function of time. 
 
  All these constructs show a decrease in tryptophan fluorescence (Figure 8.18) upon 
calcium binding, which allows us to propose that the decrease in tryptophan fluorescence 
observed upon Ca2+ binding is caused by the reorientation of the indole ring of Trp169. 
The reorientation towards the D+ conformation effectively increases the solvent 
accessibility of tryptophan as well as its proximity to Lys168, which could induce 
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quenching of the fluorescence. Consequently, the increase in fluorescence observed for 
DREAM(F219A) and DREAM(F235A) (both which show retention of the D- 
conformation regardless of metal biding) could potentially be the result of the lack of 
change in indole orientation as well as structural changes at the N-terminus which 
effectively enhances the Trp169 fluorescence. A similar transition could be present for 
DREAM-NCS1, but we have not yet performed the simulations. However, we have also 
observed that the DREAM(252A) construct shows a lack of indole reorientation and yet, it 
is characterized by a decrease in tryptophan fluorescence (Figure 8.18). The disagreement 
with the idea that reorientation of the indole ring is causing the decrease in fluorescence. 
Nonetheless, the fact that these constructs are locked into a D- conformation, in which the 
indole is deeply buried between Phe138 and Leu158, may indicate that there may be 
additional structural changes at the N-terminus which induce the decrease in fluorescence. 
In addition, it is possible that the timescales necessary to observe D- to D+ transition in the 
DREAM(F252A) mutant exceeds the time sampled by our simulations.  
8.2.10 Interdomain fluctuations in DREAM highly regulate structural stability of the 
protein.  
 Analysis of the structural rearrangement of Trp169 in the DREAM constructs 
reveals a certain degree of correlation with the tryptophan fluorescence data. However, to 
investigate whether structural dynamics play a role in the stability of DREAM we have 
conducted extensive analysis of the dynamic fluctuations of the protein. In this section we 
seek to identify whether the dynamic fluctuations of the N-terminus and C-terminus of 
DREAM can be correlated with the unfolding energy of these constructs determined in 
section 8.2.8. We hypothesize that the changes in unfolding energy of the N- and C-
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terminus domain of DREAM are correlated with the interdomain dynamics measured in 
the aMD simulations.  
Figure 8.29 (a) Helices of DREAM included in the analysis of fluctuations. The EF-hands 
1 and 2 are shown in orange and green, respectively, and form part of the N-terminus. The 
EF-hands 3 and 4 are shown in blue and red, respectively, and form the C-terminus. The 
H1 helix, the connecting loop between EF-hand 3 and 4, and the H10 helix are not used in 
the calculations and are shown in diffuse cyan. (b) A representative RMSF plot of 
apoDREAM(Δ65) N- and C-terminus as a function of simulation time, the last 80 ns of 
simulation time was used for all constructs. 
  
To test the interdomain communication hypothesis, we have determined the N-
terminus fluctuations of the alpha carbons forming the EF-hands 1 and 2 as well as the 
fluctuations of the alpha carbons forming EF-hand 3 and 4 (Figure 8.29). The first helix 
(H1), the C-terminus loop connecting EF-hand 3 and 4, and the H10 helix have not been 
including in our analysis. However, preliminary calculation show that inclusion of these 
helices does not result in significant changes of the dynamics observed. Furthermore, 
exclusion of the EF-hand metal binding loops further enhances the difference in dynamics 
fluctuations described below (data not shown). These fluctuations are defined as the 
deviation of the alpha carbon, at a particular frame, from the averaged position of the same 
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carbon in the average position of 1000 frames (10 ns). The moving window average allows 
us to identify fluctuations from equilibrium once the structure has reached its final 
conformation (Figure 8.29b). All our simulations reached equilibrium within 20 ns or 
sooner, and thus only the last 80 ns are included in our analysis. 
Figure 8.30. Plots of the root mean square fluctuations (RMSF) distribution for the last 80 
ns of aMD simulation for N- and C-terminus of the (a) DREAM(Δ65), (b) 
DREAM(Y174A), (c) DREAM(F218A), (d) DREAM(F219A), (e) DREAM(F235A) and 
(f) DREAM(F252A) construct in the Ca2+ bound and free conformations. 
 
Figure 8.30 shows the resulting distribution of root mean squared fluctuations 
(RMSF) obtained for all the twenty four simulations corresponding the N- and C-terminus 
of the apo and Ca2+ bound form of the mutants listed in the legend. The first clear 
observation is that the N-terminus of the DREAM(Δ65) construct is significantly more 
flexible than the C-terminus, and Ca2+ binding induces an increase in rigidity of both 
domains. However, in the absence of Ca2+, all the constructs show a larger flexibility of 
the C-terminus compared to the N-terminus. The only exception is the DREAM(Y174A) 
mutant, which shows similar flexibility of both domains, with RMSF magnitudes 
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intermediate to that of DREAM(Δ65). Nonetheless, Ca2+ binding still induces an increase 
in rigidity of both domains. An increase in rigidity upon Ca2+ binding compared to the Ca2+ 
free form is observed for all constructs, and in all cases the C-terminus is more rigid 
(compare blue trace to others in Figure 8.30). However, there was an exception to this 
trend, DREAM(F219A) was characterized by a larger rigidity of the N-terminus compared 
to the C-terminus, in both the apo and Ca2+ bound form (Figure 8.30d).  
We also investigated whether the changes in flexibility of the protein, as quantified 
through backbone fluctuations, have any correlation to the experimentally determined 
stability of the protein. We determined the differences in fluctuations of the N- and C-
terminus by subtracting the maximum of the RMSF distribution between the N- and C-
terminus domain for both the apo and Ca2+ bound forms. We also calculated the difference 
between N- and C-terminus unfolding energy from table 8.3 and 8.4. The resulting values 
are plotted in Figure 8.31, where the difference in unfolding energy is plotted as a function 
of the difference in RMSF. A linear fit to the data reveals a certain degree of correlation, 
with R2 = 0.68, slope = -1.16 kcal mol-1 Å-1, and intercept of 1.8 Å. The linear relationship 
highlights the role of dynamic fluctuations in interdomain communications and 
stabilization of the protein. Moreover, it is likely that the deviations from linearity are due 
to small structural differences between the mutants. 
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Figure 8.31. Plots of the difference in unfolding energy (ΔΔG = ΔGI – ΔGU) as a function 
of the difference in RMSF (ΔRMSF = RMSFN-terminus – RMSFC-terminus). The results for 
DREAM(Δ65), DREAM(Y174A), DREAM(F218A), DREAM(F219A), 
DREAM(F235A), and DREAM(F252A) are shown in the apo (symbols with green outline) 
and Ca2+ bound form. 
 
8.2.11 Modulation of protein dynamics through mutation of hydrophobic amino acids 
effectively modulates allosteric regulation of DREAM 
 As a last confirmation of the essential role of aromatic amino acids and protein 
dynamics in regulation of the activity of DREAM, we are interested to determine whether 
the mutations described above can in fact regulate the ability of this protein to interact with 
KV4 channels. In order to determine the ability of these DREAM construct to associate 
with KV4 channels, we have monitored their ability to interact with a fluorescently labeled 
synthetic peptide homologous to the site 2 of the Kv4.3 voltage gated potassium channel. 
This peptide was used in Chapter 4, and it showed a clear 50-fold increase in affinity upon 
binding to the N-terminus of Ca2+ bound DREAM(Δ65) (Figure 8.33).  
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Figure 8.32. Binding site of the KV4.3 site 2 peptide at the N-terminus of DREAM. 
 
The affinity in Chapter 4 was monitored through the increase in fluorescence of the 
dansylated N-terminus of this peptide. In Figure 8.34 we show the emission spectra of the 
DREAM constructs, DREAM(F219A) and DREAM(F252A) are not shown. In this figure, 
a clear increase in fluorescence upon binding of DREAM(Δ65), DREAM(F218A), and 
DREAM(Y174A) is observed in the presence of Ca2+. However, the affinity was 
determined to be about 90 ± 10 μM for peptide binding to the DREAM(Y174A) mutant, in 
contrast to the affinity determined for the DREAM(Δ65) construct of 10 ± 1 μM. On the 
other hand, the DREAM(F218A) showed similar affinity to the site 2 peptide as 
DREAM(Δ65), with an affinity of 17 ± 3 μM. Lastly, the DREAM(F235A) and DREAM-
NCS1 constructs showed no binding in the presence or absence of Ca2+ (Figure 8.33d and 
e). Altogether, these results show that the affinity between the KV4.3 peptide and the N-
terminus of DREAM can be modulated not only by mutations of aromatic amino acid at 
the C-terminus of DREAM but also by mutations which affect the oligomerization state of 
DREAM. 
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Figure 8.33. Emission spectra of dansylated KV4.3 site 2 peptide in the absence and in the 
presence of Ca2+ bound (a) DREAM(Δ65), (b) DREAM(Y174A), (c) DREAM(F218A), 
(d) DREAM(F235A), and (e) DREAM-NCS1. 
 
8.2.11 Coarse grained simulations reveal a potential mechanism for regulation of KV4 
binding to DREAM. 
 The data presented above highlights the role of aromatic amino acids in transducing 
dynamic information to the N-terminus. The simulations also reveal that the N-terminus of 
DREAM can reorganize upon binding of Ca2+ at the C-terminus. This reorganization of Ca2+ free 
monomeric DREAM results in the collapse of the N-terminus and a transition of the EF-hand 1 
from a perpendicular orientation to a parallel alignment of the entering and exiting helix of this EF-
hand. Close analysis of the amino acids involved in stabilizing the KChIP1:Kv4.3 interaction 
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(PDB: 2NZ0) reveals the presence of two salt bridges between Lys50 and Arg51 on KChIP1 and 
Glu77 and Asp78 on the Kv4.3, respectively (Liang et al. 2009). An additional stacking interaction 
between Tyr57 on KChIP1 and Phe73 on Kv4.3 is also present. Also, overlay of residue 86 to 242 
corresponding to EF-hand 1 through 4 on DREAM (PDB: 2jul conformation 1) with the structure 
of KChIP1:Kv4.3 (PDB: 2nz0) reveals minimal structural differences (RMSD = 1.866 Å between 
residues 50 to 201 in KChIP1 and residue 90 to 241 in DREAM).  
 
Figure 8.34. (a) Structural alignment of the EF-hand 1 exiting helix of the Ca2+ bound DREAM 
structure (PDB: 2jul) and the Ca2+ bound structure of KChIP1 bound to the T1-domain of Kv4.3, 
shown in yellow (PDB: 2nz0). The exiting helix of EF-hand 1 was used for aliment. (b) Alignment 
of the exiting helix of EF-hand 1 of Ca2+ free DREAM (structure obtained after 432 ns of cMD 
simulation) and the exiting helix of KChIP1 in complex with the Kv4.3 channel. 
 
After aligning the structures, we observe that DREAM could potentially make the same 
contacts with Kv4.3 as KChIP1, where Lys90 and Lys91 on DREAM would form a salt bridge 
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with Glu77 and Asp78 on Kv4.3, respectively. In DREAM, Tyr97 would form the stacking 
interaction with Phe73 on Kv4.3. Therefore, we investigated whether these amino acids (which 
reside on the entering helix of EF-hand 1) could potentially reorganize in the absence of Ca2+ bound 
at EF-hand 3 and 4 on DREAM.  Analysis of the structure of DREAM following 432 ns of cMD 
simulation in the absence of Ca2+ reveals that Tyr97 undergoes a slight rotation of about 60 ° 
towards the hydrophobic cavity at the N-terminus of DREAM (Figure 8.35a).  
Figure 8.35. Structural reorganization of EF-hand 1 in the Ca2+ free form of DREAM obtained 
from: (a) 435 ns cMD simulation of apoDREAM and (b) 1 μs coarse-grained simulation. The inset 
shows the rotation Tyr97 into the hydrophobic cavity lining the N-terminus domain. The EF-hand 
1 was aligned using the backbone atoms of residues 89 to 160. (c) Structure of DREAM after 1 μs 
coarse-grained simulation showing the rotation of Arg98 and Lys101 in the absence of Ca2+. 
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We speculate that in the absence of Ca2+, Tyr97 on DREAM becomes buried in the N-
terminus hydrophobic cavity of DREAM. To support this hypothesis, we carried out coarse-
grained simulations of DREAM in the absence of Ca2+ in order to access structural changes which 
could occur at longer timescales than 500 ns. As shown in figure 8.35b, we observe that Tyr97 can 
undergo an almost 180 ° rotation, and effectively become buried into the N-terminus hydrophobic 
cavity. At this position, it interacts with residues Phe148 and Val152 at the exiting helix of EF-hand 
2. In addition, we observe that Arg98 and Lys101 undergo a similar rotation; however, these amino 
acids do not make clear electrostatic interactions with the T1 domain (Figure 8.35c). The rotation 
of these amino acids may be responsible for modulation of binding of other ligands, such as DNA. 
On the other hand, Lys90 and Lys91 at the start of the entering helix of EF-hand 1 do not undergo 
any significant rotation, and remain solvent exposed. Thus, it could be possible that while the 
Tyr97:Phe73 interaction is disrupted by a helix rotation, the Lys90Lys91:Glu77Asp78 salt bridges 
are broken by a different mechanism. The structural change regulating the salt bridge interaction 
becomes obvious when the exiting helix of EF-hand 1 is aligned with the same helix of the 
KChIP1:Kv4.3 complex (Figure 8.34a). Alignment in the Ca2+ bound state shows that all these 
three interactions (2 salt bridges and 1 π- π interaction) are present . However, alignment of the 
same helix in the DREAM structure obtained after 432 ns of cMD simulation in the absence of 
Ca2+ reveals that all three of these contacts are significantly altered. The disruption of these contacts 
is mainly mediated by the transition of EF-hand 1 from a perpendicular organization, to a parallel 
one (Figure 8.34b). The translation of the entering helix of EF-hand 1 effectively displaces Lys90 
and Lys91 by about 27 Å from Glu77 and Asp78, while Ty97 is displaced by about 15 Å from 
Phe73. Altogether, the N-terminus structural reorganization of DREAM provide a clear description 
of the molecular mechanisms controlling Kv4.3 site 2 binding. Furthermore, the realignment of the 
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entering helix of EF-hand 1 may also underline the mechanism by which DREAM associates with 
DNA. In this model, the antiparallel orientation of the helices in EF-hand 1 would form favorable 
contacts, probably between the DNA groves. The effect that dimerization has on the reorganization 
of the N-terminus could also be a mechanism by which Ca2+ binding to DREAM would favor the 
dissociation from DNA. 
8.3 Summary 
 In this chapter we have presented extensive biochemical and biophysical data supporting 
the role of global and domain dynamics in regulating the propagation of structural changes induced 
by Ca2+ binding to DREAM. In the first section, we demonstrate using long timescale classical and 
accelerated molecular dynamic simulations, that dissociation of Ca2+ from EF-hands 3 and 4 
induces the collapse of the N-terminus.  The collapse of the N-terminus is, to a lower extent, also 
observed in the Ca2+ bound structure of DREAM; however, modeling of DREAM as a Ca2+ bound 
dimer effectively eliminates structural changes at the N-terminus during our simulation time. These 
results highlight the role of oligomerization and dynamic coupling between the N- and C-terminus 
of DREAM. This intradomain interaction was also clearly observed upon analysis of the molecular 
dynamic simulations using cross correlation maps and dynamic network analysis. In this analysis 
approach, we identified that DREAM is dynamically organized in clusters of amino acids 
segregated at the N- and C-terminus domains. We also show that the entering helix of EF-hand 3 
plays a pivotal role of connecting the N- and C-terminus communities. The behavior of EF-hand 3 
as a dynamic hub and the presence of numerous conserved amino acids on this helix, may indicate 
that the dynamic coupling between the N- and C-terminus observed here may be a widespread 
phenomenon in NCS proteins. Furthermore, we identified critical nodes connecting the N- and C-
terminus as well as the H10 helix. These amino acids were shown to be highly conserved among 
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NCS proteins, and could potentially represent a fundamental mechanism of dynamic 
reorganization in this group of EF-hand Ca2+ binding proteins. Using dynamic network analysis, 
we were also able to identify amino acids at the long loop connecting the EF-hands 3 and 4 which 
play a role in stabilizing the dimeric form of DREAM. The fact that DREAM has the least 
negatively charged loop, while NCS-1 has the most negatively charge loop seems to support the 
idea that modulation of the charges on this loop may help these protein to regulate their 
oligomerization inside the cell.  
 Making use of the information obtained in section 8.2.1 through 8.2.3 we generated a small 
library of DREAM mutants with the aim of selectively modulating the dynamic coupling between 
the N- and C-terminus through elimination of intersubunit and intrasubunit critical nodes. The 
hypothesis being, that by mutating these amino acid, we would effectively modify the dynamic 
coupling between the N- and C-terminus of DREAM and induce changes in the activity. However, 
to rule out the potential protein unfolding arising from the mutation of hydrophobic amino acids 
we carried out extensive biochemical characterization of the purified mutants. Based on the circular 
dichroism data, all the proteins showed a largely helical secondary structure. Furthermore, 
tryptophan fluorescence and Ca2+ binding studies demonstrate that these mutants are likely in a 
native-like conformation. This conformation is characterized by Ca2+ affinities in the low 
micromolar range, a common feature among NCS proteins (Burgoyne 2004). Altogether, 
supporting the idea that these proteins are functionally folded. However, in DREAM(F219A), 
DREAM(F235A), and DREAM-NCS1 we observed a reversal of the tryptophan fluorescence 
upon Ca2+ binding. This is an interesting finding since other NCS proteins, such as recoverin and 
NCS-1 are known to undergo an increase in tryptophan fluorescence upon Ca2+ binding (Hughes 
et al. 1998, Baldwin, Ames 1998). Interestingly, a similar reversal of tryptophan fluorescence was 
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observed in a double mutant of myristoylated recoverin protein, where Ile52 and Tyr53 where 
mutated to alanine (Baldwin, Ames 1998). In this recoverin mutant, binding of Ca2+ induced a 
decrease of the tryptophan fluorescence. These findings highlight the sensitivity of tryptophan at 
the entering helix of EF-hand 3 (Trp169 in DREAM), to changes in protein conformation induced 
by mutations of amino acids at the N- or C-terminus domain. 
 Unfolding experiments reveal the presence of subtle but significant differences in the 
stability of some of the DREAM mutants. With the most remarkable observation made for the 
DREAM(F218A) construct, which showed a completely reversal of the stability upon Ca2+ 
binding. The DREAM(F219A) construct, despite having a mutation adjacent to DREAM(F218A), 
did not show such a change in stability. We also observe that the intermediate unfolded state of 
DREAM(Δ65), DREAM(F219A), DREAM(F235A), and DREAM(F252A) protein constructs is 
associated with a bright tryptophan fluorescence. Interestingly, the emission maxima of the bright 
intermediate were similar to those observed for the DREAM(Δ160) construct at 0 M GuHCl. 
Indeed, we have determined that the quantum yield for tryptophan fluorescence of the 
DREAM(Δ160) mutant (Φ ~ 0.13) is similar to that of tryptophan in solution, while the quantum 
yield of native DREAM(Δ65) is near 0.08 (data not shown). The emission maxima of this bright 
intermediate (~352 nm) is also identical to that of DREAM(Δ160) at 0 M GuHCl in the presence 
of Ca2+. These observation allows us to speculate that the intermediate state observed for some of 
the DREAM construct may represent a conformation in which the N-terminus has been partially 
unfolded, and tryptophan is exposed to the solvent. Alternatively, it could be possible that the 
mutations have induced a complete decoupling of the tryptophan fluorescence to the N-terminus, 
as observed in the DREAM(Δ160) lacking this domain. Previous theoretical and single molecule 
studies have shown that the N-terminus domain of NCS1 unfolds first followed by the C-terminus 
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(Heidarsson et al. 2013). This model being present in DREAM is supported by our data, in which 
we observe that the first transition in DREAM(Δ65) is stabilized by the presence of Mg2+, while 
the second unfolding transition is not. Also, association of Ca2+ induces a larger stabilization of the 
second transition. With this in mind, we have analyzed all our subsequent results on the basis that 
the first transition represents unfolding of the N-terminus followed by unfolding of the C-terminus 
at GuHCl concentrations of about 3 to 4 M. The fact that the bright intermediate was only observed 
for some mutants, and only in the presence of Ca2+, indicates that the unfolding pathways of the N-
terminus can be modified by modifications of the C-terminus.  
 Furthermore, to better understand the tryptophan transition observed upon Ca2+ binding 
and the reversal of the transition observed for the DREAM(F219A) and DREAM(F235A) mutants, 
we conducted analysis of the rotameric states of tryptophan at positon 169 on DREAM. We have 
identified that in the absence of the N-terminus, Trp169 can populate two rotameric states (the t 
and g+), in each of which the indole ring can be oriented towards the carboxy (D-) or amino group 
(D+) of the peptide backbone. However, the presence of the N-terminus in the DREAM(Δ65) 
construct effectively restricts the rotameric state in the absence of Ca2+ to the t rotamer with indole 
ring pointing towards the carboxy group of the backbone (D- conformation). Upon Ca2+ binding, 
a transition to the g+ rotamer with the indole ring pointing towards the amide bond of the peptide 
bond is favored. The switching mechanism has not been studied extensively, but our findings show 
that the conformation orientation of the indole ring may play a major role in determining the 
transition in tryptophan fluorescence measured experimentally. In our model, we propose that 
transition from the D- to D+ induces a decrease in tryptophan fluorescence as a result of an increase 
in solvent quenching. In addition, in the D- conformation, Trp169 is observed to form hydrophobic 
contacts with Phe138 and Leu158. Therefore, it is possible that changes in the dynamics of the 
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interaction in the absence of Ca2+ could stabilize the N-terminus. It is also possible that the stacking 
observed between Trp169 and Leu158 could affect the stability of the dimer or binding of other 
proteins; Leu158 is known to form part of the LxxLL motif at the N-terminus of DREAM which 
has been proposed to mediate protein-protein interactions and oligomerization of DREAM (Lusin 
et al. 2008, Ledo et al. 2000). Therefore, in the model presented here, dynamic coupling between 
the exiting helix of EF-hand 4 and the entering helix of EF-hand 3 in the presence of Ca2+ (Figure 
8.13), together with switching of Trp169 from the D- to the D+ conformation (Figure 8.27), results 
in the modulation of a hydrophobic bridge spanning the N- and C-terminus.  
Figure 8.36. Summary of the mechanism by which binding of Kv4.3 site 1 at the hydrophobic 
surface of DREAM is regulated by Ca2+ binding and changes in structural dynamics. (a) Structure 
of KChIP1:Kv4.3 complex (PDB: 2nz0) highlighting the role of the N- and C-terminus 
hydrophobic cavity in ligand binding. (b) Dynamic network analysis which shows the collapse of 
the hydrophobic cavities on DREAM and the enhanced dynamic coupling of the H10 helix (black 
network). 
 
All atom and coarse-grained simulations reveal a potential mechanism by which Ca2+ 
binding to DREAM and oligomerization changes may modulate KV4 binding. In the case of site 1, 
we observe a clear transition in protein dynamics at the C-terminus of DREAM upon Ca2+ binding. 
In the absence of Ca2+, the dynamic reorganization of Phe235 induces a decoupling of the H10 
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helix. In the state described above, the H10 helix is flexible and vulnerable to displacement by the 
N-terminus (site 1) of Kv4.3, which results in the reorientation of the H10 helix as shown in Figure 
8.36a. The displacement of H10 upon ligand binding is not a new concept (Liang et al. 2009, Wang, 
Chai 2009); however, the dynamic mechanisms controlling this displacement have not been 
described before. In addition, in section 8.2.12 we show that the entering helix of EF-hand 1 
undergoes a rotation and displacement which effectively disrupt favorable contacts between the N-
terminus of DREAM and Kv4.3 (Figure 8.34). The rotation is driven by the collapse of the N-
terminus hydrophobic cavity, the magnitude of which depends on Ca2+ binding and dimerization 
of DREAM.  
 Finally, in Figure 8.32 we show that mutations affecting the intrasubunit critical nodes 
(DREAM(F218A), DREAM(F235A), and DREAM(Y174A)) can modulate binding of DREAM 
with the site 2 of KV4.3 channel. The observation allows us to postulate that structural changes 
propagated through these amino acids play a major role in inducing the proper conformation of the 
N-terminus favorable to interact with Kv4.3 site 2. However, perturbation of intradomain dynamics 
does not seem to be the only important mechanism. In fact, we observe that DREAM-NCS1 has 
the lowest affinity for the site 2 peptide, indicating that oligomerization state may also play a major 
role in ligand selectivity. We have also observed that a site 1 peptide, homologous to the N-terminus 
of KV4.3 can also induce the monomerization of DREAM upon binding. The observation would 
explain why the x-ray structure of Kv4.3 and KChIP1 shows the interaction of a single KChIP1 
subunit per N-terminus of the T1 subunit. Thus, it is possible that dimerization may allow binding 
to the site 2, while binding of site 1 induces the breakdown of the dimer into monomers. 
Alternatively, it is very likely that association of the site 1 peptide, which spans the N- and C-
terminus of DREAM, prevents the collapse of the N-terminus and allows the protein complex to 
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associate with site 2. Thus, in chapter 8 we have provided extensive evidence for the role of protein 
dynamics in regulating structural changes at the N-terminus of DREAM. We have also laid the 
foundation for what could be a fundamental structural communication pathway in neuronal 
calcium sensors. More importantly, the approach taken in this section could potentially be applied 
to other more complex proteins in order to understand the mechanisms by which these proteins 
regulate ligand binding. 
9. CONCLUSIONS 
The hydrophobic cavity at the C-terminus of DREAM regulates binding of small 
hydrophobic ligands such as 1,8-ANS, 2,6-ANS, arachidonic acids, and NS5806. These 
interactions are mediated by numerous hydrophobic amino acids that connect the EF-hands 
3 and 4. Using the solvent sensitive dyes 1,8-ANS and 2,6-ANS we show that binding of 
Ca2+ at EF-hands 3 and 4 induces the exposure of a hydrophobic surface on DREAM. In 
addition, using fluorescence anisotropy and the long lived fluorescent decay of ANS 
molecules, we show that DREAM can populate a dimer structure in the presence of Ca2+. 
Upon removal of Ca2+, rotations with correlation times of 12 ns and 50 ns were resolved. 
These rotations could represent a monomeric and tetrameric oligomerization state of 
DREAM. The bright fluorescence of 1,8-ANS upon binding to Ca2+ DREAM has allowed 
us to demonstrate, that the hydrophobic cavity at the C-terminus is a site relevant for 
binding of small hydrophobic ligands, such as arachidonic acids and NS5806. Also, we 
have shown that anisotropy decay measurement using 1,8-ANS can be successfully 
implemented to characterize the oligomerization state of this protein. 
Interestingly, association of NS5806 at the C-terminus of DREAM induces a 
structural conformation able to associate with the hydrophobic N-terminus of KV4.3, 
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independent of the presence of Ca2+. The activation of DREAM through interaction with 
this small hydrophobic ligand, indicates that the changes at the hydrophobic cavity at the 
C-terminus can result in global changes in the structure of DREAM. Furthermore, we 
demonstrate the residues Phe218 and Tyr174 play a major role in regulating binding and 
the activity of NS5806. Docking and molecular dynamics simulation allowed us to observe 
the effect of NS5806 binding at the C-terminus of DREAM. At the C-terminus site, 
NS5806 showed a clear stacking interaction with Phe218 and Phe219. The interaction 
effectively resulted in the displacement of the exiting helix of EF-hand 4. Overall, these 
findings were used to explain the observed increase in K+ current and slowing of 
inactivation kinetics in cardiac cells upon injection of NS806. Remarkably, we were able 
to recover identical affinity constants for NS5806 binding to Ca2+ and apoDREAM as the 
EC50 for current activation and inactivation kinetics determined in vivo. Thus, indicating 
that the observed in vivo effects, are likely the result of direct interaction of NS5806 with 
KChIPs.  
In addition, we have presented results which provide an insight into the potential 
structural organization of the flexible extended N-terminus of DREAM (residues 1 to 65). 
The N-terminus region of DREAM protein has largely been ignore in the literature, mainly 
because recombinant expression of DREAM proteins containing this flexible domain 
results in formation of insoluble inclusion bodies. Truncation of this N-terminus region has 
been proposed to minimally perturb the DNA and Kv4 binding properties of DREAM 
(Osawa et al. 2005). Furthermore, DREAM contains a cleavage site, which in vivo could 
lead to the production of a DREAM construct similar to that of DREAM(Δ65). 
Nonetheless, the fact that the main difference among KChIPs lies at the N-terminus, 
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indicates that the N-terminus domain of DREAM may play role in regulating the activity 
of this protein. The model of DREAM and the biochemical results presented in Chapter 5 
provide a renewed view on the potential role of this domain in regulating protein-protein 
and protein-DNA interactions. Furthermore, these results demonstrate an interesting 
interplay between a member of the calcium sensor subfamily (calmodulin) and another 
protein belonging to the neuronal calcium sensor subfamily (DREAM). The biological 
implication of this protein-protein complex remain to be studied. However, given the 
strong affinity of calmodulin for the N-terminus of DREAM, as well as the numerous 
posttranslational modification sequences present in this region, it is possible that the 
interaction of these two proteins is highly regulated in vivo. 
To further understand the role of EF-hand 3 and 4 in regulating the activity of 
DREAM; in Chapter 6 we presented an extensive biochemical study of the interactions 
between terbium(III) and DREAM. Here, we show that Tb3+ can effectively bind at EF-
hands 3 and 4, displace Ca2+, and induce minimal disruption of the oligomerization and 
exposure of a hydrophobic cavity. Isothermal calorimetry data reveals that coordination of 
the Ca2+ ion by Glu234 in EF-hand 4 is associated with a larger enthalpic contribution than 
that due to coordination of Ca2+ by Glu186 at EF-hand 3. Indicating, that the structural 
reorganization triggered by Ca2+ binding at EF-hand 4, are likely much larger than those 
due to Ca2+ binding at EF-hand 3. Using the long lived luminescent properties of Tb3+, we 
observed that binding of Mg2+ at EF-hand 2, can result in structural reorganization of the 
environment near EF-hands 3 and 4. Thus highlighting the role of Mg2+ as a potential 
cofactor in stabilizing the structure of DREAM. 
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In chapter 7, we described the theoretical and experimental details associated with 
the development of a photothermal beam deflection apparatus. We highlight different 
approaches to analyze the data as well as sample conditions to be considered when carrying 
out experiments. We further use this technique to study the ultrafast release of metal ions 
from caged compounds. The initial aim of this chapter was to employ the photosensitive 
Ca2+ chelator DM-nitrophen, in order to photo trigger the release of Ca2+ and monitor the 
photothermal profile due to Ca2+ binding to DREAM. However, the large variability of the 
purchased DM nitrophen stocks prevented the detailed analysis of the PBD signal in the 
presence of DM-nitrophen and DREAM. Also, the nonreversible photo release of Ca2+ 
from DM-nitrophen results in significant complications in terms of signal averaging. 
Nonetheless, we have shown that PBD can effectively be used to monitor the 
thermodynamics properties of metal photo release from caged compounds. We also 
demonstrate, that DM-nitrophen is able to form a highly stable complex with Tb3+ ions, 
and that photo release of this lanthanide results in enthalpy and volume changes identical 
to those observed for Ca2+. 
Finally, in Chapter 8, we combine theoretical and experimental approaches to 
investigate the role of protein dynamics in regulation of DREAM activity. The aim of this 
chapter is to decipher the precise molecular reorganization induced by Ca2+ binding to 
DREAM, and how these changes regulate ligand binding. Following extensive studies, we 
show compelling evidence for a major role of the entering helix of EF-hand 3 of DREAM 
in regulating the Ca2+ induced structural changes. In particular, we show that the dynamic 
coupling between the helices at the C-terminus is strongly modulated by Ca2+ binding. 
More importantly, we identify that residue Phe218, Phe219, Phe235, Tyr 174, and Phe171 
 293 
play a pivotal role in regulating the apo to Ca2+ transition. Of particular importance, is the 
Phe235 residue, which is observed to switch between two conformations upon metal 
binding. In addition, we observe that a conformational switch of Trp169 could explain the 
mechanism by which dynamic signals are transduced from the C- towards the N-terminus. 
The role of the dynamic coupling identified in this section is also supported by unfolding 
experiments. In these experiments, we observe the presence of a linear relationship 
between the difference in stability of the N- and C-terminus of DREAM, and the difference 
in fluctuations of these domains. Finally, we demonstrate that by mutation of the amino 
acids identified to play a major role in communication of dynamic fluctuations, we can 
effectively inhibit binding of DREAM to a peptide homologous to the human Kv4.3 
channel. The fact that the mutations are located at the C-terminus and that peptide binding 
is mediated by the N-terminus, highlights the presence of a well-defined pathway by which 
these two domains communicate. Based on our results, we can effectively identify such 
pathway, as involving the dynamic coupling of hydrophobic (aromatic amino acids in 
particular) amino acids at the C-terminus, the entering helix of EF-hand 3, and the N-
terminus.  
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10. APPENDICES 
 
10.1 Appendix 1 
 The DNA sequence of the plasmids used throughout this work is shown below. In 
all cases the T7 promoter was used as the primer for sequencing. In cases where a primer 
was used to generate the mutant, the primer sequence is underlined, while the start and stop 
codons are shown as bold letters. 
 
DREAM(65-256) sequenced by Eurofins MWG operon 
NNNNNNNNNNNNNNNTTCCCTCTNAAANAANTTTGTNNANCTTTAAGAAGGAGATATAC
ATATGGAACTGGAGTTATCCACGGTGCGCCATCAGCCAGAGGGCTTGGACCAGCTACAA
GCTCAGACCAAGTTCACCAAGAAGGAGCTGCAGTCCCTTTACCGAGGCTTCAAGAATGA
GTGTCCCACAGGCCTGGTGGATGAAGACACCTTCAAACTCATTTATTCCCAGTTCTTCC
CTCAGGGAGATGCCACCACCTATGCACACTTCCTCTTCAATGCCTTCGATGCTGATGGG
AACGGGGCCATCCACTTTGAGGACTTTGTGGTTGGGCTCTCCATCCTGCTTCGAGGGAC
GGTCCATGAGAAGCTCAAGTGGGCCTTCAATCTCTATGACATTAACAAGGATGGTTGCA
TCACCAAGGAGGAGATGCTGGCCATCATGAAGTCCATCTACGACATGATGGGCCGCCAC
ACCTACCCCATCCTGCGGGAGGATGCACCCCTGGAGCATGTGGAGAGGTTCTTTCAGAA
AATGGACAGGAACCAGGATGGAGTGGTGACCATTGATGAATTTCTGGAGACTTGTCAGA
AGGATGAGAACATCATGAACTCCATGCAGCTGTTTGAGAACGTCATCTACCTCGAGCAC
CACCACCACCACCACTAATGTTAATTAAGTTGGGCGTTCCTAGGCTGATAAAACAGAAT
TTGCCTGGCGGCAGTAGCGCGGTGGTCCCACCTGACCCCATGCCGAACTCAGAAGTGAA
ACGCCGTAGCGCCGATGGTAGTGTGGGGTCTCCCCATGCGAGAGTAGGGAACTGCCAGG
CATCAAATAAAACGAAAGGCTCAGTCGAAAGACTGGGCCTTTCGTTTTATCTGTTGTTT
GNCGGTGAACGCTCTCCTGAGNNGNNNAATCCGCCGGGAGCGGATTTGAACGTTGCGAA
GCANGGCCNGGAAGGGGGNCGGANANAAAAAAAANAAAAANNNNNNNNNNNACNGACNN
NNAATGATACNNNNTTATTANNNTATNNATAANNNNN 
 
>DREAM_E186Q_T7 Sample_Name=DREAM_E186Q_T7 Chromat_id=3790104 
Read_id=3745990 Version=1 Length=1055 
NNNNNNNNNNNNNNNNNCNNNCTNNNNNNNTTTTGTTTAACTTTAAGAAGGAGATATACATATGG
AACTGGAGTTATCNANGGTGCGCCATCAGCCAGAGGGCTTGGACCAGCTACAAGCTCAGACCAAG
TTCACCAAGAAGGAGCTGCAGTCCCTTTACCGAGGCTTCAAGAATGAGTGTCCCACAGGCCTGGT
GGATGAAGACACCTTCAAACTCATTTATTCCCAGTTCTTCCCTCAGGGAGATGCCACCACCTATG
CACACTTCCTCTTCAATGCCTTCGATGCTGATGGGAACGGGGCCATCCACTTTGAGGACTTTGTG
GTTGGGCTCTCCATCCTGCTTCGAGGGACGGTCCATGAGAAGCTCAAGTGGGCCTTCAATCTCTA
TGACATTAACAAGGATGGTTGCATCACCAAGGAGCAGATGCTGGCCATCATGAAGTCCATCTACG
ACATGATGGGCCGCCACACCTACCCCATCCTGCGGGAGGATGCACCCCTGGAGCATGTGGAGAGG
TTCTTTCAGAAAATGGACAGGAACCAGGATGGAGTGGTGACCATTGATGAATTTCTGGAGACTTG
TCAGAAGGATGAGAACATCATGAACTCCATGCAGCTGTTTGAGAACGTCATCTACCTCGAGCACC
ACCACCACCACCACTAATGTTAATTAAGTTGGGCGTTCCTAGGCTGATAAAACAGAATTTGCCTG
GCGGCAGTAGCGCGGTGGTCCCACCTGACCCCATGCCGAACTCNGAAGTGAAACGCCGTACCGCC
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GANGNTAGTGTGGGGTCTCCCCATGNNNGAGTAGGGAACTGCCAGGCATCAGATAAAAACGAAAG
GCTCAGTCGAAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCCTGAGTAG
GACAAATCCGCCNGGANGCGGATTNGAACGTTGCGANGCAACNCCCNNGGAGGNTNNNNCNNNCT
GCNNNNNNGTGNNNNGNNNNCCGNCNNNNNCTANANNNNANTATANNNNGNNNAGGNACTATACG
ATGACTNCNNNNNNN 
 
>DREAM_E234Q_T7 Sample_Name=DREAM_E234Q_T7 Chromat_id=4526469 
Read_id=4475245 Version=1 Length=1062 
GNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNTCNNNCTAGNNTAATTTTGTTTAACTTTAAGA
AGGAGATATACATATGGAACTGGAGTTATCNNCGGTGCGCCATCAGCCAGAGGGCTTGGACCAGC
TACAAGCTCAGACCAAGTTCACCAAGAAGGAGCTGCAGTCCCTTTACCGAGGCTTCAAGAATGAG
TGTCCCACAGGCCTGGTGGATGAAGACACCTTCAAACTCATTTATTCCCAGTTCTTCCCTCAGGG
AGATGCCACCACCTATGCACACTTCCTCTTCAATGCCTTCGATGCTGATGGGAACGGGGCCATCC
ACTTTGAGGACTTTGTGGTTGGGCTCTCCATCCTGCTTCGAGGGACGGTCCATGAGAAGCTCAAG
TGGGCCTTCAATCTCTATGACATTAACAAGGATGGTTGCATCACCAAGGAGGAGATGCTGGCCAT
CATGAAGTCCATCTACGACATGATGGGCCGCCACACCTACCCCATCCTGCGGGAGGATGCACCCC
TGGAGCATGTGGAGAGGTTCTTTCAGAAAATGGACAGGAACCAGGATGGAGTGGTGACCATTGAT
CAATTTCTGGAGACTTGTCAGAAGGATGAGAACATCATGAACTCCATGCAGCTGTTTGAGAACGT
CATCTACCTCGAGCACCACCACCACCACCACTAATGTTAATTAAGTTGGGCGTTCCTAGGCTGAT
AAAACAGAATTTGCCTGGCGGCAGTAGCGCGGTGGTCCCACCTGACCCCATGCCGAACTCAGAAG
TGAAACGCCGTAGCGCCGATGGTAGTGTGGGGTCTCCCCATGCGAGAGTAGGGAACTGCCAGGCA
TCAAATAAAACGAAAGGCTCAGTCGAAAGACTGGGCCTTTCGTTTTATCTGTTGTTNGTCGGTGA
ACGCTCTCCTGAGTAGGACAANTCCGCCGGGAGCGGATTTGAACGTTGCGAANNAACGGCNNCNN
NGGNTGGCGNTNNGNNNNNNNNNNNNTNNCNGCCANNGNTCNNNANNNCNNNNNNNCACANNNNN
NGANNNNNNNNNNNNTNACNNN 
>DREAM_Y174A_T7 Sample_Name=DREAM_Y174A_T7 Chromat_id=2855977 
Read_id=2829164 Version=1 Length=929 
NNNNNNNNNNNNNNNNNNNNNNCTNNNNNNNNTTTGTNNNNNTTNAAGAAGGAGATATACATATG
GAACTGGAGTTNNCANCNNNGCGCCATCAGCCAGAGGGCTTGGACCAGCTACAAGCTCANACCAA
GTTCACCAGGAAGGAGCTGCANTCCCTTTACCGAGGCTTCAAGAATGAGTGTCCCACAGGCCTGG
TGGATGAAGACACCTTCAAACTCATTTATTCCCAGTTCTTCCCTCAGGGAGATGCCACCACCTAT
GCACACTTCCTCTTCAATGCCTTCNATGCTGATGGGAACGGGGCCATCCACTTTGAGGACTTTGT
GGTTGGGCTCTCCATCCTGCTTCGAGGGACGGTCCATGAGAAGCTCAAGTGGGCCTTCAATCTCG
CGGACATTAACAAGGATGGTTGCATCACCAAGGAGGAGATGCTGGCCATCATGAAGTCCATCTAC
GACATGATGGGCCGCCACACCTACCCCATCCTGCGGGAGGATGCACCCCTGGAGCATGTGGAGAG
GTTCTTTCAGAAAATGGACAGGAACCAGGATGGAGTGGTGACCATTGATGAATTTCTGGAGACTT
GTCAGAAGGATGAGAACATCATGAACTCCATGCAGCTGTTTGAGAACGTCATCTACCTCGAGCAC
CACCACCACCACCACTAATGTTAATTAAGTTGGGCGTTCCTAGGCTGATAAAACAGAATTTGCCT
GGCGGCAGTAGCGCGGTGGTCCCACCTGACCCCATGCCGAACTCAGAAGTGAAACGCCGTAGCGC
CGATGGTAGTGTGGGGTCTCCCCATGCGAGAGTAGGGAACTGCCAGGCATCAAATAAAACGAAAG
GCTCNNTCGAAAGACTGGGCCTTTCGNNTTATCTGTTGTTTGTCGGTGAACGCTCTCCTGAGTAG
GACAANTCNNNCGGNAACG 
>DREAM_F218A_T7 Sample_Name=DREAM_F218A_T7 Chromat_id=2855910 
Read_id=2829077 Version=1 Length=1038 
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NNNNNNNNNNNNNNNNNNNNNNNNCTNNNNNANTTTNNNNTNNCNTTAAGAAGGAGATATACATA
TGGAACTGGAGCTATNNNNGGNGCGCCATCAGCCAGAGGGCTTGGACCAGCTACNAGCTCAGACC
AAGTTCACCAAGAAGGAGCTGCAGTCCCTTTACCGAGGCTTCAAGAATGAGTGTCCCACAGGCCT
GGTGGATGAAGACACCTTCAAACTCATTTATTCCCAGTTCTTCCCTCAGGGAGATGCCACCACCT
ATGCACACTTCCTCTTCAATGCCTTCGATGCTGATGGGAACGGGGCCATCCACTTTGAGGACTTT
GTGGTTGGGCTCTCCATCCTGCTTCGAGGGACGGTCCATGAGAAGCTCAAGTGGGCCTTCAATCT
CTATGACATTAACAAGGATGGTTGCATCACCAAGGAGGAGATGCTGGCCATCATGAAGTCCATCT
ACGACATGATGGGCCGCCACACCTACCCCATCCTGCGGGAGGATGCACCCCTGGAGCATGTGGAG
AGGGCGTTTCAGAAAATGGACAGGAACCAGGATGGAGTGGTGACCATTGATGAATTTCTGGAGAC
TTGTCAGAAGGATGAGAACATCATGAACTCCATGCAGCTGTTTGAGAACGTCATCTACCTCGAGC
ACCACCACCACCACCACTAATGTTAATTAAGTTGGGCGTTCCTAGGCTGATAAAACAGAATTTGC
CTGGCGGCAGTAGCGCGGTGGTCCCACCTGACCCCATGCCGAACTCAGAAGTGAAACGCCGTAGC
GCCGATGGTAGTGTGGGGTCTCCCCATGCGAGAGTAGGGAACTGCCAGGCATCAAATAAAACGAA
AGGCTCAGTCGAAAGACTGGGCCTTTCGTTTATCTGNNGTTGTCGGGAACGCTNNCCTGAGTAGA
ACAATCCGCCGGGAGCGGATTGAACGTTGCNAACAACGNNCCGGAGGNTNGCGGNCAGGACNNCC
GCCNNAACTGCCAGCANNAATTANNCAGAAGGCATCCNNNCGATGGCNNTTTNNNNNNNNAAN 
 
>DREAM_F219A_T7 Sample_Name=F219A_T7 Chromat_id=3997199 
Read_id=3950666 Version=1 Length=1017 
NNNNNNNNNNNNNNNNNNNNTCCCNTCTNNNNNNATTTTGTTNAACTTTAAGAAGGAGATATACA
TATGGAACTGGAGTTATCCNCNGNGCGCCATCAGCCAGAGGGCTTGGACCAGCTACAAGCTCAGA
CCAAGTTCACCAAGAAGGAGCTGCAGTCCCTTTACCGAGGCTTCAAGAATGAGTGTCCCACAGGC
CTGGTGGATGAAGACACCTTCAAACTCATTTATTCCCAGTTCTTCCCTCAGGGAGATGCCACCAC
CTATGCACACTTCCTCTTCAATGCCTTCGATGCTGATGGGAACGGGGCCATCCACTTTGAGGACT
TTGTGGTTGGGCTCTCCATCCTGCTTCGAGGGACGGTCCATGAGAAGCTCAAGTGGGCCTTCAAT
CTCTATGACATTAACAAGGATGGTTGCATCACCAAGGAGGAGATGCTGGCCATCATGAAGTCCAT
CTACGACATGATGGGCCGCCACACCTACCCCATCCTGCGGGAGGATGCACCCCTGGAGCATGTGG
AGAGGTTCGCGCAGAAAATGGACAGGAACCAGGATGGAGTGGTGACCATTGATGAATTTCTGGAG
ACTTGTCAGAAGGATGAGAACATCATGAACTCCATGCAGCTGTTTGAGAACGTCATCTACCTCGA
GCACCACCACCACCACCACTAATGTTAATTAAGTTGGGCGTTCCTAGGCTGATAAAACAGAATTT
GCCTGGCGGCAGTAGCGCGGTGGTCCCACCTGACCCCATGCCGAACTCAGAAGTGAAACGCCGTA
GCGCCGATGGTAGTGTGGGGTCTCCCCATGCGAGAGTAGGGAACTGCCAGGCATCAAATAAAACG
AAAGGCTCAGTCGAAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCCTGA
GTAGGACAAATCCGCCGGGAGCGGATTTGAACGTTGCGAACCAACGGCCNNANGGNTGGCGGGCA
GGNNNCCNGCCATAANCTGGCAGNNATCAANNNANGCNGAAG 
>DREAM_F235A_T7 Sample_Name=DREAMF235A_T7 Chromat_id=3424601 
Read_id=3384259 Version=1 Length=1037 
NNNNNNNNNNNNNNNNNNNNNNNCCTCTAGNATNNNTTTGTTTAACTTTAAGAAGGAGATATACA
TATGGAACTGGAGTTATCCACGGTGCGCCATCAGCCAGAGGGCTTGGACCAGCTACAAGCTCAGA
CCAAGTTCACCAAGAAGGAGCTGCAGTCCCTTTACCGAGGCTTCAAGAATGAGTGTCCCACAGGC
CTGGTGGATGAAGACACCTTCAAACTCATTTATTCCCAGTTCTTCCCTCAGGGAGATGCCACCAC
CTATGCACACTTCCTCTTCAATGCCTTCGATGCTGATGGGAACGGGGCCATCCACTTTGAGGACT
TTGTGGTTGGGCTCTCCATCCTGCTTCGAGGGACGGTCCATGAGAAGCTCAAGTGGGCCTTCAAT
CTCTATGACATTAACAAGGATGGTTGCATCACCAAGGAGGAGATGCTGGCCATCATGAAGTCCAT
CTACGACATGATGGGCCGCCACACCTACCCCATCCTGCGGGAGGATGCACCCCTGGAGCATGTGG
AGAGGTTCTTTCAGAAAATGGACAGGAACCAGGATGGAGTGGTGACCATTGATGAAGCGCTGGAG
 327 
ACTTGTCAGAAGGATGAGAACATCATGAACTCCATGCAGCTGTTTGAGAACGTCATCTACCTCGA
GCACCACCACCACCACCACTAATGTTAATTAAGTTGGGCGTTCCTAGGCTGATAAAACAGAATTT
GCCTGGCGGCAGTAGCGCGGTGGTCCCACCTGACCCCATGCCGAACTCAGAAGTGAAACGCCGTA
GCGCCGATGGTAGTGTGGGGTCTCCCCATGCGAGAGTAGGGAACTGCCAGGCATCAAATAAAACG
AAAGGCTCAGTCGAAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCCTGA
GTAGGACAAATCCGCCGGGAGCGGATTTGAACGTTGCGAAGCAACGGCCCGNANGGNTGGCGGNC
NGNACGCCNGCCATAAACTGCNNNGNNNCAANTTANNNNAANGGCNATCCGNACGNNNGNCC 
 
>DREAM_F252A_T7 Sample_Name=DREAM_K87A_T7 Chromat_id=4097482 
Read_id=4050795 Version=1 Length=1229 
NNNNNNNNNNNNNNTCCCNTCTANNNNNNTTTTGTTTAACTTTAAGAAGGAGATATACATATGGA
ACTGGAGTTATCCACGGTGCGCCATCAGCCAGAGGGCTTGGACCAGCTACAAGCTCAGACCAAGT
TCACCAAGAAGGAGCTGCAGTCCCTTTACCGAGGCTTCAAGAATGAGTGTCCCACAGGCCTGGTG
GATGAAGACACCTTCAAACTCATTTATTCCCAGTTCTTCCCTCAGGGAGATGCCACCACCTATGC
ACACTTCCTCTTCAATGCCTTCGATGCTGATGGGAACGGGGCCATCCACTTTGAGGACTTTGTGG
TTGGGCTCTCCATCCTGCTTCGAGGGACGGTCCATGAGAAGCTCAAGTGGGCCTTCAATCTCTAT
GACATTAACAAGGATGGTTGCATCACCAAGGAGGAGATGCTGGCCATCATGAAGTCCATCTACGA
CATGATGGGCCGCCACACCTACCCCATCCTGCGGGAGGATGCACCCCTGGAGCATGTGGAGAGGT
TCTTTCAGAAAATGGACAGGAACCAGGATGGAGTGGTGACCATTGATGAATTTCTGGAGACTTGT
CAGAAGGATGAGAACATCATGAACTCCATGCAGCTGGCGGAGAACGTCATCTACCTCGAGCACCA
CCACCACCACCACTAATGTTAATTAAGTTGGGCGTTCCTAGGCTGATAAAACAGAATTTGCCTGG
CGGCAGTAGCGCGGTGGTCCCACCTGACCCCATGCCGAACTCAGAAGTGAAACGCCGTAGCGCCG
ATGGTAGTGTGGGGTCTCCCCATGCGAGAGTAGGGAACTGCCAGGCATCAAATAAAACGAAAGGC
TCAGTCGAAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCCTGAGTAGGA
CAAATCCGCCGGGAGCGGATTTGAACGTTGCGAANNAACGGCNGGNAAGGNTGGCGGNCAGGACG
CCCGCCATAAACTGCCAGGCATCAAATTAAGCAGNNGGCNATCCTGACGGATGGCCTTNTNNNNT
TNNNCAANCTCTTNGGTTNTTTTNNNNNNNNNTNNAANNNGNTTCNNCTNNNNANNNNNANNNNN
CCCNTTGGGGNNTNAANNNGGACTTNNNGGGNTTTNNNNNAANNNNNNNNNNNNNCCGNNTNGNN
AANGGNAACNNCCNNNNNNNCNNNNNNNNNNGNNNNNNNGNNNNNNCNNNNNNNNNNNN 
 
>DREAM_K87A_T7 Sample_Name=DREAM_F252A_T7 Chromat_id=4097480 
Read_id=4050806 Version=1 Length=1072 
NNNNNNNNNNNNNNNNTNNNNNNNCTNNNNNNNTTTTGTTNATCTTTAAGAAGGAGATATACATA
TGGAACTGGAGTTANCNCGGNGCGCCATCAGCCAGAGGGCTTGGACCAGCTACAAGCTCAGACCG
CGTTCACCAAGAAGGAGCTGCAGTCCCTTTACCGAGGCTTCAAGAATGAGTGTCCCACAGGCCTG
GTGGATGAAGACACCTTCAAACTCATTTATTCCCAGTTCTTCCCTCAGGGAGATGCCACCACCTA
TGCACACTTCCTCTTCAATGCCTTCGATGCTGATGGGAACGGGGCCATCCACTTTGAGGACTTTG
TGGTTGGGCTCTCCATCCTGCTTCGAGGGACGGTCCATGAGAAGCTCAAGTGGGCCTTCAATCTC
TATGACATTAACAAGGATGGTTGCATCACCAAGGAGGAGATGCTGGCCATCATGAAGTCCATCTA
CGACATGATGGGCCGCCACACCTACCCCATCCTGCGGGAGGATGCACCCCTGGAGCATGTGGAGA
GGTTCTTTCAGAAAATGGACAGGAACCAGGATGGAGTGGTGACCATTGATGAATTTCTGGAGACT
TGTCAGAAGGATGAGAACATCATGAACTCCATGCAGCTGTTTGAGAACGTCATCTACCTCGAGCA
CCACCACCACCACCACTAATGTTAATTAAGTTGGGCGTTCCTAGGCTGATAAAACAGAATTTGCC
TGGCGGCAGTAGCGCGGTGGTCCCACCTGACCCCATGCCGAACTCAGAAGTGAAACGCCGTAGCG
CCGATGGTAGTGTGGGGTCTCCCCATGCGAGAGTAGGGAACTGCCAGGCATCAAATAAAACGAAA
GGCTCAGTCGAAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCCTGAGTA
GGACAANTCCGCCGGGAGCGGATTNGAACGTTGCGANNCAACGGCCCGGAGGNTGGCGGNNAGGA
CGCCNGCCTNAACTGCCAGGNNTCAANTANNNNGAAGGCATCCTGACGGATGGCNTTTNNGNNTT
CTACNNNNNNTNGGTTATTNNNNANNNNTTNN 
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>DREAM_E92A_T7 Sample_Name=E92A_T7 Chromat_id=3997196 
Read_id=3950670 Version=1 Length=1013 
NNNNNNNNNNNNNNNNNNNNNNNTCTNGNNTAATTTTGTTTAACTTNNAGAAGGAGATATACATA
TGGAACTGGAGTTANCCNNGGNNCGCCATCAGCCAGAGGGCTTGGACCAGCTACAAGCTCCCACC
AAGTTCACCAAGAAGGCGCTGCAGTCCCTTTACCGAGGCTTCAAGAATGAGTGTCCCACAGGCCT
GGTGGATGAAGACACCTTCAAACTCATTTATTCCCAGTTCTTCCCTCAGGGAGATGCCACCACCT
ATGCACACTTCCTCTTCAATGCCTTCGATGCTGATGGGAACGGGGCCATCCACTTTGAGGACTTT
GTGGTTGGGCTCTCCATCCTGCTTCGAGGGACGGTCCATGAGAAGCTCAAGTGGGCCTTCAATCT
CTATGACATTAACAAGGATGGTTGCATCACCAAGGAGGAGATGCTGGCCATCATGAAGTCCATCT
ACGACATGATGGGCCGCCACACCTACCCCATCCTGCGGGAGGATGCACCCCTGGAGCATGTGGAG
AGGTTCTTTCAGAAAATGGACAGGAACCAGGATGGAGTGGTGACCATTGATGAATTTCTGGAGAC
TTGTCAGAAGGATGAGAACATCATGAACTCCATGCAGCTGTTTGAGAACGTCATCTACCTCGAGC
ACCACCACCACCACCACTAATGTTAATTAAGTTGGGCGTTCCTAGGCTGATAAAACAGAATTTGC
CTGGCGGCAGTAGCGCGGTGGTCCCACCTGACCCCATGCCGAACTCAGAAGTGAAACGCCGTAGC
GCCGATGGTAGTGTGGGGTCTCCCCATGCGAGAGTAGGGAACTGCCAGGCATCAAATAAAACGAA
AGGCTCAGTCGAAAGACTGGGCCTTTCGTTTTATCTNNNGTTTGTCGGTGAACGCTCTCCTGAGT
AGGACAAATCCGCCGGGAGCGGATTTGAACGTTGCGAAGCAACGGCCNGGANGGNTGGCGGNNAG
GANNCCNGCNNNAANNNGCNANNNNTCAATTNAANCNN 
>CaM_A148C_T7 Sample_Name=CaM_A148C_T7 Chromat_id=2855911 
Read_id=2829062 Version=1 Length=743 
NNNNNNNNNNNNNNCNNNNNNNNNNNNNNNNTNANNNNNNGANNGAGTATACAATGGCTGACCAG
CTTACTGGCGANNANAAGGGGGAATGGAAAGAAGCTTTCTCCCTATGGGACAAGGACGGGGATGG
GACAATGACAACCAAGGAGCTGGGGACGGTGATGCGGTCTCTGGGGCAGAACCCCACAGAAGCAG
ACCTGCAGGACATGATCAAGGAAGTAAATGCCAACGGCAATGCCCCGGTCGACTTCCCTGAATTC
CTGACAAGGATGGCNACCCNAATGCAAGACACAGACAGTGAAGAAGAAATTAGAGAAGCGTTCCG
NGTGTTTGATAAGGATGGCAATGGCTACATCAGTGCAGCATAGCTTCGCCACGTGATGACTAACC
TTGGAGAGAAGTTAACAGATGAAGAGGTTGATGAAATGATCAGGGAAGCAGACATCGATGGGGAT
GGTCAGGTAAACTACGAAGAGCTTGTACAAATGATGACATGCAAGTATGGGGATCCTCTNNAGTC
GACCTGCAGCCCAAGCTTATCNNTGGCGTAATAGCGANNNGGCCNGCACCGATCGCCCTTCCCAA
CNGTTGCGCAGCCTGAATGGCGAATGTACTCTCCCTGTATCGGCGCATTANNNGCNNNNGGTGNT
NTNNTTACTCNCNNNNTNNNTGNTACACTTGNNNGCGNNNTTNTNNNNTGNNNNNTTCGCTTTCT
TCCNNNCCTTTCTNNNNNCGANNGNCGG 
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10.2 Appendix 2 
 The following scripts have been designed to work in MATLAB 2015b. Two inputs 
are necessary, the mz_table.csv and filename.csv files. The mz_table.csv file is an excel 
generated spreadsheet which contains three columns of data. Each row represents a charged 
ion species, the first column is the lowest m/z value of this specie, and the second column 
is the highest m/z value for the specie, while the third column is the charge of the ion. If 
background needs to be subtracted then a m/z range in which the background is present 
must be placed in the first and second column, while the third column must contain a 
charged state of 0. If no background is needed, then the scripts by default will not subtract 
any background. The second file, filename.csv, can be generated by right clicking the 
image of the m/z spectra versus mobility obtained from the UIMF_Viewer software and 
selecting “Export Intensity Values (Complete Bin Resolution)”. The export command will 
generate a .csv spreadsheet that can be recognized by the script. Both the mz_table.csv and 
filename.csv files must be in the same folder. I recommend appending a numeric value (i 
e. 1, 2, 3, 4, or 5) at the end of the filename in order to be able to use the “timescale” option 
at line 11 of the first script. 
% Start of Script 1 
% Signal extraction script for TIMS data version 2.0 
%This script was prepared in MATLAB R2011b, and may not work well with latest 
versions 
%this script has not been yet optimized but provides the basis for further development. 
%Script designed by WGG 01/19/2016 
% Load data from CSV matrix exported from Bruker software as .csv 
% Create transpose matrices, so that y=mobility and x=mass to charge 
clear 
clc 
%%%%%%%%%%%%%%%%%%%%%%%%%%% 
timescale='1';             %Only this part needs to be changed. 
%%%%%%%%%%%%%%%%%%%%%%%%%%% 
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directory='C:\ PATHtoFiles\'; 
  
filename = 'filename'; 
open=strcat(directory,filename,timescale,'.csv'); 
A = importdata(open,','); 
mz_axis=str2double(A.rowheaders(2:end)); 
time_range=length(A.data(1,:)); 
MT=A.data(2:end,:).'; 
%clear A; 
%% extract m/z range from matrix, skip first cell due to text in it 
clc 
[rows,columns]=size(MT); % Determine size of data matrix create new matrix without 
mobility headers 
  
%If want to load table with mz ranges to scan use this code 
filename= 'mz_table.csv'; 
open=strcat(directory,filename); 
mz_table=importdata(open,','); 
ion_number=size(mz_table); 
output=ones(rows,ion_number(1,1)); 
scan_time=[1:time_range]'; 
scan_time_range=max(scan_time); 
%% this section allows the usser to refine the m/z table values and saves a new modified 
mz table 
%all the analysis downstream is done on the modified m/z table. however, if 
%the analysis is restarted then the original table is used unless replaced 
%by the modified. 
clc 
k=1; 
format long g 
  
fig1 = figure('Name', 'Table of m/z values','Position', [500 250 700 500]); 
columnname = {'min m/z','max m/z','charge'}; 
table=uitable('Parent', fig1, 'Position', [50 50 280 180], 'Data', 
mz_table,'ColumnName',columnname); 
set(table,'units','normalized'); 
table.ColumnEditable = [true true true]; 
mz_table_in=get(table); 
  
while k <=ion_number(1,1) 
    i=1; 
    [~, index1]=min(abs(mz_axis-mz_table_in.Data(k,1))); 
    [~, index2]=min(abs(mz_axis-mz_table_in.Data(k,2))); 
     
    width=index2-index1; 
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    signal_mobility=zeros(rows,width); 
     
    for j =index1:1:index2 
        signal_mobility(:,i)=MT(:,j); 
        i=i+1;             
    end 
    output(:,k)=sum(signal_mobility,2); 
     
     
    figure(fig1) 
    subplot(2,2,[1,2]) 
    y1=mz_axis(index1:index2); 
    mesh(scan_time,y1,signal_mobility'); 
    az=0; 
    el=90; 
    view(az,el); 
    xlabel('Mobility')              % label x-axis 
    ylabel('m/z')                   % label y-axis 
    charge=mat2str(mz_table_in.Data(k,3)); 
    ion=mat2str(k); 
    lgnd=strcat('+ ',charge,'   ion number = ',ion); 
    title(lgnd) 
    subplot(2,2,4) 
    plot(scan_time,output(:,k),'DisplayName','output','YDataSource','output'); 
    title('Averaged mobility of selected m/z'); 
    xlabel('Mobility Scans'); 
    ylabel('Mobility Signal (a.u.)') 
    drawnow 
  
    choice = menu('Adjust m/z table','Modify','Undo','Refresh','Next Peak','Previous 
peak','Finish'); 
    memory=[mz_table(k,1) mz_table(k,2) mz_table(k,3)]; 
    if choice==1 
        [x,y,button] = ginput(1) 
        if button==1 
            mz_table_in.Data(k,1)=y(1,1);             
        elseif button==3        
            mz_table_in.Data(k,2)=y(1,1); 
        end 
        k=k; 
    elseif choice==2 
        mz_table_in.Data(k,:)=memory; 
        k=k; 
    elseif choice==3  
        k=k; 
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        mz_table_in=get(table); 
    elseif choice==4 && k<ion_number(1,1)+1 
        k=k+1; 
        mz_table_in=get(table); 
    elseif choice==5 && k>1 
        k=k-1; 
        mz_table_in=get(table); 
    elseif choice==6 
        k=ion_number(1,1)+1; 
         for l=1:1:ion_number(1,1) 
             [~, index1]=min(abs(mz_axis-mz_table_in.Data(l,1))); 
             [~, index2]=min(abs(mz_axis-mz_table_in.Data(l,2))); 
             width=index2-index1; 
             signal_mobility=zeros(rows,width); 
              
             for j =index1:1:index2 
                 signal_mobility(:,i)=MT(:,j); 
                 i=i+1;             
             end 
             output(:,l)=sum(signal_mobility,2); 
             mz_table_in=get(table); 
         end 
          
    end   
         
        %columnname = {'min m/z','max m/z','charge'}; 
        set(table,'Data',mz_table_in.Data) 
        table.ColumnEditable = [true true true]; 
        filename='mz_table'; %get(handles.mz_table,'String') 
        save=strcat(directory,filename,'_modified.csv'); 
        dlmwrite(save,mz_table_in.Data); 
        fclose('all'); 
end 
close all 
%% Substract background noise from each peak, 
clc 
[RowBlank, ColBlank]=find(mz_table==0); 
lengthBlank=length(RowBlank); 
[RowData, ColData]=size(output); 
TF=isempty(RowBlank); 
maxbound=ColData-lengthBlank; 
output2=ones(RowData,maxbound); 
  
if TF==1 
    disp('No Blanks to substract') 
 333 
else  
    disp('Data analysis includes background subtraction') 
    n=1; 
    for i=1:1:ColData 
        output2(:,i)=output(:,i)-output(:,RowBlank(n)); 
        if i==RowBlank(n) 
            n=n+1; 
            i=i+1; 
             
             
        end 
    end 
     output2(:,RowBlank)=[];      
     output2(output2<0)=0; 
      
     filename='mz_table';        
     save=strcat(directory,filename,'_noBlank.csv'); 
     mz_table_noBlank=mz_table_in.Data; 
     mz_table_noBlank(RowBlank,:)=[]; 
     dlmwrite(save,mz_table_noBlank); 
     fclose('all'); 
end 
  
%% This section manipulates the output matrix to include headers and axis  
%for exporting into data file 
clc 
  
corner=zeros(1,1);                  %adds a 0 to match array dimensions 
charges=mz_table_in.Data(:,3)';             %if molecular ion is added to third column then 
it is included here 
charges(:,RowBlank)=[];  
charges_shifted=[corner charges];   %shift average of selected charges by blank cell 
mz_average=mean(mz_table_in.Data(:,1:2),2)'; 
mz_average(:,RowBlank)=[]; 
ion_number=size(mz_average'); 
mz_shifted=[corner mz_average]; 
output_axes=[scan_time output2]; 
output_charges=[charges_shifted;output_axes]; 
output_header=[mz_shifted;output_charges]; 
  
%% This section will smooth the integrated mobility plots if it is necesary 
%Savitzky-Golay used but other could be used if function known 
clc 
output_smooth=ones(rows,ion_number(1,1)); 
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for k =1:1:ion_number(1,1) 
    output_smooth(:,k)=smooth(output2(:,k),15);      %select smooth model 
    output_axes_smooth=[scan_time output_smooth]; 
    output_charges_smooth=[charges_shifted;output_axes_smooth]; 
    output_header_smooth=[mz_shifted;output_charges_smooth];    
end 
  
%% Plot all data and save to file 
fig1=figure; 
subplot (2,1,1) 
plot(output_axes(:,1),output_axes(:,2:end),'DisplayName','output','YDataSource','output');
figure(gcf) 
title('Averaged mobility of selected m/z'); 
xlabel('Mobility Scans'); 
ylabel('Mobility Signal (a.u.)') 
  
subplot(2,1,2) 
mesh(output_axes(:,2:end)); 
figure(gcf);      % plot using + markers 
xlabel('ion specie number'); 
ylabel('Mobility Signal (a.u.)') 
  
%Naming of output files 
save=strcat(directory,'\','data_',timescale,'.csv'); 
dlmwrite(save,output_header); 
%save=strcat(directory,'\','data_smooth_',timescale,'.csv'); 
%dlmwrite(save,output_header_smooth); 
fclose('all'); 
  
  
%% Find the maximum peak and look for the scan time at which it happens. 
% provides initial parameters for the gaussian fit. 
clc 
coefficient_ft=zeros(12,ion_number(1,1)); 
rsquare=ones(1,ion_number(1,1)); 
ft_line=zeros(scan_time_range,ion_number(1,1)); 
ft_xpeaks_rsqr=zeros(ion_number(1,1),6); 
  
  
open=strcat(directory,'mz_Table_noBlank.csv'); 
mz_table_in = importdata(open,','); 
  
gauss=scan_time_range.*0.05; 
YY=1; 
xmin=1; 
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xmax=scan_time_range; 
%fig2=figure('Name', '3-D Mobility plot','Position', [20 60 600 400]); 
%fig3=figure('Name','Fitting','Position', [600 60 1200 700]); 
  
  
while YY<=ion_number(1,1) 
   
        %xmin=str2num(get(handles.xmin,'String')); 
        %xmax=str2num(get(handles.xmax,'String')); 
         
        [~, index1]=min(abs(mz_axis-mz_table_in(YY,1))); 
        [~, index2]=min(abs(mz_axis-mz_table_in(YY,2))); 
        i=1; 
        width=index2-index1; 
        signal_mobility=zeros(rows,width); 
        for j =index1:1:index2 
            signal_mobility(:,i)=MT(:,j); 
            i=i+1;             
        end 
  
        fig2=figure('Name', '3-D Mobility plot','Position', [20 60 600 400]); 
        y=mz_axis(index1:index2); 
        mesh(scan_time,y,signal_mobility'); 
        az = 0; 
        el = 90; 
        view(az, el); 
        xlabel('Mobility')              % label x-axis 
        ylabel('m/z')                   % label y-axis 
        zlabel('Intensity')             % label z-axis 
  
        fig3=figure('Name','Fitting','Position', [600 60 1200 700]); 
        subplot(2,1,1)         
        plot(output_axes(xmin:xmax,1),output2(xmin:xmax,YY)); 
        fig3_obj = datacursormode(fig3); 
        set(fig3_obj,'DisplayStyle','datatip','SnapToDataVertex','off','Enable','on') 
        ion=mat2str(YY); 
        charge=mat2str(mz_table_in(YY,3)); 
        lgnd=strcat('+ ',charge,' ion number:',ion); 
        legend(lgnd) 
        xlabel('Mobility - Scan') 
        ylabel('Signal') 
        title('Ion currently being fitted') 
         
        if YY<=ion_number(1,1)-1         
        subplot (2,2,4) 
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        plot(output_axes(:,1),output2(:,YY+1)); 
        ion=mat2str(YY+1); 
        charge=mat2str(mz_table_in(YY+1,3)); 
        lgnd=strcat('+ ',charge,' ion number:',ion); 
        legend(lgnd) 
        xlabel('Mobility - Scan') 
        ylabel('Signal') 
        title('Next ion to be fitted') 
        end 
         
        columnname = {'m/z','Peak 1','Peak 2','Peak3 3','Peak 4','R-square'}; 
        ft_xpeaks_rsqr=[mz_average' coefficient_ft(2,:)' coefficient_ft(5,:)' 
coefficient_ft(8,:)' coefficient_ft(11,:)' rsquare'];        
        table2=uitable('Parent', fig3, 'Position', [120 50 500 280], 'Data', 
ft_xpeaks_rsqr,'ColumnName',columnname); 
        table2.ColumnEditable = [true true true]; 
        ft_xpeaks_rsqr=get(table2);        
         
        choice = menu('Number of gaussians','1 Peaks','2 Peaks','3 Peaks','4 Peaks','Go Back 
1 ion','Go Forward 1 ion','Redraw','Auto-Fit','Manual','Finish','Quit') 
  
        [xData, yData] = prepareCurveData(output_axes(xmin:xmax,1), 
output2(xmin:xmax,YY)); 
  
    if choice==5 && YY>=2 
        YY=YY-1; 
    elseif choice==5 && YY==1 
        disp('nothing to do') 
    elseif choice==6 && YY<ion_number(1,1) 
        YY=YY+1; 
    elseif choice==7 
        YY=YY;      
    elseif choice==8 
        maxpeak=max(output_smooth(xmin:xmax,YY)); 
        [xmaxpeak, 
~]=ind2sub(size(output_smooth(:,YY)),find(output_smooth(:,YY)==maxpeak,1)); 
        locs=round(output_axes(xmaxpeak,1)); 
        w=scan_time_range.*0.15; 
        ft = fittype( 'gauss1'); 
        opts = fitoptions( ft ); 
        opts.Algorithm = 'Trust-Region'; 
        opts.DiffMaxChange = 0.01; 
        opts.Display = 'Off'; 
        opts.Lower = [-Inf -Inf 0 ]; 
        opts.MaxFunEvals = 6000; 
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        opts.MaxIter = 4000; 
        opts.StartPoint = [maxpeak locs w]; 
         
        [ftresult, gof(YY)] = fit( xData, yData, ft, opts ); 
        ft_line(xmin:xmax,YY)=feval(ftresult,xData); 
        rsquare(YY)=gof(YY).rsquare; 
        coeff=coeffvalues(ftresult)'; 
        coefficient_ft(:,YY)=[coeff(1,1);coeff(2,1);coeff(3,1);0;0;0;0;0;0;0;0;0]; 
         
        subplot(2,1,1) 
        plot( ftresult, xData, yData ); 
        ion=mat2str(YY); 
        rsqr=mat2str(round(rsquare(YY),3)); 
        lgnd=strcat('+ ',charge,' ion number:',ion, '   R^2 =   ',rsqr); 
        xlabel('Mobility - Scan') 
        ylabel('Signal') 
        YY=YY+1 
    elseif choice==9 
        i=1; 
        button=1; 
        xx=zeros(4,1); 
        while button==1 && i<=4 
            [x,y,button] = ginput(1); 
            xx(i)=x; 
            if button ==1 
            coefficient_ft(2,YY)=xx(1); 
            coefficient_ft(5,YY)=xx(2); 
            coefficient_ft(8,YY)=xx(3); 
            coefficient_ft(11,YY)=xx(4); 
            rsquare(YY)=1; 
            end 
            i=i+1; 
        end 
        YY=YY+1; 
    elseif choice==10 
        YY=ion_number(1,1)+1; 
        close all 
    elseif choice==11 
        disp('Autodestroy!') 
        close all 
        Autodestroy 
    end 
  
    if choice <=4 
        [x,y,button] = ginput(choice);  
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    for i=1:1:length(x) 
            parameters(i,:,YY)=[x(i) y(i)]; 
    end 
    if length(x)==1 
        % Set up fittype and options. 
        ft = fittype( 'gauss1'); 
        opts = fitoptions( ft ); 
        opts.Algorithm = 'Trust-Region'; 
        opts.DiffMaxChange = 0.01; 
        opts.Display = 'Off'; 
        opts.Lower = [-Inf -Inf 0 ]; 
        opts.MaxFunEvals = 6000; 
        opts.MaxIter = 4000; 
        opts.StartPoint = [parameters(1,2,YY) parameters(1,1,YY) gauss]; 
         
        [ftresult, gof(YY)] = fit( xData, yData, ft, opts ); 
        ft_line(xmin:xmax,YY)=feval(ftresult,xData); 
        rsquare(YY)=gof(YY).rsquare; 
        coeff=coeffvalues(ftresult)'; 
        coefficient_ft(:,YY)=[coeff(1,1);coeff(2,1);coeff(3,1);0;0;0;0;0;0;0;0;0]; 
         
         
        subplot(2,1,1) 
        plot( ftresult, xData, yData ); 
        ion=mat2str(YY); 
        rsqr=mat2str(round(rsquare(YY),3)); 
        lgnd=strcat('+ ',charge,' ion number:',ion, '   R^2 =   ',rsqr); 
        xlabel('Mobility - Scan') 
        ylabel('Signal') 
         
        button = 1;         
        while button ==1   % read ginputs until a mouse right-button occurs 
            [x,y,button] = ginput(1) 
            YY=YY+1;          
            if button==1 
                YY=YY-1; 
                button=3; 
            end 
        end 
     
    end 
  
    if length(x)==2 
  
        % Set up fittype and options. 
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        ft = fittype( 'gauss2'); 
        opts = fitoptions( ft ); 
        opts.Algorithm = 'Trust-Region'; 
        opts.DiffMaxChange = 0.01; 
        opts.Display = 'Off'; 
        opts.Lower = [-Inf -Inf 0 -Inf -Inf 0]; 
        opts.MaxFunEvals = 6000; 
        opts.MaxIter = 4000; 
        opts.StartPoint = [parameters(1,2,YY) parameters(1,1,YY) gauss 
parameters(2,2,YY) parameters(2,1,YY) gauss]; 
         
        [ftresult, gof(YY)] = fit( xData, yData, ft, opts ); 
        ft_line(xmin:xmax,YY)=feval(ftresult,xData); 
        rsquare(YY)=gof(YY).rsquare; 
        coeff=coeffvalues(ftresult)'; 
        
coefficient_ft(:,YY)=[coeff(1,1);coeff(2,1);coeff(3,1);coeff(4,1);coeff(5,1);coeff(6,1);0;0;
0;0;0;0]; 
          
        subplot(2,1,1) 
        plot( ftresult, xData, yData ); 
        ion=mat2str(YY); 
        rsqr=mat2str(round(rsquare(YY),3)); 
        lgnd=strcat('+ ',charge,' ion number:',ion, '   R^2 =   ',rsqr); 
        legend(lgnd) 
        xlabel('Mobility - Scan') 
        ylabel('Signal') 
         
         
        button = 1;         
        while button ==1   % read ginputs until a mouse right-button occurs 
            [x,y,button] = ginput(1) 
            YY=YY+1;          
            if button==1 
                YY=YY-1; 
                button=3; 
            end 
        end 
     
    end 
     
   if length(x)==3 
  
        % Set up fittype and options. 
        ft = fittype( 'gauss3'); 
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        opts = fitoptions( ft ); 
        opts.Algorithm = 'Trust-Region'; 
        opts.DiffMaxChange = 0.01; 
        opts.Display = 'Off'; 
        opts.Lower = [-Inf -Inf 0 -Inf -Inf 0 -Inf -Inf 0]; 
        opts.MaxFunEvals = 6000; 
        opts.MaxIter = 4000; 
        opts.StartPoint = [parameters(1,2,YY) parameters(1,1,YY) gauss 
parameters(2,2,YY) parameters(2,1,YY) gauss parameters(3,2,YY) parameters(3,1,YY) 
gauss]; 
         
        [ftresult, gof(YY)] = fit( xData, yData, ft, opts ); 
        ft_line(xmin:xmax,YY)=feval(ftresult,xData); 
        rsquare(YY)=gof(YY).rsquare; 
        coeff=coeffvalues(ftresult)'; 
        
coefficient_ft(:,YY)=[coeff(1,1);coeff(2,1);coeff(3,1);coeff(4,1);coeff(5,1);coeff(7,1);coe
ff(8,1);coeff(9,1);coeff(6,1);0;0;0]; 
         
        subplot(2,1,1) 
        plot( ftresult, xData, yData ); 
        ion=mat2str(YY); 
        rsqr=mat2str(round(rsquare(YY),3)); 
        lgnd=strcat('+ ',charge,' ion number:',ion, '   R^2 =   ',rsqr); 
        legend(lgnd) 
        xlabel('Mobility - Scan') 
        ylabel('Signal') 
         
        button = 1;         
        while button ==1   % read ginputs until a mouse right-button occurs 
            [x,y,button] = ginput(1) 
            YY=YY+1;          
            if button==1 
                YY=YY-1; 
                button=3; 
            end 
        end 
     
   end 
     
    if length(x)==4 
  
        % Set up fittype and options. 
        ft = fittype( 'gauss4'); 
        opts = fitoptions( ft ); 
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        opts.Algorithm = 'Trust-Region'; 
        opts.DiffMaxChange = 0.01; 
        opts.Display = 'Off'; 
        opts.Lower = [-Inf -Inf 0 -Inf -Inf 0 -Inf -Inf 0 -Inf -Inf 0]; 
        opts.MaxFunEvals = 6000; 
        opts.MaxIter = 4000; 
        opts.StartPoint = [parameters(1,2,YY) parameters(1,1,YY) gauss 
parameters(2,2,YY) parameters(2,1,YY) gauss parameters(3,2,YY) parameters(3,1,YY) 
gauss parameters(4,2,YY) parameters(4,1,YY) gauss]; 
         
        [ftresult, gof(YY)] = fit( xData, yData, ft, opts ); 
        ft_line(xmin:xmax,YY)=feval(ftresult,xData); 
        rsquare(YY)=gof(YY).rsquare; 
        coeff=coeffvalues(ftresult)'; 
        
coefficient_ft(:,YY)=[coeff(1,1);coeff(2,1);coeff(3,1);coeff(4,1);coeff(5,1);coeff(6,1);coe
ff(7,1);coeff(8,1);coeff(9,1);coeff(10,1);coeff(11,1);coeff(12,1)];         
         
        subplot(2,1,1) 
        plot( ftresult, xData, yData ); 
        ion=mat2str(YY); 
        rsqr=mat2str(round(rsquare(YY),3)); 
        lgnd=strcat('+ ',charge,' ion number:',ion, '   R^2 =   ',rsqr); 
        legend(lgnd) 
        xlabel('Mobility - Scan') 
        ylabel('Signal') 
          
        button = 1;         
        while button ==1   % read ginputs until a mouse right-button occurs 
            [x,y,button] = ginput(1) 
            YY=YY+1;          
            if button==1 
                YY=YY-1; 
                button=3; 
            end 
        end 
     
    end 
    end 
    close(fig2,fig3) 
end 
 
%% Save fit lines and parameters 
clc 
%ft_line_axes=[scan_time ft_line]; 
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%ft_line_header=[mz_shifted;ft_line_axes]; 
%save=strcat(directory,'\','fit_line_',timescale,'.csv'); 
%dlmwrite(save,ft_line_header); 
%fclose('all'); 
  
ft_xpeaks_rsqr=[mz_average' coefficient_ft(2,:)' coefficient_ft(5,:)' coefficient_ft(8,:)' 
rsquare']; 
save=strcat(directory,'\','mz_Peak_Rsqr_',timescale,'.csv'); 
dlmwrite(save,ft_xpeaks_rsqr); 
fclose('all'); 
%notification='No more data to analyze. Fits and peaks saved in files fit_file and 
mz_Peak_Rsqr'; 
%set(handles.notification, 'String',notification); 
  
% End of Script 1 
 
% Start of Script 2 
% CCS calculator version 2.0 
%This script was prepared in MATLAB R2011b, and may not work well with latest 
versions 
%this script has not been yet optimized bu provides the basis for further 
%developmet. 
%Script designed by WGG 01/19/2016 
% Data analsysis to extract CCS from TIMS experiments 
%this script requires the outputs from Singal_extraction_V2 to be present 
%The script is designed to analyze 5 timescales (100 200 300 400 and 500ms) 
clc 
clear 
% 
directory='PATHtoFILE\'; 
  
for mmm=100:100:500 
timescale_export=mmm;                           %<<<<<<< only need to change this number to 
100, 200, 300 etc and F5 
voltage=-42;                                   %Voltage set by user 
%calibration=-125.8;                             %Calibration detertmined using tunemix 
calibration=-101;  
peak_number=1; 
%TIMS_ramp_duration=[400;650;800;1200;1600];     %ramp times used  
TIMS_ramp_duration=[705;1205;1905;2605;3405];     %ramp times used  
  
P0_average=0;            % if 0 then determined for each ion, otherwise obtained assuming a 
gaussian distribution of P0 vs ion 
  
%Import extracted data 
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timescale1='1.csv';  
filename = 'mz_Peak_Rsqr_'; 
filename2='data_'; 
open=strcat(directory,filename,timescale1); 
open2=strcat(directory,filename2,timescale1); 
mz_Peak_Rsqr_1 = importdata(open,','); 
mobility_signal_1=importdata(open2,','); 
  
timescale2='2.csv'; 
open=strcat(directory,filename,timescale2); 
open2=strcat(directory,filename2,timescale2); 
mz_Peak_Rsqr_2 = importdata(open,','); 
mobility_signal_2=importdata(open2,','); 
  
timescale3='3.csv'; 
open=strcat(directory,filename,timescale3); 
open2=strcat(directory,filename2,timescale3); 
mz_Peak_Rsqr_3 = importdata(open,','); 
mobility_signal_3=importdata(open2,','); 
  
timescale4='4.csv'; 
open=strcat(directory,filename,timescale4); 
open2=strcat(directory,filename2,timescale4); 
mz_Peak_Rsqr_4 = importdata(open,','); 
mobility_signal_4=importdata(open2,','); 
  
timescale5='5.csv'; 
open=strcat(directory,filename,timescale5); 
open2=strcat(directory,filename2,timescale5); 
mz_Peak_Rsqr_5 = importdata(open,','); 
mobility_signal_5=importdata(open2,','); 
  
mz_Peak_Rsqr=[mz_Peak_Rsqr_1(:,1) mz_Peak_Rsqr_1(:,peak_number+1) 
mz_Peak_Rsqr_2(:,peak_number+1) mz_Peak_Rsqr_3(:,peak_number+1) 
mz_Peak_Rsqr_4(:,peak_number+1) mz_Peak_Rsqr_5(:,peak_number+1)]; 
clear mz_Peak_Rsqr_1 mz_Peak_Rsqr_2 mz_Peak_Rsqr_3 mz_Peak_Rsqr_4 
mz_Peak_Rsqr_5; 
clear open open2 filename filename2 
%% Rearrange matrices and calculate P0 
clc 
  
data_table=size(mz_Peak_Rsqr); 
rows=length(TIMS_ramp_duration); 
peak_vs_ramp=zeros(rows,data_table(1,1)+1); 
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peak_vs_ramp(:,1)=TIMS_ramp_duration'; 
  
for j=1:1:data_table(1,1);  
        peak_vs_ramp(:,j+1)=mz_Peak_Rsqr(j,2:end)';    
end 
clear i j 
%% Fit peak shift vs scan time with linear equations 
clc 
rsquare=ones(data_table(1,1),2); 
coefficient_ft=zeros(2,data_table(1,1)); 
mz_P0=zeros(data_table(1,1),2); 
mz_P0(:,1)=mz_Peak_Rsqr(:,1); 
for i=1:1:data_table(1,1) 
    [xData, yData]=prepareCurveData(peak_vs_ramp(:,1),peak_vs_ramp(:,i+1)); 
     
% Set up fittype and options. 
ft = fittype( 'poly1' ); 
opts = fitoptions( ft ); 
opts.Lower = [0 0]; 
opts.Upper = [Inf Inf]; 
  
% Fit model to data. 
[ftresult, gof] = fit( xData, yData, ft, opts ); 
coefficient_ft(:,i)=coeffvalues(ftresult)'; 
if coefficient_ft(2,i)>10 && coefficient_ft(2,i)<80 
    mz_P0(i,2)=coefficient_ft(2,i)'; 
else if i>1 
    mz_P0(i,2)=mz_P0(i-1,2)-0.8; 
    else 
       mz_P0(i,2)=40; 
    end 
end 
rsquare(i,2)=gof.rsquare; 
  
  
% Show Fitting 
%subplot(2,2,1:2) 
%plot( ftresult, xData, yData ); 
%xlabel('Scan time'); 
%ylabel('Mobility Signal (a.u.)'); 
%legend('off'); 
%subplot(2,2,3) 
%plot(rsquare(:,2)); 
%xlabel('Ion number'); 
%ylabel('R-squared'); 
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%legend('off'); 
%subplot(2,2,4) 
%plot(mz_P0(:,2)); 
%xlabel('Ion number'); 
%ylabel('P0 clculated'); 
%legend('off'); 
%drawnow 
end 
clear i 
%% Load charges from table and calculate Velution and K0 
clc 
filename= 'mz_table_noBlank.csv'; 
open=strcat(directory,filename); 
mz_table=csvread(open); 
mz_average=mean(mz_table(:,1:2),2); 
charges=mz_table(:,3)'; 
%% 
%Velution calculation: -voltage+(x-P0)*abs(voltage/TIMS_ramp_duration) 
%where x is the scan frame (1st column in the mobility signal, x axis) 
clc 
  
if timescale_export==100; 
    mobility_scans=length(mobility_signal_1)-1; 
    A=mobility_signal_1(2:end,1); 
    else if timescale_export==200; 
        mobility_scans=length(mobility_signal_2)-1; 
        A=mobility_signal_2(2:end,1);   
        else if timescale_export==300; 
            mobility_scans=length(mobility_signal_3)-1; 
            A=mobility_signal_3(2:end,1);   
            else if timescale_export==400; 
                mobility_scans=length(mobility_signal_4)-1; 
                A=mobility_signal_4(2:end,1);   
                else if timescale_export==500; 
                    mobility_scans=length(mobility_signal_5)-1; 
                    A=mobility_signal_5(2:end,1);   
                    end 
                end 
            end 
        end 
end 
  
%%    
Velution=zeros(mobility_scans,5); 
D=zeros(data_table(1,1),1); 
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C=zeros(data_table(1,1),1); 
E=zeros(data_table(1,1),1); 
for i=1:1:rows 
    B=abs(voltage./TIMS_ramp_duration(i)); 
    for j=1:1:data_table(1,1) 
        C(j)=mz_P0(j,2); 
        for k=1:1:mobility_scans 
            if P0_average > 0 
            D(k)=A(k)-P0_average; %P0_average;    %if C(j) used then the P0 value for each 
ion is used. 
            else 
            D(k)=A(k)-C(j); %P0_average;    %if C(j) used then the P0 value for each ion is 
used. 
            end 
            E(k)=D(k).*B; 
            Velution(k,j,i)=voltage+E(k); %this is a 3D matrix with P0 outputs 
        end 
    end 
end 
clear A B C D E i j k 
%% Calculate K0 using -101/(Velution-60) 
  
A=zeros(mobility_scans,data_table(1,1),rows); 
K0=zeros(mobility_scans,data_table(1,1),rows); 
for i=1:1:rows 
     
    for j=1:1:data_table(1,1) 
         
        for k=1:1:mobility_scans 
            A(k,j,i)=Velution(k,j,i)-60; 
            %calibration=A(k,j,i).*0.2128-93.38; 
            K0(k,j,i)=calibration./A(k,j,i); %this is a 3D matrix with K0 outputs 
        end 
    end 
end 
clear A i j k 
%% Calculate CCS in Angstrons squared using 
% (1/K0)*(18195*charge)/(sqrt((temperature*mw*28)/(mw+28)) 
clc 
  
A=zeros(mobility_scans,data_table(1,1),rows); 
mw=zeros(data_table(1,1),1); 
B=zeros(mobility_scans,data_table(1,1),rows); 
CCS=zeros(mobility_scans,data_table(1,1),rows); 
C=zeros(data_table(1,1),1); 
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for i=1:1:rows 
     
    for j=1:1:data_table(1,1) 
         
        mw(j)=mz_table(j,3).*mz_average(j,1)-mz_table(j,3); 
        C(j)=mz_table(j,3).*18195; 
        for k=1:1:mobility_scans 
            A(k,j,i)=1/K0(k,j,i);             
            B(k,j,i)=sqrt((294*mw(j)*28)./(mw(j)+28)); 
             
            CCS(k,j,i)=A(k,j,i).*C(j)./B(k,j,i); %this is a 3D matrix with CCS outputs 
        end 
    end 
end 
clear A B C i j k 
%% Save files with CCS and mobility data 
clc 
extension=data_table(1,1).*2; 
CCS_mobility=ones(mobility_scans,extension); 
j2=1; 
j3=2; 
  
if timescale_export==100; 
    k=1; 
    timescale='_1.csv';   
    else if timescale_export==200; 
         k=2; 
         timescale='_2.csv';   
        else if timescale_export==300; 
             k=3; 
             timescale='_3.csv';   
            else if timescale_export==400; 
                 k=4; 
                 timescale='_4.csv';   
                else if timescale_export==500; 
                     k=5;  
                     timescale='_5.csv';   
                    end 
                end 
            end 
        end 
end 
  
for j=1:1:data_table(1,1) 
    Intensity_Max1=sum(mobility_signal_1(3:end,j+1)); 
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    Intensity_Max2=sum(mobility_signal_2(3:end,j+1)); 
    Intensity_Max3=sum(mobility_signal_3(3:end,j+1)); 
    Intensity_Max4=sum(mobility_signal_4(3:end,j+1)); 
    Intensity_Max5=sum(mobility_signal_5(3:end,j+1)); 
    CCS_mobility(:,j2)=CCS(:,j,k);   %%%%%%%%%%%%increase last axes for diff 
timescales 
    j2=j2+2; 
     
if timescale_export==100; 
    CCS_mobility(:,j3)=mobility_signal_1(2:end,j+1)./Intensity_Max1;   
%%%%%%%%%%%%  
    else if timescale_export==200; 
         CCS_mobility(:,j3)=mobility_signal_2(2:end,j+1)./Intensity_Max2;   
%%%%%%%%%%%%  
        else if timescale_export==300; 
             CCS_mobility(:,j3)=mobility_signal_3(2:end,j+1)./Intensity_Max3;   
%%%%%%%%%%%%   
            else if timescale_export==400; 
                 CCS_mobility(:,j3)=mobility_signal_4(2:end,j+1)./Intensity_Max4;   
%%%%%%%%%%%%   
                else if timescale_export==500; 
                     CCS_mobility(:,j3)=mobility_signal_5(2:end,j+1)./Intensity_Max5;   
%%%%%%%%%%%%     
                    end 
                end 
            end 
        end 
end  
    j3=j3+2; 
end 
  
filename='Mobility_CCS'; 
if P0_average>0 
P0set=num2str(P0_average); 
save=strcat(directory,filename,'_',P0set,timescale); 
dlmwrite(save,CCS_mobility); 
fclose('all'); 
disp(strcat(filename,timescale)); 
else 
pks=num2str(peak_number); 
save=strcat(directory,filename,'_',pks,timescale); 
dlmwrite(save,CCS_mobility); 
fclose('all'); 
disp(strcat(filename,timescale)); 
end 
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 end 
if P0_average>0 && mmm==500 
    filename='_mz_P0.csv'; 
    P0set=num2str(P0_average); 
    save=strcat(directory,'Avg_',P0set,filename); 
    dlmwrite(save,mz_P0); 
else 
    filename='_mz_P0.csv'; 
    pks=num2str(peak_number); 
    save=strcat(directory,pks,filename); 
    dlmwrite(save,mz_P0); 
end 
fclose('all');     
 
% End of Script 2 
 
% Start of Script 3 
%% Import the data generated from CCS_calculator in order to create a binned histogram 
clc 
clear 
binsize=500; 
directory='C:\PATHtoFILE\'; 
  
timescale1='1.csv';  
filename = 'Mobility_CCS_1_'; 
open=strcat(directory,filename,timescale1); 
Intensity_CCS1 = importdata(open,','); 
  
timescale1='2.csv';  
filename = 'Mobility_CCS_1_'; 
open=strcat(directory,filename,timescale1); 
Intensity_CCS2 = importdata(open,','); 
  
timescale1='3.csv';  
filename = 'Mobility_CCS_1_'; 
open=strcat(directory,filename,timescale1); 
Intensity_CCS3 = importdata(open,','); 
  
timescale1='4.csv';  
filename = 'Mobility_CCS_1_'; 
open=strcat(directory,filename,timescale1); 
Intensity_CCS4 = importdata(open,','); 
  
timescale1='5.csv';  
filename = 'Mobility_CCS_1_'; 
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open=strcat(directory,filename,timescale1); 
Intensity_CCS5 = importdata(open,','); 
  
%% Concatenate Datasets at different ramp time 
clc 
SuperData=vertcat(Intensity_CCS1,Intensity_CCS2,Intensity_CCS3,Intensity_CCS4,Inte
nsity_CCS5); 
%clear('Intensity_CCS1','Intensity_CCS2','Intensity_CCS3','Intensity_CCS4','Intensity_C
CS5'); 
DataSize=size(SuperData); 
Intensity=ones(DataSize(1,1),1); 
DataSorted=ones(DataSize(1,1),DataSize(1,2)); 
  
for i=1:2:DataSize(1,2) 
    [SortedMZ,SortedIndex]=sort(SuperData(:,i)); 
    for j=1:1:DataSize(1,1) 
        Intensity(j)=SuperData(SortedIndex(j),i+1); 
    end 
     
    DataSorted(:,i)=SortedMZ; 
    DataSorted(:,i+1)=Intensity.'; 
end 
%% Smotthing the data 
DataSmooth=DataSorted; 
for i=2:2:DataSize(1,2) 
    YY=smooth(DataSorted(:,i),100,'lowess'); 
    DataSmooth(:,i)=YY; 
end 
%compress 
  
filename='Average_CCS_Mobility_'; 
save=strcat(directory,filename,'.csv'); 
dlmwrite(save,DataSmooth); 
filename='Combined_CCS_Mobility_'; 
save=strcat(directory,filename,'.csv'); 
dlmwrite(save,DataSorted); 
  
 %% Create binned data 
clc 
CCS_domain=zeros(binsize,DataSize(1,2)); 
for m=1:2:DataSize(1,2) 
CCS_min=min(DataSorted(:,m)); 
CCS_max=max(DataSorted(:,m)); 
domain=CCS_max-CCS_min; 
bin(m)=domain./binsize; 
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limits=CCS_min:bin(m):CCS_max; 
CCS_domain(:,m)=limits(2:end).'; 
  
end 
%% 
BinnedData=zeros(binsize,DataSize(1,2)); 
for k=2:2:DataSize(1,2) 
j=2;     
    for i=1:1:binsize 
        while DataSorted(j,k-1)<=CCS_domain(i,k-1) && j<DataSize(1,1) 
             
            BinnedData(i,k)=DataSorted(j,k)+BinnedData(i,k); 
             
            j=j+1; 
        end 
    end 
    BinnedData(:,k-1)=CCS_domain(:,k-1); 
end 
  
%Normalize the data 
for k=2:2:DataSize(1,2) 
    Intensity_Max(k)=sum(BinnedData(:,k)); 
    BinnedData(:,k)=BinnedData(:,k)./Intensity_Max(k); 
end 
filename='Binned_CCS_Mobility_'; 
save=strcat(directory,filename,'.csv'); 
dlmwrite(save,BinnedData); 
     
 
 
 
10.3 Appendix 3 
 
 Scripts used for preparing the system and performing the cMD and aMD 
simulations are shown below, note that these must be copied into independent 
configurations file for them to be run by NAMD. 
 
###################### MINIMIZATION######################## 
 
############################################################# 
## ADJUSTABLE PARAMETERS                         
############################################################# 
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structure           ../PROTEIN.psf 
coordinates         ../PROTEIN.pdb 
 
############################################################# 
## FORCE FIELD BLOCK  
############################################################# 
ParaTypeCharmm  on 
parameters           ../par_all27_prot_lipid.inp 
exclude   scaled1-4 
1-4scaling  1.0 
dielectric  1.0 
 
############################################################# 
## LONG-RANGE INTERACTIONS      
############################################################# 
switching  on 
switchdist  8.0 
cutoff   12.0 
pairlistdist  13.5 
stepspercycle  20 
rigidBonds  all 
 
############################################################# 
## Edwald electrostatics         
############################################################# 
# PME (for full-system periodic electrostatics) 
PME                  yes 
PMEGridSpacing       1.0 
minimization on 
 
############################################################# 
## Force patch GRID to improve performance of small systems 
############################################################# 
TwoAwayX   no 
TwoAwayY  no 
TwoAwayZ  no 
 
############################################################# 
## Output  
############################################################# 
outputenergies  1000 
outputtiming  1000 
binaryoutput  no 
outputname  ../output/1_PROTEIN_min 
restartname  ../output/1_PROTEIN_min_rest 
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restartfreq  100000 
binaryrestart  no 
DCDfile   ../output/1_PROTEIN_min.dcd 
dcdfreq   1000 
numsteps  100000 
 
############################################################# 
## Periodic boundary specifications                        
############################################################# 
# Periodic Boundary Conditions 
cellBasisVector1      60.4179992676 0.0   0.0 
cellBasisVector2      0.0   56.6269989014 0.0 
cellBasisVector3       0.0    0.0   77.7019996643 
cellOrigin         -45.022178649902344 10.466216087341309 24.586162567138672 
wrapAll             on 
 
 
###################### HEATING############################# 
 
############################################################# 
## ADJUSTABLE PARAMETERS                                  
############################################################# 
structure          ../PROTEIN.psf 
coordinates      ../output/1_PROTEIN_min.coor 
 
############################################################# 
## FORCE FIELD BLOCK                                    
############################################################# 
ParaTypeCharmm      on 
parameters           ../par_all27_prot_lipid.inp 
exclude   scaled1-4 
1-4scaling  1.0 
dielectric  1.0 
 
 
############################################################# 
## LONG-RANGE INTERACTIONS                                  
############################################################# 
switching  on 
switchdist  8.0 
cutoff   12.0 
pairlistdist  13.5 
stepspercycle  20 
rigidBonds  all 
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############################################################# 
## Edwald electrostatics                                  
############################################################# 
# PME (for full-system periodic electrostatics) 
PME                  yes 
PMEGridSpacing       1.0 
 
############################################################# 
## Force patch GRID to improve performance of small systems ## 
############################################################# 
TwoAwayX   no 
TwoAwayY  no 
TwoAwayZ  no 
 
############################################################# 
## Parameters for integrator and MTS                      
############################################################# 
timestep  1.0 
fullElectFrequency 4 
 
############################################################# 
## Output specifications                                    
############################################################# 
outputenergies  1000 
outputtiming  1000 
binaryoutput  no 
outputname  ../output/2_PROTEIN_heat1 
restartname  ../output/2_PROTEIN_heat1 
restartfreq  10000 
binaryrestart  yes 
DCDfile  ../output/2_PROTEIN_heat1.dcd 
dcdfreq  1000 
 
############################################################# 
## MD protocol block                                        
############################################################# 
seed    1010 
 
numsteps  31000 
temperature  0 
reassignFreq  1 
reassignIncr  0.005 
reassignHold  155 
 
############################################################# 
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## Periodic boundary specifications                        
############################################################# 
# Periodic Boundary Conditions 
cellBasisVector1    60.4179992676 0.0   0.0 
cellBasisVector2     0.0   56.6269989014 0.0 
cellBasisVector3     0.0    0.0   77.7019996643 
cellOrigin         -45.022178649902344 10.466216087341309 24.586162567138672 
wrapAll             on 
 
 
#################PRE-EQUILIBRATION NPT#################### 
 
############################################################# 
## ADJUSTABLE PARAMETERS                                   ## 
############################################################# 
structure          ../PROTEIN.psf 
coordinates      ../output/2_PROTEIN_heat1.coor 
 
############################################################# 
## FORCE FIELD BLOCK                                    ## 
############################################################# 
ParaTypeCharmm      on 
parameters           ../par_all27_prot_lipid.inp 
exclude   scaled1-4 
 
1-4scaling  1.0 
dielectric  1.0 
 
 
############################################################# 
## LONG-RANGE INTERACTIONS                                 ## 
############################################################# 
switching  on 
switchdist  8.0 
cutoff   12.0 
pairlistdist  13.5 
stepspercycle  20 
rigidBonds  all 
 
############################################################# 
## Edwald electrostatics                                   ## 
############################################################# 
# PME (for full-system periodic electrostatics) 
PME                  yes 
PMEGridSpacing       1.0 
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############################################################# 
## Force patch GRID to improve performance of small systems  
############################################################# 
TwoAwayX   no 
TwoAwayY  no 
TwoAwayZ  no 
 
############################################################# 
## Parameters for integrator and MTS                      
############################################################# 
timestep  1.0 
fullElectFrequency 4 
 
############################################################# 
## Output specifications                                    
############################################################# 
outputenergies  1000 
outputtiming  1000 
binaryoutput  no 
outputname  ../output/3_PROTEIN_npt_prequil 
restartname  ../output/3_PROTEIN_npt_prequil 
restartfreq  10000 
binaryrestart  yes 
DCDfile  ../output/3_PROTEIN_npt_prequil.dcd 
dcdfreq  1000 
 
############################################################# 
## Constant Temperature Control                             
############################################################# 
#Constant-energy simulations are not recommended for equilibration because, without 
#the energy flow facilitated  
#by the temperature control methods, the desired temperature cannot be achieved. 
langevin            on       # do langevin dynamics 
langevinDamping     1      # damping coefficient (gamma) of 1/ps 
langevinTemp        155 
langevinHydrogen    off      # don't couple langevin bath to hydrogens 
 
############################################################# 
## Constant Pressure Control (variable volume)              
############################################################# 
useGroupPressure      yes   # needed for rigidBonds 
useFlexibleCell        no 
useConstantArea       no 
langevinPiston         on 
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langevinPistonTarget  1.01325  #  in bar -> 1 atm 
langevinPistonPeriod  100.0 
langevinPistonDecay   50.0 
langevinPistonTemp    155 
 
############################################################# 
## MD protocol block                                        
############################################################# 
seed    3010 
numsteps  100000 
temperature  155 
rescaleFreq  1 
rescaleTemp  155 
 
############################################################# 
## Periodic boundary specifications                        
############################################################# 
# Periodic Boundary Conditions 
cellBasisVector1    60.4179992676 0.0   0.0 
cellBasisVector2     0.0   56.6269989014 0.0 
cellBasisVector3     0.0    0.0   77.7019996643 
cellOrigin         -45.022178649902344 10.466216087341309 24.586162567138672 
wrapAll             on 
 
##########################HEATING########################## 
 
############################################################# 
## ADJUSTABLE PARAMETERS                                   
############################################################# 
 
structure          ../PROTEIN.psf 
coordinates        ../output/3_PROTEIN_npt_prequil.coor 
 
############################################################# 
## FORCE FIELD BLOCK                                     
############################################################# 
ParaTypeCharmm      on 
parameters           ../par_all27_prot_lipid.inp 
exclude   scaled1-4 
 
1-4scaling  1.0 
dielectric  1.0 
 
 
############################################################# 
 358 
## LONG-RANGE INTERACTIONS                                 
############################################################# 
switching  on 
switchdist  8.0 
cutoff   12.0 
pairlistdist  13.5 
stepspercycle  20 
rigidBonds  all 
 
############################################################# 
## Edwald electrostatics                                   
############################################################# 
# PME (for full-system periodic electrostatics) 
PME                  yes 
PMEGridSpacing       1.0 
 
############################################################# 
## Force Patch Grid To Improve Performance Of Small Systems 
############################################################# 
TwoAwayX   no 
TwoAwayY  no 
TwoAwayZ  no 
 
############################################################# 
## PARAMETERS FOR INTEGRATOR AND MTS                     
############################################################# 
timestep  1.0 
fullElectFrequency 4 
 
############################################################# 
## OUTPUT SPECIFICATIONS                                   
############################################################# 
outputenergies  1000 
outputtiming  1000 
binaryoutput  no 
outputname  ../output/4_PROTEIN_heat2 
restartname  ../output/4_PROTEIN_heat2 
restartfreq  10000 
binaryrestart  yes 
DCDfile  ../output/4_PROTEIN_heat2.dcd 
dcdfreq  1000 
 
############################################################# 
## MD PROTOCOL BLOCK                                        
############################################################# 
 359 
seed    1010 
numsteps  31000 
temperature  155 
reassignFreq  1 
reassignIncr  0.005 
reassignHold  310 
 
 
############################################################# 
## PERIODIC BOUNDARY SPECIFICATIONS                       
############################################################# 
# Periodic Boundary Conditions 
cellBasisVector1    60.4179992676 0.0   0.0 
cellBasisVector2     0.0   56.6269989014 0.0 
cellBasisVector3     0.0    0.0   77.7019996643 
cellOrigin         -45.022178649902344 10.466216087341309 24.586162567138672 
wrapAll             on 
 
 
#####################EQUILIBRATION NPT#################### 
 
############################################################# 
## ADJUSTABLE PARAMETERS                                   
############################################################# 
structure          ../PROTEIN.psf 
coordinates        ../output/4_PROTEIN_heat2.coor 
 
############################################################# 
## FORCE FIELD BLOCK                                     
############################################################# 
ParaTypeCharmm      on 
parameters           ../par_all27_prot_lipid.inp 
exclude   scaled1-4 
1-4scaling  1.0 
dielectric  1.0 
 
 
############################################################# 
## LONG-RANGE INTERACTIONS                                  
############################################################# 
switching  on 
switchdist  8.0 
cutoff   12.0 
pairlistdist  13.5 
stepspercycle  20 
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rigidBonds  all 
 
############################################################# 
## EDWALD ELECTROSTATICS                                   
############################################################# 
# PME (for full-system periodic electrostatics) 
PME                  yes 
PMEGridSpacing       1.0 
 
############################################################# 
## Force Patch Grid To Improve Performance Of Small Systems  
############################################################# 
TwoAwayX   no 
TwoAwayY  no 
TwoAwayZ  no 
 
############################################################# 
## PARAMETERS FOR INTEGRATOR AND MTS                    
############################################################# 
timestep  1.0 
fullElectFrequency 4 
 
############################################################# 
## OUTPUT SPECIFICATIONS                                  
############################################################# 
outputenergies  1000 
outputtiming  1000 
binaryoutput  no 
outputname  ../output/5_PROTEIN_npt_equil2 
restartname  ../output/5_PROTEIN_npt_equil2 
restartfreq  10000 
binaryrestart  yes 
DCDfile  ../output/5_PROTEIN_npt_equil2.dcd 
dcdfreq  1000 
 
############################################################# 
## CONSTANT TEMPERATURE CONTROL                            
############################################################# 
langevin            on         
langevinDamping     1         
langevinTemp        310 
langevinHydrogen    off         
 
############################################################# 
## CONSTANT PRESSURE CONTROL   
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############################################################# 
useGroupPressure      yes     ;# needed for rigidBonds 
useFlexibleCell       no 
useConstantArea       no 
langevinPiston        on 
langevinPistonTarget  1.01325     ;#  in bar -> 1 atm 
langevinPistonPeriod  100.0 
langevinPistonDecay   50.0 
langevinPistonTemp    310 
 
############################################################# 
## MD PROTOCOL BLOCK                                       
############################################################# 
seed    3010 
numsteps  100000 
temperature  310 
rescaleFreq  1 
rescaleTemp  310 
 
############################################################# 
## PERIODIC BOUNDARY SPECIFICATIONS                        
############################################################# 
# Periodic Boundary Conditions 
cellBasisVector1    60.4179992676 0.0   0.0 
cellBasisVector2     0.0   56.6269989014 0.0 
cellBasisVector3     0.0    0.0   77.7019996643 
cellOrigin         -45.022178649902344 10.466216087341309 24.586162567138672 
wrapAll             on 
 
 
 
#######################EQUILIBRATION NVT####################### 
 
############################################################# 
## ADJUSTABLE PARAMETERS                                    
############################################################# 
structure          ../PROTEIN.psf 
coordinates        ../output/5_PROTEIN_npt_equil2.coor 
 
############################################################# 
## FORCE FIELD BLOCK                                    
############################################################# 
ParaTypeCharmm      on 
parameters           ../par_all27_prot_lipid.inp 
exclude   scaled1-4 
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1-4scaling  1.0 
dielectric  1.0 
 
############################################################# 
## LONG-RANGE INTERACTIONS                                 
############################################################# 
switching  on 
switchdist  8.0 
cutoff   12.0 
pairlistdist  13.5 
stepspercycle  20 
rigidBonds  all 
 
############################################################# 
## EDWALD ELECTROSTATICS                                   
############################################################# 
# PME (for full-system periodic electrostatics) 
PME                  yes 
PMEGridSpacing       1.0 
 
############################################################# 
## Force Patch Grid To Improve Performance Of Small Systems 
############################################################# 
TwoAwayX   no 
TwoAwayY  no 
TwoAwayZ  no 
 
############################################################# 
## PARAMETERS FOR INTEGRATORR AND MTS                     
############################################################# 
timestep  1.0 
fullElectFrequency 4 
 
############################################################# 
## OUTPUT SPECIFICATIONS                                
############################################################# 
outputenergies  1000 
outputtiming  1000 
binaryoutput  no 
outputname  ../output/6_PROTEIN_nvt_equil 
restartname  ../output/6_PROTEIN_nvt_equil 
restartfreq  10000 
binaryrestart  yes 
DCDfile  ../output/6_PROTEIN_nvt_equil.dcd 
dcdfreq  1000 
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############################################################# 
## CONSTANT TEMPERATURE CONTROL                             
############################################################# 
langevin            on         
langevinDamping     1         
langevinTemp        310 
langevinHydrogen    off         
 
############################################################# 
## MD PROTOCOL BLOCK                                        
############################################################# 
seed    2010 
numsteps  100000 
temperature  310 
rescaleFreq  1 
rescaleTemp  310 
 
############################################################# 
## PERIODIC BOUNDARY SPECIFICATIONS                       
############################################################# 
cellBasisVector1    60.4179992676 0.0   0.0 
cellBasisVector2     0.0   56.6269989014 0.0 
cellBasisVector3     0.0    0.0   77.7019996643 
cellOrigin         -45.022178649902344 10.466216087341309 24.586162567138672 
wrapAll             on 
 
 
 
 
 
#####################PRODUCTION NPT####################### 
 
############################################################# 
## ADJUSTABLE PARAMETERS                                    
############################################################# 
structure          ../PROTEIN.psf 
coordinates        ../output/6_PROTEIN_nvt_equil.coor 
 
############################################################# 
## FORCE FIELD BLOCK 
############################################################# 
ParaTypeCharmm      on 
parameters           ../par_all27_prot_lipid.inp 
exclude   scaled1-4 
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1-4scaling  1.0 
dielectric  1.0 
 
############################################################# 
## LONG-RANGE INTERACTIONS                     
############################################################# 
switching  on 
switchdist  8.0 
cutoff   12.0 
pairlistdist  13.5 
stepspercycle  20 
rigidBonds  all 
 
############################################################# 
## EDWALD ELECTROSTATICS                                    
############################################################# 
# PME (for full-system periodic electrostatics) 
PME                  yes 
PMEGridSpacing       1.0 
 
############################################################# 
## Force Patch Grid To Improve Performance Of Small Systems  
############################################################# 
TwoAwayX   no 
TwoAwayY  no 
TwoAwayZ  no 
 
############################################################# 
## PARAMETERS FOR INTEGRATOR AND MTS                      
############################################################# 
timestep  2.0 
fullElectFrequency 4 
 
############################################################# 
## OUTPUT SPECIFICATIONS                                   
############################################################# 
outputenergies  10000 
outputtiming  10000 
binaryoutput  no 
outputname  ../output/7apo65_npt_prodrun 
restartname  ../output/7apo65_npt_prodrun 
restartfreq  100000 
binaryrestart  yes 
DCDfile  ../output/7apo65_npt_prodrun.dcd 
dcdfreq  10000 
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############################################################# 
## Constant Temperature Control                             
############################################################# 
langevin             on         
langevinDamping      1         
langevinTemp         310 
langevinHydrogen     off         
 
############################################################# 
## Constant Pressure Control (variable volume)             
############################################################# 
useGroupPressure       yes      
useFlexibleCell        no 
useConstantArea        no 
langevinPiston         on 
langevinPistonTarget  1.01325      
langevinPistonPeriod  100.0 
langevinPistonDecay   50.0 
langevinPistonTemp    310 
 
############################################################# 
## PARAMETERS FOR AMD SIMULATIONS                    
############################################################# 
#accelMD   on 
#accelMDdihe  on 
#accelMDE   1193 
#accelMDalpha  118 
#accelMDOutFreq  10000 
 
############################################################# 
## MD protocol block                                        
############################################################# 
seed    3010 
numsteps  50000000 
temperature  310 
rescaleFreq  1000 
rescaleTemp  310 
 
############################################################# 
## Periodic boundary specifications                         
############################################################# 
# Periodic Boundary Conditions 
cellBasisVector1    60.4179992676 0.0   0.0 
cellBasisVector2     0.0   56.6269989014 0.0 
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cellBasisVector3     0.0    0.0   77.7019996643 
cellOrigin         -45.022178649902344 10.466216087341309 24.586162567138672 
wrapAll             on 
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